INSERT INTO `micro_posts` VALUES (4253,2,'2020-02-03 05:48:55','2020-02-03 05:48:55','Preparation of microbial suspensions is usually one of the simple, routine and repetitive tasks generally performed in a microbiological laboratory. Commonly used bacterial suspension fluids include bacteriological saline, phosphate buffered saline (PBS) and Ringer’s solution. An ideal suspension fluid should ensure preservation of health of bacterial cells without allowing them to multiply further. However, saline, PBS and Ringer’s solution do not support bacterial viability beyond 6 hours of suspension. Aquino Rehydrol<sup>TM</sup> Rehydration fluid for GPT (Growth Promotion Testing), an isotonic solution helps to resolve the issues faced with these common bacterial suspension fluids.\r\n\r\n<strong>Underlying Concept:</strong>\r\n\r\nDesigning a successful suspension fluid necessitates understanding the complex science underlying these simple formulations. Bacterial cells are surrounded by a highly sensitive, semi-permeable membrane which maintains a continuous dialogue with external environment. This dialogue is facilitated <em>via</em> various facets of cellular machinery.\r\n\r\nPorins /aqua-porins located in the cell membrane are amongst the first to respond to changes in the osmotic pressure.  Accumulation of ‘Osmolytes’ (inorganic ions, commonly K<sup>+</sup> and organic molecules like Trehalose, Glutamate, Glycine-Betaine) is another significant response to the osmotic changes in the environment. Co-ordinated control of accumulation and release of these solutes is mediated through various enzymes, transporters and channels. Studies have shown direct correlation of solute concentrations within the cells with the growth rate of the bacterial cells. Growth is found to be directly proportional to cytoplasmic hydration which in turn is governed through solute concentration within the cells. Organic osmolytes are known to rehydrate cytoplasmic environment stimulating the growth of cells. Careful formulation of suspension fluid in coherence to cellular dynamics can impart stability to suspended cells thereby effectively serving the purpose of the formulation.\r\n\r\n<strong>HiMedia Innovations: Aquino Rehydrol</strong><sup>TM</sup>\r\n\r\nAquino Rehydrol keeps bacterial cells healthy, viable and stable (without multiplication) in suspension for up to 20 days at -20 ⁰C. This cost - effective solution ensures hassle free growth promotion testing by reducing tedious and time consuming dilution preparations. Clinicians and microbiologists can maintain and study their isolates from any samples/specimens using this multipurpose suspension solution. The convenience of Aquino Rehydrol additionally makes detailed antibiotic sensitivity studies and identification stress-free.\r\n\r\n<strong>For more information:</strong>\r\n\r\n<em>Dr. Rahul Warke, Ph.D\r\nDirector Research and Development (Microbiology),</em>\r\n\r\n<em>HiMedia Laboratories Pvt. Ltd.</em>','Isotonic Solutions: Secret of Bacterial Viability in Suspensions','','publish','open','open','','isotonic-solutions-secret-of-bacterial-viability-in-suspensions','','','2020-02-03 05:48:55','2020-02-03 05:48:55','',0,'https://microbiozindia.com/?p=4253',0,'post','',0),(4254,2,'2020-02-03 05:48:45','2020-02-03 05:48:45','','HIMEDIA','','inherit','open','closed','','himedia-2','','','2020-02-03 05:48:45','2020-02-03 05:48:45','',4253,'https://microbiozindia.com/wp-content/uploads/2020/02/HIMEDIA.png',0,'attachment','image/png',0),(4255,2,'2020-02-03 05:48:55','2020-02-03 05:48:55','Preparation of microbial suspensions is usually one of the simple, routine and repetitive tasks generally performed in a microbiological laboratory. Commonly used bacterial suspension fluids include bacteriological saline, phosphate buffered saline (PBS) and Ringer’s solution. An ideal suspension fluid should ensure preservation of health of bacterial cells without allowing them to multiply further. However, saline, PBS and Ringer’s solution do not support bacterial viability beyond 6 hours of suspension. Aquino Rehydrol<sup>TM</sup> Rehydration fluid for GPT (Growth Promotion Testing), an isotonic solution helps to resolve the issues faced with these common bacterial suspension fluids.\r\n\r\n<strong>Underlying Concept:</strong>\r\n\r\nDesigning a successful suspension fluid necessitates understanding the complex science underlying these simple formulations. Bacterial cells are surrounded by a highly sensitive, semi-permeable membrane which maintains a continuous dialogue with external environment. This dialogue is facilitated <em>via</em> various facets of cellular machinery.\r\n\r\nPorins /aqua-porins located in the cell membrane are amongst the first to respond to changes in the osmotic pressure.  Accumulation of ‘Osmolytes’ (inorganic ions, commonly K<sup>+</sup> and organic molecules like Trehalose, Glutamate, Glycine-Betaine) is another significant response to the osmotic changes in the environment. Co-ordinated control of accumulation and release of these solutes is mediated through various enzymes, transporters and channels. Studies have shown direct correlation of solute concentrations within the cells with the growth rate of the bacterial cells. Growth is found to be directly proportional to cytoplasmic hydration which in turn is governed through solute concentration within the cells. Organic osmolytes are known to rehydrate cytoplasmic environment stimulating the growth of cells. Careful formulation of suspension fluid in coherence to cellular dynamics can impart stability to suspended cells thereby effectively serving the purpose of the formulation.\r\n\r\n<strong>HiMedia Innovations: Aquino Rehydrol</strong><sup>TM</sup>\r\n\r\nAquino Rehydrol keeps bacterial cells healthy, viable and stable (without multiplication) in suspension for up to 20 days at -20 ⁰C. This cost - effective solution ensures hassle free growth promotion testing by reducing tedious and time consuming dilution preparations. Clinicians and microbiologists can maintain and study their isolates from any samples/specimens using this multipurpose suspension solution. The convenience of Aquino Rehydrol additionally makes detailed antibiotic sensitivity studies and identification stress-free.\r\n\r\n<strong>For more information:</strong>\r\n\r\n<em>Dr. Rahul Warke, Ph.D\r\nDirector Research and Development (Microbiology),</em>\r\n\r\n<em>HiMedia Laboratories Pvt. Ltd.</em>','Isotonic Solutions: Secret of Bacterial Viability in Suspensions','','inherit','closed','closed','','4253-revision-v1','','','2020-02-03 05:48:55','2020-02-03 05:48:55','',4253,'https://microbiozindia.com/uncategorized/4253-revision-v1/',0,'revision','',0),(4256,2,'2020-02-05 10:51:52','2020-02-05 10:51:52','When we get what we have been dreaming and working for! we are successful.\r\n\r\nMicrobioz India, performed an interview with Sivaprasad Patnam, CEO, Analytical Technologies Limited, a leading manufacturer, supplier and exporter of Analytical, Chromatography, Spectroscopy, Biotechnology, Biomedical, Clinical Diagnostics and Material Science &amp; General Laboratory Instrumentation, here I am sharing you a few lines of interview with him.\r\n\r\n<strong>Question:</strong> How would you define “success” for someone in your chosen career?\r\n\r\nSivaprasad Patnam, CEO, Analytical Technologies Limited\r\n\r\n<strong>Answer:</strong> When we get what we have been dreaming and working for ! we are successful. Like we had been dreaming to establish our Indian brand against the foreign multinationals like waters, shimadzu and Agilent, we are happy to share we are successful after decades of struggle, now many customers in India are accepting our products rejecting others.\r\n\r\n<strong>Question:</strong> Sir, what do you consider the most important contribution of your academic experiences have made to Analytical Technologies Limited?  What was your role?\r\n\r\nAnswer:Academic qualifications help you achieve your goals much easily compared to the one who’s not qualified , but what’s important is the passion , dedication , commitment more than the qualifications and certificates. As fas as our company ATL is concerned all the requisites like academic and passion, dedication, commitment helped. My personal role was to find solutions to make India self-sufficient and to provide import substitutes in highly innovative Analytical and scientific technologies space through our companies and brands like ATL and Multiple Labs.\r\n\r\n<strong>Question:</strong> Sir sometimes it’s just not possible to get everything on your to-do list done. Tell me about a time your responsibilities got a little overwhelming. What did you do?\r\n\r\n<strong>Answer:</strong> To get the things done , what we need is the leadership and bring the momentum in the team to achieve the common goals set by the company.\r\n\r\n<strong>Question:</strong> Please tell me about a project that forced you to be innovative and creative.\r\n\r\n<strong>Answer:</strong> The most challenging project was the Lab setup project we did for BSTI ( Bangladesh Standards Testing Lab), owned by the Bangladesh government  where we set up standards testing labs for Food Safety, Water Testing, Chemicals Testing, Cement and bricks testing , and precision metals testing. This project made our teams more robust and forced to find solutions through innovation.\r\n\r\n[caption id=\"attachment_4257\" align=\"alignright\" width=\"243\"]<img class=\"wp-image-4257\" src=\"https://microbiozindia.com/wp-content/uploads/2020/02/SIVAPRASADg-226x300.png\" alt=\"\" width=\"243\" height=\"321\" /> Sivaprasad Patnam, CEO, Analytical Technologies Limited[/caption]\r\n\r\n<strong>Question:</strong> Can you please let us know 3 things you like and 3 things you dislike about your current position.\r\n\r\n<strong>Answer:</strong> I like our products, brands and team members.\r\n\r\nI dislike\r\n\r\ngovernment not taking initiatives to boost our analytical and medical technologies space, though we made series of representations through our IAMIMA (Indian Analytical and Medical Instruments Manufacturers Association), where am heading.\r\n\r\nForeign manufacturers dumping the rejected and used systems too Indian market as they get 100% advance through L/Cs.\r\n\r\nCustomers still thinking only foreign brands can work\r\n\r\n<strong>Question:</strong> Sir, what are Your 3 Biggest Accomplishments in your career.?\r\n\r\n<strong>Answer:</strong> 1. Successfully establish our Analytical brand globally in the Chromatography space where HPLC, GC, IC, GPC against the big boys WATERS, AGILENT AND SHIMDAZU.\r\n\r\nHappy to be founder of MULTIPLELABS, a lab setup/ Turnkeys solutions brand across the globe and successfully completed projects for industries life science, healthcare, railways, mining, forensic science food safety worth several million USD.\r\nHappy to be founder of ANALYTICAL FOUNDATION, and the president of IAMIMA (Indian Analytical and Medical Instruments\r\n\r\nManufacturers Association), a trust as a part of CSR activities.\r\n\r\n<strong>Question:</strong> How would you like to define role of Analytical Technologies product and services for better quality control and production in Bio-Pharmaceutical and Analytical Industry.\r\n\r\n<strong>Answer:</strong> Innovation is possible only by research in lab and scaling to pilot and production of the natural extractions, synthesized products and\r\n\r\nAPI’s. We provide Preparative Chromatography Purification Systems for lab, pilot and production scale for BioPharma.\r\n\r\nFor analytical industry we have been striving to be synonymous for our name Analytical Technologies, offering all kinds of technologies for analysis and research focussed into various groups Chromatography, Spectroscopy, Biotechnology Clinical Diagnostics, Material SCIENCES AND General Lab equipments','Sivaprasad Patnam explored new opportunity in the field of Analytical technologies','','publish','open','open','','sivaprasad-patnam-explored-new-opportunity-in-the-field-of-analytical-technologies','','','2020-02-05 11:04:26','2020-02-05 11:04:26','',0,'https://microbiozindia.com/?p=4256',0,'post','',0),(4257,2,'2020-02-05 10:13:30','2020-02-05 10:13:30','','SIVAPRASADg','','inherit','open','closed','','sivaprasadg','','','2020-02-05 10:13:30','2020-02-05 10:13:30','',4256,'https://microbiozindia.com/wp-content/uploads/2020/02/SIVAPRASADg.png',0,'attachment','image/png',0),(4258,2,'2020-02-05 10:49:56','2020-02-05 10:49:56','','AAG','','inherit','open','closed','','aag','','','2020-02-05 10:49:56','2020-02-05 10:49:56','',4256,'https://microbiozindia.com/wp-content/uploads/2020/02/AAG.png',0,'attachment','image/png',0),(4259,2,'2020-02-05 10:51:52','2020-02-05 10:51:52','When we get what we have been dreaming and working for! we are successful\r\n\r\n<em>Microbioz India, performed an interview with <strong>Sivaprasad Patnam, CEO, Analytical Technologies Limited,</strong> a leading manufacturer, supplier and exporter of Analytical, Chromatography, Spectroscopy, Biotechnology, Biomedical, Clinical Diagnostics and Material Science &amp; General Laboratory Instrumentation, here I am sharing you a few lines of interview with him.</em>\r\n\r\n<strong>Question: How would you define “success” for someone in your chosen career?</strong>\r\n\r\n<strong>Answer:</strong> When we get what we have been dreaming and working for ! we are successful. Like we had been dreaming to establish our Indian brand against the foreign multinationals like waters, shimadzu and Agilent, we are happy to share we are successful after decades of struggle, now many customers in India are accepting our products rejecting others.\r\n\r\n<strong>Question: Sir, what do you consider the most important contribution of your academic experiences have made to Analytical Technologies Limited?  What was your role?</strong>\r\n\r\n<strong>Answer:</strong>Academic qualifications help you achieve your goals much easily compared to the one who’s not qualified , but what’s important is the passion , dedication , commitment more than the qualifications and certificates. As fas as our company ATL is concerned all the requisites like academic and passion, dedication, commitment helped. My personal role was to find solutions to make India self-sufficient and to provide import substitutes in highly innovative Analytical and scientific technologies space through our companies and brands like ATL and Multiple Labs.\r\n\r\nQuestion: Sir sometimes it’s just not possible to get everything on your to-do list done. Tell me about a time your responsibilities got a little overwhelming. What did you do?\r\n\r\n<strong>Answer:</strong> To get the things done , what we need is the leadership and bring the momentum in the team to achieve the common goals set by the company.\r\n\r\n<strong>Question: Please tell me about a project that forced you to be innovative and creative.</strong>\r\n\r\n<strong>Answer:</strong> The most challenging project was the Lab setup project we did for BSTI ( Bangladesh Standards Testing Lab), owned by the Bangladesh government  where we set up standards testing labs for Food Safety, Water Testing, Chemicals Testing, Cement and bricks testing , and precision metals testing. This project made our teams more robust and forced to find solutions through innovation.\r\n\r\n[caption id=\"attachment_4257\" align=\"alignright\" width=\"283\"]<img class=\"wp-image-4257\" src=\"https://microbiozindia.com/wp-content/uploads/2020/02/SIVAPRASADg-226x300.png\" alt=\"\" width=\"283\" height=\"376\" /> <em>Sivaprasad Patnam,CEO Analytical Technologies, discussing with International Csutomer</em>[/caption]\r\n\r\n<strong>Question: Can you please let us know 3 things you like and 3 things you dislike about your current position.</strong>\r\n\r\n<strong>Answer:</strong> I like our products, brands and team members.\r\n\r\nI dislike\r\n\r\ngovernment not taking initiatives to boost our analytical and medical technologies space, though we made series of representations through our IAMIMA (Indian Analytical and Medical Instruments Manufacturers Association), where am heading.\r\n\r\nForeign manufacturers dumping the rejected and used systems too Indian market as they get 100% advance through L/Cs.\r\n\r\nCustomers still thinking only foreign brands can work\r\n\r\n<strong>Question: Sir, what are Your 3 Biggest Accomplishments in your career.?</strong>\r\n\r\n<strong>Answer:</strong> 1. Successfully establish our Analytical brand globally in the Chromatography space where HPLC, GC, IC, GPC against the big boys WATERS, AGILENT AND SHIMDAZU.\r\n<ol start=\"2\">\r\n 	<li>Happy to be founder of MULTIPLELABS, a lab setup/ Turnkeys solutions brand across the globe and successfully completed projects for industries life science, healthcare, railways, mining, forensic science food safety worth several million USD.</li>\r\n 	<li>Happy to be founder of ANALYTICAL FOUNDATION, and the president of IAMIMA (Indian Analytical and Medical Instruments</li>\r\n</ol>\r\nManufacturers Association), a trust as a part of CSR activities.\r\n\r\n<strong>Question: How would you like to define role of Analytical Technologies product and services for better quality control and production in Bio-Pharmaceutical and Analytical Industry.</strong>\r\n\r\n<strong>Answer:</strong> Innovation is possible only by research in lab and scaling to pilot and production of the natural extractions, synthesized products and\r\n\r\nAPI’s. We provide Preparative Chromatography Purification Systems for lab, pilot and production scale for BioPharma.\r\n\r\nFor analytical industry we have been striving to be synonymous for our name Analytical Technologies, offering all kinds of technologies for analysis and research focussed into various groups Chromatography, Spectroscopy, Biotechnology Clinical Diagnostics, Material SCIENCES AND General Lab equipments','Sivaprasad Patnam explored new opportunity in the field of Analytical technologies','','inherit','closed','closed','','4256-revision-v1','','','2020-02-05 10:51:52','2020-02-05 10:51:52','',4256,'https://microbiozindia.com/uncategorized/4256-revision-v1/',0,'revision','',0),(4260,2,'2020-02-05 11:04:03','2020-02-05 11:04:03','When we get what we have been dreaming and working for! we are successful.\n\nMicrobioz India, performed an interview with Sivaprasad Patnam, CEO, Analytical Technologies Limited, a leading manufacturer, supplier and exporter of Analytical, Chromatography, Spectroscopy, Biotechnology, Biomedical, Clinical Diagnostics and Material Science &amp; General Laboratory Instrumentation, here I am sharing you a few lines of interview with him.\n\n<strong>Question:</strong> How would you define “success” for someone in your chosen career?\n\nSivaprasad Patnam, CEO, Analytical Technologies Limited\n\n<strong>Answer:</strong> When we get what we have been dreaming and working for ! we are successful. Like we had been dreaming to establish our Indian brand against the foreign multinationals like waters, shimadzu and Agilent, we are happy to share we are successful after decades of struggle, now many customers in India are accepting our products rejecting others.\n\n<strong>Question:</strong> Sir, what do you consider the most important contribution of your academic experiences have made to Analytical Technologies Limited?  What was your role?\n\nAnswer:Academic qualifications help you achieve your goals much easily compared to the one who’s not qualified , but what’s important is the passion , dedication , commitment more than the qualifications and certificates. As fas as our company ATL is concerned all the requisites like academic and passion, dedication, commitment helped. My personal role was to find solutions to make India self-sufficient and to provide import substitutes in highly innovative Analytical and scientific technologies space through our companies and brands like ATL and Multiple Labs.\n\n<strong>Question:</strong> Sir sometimes it’s just not possible to get everything on your to-do list done. Tell me about a time your responsibilities got a little overwhelming. What did you do?\n\n<strong>Answer:</strong> To get the things done , what we need is the leadership and bring the momentum in the team to achieve the common goals set by the company.\n\n<strong>Question:</strong> Please tell me about a project that forced you to be innovative and creative.\n\n<strong>Answer:</strong> The most challenging project was the Lab setup project we did for BSTI ( Bangladesh Standards Testing Lab), owned by the Bangladesh government  where we set up standards testing labs for Food Safety, Water Testing, Chemicals Testing, Cement and bricks testing , and precision metals testing. This project made our teams more robust and forced to find solutions through innovation.\n\n<img class=\"wp-image-4257 alignright\" src=\"https://microbiozindia.com/wp-content/uploads/2020/02/SIVAPRASADg-226x300.png\" alt=\"\" width=\"243\" height=\"321\" data-wp-editing=\"1\" />\n\n<strong>Question:</strong> Can you please let us know 3 things you like and 3 things you dislike about your current position.\n\n<strong>Answer:</strong> I like our products, brands and team members.\n\nI dislike\n\ngovernment not taking initiatives to boost our analytical and medical technologies space, though we made series of representations through our IAMIMA (Indian Analytical and Medical Instruments Manufacturers Association), where am heading.\n\nForeign manufacturers dumping the rejected and used systems too Indian market as they get 100% advance through L/Cs.\n\nCustomers still thinking only foreign brands can work\n\n<strong>Question:</strong> Sir, what are Your 3 Biggest Accomplishments in your career.?\n\n<strong>Answer:</strong> 1. Successfully establish our Analytical brand globally in the Chromatography space where HPLC, GC, IC, GPC against the big boys WATERS, AGILENT AND SHIMDAZU.\n\nHappy to be founder of MULTIPLELABS, a lab setup/ Turnkeys solutions brand across the globe and successfully completed projects for industries life science, healthcare, railways, mining, forensic science food safety worth several million USD.\nHappy to be founder of ANALYTICAL FOUNDATION, and the president of IAMIMA (Indian Analytical and Medical Instruments\n\nManufacturers Association), a trust as a part of CSR activities.\n\n<strong>Question:</strong> How would you like to define role of Analytical Technologies product and services for better quality control and production in Bio-Pharmaceutical and Analytical Industry.\n\n<strong>Answer:</strong> Innovation is possible only by research in lab and scaling to pilot and production of the natural extractions, synthesized products and\n\nAPI’s. We provide Preparative Chromatography Purification Systems for lab, pilot and production scale for BioPharma.\n\nFor analytical industry we have been striving to be synonymous for our name Analytical Technologies, offering all kinds of technologies for analysis and research focussed into various groups Chromatography, Spectroscopy, Biotechnology Clinical Diagnostics, Material SCIENCES AND General Lab equipments','Sivaprasad Patnam explored new opportunity in the field of Analytical technologies','','inherit','closed','closed','','4256-autosave-v1','','','2020-02-05 11:04:03','2020-02-05 11:04:03','',4256,'https://microbiozindia.com/uncategorized/4256-autosave-v1/',0,'revision','',0),(4261,2,'2020-02-05 10:56:53','2020-02-05 10:56:53','When we get what we have been dreaming and working for! we are successful.\r\n\r\n<em>Microbioz India, performed an interview with Sivaprasad Patnam, CEO, Analytical Technologies Limited, a leading manufacturer, supplier and exporter of Analytical, Chromatography, Spectroscopy, Biotechnology, Biomedical, Clinical Diagnostics and Material Science &amp; General Laboratory Instrumentation, here I am sharing you a few lines of interview with him.</em>\r\n\r\n<strong>Question: How would you define “success” for someone in your chosen career?</strong>\r\n\r\n[caption id=\"attachment_4257\" align=\"alignright\" width=\"226\"]<img class=\"wp-image-4257 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/02/SIVAPRASADg-226x300.png\" alt=\"\" width=\"226\" height=\"300\" /> <em>Sivaprasad Patnam, CEO, Analytical Technologies Limited</em>[/caption]\r\n\r\n<strong>Answer:</strong> When we get what we have been dreaming and working for ! we are successful. Like we had been dreaming to establish our Indian brand against the foreign multinationals like waters, shimadzu and Agilent, we are happy to share we are successful after decades of struggle, now many customers in India are accepting our products rejecting others.\r\n\r\n<strong>Question: Sir, what do you consider the most important contribution of your academic experiences have made to Analytical Technologies Limited?  What was your role?</strong>\r\n\r\n<strong>Answer</strong>:Academic qualifications help you achieve your goals much easily compared to the one who’s not qualified , but what’s important is the passion , dedication , commitment more than the qualifications and certificates. As fas as our company ATL is concerned all the requisites like academic and passion, dedication, commitment helped. My personal role was to find solutions to make India self-sufficient and to provide import substitutes in highly innovative Analytical and scientific technologies space through our companies and brands like ATL and Multiple Labs.\r\n\r\n<strong>Question: Sir sometimes it’s just not possible to get everything on your to-do list done. Tell me about a time your responsibilities got a little overwhelming. What did you do?</strong>\r\n\r\n<strong>Answer:</strong> To get the things done , what we need is the leadership and bring the momentum in the team to achieve the common goals set by the company.\r\n\r\n<strong>Question: Please tell me about a project that forced you to be innovative and creative.</strong>\r\n\r\n<strong>Answer:</strong> The most challenging project was the Lab setup project we did for BSTI ( Bangladesh Standards Testing Lab), owned by the Bangladesh government  where we set up standards testing labs for Food Safety, Water Testing, Chemicals Testing, Cement and bricks testing , and precision metals testing. This project made our teams more robust and forced to find solutions through innovation.\r\n\r\nSivaprasad Patnam,CEO Analytical Technologies, discussing with International Csutomer\r\n\r\n<strong>Question: Can you please let us know 3 things you like and 3 things you dislike about your current position.</strong>\r\n\r\n<strong>Answer:</strong> I like our products, brands and team members.\r\n\r\nI dislike\r\n\r\ngovernment not taking initiatives to boost our analytical and medical technologies space, though we made series of representations through our IAMIMA (Indian Analytical and Medical Instruments Manufacturers Association), where am heading.\r\n\r\nForeign manufacturers dumping the rejected and used systems too Indian market as they get 100% advance through L/Cs.\r\n\r\nCustomers still thinking only foreign brands can work\r\n\r\n<strong>Question: Sir, what are Your 3 Biggest Accomplishments in your career.?</strong>\r\n\r\n<strong>Answer:</strong> 1. Successfully establish our Analytical brand globally in the Chromatography space where HPLC, GC, IC, GPC against the big boys WATERS, AGILENT AND SHIMDAZU.\r\n\r\nHappy to be founder of MULTIPLELABS, a lab setup/ Turnkeys solutions brand across the globe and successfully completed projects for industries life science, healthcare, railways, mining, forensic science food safety worth several million USD.\r\nHappy to be founder of ANALYTICAL FOUNDATION, and the president of IAMIMA (Indian Analytical and Medical Instruments\r\n\r\nManufacturers Association), a trust as a part of CSR activities.\r\n\r\n<strong>Question: How would you like to define role of Analytical Technologies product and services for better quality control and production in Bio-Pharmaceutical and Analytical Industry.</strong>\r\n\r\n<strong>Answer:</strong> Innovation is possible only by research in lab and scaling to pilot and production of the natural extractions, synthesized products and\r\n\r\nAPI’s. We provide Preparative Chromatography Purification Systems for lab, pilot and production scale for BioPharma.\r\n\r\nFor analytical industry we have been striving to be synonymous for our name Analytical Technologies, offering all kinds of technologies for analysis and research focussed into various groups Chromatography, Spectroscopy, Biotechnology Clinical Diagnostics, Material SCIENCES AND General Lab equipments','Sivaprasad Patnam explored new opportunity in the field of Analytical technologies','','inherit','closed','closed','','4256-revision-v1','','','2020-02-05 10:56:53','2020-02-05 10:56:53','',4256,'https://microbiozindia.com/uncategorized/4256-revision-v1/',0,'revision','',0),(4262,2,'2020-02-05 10:58:24','2020-02-05 10:58:24','When we get what we have been dreaming and working for! we are successful.\r\n\r\n<em>Microbioz India, performed an interview with Sivaprasad Patnam, CEO, Analytical Technologies Limited, a leading manufacturer, supplier and exporter of Analytical, Chromatography, Spectroscopy, Biotechnology, Biomedical, Clinical Diagnostics and Material Science &amp; General Laboratory Instrumentation, here I am sharing you a few lines of interview with him.</em>\r\n\r\n<strong>Question: How would you define “success” for someone in your chosen career?</strong>\r\n\r\n[caption id=\"attachment_4257\" align=\"alignnone\" width=\"226\"]<img class=\"wp-image-4257 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/02/SIVAPRASADg-226x300.png\" alt=\"\" width=\"226\" height=\"300\" /> <em>Sivaprasad Patnam, CEO, Analytical Technologies Limited</em>[/caption]\r\n\r\n<strong>Answer:</strong> When we get what we have been dreaming and working for ! we are successful. Like we had been dreaming to establish our Indian brand against the foreign multinationals like waters, shimadzu and Agilent, we are happy to share we are successful after decades of struggle, now many customers in India are accepting our products rejecting others.\r\n\r\n<strong>Question: Sir, what do you consider the most important contribution of your academic experiences have made to Analytical Technologies Limited?  What was your role?</strong>\r\n\r\n<strong>Answer</strong>:Academic qualifications help you achieve your goals much easily compared to the one who’s not qualified , but what’s important is the passion , dedication , commitment more than the qualifications and certificates. As fas as our company ATL is concerned all the requisites like academic and passion, dedication, commitment helped. My personal role was to find solutions to make India self-sufficient and to provide import substitutes in highly innovative Analytical and scientific technologies space through our companies and brands like ATL and Multiple Labs.\r\n\r\n<strong>Question: Sir sometimes it’s just not possible to get everything on your to-do list done. Tell me about a time your responsibilities got a little overwhelming. What did you do?</strong>\r\n\r\n<strong>Answer:</strong> To get the things done , what we need is the leadership and bring the momentum in the team to achieve the common goals set by the company.\r\n\r\n<strong>Question: Please tell me about a project that forced you to be innovative and creative.</strong>\r\n\r\n<strong>Answer:</strong> The most challenging project was the Lab setup project we did for BSTI ( Bangladesh Standards Testing Lab), owned by the Bangladesh government  where we set up standards testing labs for Food Safety, Water Testing, Chemicals Testing, Cement and bricks testing , and precision metals testing. This project made our teams more robust and forced to find solutions through innovation.\r\n\r\nSivaprasad Patnam,CEO Analytical Technologies, discussing with International Csutomer\r\n\r\n<strong>Question: Can you please let us know 3 things you like and 3 things you dislike about your current position.</strong>\r\n\r\n<strong>Answer:</strong> I like our products, brands and team members.\r\n\r\nI dislike\r\n\r\ngovernment not taking initiatives to boost our analytical and medical technologies space, though we made series of representations through our IAMIMA (Indian Analytical and Medical Instruments Manufacturers Association), where am heading.\r\n\r\nForeign manufacturers dumping the rejected and used systems too Indian market as they get 100% advance through L/Cs.\r\n\r\nCustomers still thinking only foreign brands can work\r\n\r\n<strong>Question: Sir, what are Your 3 Biggest Accomplishments in your career.?</strong>\r\n\r\n<strong>Answer:</strong> 1. Successfully establish our Analytical brand globally in the Chromatography space where HPLC, GC, IC, GPC against the big boys WATERS, AGILENT AND SHIMDAZU.\r\n\r\nHappy to be founder of MULTIPLELABS, a lab setup/ Turnkeys solutions brand across the globe and successfully completed projects for industries life science, healthcare, railways, mining, forensic science food safety worth several million USD.\r\nHappy to be founder of ANALYTICAL FOUNDATION, and the president of IAMIMA (Indian Analytical and Medical Instruments\r\n\r\nManufacturers Association), a trust as a part of CSR activities.\r\n\r\n<strong>Question: How would you like to define role of Analytical Technologies product and services for better quality control and production in Bio-Pharmaceutical and Analytical Industry.</strong>\r\n\r\n<strong>Answer:</strong> Innovation is possible only by research in lab and scaling to pilot and production of the natural extractions, synthesized products and\r\n\r\nAPI’s. We provide Preparative Chromatography Purification Systems for lab, pilot and production scale for BioPharma.\r\n\r\nFor analytical industry we have been striving to be synonymous for our name Analytical Technologies, offering all kinds of technologies for analysis and research focussed into various groups Chromatography, Spectroscopy, Biotechnology Clinical Diagnostics, Material SCIENCES AND General Lab equipments','Sivaprasad Patnam explored new opportunity in the field of Analytical technologies','','inherit','closed','closed','','4256-revision-v1','','','2020-02-05 10:58:24','2020-02-05 10:58:24','',4256,'https://microbiozindia.com/uncategorized/4256-revision-v1/',0,'revision','',0),(4263,2,'2020-02-05 10:59:18','2020-02-05 10:59:18','When we get what we have been dreaming and working for! we are successful.\r\n\r\n<em>Microbioz India, performed an interview with Sivaprasad Patnam, CEO, Analytical Technologies Limited, a leading manufacturer, supplier and exporter of Analytical, Chromatography, Spectroscopy, Biotechnology, Biomedical, Clinical Diagnostics and Material Science &amp; General Laboratory Instrumentation,</em> here<em> I am sharing you a few lines of interview with him.</em>\r\n\r\n<strong>Question: How would you define “success” for someone in your chosen career?</strong>\r\n\r\n[caption id=\"attachment_4257\" align=\"alignnone\" width=\"226\"]<img class=\"wp-image-4257 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/02/SIVAPRASADg-226x300.png\" alt=\"\" width=\"226\" height=\"300\" /> <em>Sivaprasad Patnam, CEO, Analytical Technologies Limited</em>[/caption]\r\n\r\n<strong>Answer:</strong> When we get what we have been dreaming and working for ! we are successful. Like we had been dreaming to establish our Indian brand against the foreign multinationals like waters, shimadzu and Agilent, we are happy to share we are successful after decades of struggle, now many customers in India are accepting our products rejecting others.\r\n\r\n<strong>Question: Sir, what do you consider the most important contribution of your academic experiences have made to Analytical Technologies Limited?  What was your role?</strong>\r\n\r\n<strong>Answer</strong>:Academic qualifications help you achieve your goals much easily compared to the one who’s not qualified , but what’s important is the passion , dedication , commitment more than the qualifications and certificates. As fas as our company ATL is concerned all the requisites like academic and passion, dedication, commitment helped. My personal role was to find solutions to make India self-sufficient and to provide import substitutes in highly innovative Analytical and scientific technologies space through our companies and brands like ATL and Multiple Labs.\r\n\r\n<strong>Question: Sir sometimes it’s just not possible to get everything on your to-do list done. Tell me about a time your responsibilities got a little overwhelming. What did you do?</strong>\r\n\r\n<strong>Answer:</strong> To get the things done , what we need is the leadership and bring the momentum in the team to achieve the common goals set by the company.\r\n\r\n<strong>Question: Please tell me about a project that forced you to be innovative and creative.</strong>\r\n\r\n<strong>Answer:</strong> The most challenging project was the Lab setup project we did for BSTI ( Bangladesh Standards Testing Lab), owned by the Bangladesh government  where we set up standards testing labs for Food Safety, Water Testing, Chemicals Testing, Cement and bricks testing , and precision metals testing. This project made our teams more robust and forced to find solutions through innovation.\r\n\r\nSivaprasad Patnam,CEO Analytical Technologies, discussing with International Csutomer\r\n\r\n<strong>Question: Can you please let us know 3 things you like and 3 things you dislike about your current position.</strong>\r\n\r\n<strong>Answer:</strong> I like our products, brands and team members.\r\n\r\nI dislike\r\n\r\ngovernment not taking initiatives to boost our analytical and medical technologies space, though we made series of representations through our IAMIMA (Indian Analytical and Medical Instruments Manufacturers Association), where am heading.\r\n\r\nForeign manufacturers dumping the rejected and used systems too Indian market as they get 100% advance through L/Cs.\r\n\r\nCustomers still thinking only foreign brands can work\r\n\r\n<strong>Question: Sir, what are Your 3 Biggest Accomplishments in your career.?</strong>\r\n\r\n<strong>Answer:</strong> 1. Successfully establish our Analytical brand globally in the Chromatography space where HPLC, GC, IC, GPC against the big boys WATERS, AGILENT AND SHIMDAZU.\r\n\r\nHappy to be founder of MULTIPLELABS, a lab setup/ Turnkeys solutions brand across the globe and successfully completed projects for industries life science, healthcare, railways, mining, forensic science food safety worth several million USD.\r\nHappy to be founder of ANALYTICAL FOUNDATION, and the president of IAMIMA (Indian Analytical and Medical Instruments\r\n\r\nManufacturers Association), a trust as a part of CSR activities.\r\n\r\n<strong>Question: How would you like to define role of Analytical Technologies product and services for better quality control and production in Bio-Pharmaceutical and Analytical Industry.</strong>\r\n\r\n<strong>Answer:</strong> Innovation is possible only by research in lab and scaling to pilot and production of the natural extractions, synthesized products and\r\n\r\nAPI’s. We provide Preparative Chromatography Purification Systems for lab, pilot and production scale for BioPharma.\r\n\r\nFor analytical industry we have been striving to be synonymous for our name Analytical Technologies, offering all kinds of technologies for analysis and research focussed into various groups Chromatography, Spectroscopy, Biotechnology Clinical Diagnostics, Material SCIENCES AND General Lab equipments','Sivaprasad Patnam explored new opportunity in the field of Analytical technologies','','inherit','closed','closed','','4256-revision-v1','','','2020-02-05 10:59:18','2020-02-05 10:59:18','',4256,'https://microbiozindia.com/uncategorized/4256-revision-v1/',0,'revision','',0),(4264,2,'2020-02-05 11:00:04','2020-02-05 11:00:04','When we get what we have been dreaming and working for! we are successful.\r\n\r\nMicrobioz India, performed an interview with Sivaprasad Patnam, CEO, Analytical Technologies Limited, a leading manufacturer, supplier and exporter of Analytical, Chromatography, Spectroscopy, Biotechnology, Biomedical, Clinical Diagnostics and Material Science &amp; General Laboratory Instrumentation, here I am sharing you a few lines of interview with him.\r\n\r\nQuestion: How would you define “success” for someone in your chosen career?\r\n\r\nSivaprasad Patnam, CEO, Analytical Technologies Limited\r\n\r\nAnswer: When we get what we have been dreaming and working for ! we are successful. Like we had been dreaming to establish our Indian brand against the foreign multinationals like waters, shimadzu and Agilent, we are happy to share we are successful after decades of struggle, now many customers in India are accepting our products rejecting others.\r\n\r\nQuestion: Sir, what do you consider the most important contribution of your academic experiences have made to Analytical Technologies Limited?  What was your role?\r\n\r\nAnswer:Academic qualifications help you achieve your goals much easily compared to the one who’s not qualified , but what’s important is the passion , dedication , commitment more than the qualifications and certificates. As fas as our company ATL is concerned all the requisites like academic and passion, dedication, commitment helped. My personal role was to find solutions to make India self-sufficient and to provide import substitutes in highly innovative Analytical and scientific technologies space through our companies and brands like ATL and Multiple Labs.\r\n\r\nQuestion: Sir sometimes it’s just not possible to get everything on your to-do list done. Tell me about a time your responsibilities got a little overwhelming. What did you do?\r\n\r\nAnswer: To get the things done , what we need is the leadership and bring the momentum in the team to achieve the common goals set by the company.\r\n\r\nQuestion: Please tell me about a project that forced you to be innovative and creative.\r\n\r\nAnswer: The most challenging project was the Lab setup project we did for BSTI ( Bangladesh Standards Testing Lab), owned by the Bangladesh government  where we set up standards testing labs for Food Safety, Water Testing, Chemicals Testing, Cement and bricks testing , and precision metals testing. This project made our teams more robust and forced to find solutions through innovation.\r\n\r\nSivaprasad Patnam,CEO Analytical Technologies, discussing with International Csutomer\r\n\r\nQuestion: Can you please let us know 3 things you like and 3 things you dislike about your current position.\r\n\r\nAnswer: I like our products, brands and team members.\r\n\r\nI dislike\r\n\r\ngovernment not taking initiatives to boost our analytical and medical technologies space, though we made series of representations through our IAMIMA (Indian Analytical and Medical Instruments Manufacturers Association), where am heading.\r\n\r\nForeign manufacturers dumping the rejected and used systems too Indian market as they get 100% advance through L/Cs.\r\n\r\nCustomers still thinking only foreign brands can work\r\n\r\nQuestion: Sir, what are Your 3 Biggest Accomplishments in your career.?\r\n\r\nAnswer: 1. Successfully establish our Analytical brand globally in the Chromatography space where HPLC, GC, IC, GPC against the big boys WATERS, AGILENT AND SHIMDAZU.\r\n\r\nHappy to be founder of MULTIPLELABS, a lab setup/ Turnkeys solutions brand across the globe and successfully completed projects for industries life science, healthcare, railways, mining, forensic science food safety worth several million USD.\r\nHappy to be founder of ANALYTICAL FOUNDATION, and the president of IAMIMA (Indian Analytical and Medical Instruments\r\n\r\nManufacturers Association), a trust as a part of CSR activities.\r\n\r\nQuestion: How would you like to define role of Analytical Technologies product and services for better quality control and production in Bio-Pharmaceutical and Analytical Industry.\r\n\r\nAnswer: Innovation is possible only by research in lab and scaling to pilot and production of the natural extractions, synthesized products and\r\n\r\nAPI’s. We provide Preparative Chromatography Purification Systems for lab, pilot and production scale for BioPharma.\r\n\r\nFor analytical industry we have been striving to be synonymous for our name Analytical Technologies, offering all kinds of technologies for analysis and research focussed into various groups Chromatography, Spectroscopy, Biotechnology Clinical Diagnostics, Material SCIENCES AND General Lab equipments','Sivaprasad Patnam explored new opportunity in the field of Analytical technologies','','inherit','closed','closed','','4256-revision-v1','','','2020-02-05 11:00:04','2020-02-05 11:00:04','',4256,'https://microbiozindia.com/uncategorized/4256-revision-v1/',0,'revision','',0),(4265,2,'2020-02-05 11:02:58','2020-02-05 11:02:58','When we get what we have been dreaming and working for! we are successful.\r\n\r\nMicrobioz India, performed an interview with Sivaprasad Patnam, CEO, Analytical Technologies Limited, a leading manufacturer, supplier and exporter of Analytical, Chromatography, Spectroscopy, Biotechnology, Biomedical, Clinical Diagnostics and Material Science &amp; General Laboratory Instrumentation, here I am sharing you a few lines of interview with him.\r\n\r\n<strong>Question:</strong> How would you define “success” for someone in your chosen career?\r\n\r\nSivaprasad Patnam, CEO, Analytical Technologies Limited\r\n\r\n<strong>Answer:</strong> When we get what we have been dreaming and working for ! we are successful. Like we had been dreaming to establish our Indian brand against the foreign multinationals like waters, shimadzu and Agilent, we are happy to share we are successful after decades of struggle, now many customers in India are accepting our products rejecting others.\r\n\r\n<strong>Question:</strong> Sir, what do you consider the most important contribution of your academic experiences have made to Analytical Technologies Limited?  What was your role?\r\n\r\nAnswer:Academic qualifications help you achieve your goals much easily compared to the one who’s not qualified , but what’s important is the passion , dedication , commitment more than the qualifications and certificates. As fas as our company ATL is concerned all the requisites like academic and passion, dedication, commitment helped. My personal role was to find solutions to make India self-sufficient and to provide import substitutes in highly innovative Analytical and scientific technologies space through our companies and brands like ATL and Multiple Labs.\r\n\r\n<strong>Question:</strong> Sir sometimes it’s just not possible to get everything on your to-do list done. Tell me about a time your responsibilities got a little overwhelming. What did you do?\r\n\r\n<strong>Answer:</strong> To get the things done , what we need is the leadership and bring the momentum in the team to achieve the common goals set by the company.\r\n\r\n<strong>Question:</strong> Please tell me about a project that forced you to be innovative and creative.\r\n\r\n<strong>Answer:</strong> The most challenging project was the Lab setup project we did for BSTI ( Bangladesh Standards Testing Lab), owned by the Bangladesh government  where we set up standards testing labs for Food Safety, Water Testing, Chemicals Testing, Cement and bricks testing , and precision metals testing. This project made our teams more robust and forced to find solutions through innovation.\r\n\r\n&nbsp;\r\n\r\n<img class=\"alignnone  wp-image-4257\" src=\"https://microbiozindia.com/wp-content/uploads/2020/02/SIVAPRASADg-226x300.png\" alt=\"\" width=\"243\" height=\"321\" />\r\n\r\n<strong>Question:</strong> Can you please let us know 3 things you like and 3 things you dislike about your current position.\r\n\r\n<strong>Answer:</strong> I like our products, brands and team members.\r\n\r\nI dislike\r\n\r\ngovernment not taking initiatives to boost our analytical and medical technologies space, though we made series of representations through our IAMIMA (Indian Analytical and Medical Instruments Manufacturers Association), where am heading.\r\n\r\nForeign manufacturers dumping the rejected and used systems too Indian market as they get 100% advance through L/Cs.\r\n\r\nCustomers still thinking only foreign brands can work\r\n\r\n<strong>Question:</strong> Sir, what are Your 3 Biggest Accomplishments in your career.?\r\n\r\n<strong>Answer:</strong> 1. Successfully establish our Analytical brand globally in the Chromatography space where HPLC, GC, IC, GPC against the big boys WATERS, AGILENT AND SHIMDAZU.\r\n\r\nHappy to be founder of MULTIPLELABS, a lab setup/ Turnkeys solutions brand across the globe and successfully completed projects for industries life science, healthcare, railways, mining, forensic science food safety worth several million USD.\r\nHappy to be founder of ANALYTICAL FOUNDATION, and the president of IAMIMA (Indian Analytical and Medical Instruments\r\n\r\nManufacturers Association), a trust as a part of CSR activities.\r\n\r\n<strong>Question:</strong> How would you like to define role of Analytical Technologies product and services for better quality control and production in Bio-Pharmaceutical and Analytical Industry.\r\n\r\n<strong>Answer:</strong> Innovation is possible only by research in lab and scaling to pilot and production of the natural extractions, synthesized products and\r\n\r\nAPI’s. We provide Preparative Chromatography Purification Systems for lab, pilot and production scale for BioPharma.\r\n\r\nFor analytical industry we have been striving to be synonymous for our name Analytical Technologies, offering all kinds of technologies for analysis and research focussed into various groups Chromatography, Spectroscopy, Biotechnology Clinical Diagnostics, Material SCIENCES AND General Lab equipments','Sivaprasad Patnam explored new opportunity in the field of Analytical technologies','','inherit','closed','closed','','4256-revision-v1','','','2020-02-05 11:02:58','2020-02-05 11:02:58','',4256,'https://microbiozindia.com/uncategorized/4256-revision-v1/',0,'revision','',0),(4266,2,'2020-02-05 11:04:26','2020-02-05 11:04:26','When we get what we have been dreaming and working for! we are successful.\r\n\r\nMicrobioz India, performed an interview with Sivaprasad Patnam, CEO, Analytical Technologies Limited, a leading manufacturer, supplier and exporter of Analytical, Chromatography, Spectroscopy, Biotechnology, Biomedical, Clinical Diagnostics and Material Science &amp; General Laboratory Instrumentation, here I am sharing you a few lines of interview with him.\r\n\r\n<strong>Question:</strong> How would you define “success” for someone in your chosen career?\r\n\r\nSivaprasad Patnam, CEO, Analytical Technologies Limited\r\n\r\n<strong>Answer:</strong> When we get what we have been dreaming and working for ! we are successful. Like we had been dreaming to establish our Indian brand against the foreign multinationals like waters, shimadzu and Agilent, we are happy to share we are successful after decades of struggle, now many customers in India are accepting our products rejecting others.\r\n\r\n<strong>Question:</strong> Sir, what do you consider the most important contribution of your academic experiences have made to Analytical Technologies Limited?  What was your role?\r\n\r\nAnswer:Academic qualifications help you achieve your goals much easily compared to the one who’s not qualified , but what’s important is the passion , dedication , commitment more than the qualifications and certificates. As fas as our company ATL is concerned all the requisites like academic and passion, dedication, commitment helped. My personal role was to find solutions to make India self-sufficient and to provide import substitutes in highly innovative Analytical and scientific technologies space through our companies and brands like ATL and Multiple Labs.\r\n\r\n<strong>Question:</strong> Sir sometimes it’s just not possible to get everything on your to-do list done. Tell me about a time your responsibilities got a little overwhelming. What did you do?\r\n\r\n<strong>Answer:</strong> To get the things done , what we need is the leadership and bring the momentum in the team to achieve the common goals set by the company.\r\n\r\n<strong>Question:</strong> Please tell me about a project that forced you to be innovative and creative.\r\n\r\n<strong>Answer:</strong> The most challenging project was the Lab setup project we did for BSTI ( Bangladesh Standards Testing Lab), owned by the Bangladesh government  where we set up standards testing labs for Food Safety, Water Testing, Chemicals Testing, Cement and bricks testing , and precision metals testing. This project made our teams more robust and forced to find solutions through innovation.\r\n\r\n[caption id=\"attachment_4257\" align=\"alignright\" width=\"243\"]<img class=\"wp-image-4257\" src=\"https://microbiozindia.com/wp-content/uploads/2020/02/SIVAPRASADg-226x300.png\" alt=\"\" width=\"243\" height=\"321\" /> Sivaprasad Patnam, CEO, Analytical Technologies Limited[/caption]\r\n\r\n<strong>Question:</strong> Can you please let us know 3 things you like and 3 things you dislike about your current position.\r\n\r\n<strong>Answer:</strong> I like our products, brands and team members.\r\n\r\nI dislike\r\n\r\ngovernment not taking initiatives to boost our analytical and medical technologies space, though we made series of representations through our IAMIMA (Indian Analytical and Medical Instruments Manufacturers Association), where am heading.\r\n\r\nForeign manufacturers dumping the rejected and used systems too Indian market as they get 100% advance through L/Cs.\r\n\r\nCustomers still thinking only foreign brands can work\r\n\r\n<strong>Question:</strong> Sir, what are Your 3 Biggest Accomplishments in your career.?\r\n\r\n<strong>Answer:</strong> 1. Successfully establish our Analytical brand globally in the Chromatography space where HPLC, GC, IC, GPC against the big boys WATERS, AGILENT AND SHIMDAZU.\r\n\r\nHappy to be founder of MULTIPLELABS, a lab setup/ Turnkeys solutions brand across the globe and successfully completed projects for industries life science, healthcare, railways, mining, forensic science food safety worth several million USD.\r\nHappy to be founder of ANALYTICAL FOUNDATION, and the president of IAMIMA (Indian Analytical and Medical Instruments\r\n\r\nManufacturers Association), a trust as a part of CSR activities.\r\n\r\n<strong>Question:</strong> How would you like to define role of Analytical Technologies product and services for better quality control and production in Bio-Pharmaceutical and Analytical Industry.\r\n\r\n<strong>Answer:</strong> Innovation is possible only by research in lab and scaling to pilot and production of the natural extractions, synthesized products and\r\n\r\nAPI’s. We provide Preparative Chromatography Purification Systems for lab, pilot and production scale for BioPharma.\r\n\r\nFor analytical industry we have been striving to be synonymous for our name Analytical Technologies, offering all kinds of technologies for analysis and research focussed into various groups Chromatography, Spectroscopy, Biotechnology Clinical Diagnostics, Material SCIENCES AND General Lab equipments','Sivaprasad Patnam explored new opportunity in the field of Analytical technologies','','inherit','closed','closed','','4256-revision-v1','','','2020-02-05 11:04:26','2020-02-05 11:04:26','',4256,'https://microbiozindia.com/uncategorized/4256-revision-v1/',0,'revision','',0),(4267,2,'2020-02-07 09:39:18','2020-02-07 09:39:18','FLIR Systems announce the FLIR A8580 series of entry-level, cooled high-definition thermal science cameras designed for a wide range of industrial, military, science, and product research and development (R&amp;D) applications.\r\n\r\nThese 1.3-megapixel cameras record blur-free images of high-speed targets, offer a wide range of precision, manual and motorized lenses, and integrate seamlessly with the new FLIR Research Studio thermal analysis software – to provide users with a high-end experience in a compact, easy-to-use device.\r\n\r\nThe A8580 series includes four mid-wave infrared (MWIR) models as well as a long-wave model that provides better uniformity and stability than other, similar LWIR cameras. This unique LWIR camera also offers wide temperature calibration ranges, reducing the need for repeated testing to fully measure a high dynamic scene, and fast integration times. All five models produce sharp, 1280×1024 thermal pixel imagery for a 30% improvement over previous FLIR compact science cameras. Users can maximize the number of pixels on their target through a suite of lens options, from the 200-millimeter telephoto lens to the 3x microscope lens for imaging extremely small targets. The cameras’ quick response times and advanced triggering options help users record crisply focused images of fast-moving targets or accurately measure rapid changes in temperature. An internal filter mechanism allows the user to quickly switch between standard and high temperature ranges with a click of a button instead of manually changing neutral density filters.\r\n\r\nTo compliment these advanced features, FLIR designed the A8580 with simplified connections and controls so it’s easy to set-up and begin testing. The camera ramps up quickly and connects via Gigabit Ethernet or CoaXPress to a computer running FLIR Research Studio software. This included software allows users to view the live camera image, record the image stream, and evaluate thermal data from multiple FLIR cameras and recorded sources simultaneously.\r\n\r\nFLIR A8580 series science cameras are available for purchase today globally through the FLIR authorized network of distributors. To learn more, please visit www.flir.com/A8580-MWIR / www.flir.com/A8580-SLS or contact FLIR Systems on research@flir.com and +32-3665-5100.\r\n\r\nFounded in 1978, FLIR Systems is a world-leading industrial technology company focused on intelligent sensing solutions for defense, industrial, and commercial applications. FLIR Systems’ vision is to be “The World’s Sixth Sense,” creating technologies to help professionals make more informed decisions that save lives and livelihoods. For more information, please visit www.flir.com and follow @flir.','Compact, High-Definition Thermal Science Cameras','','publish','open','open','','compact-high-definition-thermal-science-cameras','','','2020-02-07 09:39:18','2020-02-07 09:39:18','',0,'https://microbiozindia.com/?p=4267',0,'post','',0),(4268,2,'2020-02-07 09:39:04','2020-02-07 09:39:04','','AAA','','inherit','open','closed','','aaa-5','','','2020-02-07 09:39:04','2020-02-07 09:39:04','',4267,'https://microbiozindia.com/wp-content/uploads/2020/02/AAA.png',0,'attachment','image/png',0),(4269,2,'2020-02-07 09:39:18','2020-02-07 09:39:18','FLIR Systems announce the FLIR A8580 series of entry-level, cooled high-definition thermal science cameras designed for a wide range of industrial, military, science, and product research and development (R&amp;D) applications.\r\n\r\nThese 1.3-megapixel cameras record blur-free images of high-speed targets, offer a wide range of precision, manual and motorized lenses, and integrate seamlessly with the new FLIR Research Studio thermal analysis software – to provide users with a high-end experience in a compact, easy-to-use device.\r\n\r\nThe A8580 series includes four mid-wave infrared (MWIR) models as well as a long-wave model that provides better uniformity and stability than other, similar LWIR cameras. This unique LWIR camera also offers wide temperature calibration ranges, reducing the need for repeated testing to fully measure a high dynamic scene, and fast integration times. All five models produce sharp, 1280×1024 thermal pixel imagery for a 30% improvement over previous FLIR compact science cameras. Users can maximize the number of pixels on their target through a suite of lens options, from the 200-millimeter telephoto lens to the 3x microscope lens for imaging extremely small targets. The cameras’ quick response times and advanced triggering options help users record crisply focused images of fast-moving targets or accurately measure rapid changes in temperature. An internal filter mechanism allows the user to quickly switch between standard and high temperature ranges with a click of a button instead of manually changing neutral density filters.\r\n\r\nTo compliment these advanced features, FLIR designed the A8580 with simplified connections and controls so it’s easy to set-up and begin testing. The camera ramps up quickly and connects via Gigabit Ethernet or CoaXPress to a computer running FLIR Research Studio software. This included software allows users to view the live camera image, record the image stream, and evaluate thermal data from multiple FLIR cameras and recorded sources simultaneously.\r\n\r\nFLIR A8580 series science cameras are available for purchase today globally through the FLIR authorized network of distributors. To learn more, please visit www.flir.com/A8580-MWIR / www.flir.com/A8580-SLS or contact FLIR Systems on research@flir.com and +32-3665-5100.\r\n\r\nFounded in 1978, FLIR Systems is a world-leading industrial technology company focused on intelligent sensing solutions for defense, industrial, and commercial applications. FLIR Systems’ vision is to be “The World’s Sixth Sense,” creating technologies to help professionals make more informed decisions that save lives and livelihoods. For more information, please visit www.flir.com and follow @flir.','Compact, High-Definition Thermal Science Cameras','','inherit','closed','closed','','4267-revision-v1','','','2020-02-07 09:39:18','2020-02-07 09:39:18','',4267,'https://microbiozindia.com/uncategorized/4267-revision-v1/',0,'revision','',0),(4270,2,'2020-02-08 06:47:51','2020-02-08 06:47:51','Mumbai, India; February 08, 2020: Cipla Ltd. (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced the acquisition of nutrition products’ portfolio from Wanbury Ltd. Cipla has acquired 4 brands — CPink, CDense, Productiv and Folinine to further strengthen its presence in women’s health.\r\n\r\nThe nutraceutical products, to be sold under the 4 umbrella brands, would address various health needs for conditions arising due to nutritional deficiencies or insufficiencies. This includes supplements such as multivitamins, multi-mineral and antioxidants for adolescent girls, pregnant and lactating women, women going through menopause and for male and female reproductive health.\r\n\r\nNikhil Chopra, Head India Business, Cipla Limited, said: \"We are focused on strengthening our play in the women’s health segment by amplifying our four-decade long presence in this category. Through this newly acquired portfolio, we shall be catering to a wide range of patient needs including nutritional deficiencies, bone health and sexual health”.\r\n\r\nAs per (IQVIA MAT Dec’19), the above molecules previously commercialized by Wanbury Ltd have a market size of INR 3,100 Cr in India with sales value of INR 59.6 Cr.','Cipla Expands Women’s Health Portfolio through Acquisition of 4 Key Brands from Wanbury','','publish','open','open','','cipla-expands-womens-health-portfolio-through-acquisition-of-4-key-brands-from-wanbury','','','2020-02-08 06:47:51','2020-02-08 06:47:51','',0,'https://microbiozindia.com/?p=4270',0,'post','',0),(4271,2,'2020-02-08 06:47:40','2020-02-08 06:47:40','','AAAGG','','inherit','open','closed','','aaagg','','','2020-02-08 06:47:40','2020-02-08 06:47:40','',4270,'https://microbiozindia.com/wp-content/uploads/2020/02/AAAGG.png',0,'attachment','image/png',0),(4272,2,'2020-02-08 06:47:51','2020-02-08 06:47:51','Mumbai, India; February 08, 2020: Cipla Ltd. (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced the acquisition of nutrition products’ portfolio from Wanbury Ltd. Cipla has acquired 4 brands — CPink, CDense, Productiv and Folinine to further strengthen its presence in women’s health.\r\n\r\nThe nutraceutical products, to be sold under the 4 umbrella brands, would address various health needs for conditions arising due to nutritional deficiencies or insufficiencies. This includes supplements such as multivitamins, multi-mineral and antioxidants for adolescent girls, pregnant and lactating women, women going through menopause and for male and female reproductive health.\r\n\r\nNikhil Chopra, Head India Business, Cipla Limited, said: \"We are focused on strengthening our play in the women’s health segment by amplifying our four-decade long presence in this category. Through this newly acquired portfolio, we shall be catering to a wide range of patient needs including nutritional deficiencies, bone health and sexual health”.\r\n\r\nAs per (IQVIA MAT Dec’19), the above molecules previously commercialized by Wanbury Ltd have a market size of INR 3,100 Cr in India with sales value of INR 59.6 Cr.','Cipla Expands Women’s Health Portfolio through Acquisition of 4 Key Brands from Wanbury','','inherit','closed','closed','','4270-revision-v1','','','2020-02-08 06:47:51','2020-02-08 06:47:51','',4270,'https://microbiozindia.com/uncategorized/4270-revision-v1/',0,'revision','',0),(4273,2,'2020-02-08 07:09:31','2020-02-08 07:09:31','An awareness campaign on safe insulin injection practices, organized by BD-India on Insulin Injection Day\r\nInsulin therapy is often a crucial part of diabetes management. Type 2 diabetes patients ultimately require insulin therapy in the course of the disease for effective glycemic control and injection technique remains crucial in the process. To enhance awareness on safe insulin injection practices, a multi-city educational campaign was organised by BD-India with leading endocrinologists on Insulin Injection Day. Insulin Injection Day commemorates the 98th anniversary of first successful insulin administration on 11th January 1922, at Toronto General Hospital, Canada.\r\n\r\nDr. K. Venu Gopal Reddy, Director - V. G. R. Diabetes Specialities Hospital, Vijaywada said, “It is important for patients living with diabetes to have proper knowledge about their condition and guidelines on correct usage of insulin injection. I extend my support to Insulin Injection Day awareness campaign led by BD in India which can help patients to learn the right techniques and manage their condition well.”\r\nAdded Dr. Arun Vadavi, Diabetologist, Sudha-The Prevention Centre, Bangalore, “Knowing the right technique for insulin injection is a critical factor in managing diabetes and can improve the injection experience for people living with diabetes. With awareness campaign led by BD on right injection techniques for insulin, I believe people will be better informed on appropriate injection and avoid complications during their therapy.”\r\nHighlighting the need for such awareness campaigns Pavan Mocherla, Managing Director-BD India &amp; South Asia said, “Insulin therapy is a crucial part of diabetes management. We at BD, understand the importance of right insulin injection techniques for a patient living with diabetes. BD has been a leader in diabetes injection devices for more than 90 years now and Insulin Injection Day is a perfect occasion for us to encourage talking about the best practices in managing insulin therapy for better outcomes.”\r\nThe experts also emphasized that incorrect insulin injection technique could lead to lipohypertrophy, which is a thickened, rubbery swelling under the skin at the patient’s usual injection sites. Lipohypertrophy can lead to poor glycaemic control, hypoglycemia and glycaemic variability.\r\nSome of the recommendations from Forum for Injection Technique &amp; Therapy Expert Recommendations (FITTER) India are listed below:\r\n\r\n<strong>Some of the FILTER insulin injection recommendations:</strong>\r\n<table style=\"border-collapse: collapse; width: 100%;\">\r\n<tbody>\r\n<tr>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 10pt;\"><strong>Site rotation</strong></span></td>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 8pt;\">• An easy-to-follow rotation scheme should be taught to the patients from the onset of injection therapy. </span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 10pt;\"><strong>Needle/syringe hygiene</strong></span></td>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 8pt;\">• Do not reuse needles. Use a new needle for each injection. </span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 10pt;\"><strong>Lipohypertrophy</strong></span></td>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 8pt;\">• Injection sites should be inspected at every visit. Patients should be taught to inspect their own sites and should also be given training on how to detect lipohypertrophy. </span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 10pt;\"><strong>Injection sites</strong></span></td>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 8pt;\">• Injection should be given at a clean site with clean hands. </span>\r\n<span style=\"font-size: 8pt;\">• Prior to the injection, the site has to be palpated for lipohypertrophy and inspected for wounds, bruises, or blisters. </span></td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<strong>About BD- India</strong>\r\n\r\n<span style=\"font-size: 10pt;\"><em>BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.</em></span>\r\n\r\n&nbsp;','Correct insulin injection technique is key to better diabetes management: say experts','','publish','open','open','','correct-insulin-injection-technique-is-key-to-better-diabetes-management-say-experts','','','2020-02-08 07:16:00','2020-02-08 07:16:00','',0,'https://microbiozindia.com/?p=4273',0,'post','',0),(4274,2,'2020-02-08 07:09:20','2020-02-08 07:09:20','','GGG','','inherit','open','closed','','ggg-3','','','2020-02-08 07:09:20','2020-02-08 07:09:20','',4273,'https://microbiozindia.com/wp-content/uploads/2020/02/GGG.png',0,'attachment','image/png',0),(4275,2,'2020-02-08 07:09:31','2020-02-08 07:09:31','An awareness campaign on safe insulin injection practices, organized by BD-India on Insulin Injection Day\r\nInsulin therapy is often a crucial part of diabetes management. Type 2 diabetes patients ultimately require insulin therapy in the course of the disease for effective glycemic control and injection technique remains crucial in the process. To enhance awareness on safe insulin injection practices, a multi-city educational campaign was organised by BD-India with leading endocrinologists on Insulin Injection Day. Insulin Injection Day commemorates the 98th anniversary of first successful insulin administration on 11th January 1922, at Toronto General Hospital, Canada.\r\n\r\nDr. K. Venu Gopal Reddy, Director - V. G. R. Diabetes Specialities Hospital, Vijaywada said, “It is important for patients living with diabetes to have proper knowledge about their condition and guidelines on correct usage of insulin injection. I extend my support to Insulin Injection Day awareness campaign led by BD in India which can help patients to learn the right techniques and manage their condition well.”\r\nAdded Dr. Arun Vadavi, Diabetologist, Sudha-The Prevention Centre, Bangalore, “Knowing the right technique for insulin injection is a critical factor in managing diabetes and can improve the injection experience for people living with diabetes. With awareness campaign led by BD on right injection techniques for insulin, I believe people will be better informed on appropriate injection and avoid complications during their therapy.”\r\nHighlighting the need for such awareness campaigns Pavan Mocherla, Managing Director-BD India &amp; South Asia said, “Insulin therapy is a crucial part of diabetes management. We at BD, understand the importance of right insulin injection techniques for a patient living with diabetes. BD has been a leader in diabetes injection devices for more than 90 years now and Insulin Injection Day is a perfect occasion for us to encourage talking about the best practices in managing insulin therapy for better outcomes.”\r\nThe experts also emphasized that incorrect insulin injection technique could lead to lipohypertrophy, which is a thickened, rubbery swelling under the skin at the patient’s usual injection sites. Lipohypertrophy can lead to poor glycaemic control, hypoglycemia and glycaemic variability.\r\nSome of the recommendations from Forum for Injection Technique &amp; Therapy Expert Recommendations (FITTER) India are listed below:\r\n\r\n&nbsp;\r\n<table style=\"width: 116.556%; height: 436px;\" width=\"762\">\r\n<tbody>\r\n<tr>\r\n<td colspan=\"2\"><strong>Some of the FITTER insulin injection recommendations </strong></td>\r\n</tr>\r\n<tr>\r\n<td><strong>Site rotation</strong></td>\r\n<td>· An easy-to-follow rotation scheme should be taught to the patients from the onset of injection therapy.</td>\r\n</tr>\r\n<tr>\r\n<td><strong>Needle/syringe hygiene</strong></td>\r\n<td>· Do not reuse needles. Use a new needle for each injection.</td>\r\n</tr>\r\n<tr>\r\n<td><strong>Lipohypertrophy</strong></td>\r\n<td>· Injection sites should be inspected at every visit. Patients should be taught to inspect their own sites and should also be given training on how to detect lipohypertrophy.</td>\r\n</tr>\r\n<tr>\r\n<td><strong>Injection sites</strong></td>\r\n<td>· Injection should be given at a clean site with clean hands.\r\n\r\n· Prior to the injection, the site has to be palpated for lipohypertrophy and inspected for wounds, bruises, or blisters.</td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<strong>About BD- India</strong>\r\n\r\n<span style=\"font-size: 10pt;\"><em>BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.</em></span>\r\n\r\n&nbsp;','Correct insulin injection technique is key to better diabetes management: say experts','','inherit','closed','closed','','4273-revision-v1','','','2020-02-08 07:09:31','2020-02-08 07:09:31','',4273,'https://microbiozindia.com/uncategorized/4273-revision-v1/',0,'revision','',0),(4276,2,'2020-02-08 07:15:35','2020-02-08 07:15:35','An awareness campaign on safe insulin injection practices, organized by BD-India on Insulin Injection Day\nInsulin therapy is often a crucial part of diabetes management. Type 2 diabetes patients ultimately require insulin therapy in the course of the disease for effective glycemic control and injection technique remains crucial in the process. To enhance awareness on safe insulin injection practices, a multi-city educational campaign was organised by BD-India with leading endocrinologists on Insulin Injection Day. Insulin Injection Day commemorates the 98th anniversary of first successful insulin administration on 11th January 1922, at Toronto General Hospital, Canada.\n\nDr. K. Venu Gopal Reddy, Director - V. G. R. Diabetes Specialities Hospital, Vijaywada said, “It is important for patients living with diabetes to have proper knowledge about their condition and guidelines on correct usage of insulin injection. I extend my support to Insulin Injection Day awareness campaign led by BD in India which can help patients to learn the right techniques and manage their condition well.”\nAdded Dr. Arun Vadavi, Diabetologist, Sudha-The Prevention Centre, Bangalore, “Knowing the right technique for insulin injection is a critical factor in managing diabetes and can improve the injection experience for people living with diabetes. With awareness campaign led by BD on right injection techniques for insulin, I believe people will be better informed on appropriate injection and avoid complications during their therapy.”\nHighlighting the need for such awareness campaigns Pavan Mocherla, Managing Director-BD India &amp; South Asia said, “Insulin therapy is a crucial part of diabetes management. We at BD, understand the importance of right insulin injection techniques for a patient living with diabetes. BD has been a leader in diabetes injection devices for more than 90 years now and Insulin Injection Day is a perfect occasion for us to encourage talking about the best practices in managing insulin therapy for better outcomes.”\nThe experts also emphasized that incorrect insulin injection technique could lead to lipohypertrophy, which is a thickened, rubbery swelling under the skin at the patient’s usual injection sites. Lipohypertrophy can lead to poor glycaemic control, hypoglycemia and glycaemic variability.\nSome of the recommendations from Forum for Injection Technique &amp; Therapy Expert Recommendations (FITTER) India are listed below:\n\nSome of the FILTER insulin inject\n<table style=\"border-collapse: collapse; width: 100%;\">\n<tbody>\n<tr>\n<td style=\"width: 50%;\"><span style=\"font-size: 10pt;\"><strong>Site rotation</strong></span></td>\n<td style=\"width: 50%;\"><span style=\"font-size: 8pt;\">• An easy-to-follow rotation scheme should be taught to the patients from the onset of injection therapy. </span></td>\n</tr>\n<tr>\n<td style=\"width: 50%;\"><span style=\"font-size: 10pt;\"><strong>Needle/syringe hygiene</strong></span></td>\n<td style=\"width: 50%;\"><span style=\"font-size: 8pt;\">• Do not reuse needles. Use a new needle for each injection. </span></td>\n</tr>\n<tr>\n<td style=\"width: 50%;\"><span style=\"font-size: 10pt;\"><strong>Lipohypertrophy</strong></span></td>\n<td style=\"width: 50%;\"><span style=\"font-size: 8pt;\">• Injection sites should be inspected at every visit. Patients should be taught to inspect their own sites and should also be given training on how to detect lipohypertrophy. </span></td>\n</tr>\n<tr>\n<td style=\"width: 50%;\"><span style=\"font-size: 10pt;\"><strong>Injection sites</strong></span></td>\n<td style=\"width: 50%;\"><span style=\"font-size: 8pt;\">• Injection should be given at a clean site with clean hands. </span>\n<span style=\"font-size: 8pt;\">• Prior to the injection, the site has to be palpated for lipohypertrophy and inspected for wounds, bruises, or blisters. </span></td>\n</tr>\n</tbody>\n</table>\n<strong>About BD- India</strong>\n\n<span style=\"font-size: 10pt;\"><em>BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.</em></span>\n\n&nbsp;','Correct insulin injection technique is key to better diabetes management: say experts','','inherit','closed','closed','','4273-autosave-v1','','','2020-02-08 07:15:35','2020-02-08 07:15:35','',4273,'https://microbiozindia.com/uncategorized/4273-autosave-v1/',0,'revision','',0),(4277,2,'2020-02-08 07:16:00','2020-02-08 07:16:00','An awareness campaign on safe insulin injection practices, organized by BD-India on Insulin Injection Day\r\nInsulin therapy is often a crucial part of diabetes management. Type 2 diabetes patients ultimately require insulin therapy in the course of the disease for effective glycemic control and injection technique remains crucial in the process. To enhance awareness on safe insulin injection practices, a multi-city educational campaign was organised by BD-India with leading endocrinologists on Insulin Injection Day. Insulin Injection Day commemorates the 98th anniversary of first successful insulin administration on 11th January 1922, at Toronto General Hospital, Canada.\r\n\r\nDr. K. Venu Gopal Reddy, Director - V. G. R. Diabetes Specialities Hospital, Vijaywada said, “It is important for patients living with diabetes to have proper knowledge about their condition and guidelines on correct usage of insulin injection. I extend my support to Insulin Injection Day awareness campaign led by BD in India which can help patients to learn the right techniques and manage their condition well.”\r\nAdded Dr. Arun Vadavi, Diabetologist, Sudha-The Prevention Centre, Bangalore, “Knowing the right technique for insulin injection is a critical factor in managing diabetes and can improve the injection experience for people living with diabetes. With awareness campaign led by BD on right injection techniques for insulin, I believe people will be better informed on appropriate injection and avoid complications during their therapy.”\r\nHighlighting the need for such awareness campaigns Pavan Mocherla, Managing Director-BD India &amp; South Asia said, “Insulin therapy is a crucial part of diabetes management. We at BD, understand the importance of right insulin injection techniques for a patient living with diabetes. BD has been a leader in diabetes injection devices for more than 90 years now and Insulin Injection Day is a perfect occasion for us to encourage talking about the best practices in managing insulin therapy for better outcomes.”\r\nThe experts also emphasized that incorrect insulin injection technique could lead to lipohypertrophy, which is a thickened, rubbery swelling under the skin at the patient’s usual injection sites. Lipohypertrophy can lead to poor glycaemic control, hypoglycemia and glycaemic variability.\r\nSome of the recommendations from Forum for Injection Technique &amp; Therapy Expert Recommendations (FITTER) India are listed below:\r\n\r\n<strong>Some of the FILTER insulin injection recommendations:</strong>\r\n<table style=\"border-collapse: collapse; width: 100%;\">\r\n<tbody>\r\n<tr>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 10pt;\"><strong>Site rotation</strong></span></td>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 8pt;\">• An easy-to-follow rotation scheme should be taught to the patients from the onset of injection therapy. </span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 10pt;\"><strong>Needle/syringe hygiene</strong></span></td>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 8pt;\">• Do not reuse needles. Use a new needle for each injection. </span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 10pt;\"><strong>Lipohypertrophy</strong></span></td>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 8pt;\">• Injection sites should be inspected at every visit. Patients should be taught to inspect their own sites and should also be given training on how to detect lipohypertrophy. </span></td>\r\n</tr>\r\n<tr>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 10pt;\"><strong>Injection sites</strong></span></td>\r\n<td style=\"width: 50%;\"><span style=\"font-size: 8pt;\">• Injection should be given at a clean site with clean hands. </span>\r\n<span style=\"font-size: 8pt;\">• Prior to the injection, the site has to be palpated for lipohypertrophy and inspected for wounds, bruises, or blisters. </span></td>\r\n</tr>\r\n</tbody>\r\n</table>\r\n<strong>About BD- India</strong>\r\n\r\n<span style=\"font-size: 10pt;\"><em>BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.</em></span>\r\n\r\n&nbsp;','Correct insulin injection technique is key to better diabetes management: say experts','','inherit','closed','closed','','4273-revision-v1','','','2020-02-08 07:16:00','2020-02-08 07:16:00','',4273,'https://microbiozindia.com/uncategorized/4273-revision-v1/',0,'revision','',0),(4279,2,'2020-02-09 03:30:05','2020-02-09 03:30:05','','Laboratory Equipment Magazine,Microbiology and Healthcare News,Scientific Equipment News','','inherit','closed','closed','','41-revision-v1','','','2020-02-09 03:30:05','2020-02-09 03:30:05','',41,'https://microbiozindia.com/uncategorized/41-revision-v1/',0,'revision','',0),(4280,2,'2020-02-10 11:27:43','2020-02-10 11:27:43','The FlowSyn Maxi&#x2122; from Uniqsis is a high throughput flow reactor for process chemists looking to optimise reaction conditions before scaling-up synthetic production to multiple kilograms per day.\r\n\r\nCombining the benefits of Uniqsis\'s proven FlowSyn technology with high flow rates (up to 100 ml/min) in a compact benchtop design the FlowSyn Maxi&#x2122; sets a new standard for higher throughput applications.\r\n\r\nDesigned for ease of use the highly intuitive user interface quickly guides you through the process for setting up a flow chemistry reaction. Once set up, FlowSyn Maxi automatically runs the experiment unattended, ensuring that critical parameters remain within defined limits.\r\n\r\nRobustly constructed from epoxy coated and bead-blasted stainless steel, the FlowSyn Maxi&#x2122; can be specified with stainless steel, Hastelloy® or PTFE flow paths. The unit is fitted with larger bore inlet tubing and upgraded inlet/outlet solenoid valves with bigger fluidic channels to cope with the increased flow rate.\r\n\r\nThe FlowSyn Maxi&#x2122; is designed to carry out superheated reactions up to +260°C (1400 psi) and cooled reactions down to -70°C - making it one of the most versatile process scale flow reactors available.\r\n\r\nThe system is compatible with all existing Uniqsis coil reactors, and is particularly suitable for use with larger reactors up to 60ml constructed using 1/8-inch OD tubing in conjunction with glass static mixer chips to ensure efficient and reproducible mixing. Reagents can be delivered from large stock bottles or from sample loops (up to 50 ml).\r\n\r\nOptimised configurations of the FlowSyn Maxi&#x2122; are also available, for instance integrated with the FlowSyn Multi-X for reaction optimisation or the FlowSyn Auto-LF for library synthesis.\r\n\r\nFor laboratories tasked with both reaction optimisation and production scale synthesis the FlowSyn Maxi can be converted to a FlowSyn flow reactor and vice versa. Simply by changing the pump heads, flow path tubing and fittings.\r\n\r\nFor further information on the FlowSyn Maxi&#x2122; please visit http://www.uniqsis.com/paProductsDetail.aspx?ID=FLW_MAXI or contact Uniqsis on +44-845-864-7747 / info@uniqsis.com.\r\n\r\nSince 2007, Uniqsis has specialised in the design and supply of mesoscale continuous flow chemistry systems for a wide range of applications in chemical and pharmaceutical research. The company’s aim is to make flow chemistry easily accessible to both novices and experienced users.','Uniqsis Flow Reactor for Kilogram Scale Production','','publish','open','open','','uniqsis-flow-reactor-for-kilogram-scale-production','','','2020-02-10 11:27:43','2020-02-10 11:27:43','',0,'https://microbiozindia.com/?p=4280',0,'post','',0),(4281,2,'2020-02-10 11:17:15','2020-02-10 11:17:15','','AAA','','inherit','open','closed','','aaa-6','','','2020-02-10 11:17:15','2020-02-10 11:17:15','',4280,'https://microbiozindia.com/wp-content/uploads/2020/02/AAA-1.png',0,'attachment','image/png',0),(4282,2,'2020-02-10 11:27:43','2020-02-10 11:27:43','The FlowSyn Maxi&#x2122; from Uniqsis is a high throughput flow reactor for process chemists looking to optimise reaction conditions before scaling-up synthetic production to multiple kilograms per day.\r\n\r\nCombining the benefits of Uniqsis\'s proven FlowSyn technology with high flow rates (up to 100 ml/min) in a compact benchtop design the FlowSyn Maxi&#x2122; sets a new standard for higher throughput applications.\r\n\r\nDesigned for ease of use the highly intuitive user interface quickly guides you through the process for setting up a flow chemistry reaction. Once set up, FlowSyn Maxi automatically runs the experiment unattended, ensuring that critical parameters remain within defined limits.\r\n\r\nRobustly constructed from epoxy coated and bead-blasted stainless steel, the FlowSyn Maxi&#x2122; can be specified with stainless steel, Hastelloy® or PTFE flow paths. The unit is fitted with larger bore inlet tubing and upgraded inlet/outlet solenoid valves with bigger fluidic channels to cope with the increased flow rate.\r\n\r\nThe FlowSyn Maxi&#x2122; is designed to carry out superheated reactions up to +260°C (1400 psi) and cooled reactions down to -70°C - making it one of the most versatile process scale flow reactors available.\r\n\r\nThe system is compatible with all existing Uniqsis coil reactors, and is particularly suitable for use with larger reactors up to 60ml constructed using 1/8-inch OD tubing in conjunction with glass static mixer chips to ensure efficient and reproducible mixing. Reagents can be delivered from large stock bottles or from sample loops (up to 50 ml).\r\n\r\nOptimised configurations of the FlowSyn Maxi&#x2122; are also available, for instance integrated with the FlowSyn Multi-X for reaction optimisation or the FlowSyn Auto-LF for library synthesis.\r\n\r\nFor laboratories tasked with both reaction optimisation and production scale synthesis the FlowSyn Maxi can be converted to a FlowSyn flow reactor and vice versa. Simply by changing the pump heads, flow path tubing and fittings.\r\n\r\nFor further information on the FlowSyn Maxi&#x2122; please visit http://www.uniqsis.com/paProductsDetail.aspx?ID=FLW_MAXI or contact Uniqsis on +44-845-864-7747 / info@uniqsis.com.\r\n\r\nSince 2007, Uniqsis has specialised in the design and supply of mesoscale continuous flow chemistry systems for a wide range of applications in chemical and pharmaceutical research. The company’s aim is to make flow chemistry easily accessible to both novices and experienced users.','Uniqsis Flow Reactor for Kilogram Scale Production','','inherit','closed','closed','','4280-revision-v1','','','2020-02-10 11:27:43','2020-02-10 11:27:43','',4280,'https://microbiozindia.com/uncategorized/4280-revision-v1/',0,'revision','',0),(4283,2,'2020-02-10 16:39:27','2020-02-10 16:39:27','Mumbai, India; February 10, 2020: As part of its quest to provide access to life-saving medication and making a difference in the lives of patients, Cipla Medpro South Africa (Pty) Limited (“Cipla Medpro”), wholly-owned subsidiary of Cipla Limited, India (“Cipla”) and South Africa’s third largest pharmaceutical company in the private sector, has recently concluded an exclusive agreement (the “Agreement”) securing originator and authorised generic brands of an atypical anti-psychotic drug, Quetiapine (the “Medicine”).\r\n\r\nThe agreement involves AstraZeneca Pharmaceuticals (Pty) Limited, the originator of the Medicine, and Luye Pharma Hong Kong Limited, which acquired the assets and rights to the medicine in select territories. The transaction allows Cipla Medpro to market and distribute the Medicine in South Africa and neighbouring countries.\r\n\r\nThe existing portfolio consists of the originator brand Seroquel® and the authorised generic brand Truvalin®, medication which is used to treat mental health conditions such as schizophrenia, bipolar disorder, and major depressive disorder.\r\n\r\nPaul Miller, CEO of Cipla South Africa, said the agreement strategically enhances Cipla’s Central Nervous System (CNS) portfolio: “We want people to live a long and healthy life and have invested significantly in public awareness campaigns to educate people about the importance of mental health and the fact that there is help and hope. This transaction will help ensure that people have access to affordable and quality medicine that will help improve quality of life for people living with these conditions.”\r\n\r\n“This partnership amplifies Cipla’s growing intent to partner with innovator companies and this is a further demonstration of our core competence in building and growing originator brands, ably strengthened by strong corporate governance and quality mindset,” said Miller.','Cipla SA Signs Agreement For Anti-Psychotic Drug','','publish','open','open','','cipla-sa-signs-agreement-for-anti-psychotic-drug','','','2020-02-10 16:39:27','2020-02-10 16:39:27','',0,'https://microbiozindia.com/?p=4283',0,'post','',0),(4284,2,'2020-02-10 16:38:31','2020-02-10 16:38:31','','AAA','','inherit','open','closed','','aaa-7','','','2020-02-10 16:38:31','2020-02-10 16:38:31','',4283,'https://microbiozindia.com/wp-content/uploads/2020/02/AAA-2.png',0,'attachment','image/png',0),(4285,2,'2020-02-10 16:39:27','2020-02-10 16:39:27','Mumbai, India; February 10, 2020: As part of its quest to provide access to life-saving medication and making a difference in the lives of patients, Cipla Medpro South Africa (Pty) Limited (“Cipla Medpro”), wholly-owned subsidiary of Cipla Limited, India (“Cipla”) and South Africa’s third largest pharmaceutical company in the private sector, has recently concluded an exclusive agreement (the “Agreement”) securing originator and authorised generic brands of an atypical anti-psychotic drug, Quetiapine (the “Medicine”).\r\n\r\nThe agreement involves AstraZeneca Pharmaceuticals (Pty) Limited, the originator of the Medicine, and Luye Pharma Hong Kong Limited, which acquired the assets and rights to the medicine in select territories. The transaction allows Cipla Medpro to market and distribute the Medicine in South Africa and neighbouring countries.\r\n\r\nThe existing portfolio consists of the originator brand Seroquel® and the authorised generic brand Truvalin®, medication which is used to treat mental health conditions such as schizophrenia, bipolar disorder, and major depressive disorder.\r\n\r\nPaul Miller, CEO of Cipla South Africa, said the agreement strategically enhances Cipla’s Central Nervous System (CNS) portfolio: “We want people to live a long and healthy life and have invested significantly in public awareness campaigns to educate people about the importance of mental health and the fact that there is help and hope. This transaction will help ensure that people have access to affordable and quality medicine that will help improve quality of life for people living with these conditions.”\r\n\r\n“This partnership amplifies Cipla’s growing intent to partner with innovator companies and this is a further demonstration of our core competence in building and growing originator brands, ably strengthened by strong corporate governance and quality mindset,” said Miller.','Cipla SA Signs Agreement For Anti-Psychotic Drug','','inherit','closed','closed','','4283-revision-v1','','','2020-02-10 16:39:27','2020-02-10 16:39:27','',4283,'https://microbiozindia.com/uncategorized/4283-revision-v1/',0,'revision','',0),(4286,2,'2020-02-14 17:03:11','2020-02-14 17:03:11','Titan Enterprises reports that its popular 800 series turbine flowmeter offers easy integration with battery powered or portable equipment.\r\n\r\nDesigned to operate with minimal power input, Titan’s competitively priced, low power 800 series flowmeter maintains high performance over 6 flow ranges from 0.05 to 15 litres per minute. Totally non-metallic wetted components, including a moulded PVDF body and Viton \'O\' seals, makes the lower 800 series flowmeter the ideal choice for the metering of even aggressive chemicals. The standard inlet tubes are barbed to accept a hose size of 8mm although for OEM use - alternatives are available.\r\n\r\nAt the heart of the low power 800 series flowmeter is a precision turbine that rotates freely on robust sapphire bearings. The turbine contains fully moulded-in magnets that are detected through the chamber wall by an extremely low drag, low power detector. The output for the low power 800 series flowmeter is a stream of pulses that are readily interfaced with most electronic displays or recording devices. This combination of materials and technology ensures a long life, high performance product with continuous reliable operation.\r\n\r\nFor further information on the low power 800-series flowmeter please\r\nvisit www.flowmeters.co.uk/low-power-flow-meters-800-series-low-power-turbine-flow-sensor/ or contact Titan Enterprises on +44-1935-812790 or sales@flowmeters.com.uk.\r\n\r\nWith over 40 years’ experience in flowmeter innovation and manufacture, Titan\'s company philosophy of \"pushing the envelope by trying to do things a little different and better\" has resulted in sales of over 500,000 products into 40 countries worldwide and a repeat purchase rate of 95%. Today Titan supplies innovative flow measurement solutions to a broad range of market sectors, including medical, chemical, petrochemical, food and drink, laboratory and pharmaceutical. For further information please visit www.flowmeters.co.uk.','Turbine Flowmeter for Battery Powered or Portable Equipment','','publish','open','open','','turbine-flowmeter-for-battery-powered-or-portable-equipment','','','2020-02-14 17:03:11','2020-02-14 17:03:11','',0,'https://microbiozindia.com/?p=4286',0,'post','',0),(4287,2,'2020-02-14 17:02:47','2020-02-14 17:02:47','','TTT','','inherit','open','closed','','ttt','','','2020-02-14 17:02:47','2020-02-14 17:02:47','',4286,'https://microbiozindia.com/wp-content/uploads/2020/02/TTT.png',0,'attachment','image/png',0),(4288,2,'2020-02-14 17:03:11','2020-02-14 17:03:11','Titan Enterprises reports that its popular 800 series turbine flowmeter offers easy integration with battery powered or portable equipment.\r\n\r\nDesigned to operate with minimal power input, Titan’s competitively priced, low power 800 series flowmeter maintains high performance over 6 flow ranges from 0.05 to 15 litres per minute. Totally non-metallic wetted components, including a moulded PVDF body and Viton \'O\' seals, makes the lower 800 series flowmeter the ideal choice for the metering of even aggressive chemicals. The standard inlet tubes are barbed to accept a hose size of 8mm although for OEM use - alternatives are available.\r\n\r\nAt the heart of the low power 800 series flowmeter is a precision turbine that rotates freely on robust sapphire bearings. The turbine contains fully moulded-in magnets that are detected through the chamber wall by an extremely low drag, low power detector. The output for the low power 800 series flowmeter is a stream of pulses that are readily interfaced with most electronic displays or recording devices. This combination of materials and technology ensures a long life, high performance product with continuous reliable operation.\r\n\r\nFor further information on the low power 800-series flowmeter please\r\nvisit www.flowmeters.co.uk/low-power-flow-meters-800-series-low-power-turbine-flow-sensor/ or contact Titan Enterprises on +44-1935-812790 or sales@flowmeters.com.uk.\r\n\r\nWith over 40 years’ experience in flowmeter innovation and manufacture, Titan\'s company philosophy of \"pushing the envelope by trying to do things a little different and better\" has resulted in sales of over 500,000 products into 40 countries worldwide and a repeat purchase rate of 95%. Today Titan supplies innovative flow measurement solutions to a broad range of market sectors, including medical, chemical, petrochemical, food and drink, laboratory and pharmaceutical. For further information please visit www.flowmeters.co.uk.','Turbine Flowmeter for Battery Powered or Portable Equipment','','inherit','closed','closed','','4286-revision-v1','','','2020-02-14 17:03:11','2020-02-14 17:03:11','',4286,'https://microbiozindia.com/uncategorized/4286-revision-v1/',0,'revision','',0),(4289,2,'2020-02-14 17:03:15','2020-02-14 17:03:15','Titan Enterprises reports that its popular 800 series turbine flowmeter offers easy integration with battery powered or portable equipment.\n\nDesigned to operate with minimal power input, Titan’s competitively priced, low power 800 series flowmeter maintains high performance over 6 flow ranges from 0.05 to 15 litres per minute. Totally non-metallic wetted components, including a moulded PVDF body and Viton \'O\' seals, makes the lower 800 series flowmeter the ideal choice for the metering of even aggressive chemicals. The standard inlet tubes are barbed to accept a hose size of 8mm although for OEM use - alternatives are available.\n\nAt the heart of the low power 800 series flowmeter is a precision turbine that rotates freely on robust sapphire bearings. The turbine contains fully moulded-in magnets that are detected through the chamber wall by an extremely low drag, low power detector. The output for the low power 800 series flowmeter is a stream of pulses that are readily interfaced with most electronic displays or recording devices. This combination of materials and technology ensures a long life, high performance product with continuous reliable operation.\n\nFor further information on the low power 800-series flowmeter please\nvisit www.flowmeters.co.uk/low-power-flow-meters-800-series-low-power-turbine-flow-sensor/ or contact Titan Enterprises on +44-1935-812790 or sales@flowmeters.com.uk.\n\nWith over 40 years’ experience in flowmeter innovation and manufacture, Titan\'s company philosophy of \"pushing the envelope by trying to do things a little different and better\" has resulted in sales of over 500,000 products into 40 countries worldwide and a repeat purchase rate of 95%. Today Titan supplies innovative flow measurement solutions to a broad range of market sectors, including medical, chemical, petrochemical, food and drink, laboratory and pharmaceutical. For further information please visit www.flowmeters.co.uk.','Turbine Flowmeter for Battery Powered or Portable Equipment','','inherit','closed','closed','','4286-autosave-v1','','','2020-02-14 17:03:15','2020-02-14 17:03:15','',4286,'https://microbiozindia.com/uncategorized/4286-autosave-v1/',0,'revision','',0),(4290,2,'2020-02-17 09:32:51','2020-02-17 09:32:51','Sartorius a leading international partner of life science research and the biopharmaceutical industry, the company has revised its brand look. At the focus of this relaunch is Sartorius’ new brand promise that it summarizes in its new claim: Simplifying Progress. With its products and technologies, the company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster. Sartorius has also revised its visuals, launched a new logo and consolidated its profile at the subgroup and division levels to underscore its new brand claim.\r\n“Sartorius has evolved over the past 20 years into a different company, especially considering what we have contributed in promoting the development and manufacture of advanced biopharmaceuticals. At the same time, the requirements of our customers worldwide are significantly changing and our competitive environment is also moving,” commented Sartorius CEO and Executive Board Chairman Joachim Kreuzburg. “The Sartorius brand needs to embed the appropriate key messages in the minds of our customers; namely, that we give them powerful tools to discover and develop medical drugs faster and more simply and to manufacture medications more efficiently. In this way, we are contributing toward accelerating the availability of new medications to a wider range of patients. And, after all, it is also part of our brand promise that we make it easy for our customers to work with us.”\r\nThe entire rebranding will take some time to complete as Sartorius has decided on a gradual and environmentally friendly change-over process. Over the next few months, its new brand design will be extended to all Sartorius products. The product brands of both divisions, such as ambr®, IncuCyte®, BIOSTAT® and Cubis®, will continue to be used.\r\nNote : the story may be edited or resize as per editorial format for more information please go through: <a href=\"https://www.sartorius.com/en/company/newsroom/corporate-news/419640-419640?utm_source=linkedin&amp;utm_medium=socialorganic&amp;utm_campaign=simplifiying-progress&amp;utm_term=linkedinssb&amp;utm_content=pauseroom\">https://www.sartorius.com/en/company/newsroom/corporate-news/419640-419640?utm_source=linkedin&amp;utm_medium=socialorganic&amp;utm_campaign=simplifiying-progress&amp;utm_term=linkedinssb&amp;utm_content=pauseroom</a>','Sartorius new logo underscore new brand positioning','','publish','open','open','','sartorius-new-logo-underscore-new-brand-positioning','','','2020-02-17 09:39:33','2020-02-17 09:39:33','',0,'https://microbiozindia.com/?p=4290',0,'post','',0),(4291,2,'2020-02-17 09:32:41','2020-02-17 09:32:41','','ffg','','inherit','open','closed','','ffg','','','2020-02-17 09:32:41','2020-02-17 09:32:41','',4290,'https://microbiozindia.com/wp-content/uploads/2020/02/ffg.png',0,'attachment','image/png',0),(4292,2,'2020-02-17 09:32:51','2020-02-17 09:32:51','Sartorius a leading international partner of life science research and the biopharmaceutical industry, the company has revised its brand look. At the focus of this relaunch is Sartorius’ new brand promise that it summarizes in its new claim: Simplifying Progress. With its products and technologies, the company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster. Sartorius has also revised its visuals, launched a new logo and consolidated its profile at the subgroup and division levels to underscore its new brand claim.\r\n“Sartorius has evolved over the past 20 years into a different company, especially considering what we have contributed in promoting the development and manufacture of advanced biopharmaceuticals. At the same time, the requirements of our customers worldwide are significantly changing and our competitive environment is also moving,” commented Sartorius CEO and Executive Board Chairman Joachim Kreuzburg. “The Sartorius brand needs to embed the appropriate key messages in the minds of our customers; namely, that we give them powerful tools to discover and develop medical drugs faster and more simply and to manufacture medications more efficiently. In this way, we are contributing toward accelerating the availability of new medications to a wider range of patients. And, after all, it is also part of our brand promise that we make it easy for our customers to work with us.”\r\nThe entire rebranding will take some time to complete as Sartorius has decided on a gradual and environmentally friendly change-over process. Over the next few months, its new brand design will be extended to all Sartorius products. The product brands of both divisions, such as ambr®, IncuCyte®, BIOSTAT® and Cubis®, will continue to be used.\r\nNote : the story may be edited or resize as per editorial format for more information please go through: https://www.sartorius.com/en/company/newsroom/corporate-news/419640-419640?utm_source=linkedin&amp;utm_medium=socialorganic&amp;utm_campaign=simplifiying-progress&amp;utm_term=linkedinssb&amp;utm_content=pauseroom','Sartorius new logo underscore new brand positioning','','inherit','closed','closed','','4290-revision-v1','','','2020-02-17 09:32:51','2020-02-17 09:32:51','',4290,'https://microbiozindia.com/uncategorized/4290-revision-v1/',0,'revision','',0),(4293,2,'2020-02-17 09:39:33','2020-02-17 09:39:33','Sartorius a leading international partner of life science research and the biopharmaceutical industry, the company has revised its brand look. At the focus of this relaunch is Sartorius’ new brand promise that it summarizes in its new claim: Simplifying Progress. With its products and technologies, the company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster. Sartorius has also revised its visuals, launched a new logo and consolidated its profile at the subgroup and division levels to underscore its new brand claim.\r\n“Sartorius has evolved over the past 20 years into a different company, especially considering what we have contributed in promoting the development and manufacture of advanced biopharmaceuticals. At the same time, the requirements of our customers worldwide are significantly changing and our competitive environment is also moving,” commented Sartorius CEO and Executive Board Chairman Joachim Kreuzburg. “The Sartorius brand needs to embed the appropriate key messages in the minds of our customers; namely, that we give them powerful tools to discover and develop medical drugs faster and more simply and to manufacture medications more efficiently. In this way, we are contributing toward accelerating the availability of new medications to a wider range of patients. And, after all, it is also part of our brand promise that we make it easy for our customers to work with us.”\r\nThe entire rebranding will take some time to complete as Sartorius has decided on a gradual and environmentally friendly change-over process. Over the next few months, its new brand design will be extended to all Sartorius products. The product brands of both divisions, such as ambr®, IncuCyte®, BIOSTAT® and Cubis®, will continue to be used.\r\nNote : the story may be edited or resize as per editorial format for more information please go through: <a href=\"https://www.sartorius.com/en/company/newsroom/corporate-news/419640-419640?utm_source=linkedin&amp;utm_medium=socialorganic&amp;utm_campaign=simplifiying-progress&amp;utm_term=linkedinssb&amp;utm_content=pauseroom\">https://www.sartorius.com/en/company/newsroom/corporate-news/419640-419640?utm_source=linkedin&amp;utm_medium=socialorganic&amp;utm_campaign=simplifiying-progress&amp;utm_term=linkedinssb&amp;utm_content=pauseroom</a>','Sartorius new logo underscore new brand positioning','','inherit','closed','closed','','4290-revision-v1','','','2020-02-17 09:39:33','2020-02-17 09:39:33','',4290,'https://microbiozindia.com/uncategorized/4290-revision-v1/',0,'revision','',0),(4294,2,'2020-02-19 04:17:01','2020-02-19 04:17:01','Ziath has announced the launch of impressiOn - a versatile new semi-automatic device designed to take the strain out of applying friction sealing mats or septum sealing caps to SBS format tube racks.\r\n\r\nTube racks are a valuable tool in life science research and clinical diagnostic testing laboratories as they can be used to simplify the handling and storage of large numbers of samples. It is essential that tube racks can be securely sealed in order to avoid contamination and evaporation thereby maintaining the integrity of your samples. The Ziath impressiOn sets a new industry leading benchmark for high integrity, cost effective sealing of single use SBS format tube racks.\r\n\r\nUsing the impressiOn is simple and quick, just place your rack or plate with its attendant friction mat or septum cap web in the drawer and push it firmly shut. Sealing is initiated using the single action large start button, then sophisticated electronics take over applying reproducible and even pressure every time to force the septum seals down into each tube. Time after time, impressiOn does the hard work for you. It’s sealing results are more reproducible, faster and less likely to cause a strain injury than trying to do this task manually.\r\n\r\nThe compact unit requires only a 110v or 220v power supply to operate and is small enough to sit on most lab benches. The Ziath impressiOn will work with most commercially available septum cap mats and different manufacturers 2D-coded and uncoded tubes in\r\n\r\nSBS-format racks. Both friction and septum seals for 96-, 48- and 24-tube plates have been shown to work well using the ImpressiOn sealing device. As standard, the unit is also supplied with two rack adaptors to enable sealing of shallow and deep racks. Alternative rack adaptors are available to suit specific manufacturers’ tube racks.\r\n\r\nFor further information on the impressiOn semi-automatic sealing tube rack sealing device please visit http://ziath.com/index.php/products/tube-devices/impression or contact Ziath on +44-1223-855021 / +1 858-880-6920 and via email to info@ziath.com\r\n\r\nFounded in 2005, Ziath specialises in development of innovative instrumentation control and information management products using 2D DataMatrix bar-coded tubes to simplify automation processes in life science organisations, from academia, to the biotech and pharma industries. For further information please visit <a href=\"http://www.ziath.com\">www.ziath.com</a>','Secure Sealing of SBS Format Tube Racks b Ziath','','publish','open','open','','secure-sealing-of-sbs-format-tube-racks-b-ziath','','','2020-02-19 04:17:01','2020-02-19 04:17:01','',0,'https://microbiozindia.com/?p=4294',0,'post','',0),(4295,2,'2020-02-19 04:16:51','2020-02-19 04:16:51','','AAA','','inherit','open','closed','','aaa-8','','','2020-02-19 04:16:51','2020-02-19 04:16:51','',4294,'https://microbiozindia.com/wp-content/uploads/2020/02/AAA-3.png',0,'attachment','image/png',0),(4296,2,'2020-02-19 04:17:01','2020-02-19 04:17:01','Ziath has announced the launch of impressiOn - a versatile new semi-automatic device designed to take the strain out of applying friction sealing mats or septum sealing caps to SBS format tube racks.\r\n\r\nTube racks are a valuable tool in life science research and clinical diagnostic testing laboratories as they can be used to simplify the handling and storage of large numbers of samples. It is essential that tube racks can be securely sealed in order to avoid contamination and evaporation thereby maintaining the integrity of your samples. The Ziath impressiOn sets a new industry leading benchmark for high integrity, cost effective sealing of single use SBS format tube racks.\r\n\r\nUsing the impressiOn is simple and quick, just place your rack or plate with its attendant friction mat or septum cap web in the drawer and push it firmly shut. Sealing is initiated using the single action large start button, then sophisticated electronics take over applying reproducible and even pressure every time to force the septum seals down into each tube. Time after time, impressiOn does the hard work for you. It’s sealing results are more reproducible, faster and less likely to cause a strain injury than trying to do this task manually.\r\n\r\nThe compact unit requires only a 110v or 220v power supply to operate and is small enough to sit on most lab benches. The Ziath impressiOn will work with most commercially available septum cap mats and different manufacturers 2D-coded and uncoded tubes in\r\n\r\nSBS-format racks. Both friction and septum seals for 96-, 48- and 24-tube plates have been shown to work well using the ImpressiOn sealing device. As standard, the unit is also supplied with two rack adaptors to enable sealing of shallow and deep racks. Alternative rack adaptors are available to suit specific manufacturers’ tube racks.\r\n\r\nFor further information on the impressiOn semi-automatic sealing tube rack sealing device please visit http://ziath.com/index.php/products/tube-devices/impression or contact Ziath on +44-1223-855021 / +1 858-880-6920 and via email to info@ziath.com\r\n\r\nFounded in 2005, Ziath specialises in development of innovative instrumentation control and information management products using 2D DataMatrix bar-coded tubes to simplify automation processes in life science organisations, from academia, to the biotech and pharma industries. For further information please visit <a href=\"http://www.ziath.com\">www.ziath.com</a>','Secure Sealing of SBS Format Tube Racks b Ziath','','inherit','closed','closed','','4294-revision-v1','','','2020-02-19 04:17:01','2020-02-19 04:17:01','',4294,'https://microbiozindia.com/uncategorized/4294-revision-v1/',0,'revision','',0),(4297,2,'2020-02-19 12:16:13','2020-02-19 12:16:13','Resolve Optics reports on how ultra large format lenses it has developed are helping a next generation aerial surveillance camera gain data on coastal erosion faster and in more detail.\r\n\r\nCoastal erosion is a main environmental concern which requires accurate aerial data. Aerial surveillance specialists – IMAO SAS have recently undertaken a photogrammetric survey in the North of France using their extra large format camera which incorporates Resolve Optics high performance lenses.\r\n\r\n<img class=\"alignnone  wp-image-4299\" src=\"https://microbiozindia.com/wp-content/uploads/2020/02/resolveopticspr174-imageA-300x200.jpg\" alt=\"\" width=\"372\" height=\"248\" />\r\n\r\nAerial Surveillance work depends on the weather, and is challenged every day by how much data you can acquire when the sky is clear. Incorporating 3 ultra large format, low distortion custom lenses, developed by Resolve Optics, the IMAO B66 extra large format camera produces high quality aerial surveillance images two to three times larger than the standard image size generated by other large format cameras on the market. As a consequence not only are less images required for geographic data mapping but also these images require less processing time saving operators time and money.\r\n\r\nIn 2017, IMAO SAS and Resolve Optics Ltd. received €1.68 million funding from a European Union Horizon 2020 programme to develop an ultra-large format aerial surveillance camera.\r\n\r\nFor further information on development of low distortion, large format lenses matched to your application please contact Resolve Optics Ltd. on +44-1494-777100 or sales@resolveoptics.com\r\n\r\nDrawing upon approaching 30 years experience – Resolve Optics Ltd. has built a strong reputation for specialist lens design and manufacture of production quantities of low distortion, large format lenses on time to strict quality and target price guidelines. The company has the proven and rare capability to produce OEM quantities of specialist lenses with the look, feel and quality equivalent to the best professional photographic lenses.','Improving Surveillance of Coastal Erosion','','publish','open','open','','improving-surveillance-of-coastal-erosion','','','2020-02-19 12:16:13','2020-02-19 12:16:13','',0,'https://microbiozindia.com/?p=4297',0,'post','',0),(4298,2,'2020-02-19 12:15:29','2020-02-19 12:15:29','','AAADDD','','inherit','open','closed','','aaaddd','','','2020-02-19 12:15:29','2020-02-19 12:15:29','',4297,'https://microbiozindia.com/wp-content/uploads/2020/02/AAADDD.png',0,'attachment','image/png',0),(4299,2,'2020-02-19 12:15:31','2020-02-19 12:15:31','','resolveopticspr174-imageA','','inherit','open','closed','','resolveopticspr174-imagea','','','2020-02-19 12:15:31','2020-02-19 12:15:31','',4297,'https://microbiozindia.com/wp-content/uploads/2020/02/resolveopticspr174-imageA.jpg',0,'attachment','image/jpeg',0),(4300,2,'2020-02-19 12:16:13','2020-02-19 12:16:13','Resolve Optics reports on how ultra large format lenses it has developed are helping a next generation aerial surveillance camera gain data on coastal erosion faster and in more detail.\r\n\r\nCoastal erosion is a main environmental concern which requires accurate aerial data. Aerial surveillance specialists – IMAO SAS have recently undertaken a photogrammetric survey in the North of France using their extra large format camera which incorporates Resolve Optics high performance lenses.\r\n\r\n<img class=\"alignnone  wp-image-4299\" src=\"https://microbiozindia.com/wp-content/uploads/2020/02/resolveopticspr174-imageA-300x200.jpg\" alt=\"\" width=\"372\" height=\"248\" />\r\n\r\nAerial Surveillance work depends on the weather, and is challenged every day by how much data you can acquire when the sky is clear. Incorporating 3 ultra large format, low distortion custom lenses, developed by Resolve Optics, the IMAO B66 extra large format camera produces high quality aerial surveillance images two to three times larger than the standard image size generated by other large format cameras on the market. As a consequence not only are less images required for geographic data mapping but also these images require less processing time saving operators time and money.\r\n\r\nIn 2017, IMAO SAS and Resolve Optics Ltd. received €1.68 million funding from a European Union Horizon 2020 programme to develop an ultra-large format aerial surveillance camera.\r\n\r\nFor further information on development of low distortion, large format lenses matched to your application please contact Resolve Optics Ltd. on +44-1494-777100 or sales@resolveoptics.com\r\n\r\nDrawing upon approaching 30 years experience – Resolve Optics Ltd. has built a strong reputation for specialist lens design and manufacture of production quantities of low distortion, large format lenses on time to strict quality and target price guidelines. The company has the proven and rare capability to produce OEM quantities of specialist lenses with the look, feel and quality equivalent to the best professional photographic lenses.','Improving Surveillance of Coastal Erosion','','inherit','closed','closed','','4297-revision-v1','','','2020-02-19 12:16:13','2020-02-19 12:16:13','',4297,'https://microbiozindia.com/uncategorized/4297-revision-v1/',0,'revision','',0),(4301,2,'2020-02-24 15:51:19','2020-02-24 15:51:19','Testa Analytical Solutions e.K reports on its development of a unique high temperature UV detector for a leading European polymer research centre.\r\n\r\nThe new high temperature UV detector is being used as part of a temperature-dependent size exclusion chromatography (TD-SEC) system to provide insights into reaction processes that were not accessible with previous methods. By measuring the size of macromolecules during polymerisation, it is now possible to obtain information about the mechanisms of attachment and cleavage of chemical bonds triggered by temperature changes and thus to better understand the thermodynamics of reactions.\r\n\r\nDr Carlo Dessy, Managing Director of Testa Analytical said \"Operate over a wide temperature range (25 to 200 °C) the potential applications for TD-SEC are considerable. Since essentially only changes in the size of polymers and molar mass distribution are observed, the TD-SEC technique can be used to study many polymer systems without preconditions (such as the presence of certain functional groups required by some spectroscopic methods). Using the TD-SEC technique allows researchers to determine complete molar mass distributions rather than average values. The integration of our new high-temperature UV detector into the TD-SEC system has enabled chemical composition to be determined in even greater depth\".\r\n\r\nHe added \"Initial work using the TD-SEC system with high temperature UV detector has focused on the development of novel self-healing materials. In this work the researchers are investigating temperature-dependent binding mechanisms that restore the chemical structure of polymer materials after they had been damaged\".\r\n\r\nBacked by decades of experience, Testa Analytical has created a range of high-performance GPC/SEC detectors, GPC/SEC Pumps, accessories and software products customizable to meet your exact needs. Our team of knowledgeable technical and engineering staff are available to discuss your OEM needs and to provide seamless integration of our technology into your existing or new product.\r\n\r\nFor further information on contract OEM development of optimised GPC/SEC detectors and systems please visit www.testa-analytical.com/oem-projects.html or contact Testa Analytical Solutions on +49-30-864-24076 / info@testa-analytical.com.\r\n\r\nTesta Analytical Solutions e.K. is a company dedicated to supplying the best possible instrumental solutions for characterization of polymers, particles, nanomaterials and proteins. Drawing upon over 30 years’ experience of technologies serving these markets, the staff at Testa Analytical are happy to share their knowledge with researchers worldwide to help provide them with a working solution for even the most demanding applications.','UV Detector for High Temperature Applications','','publish','open','open','','uv-detector-for-high-temperature-applications','','','2020-02-24 16:22:36','2020-02-24 16:22:36','',0,'https://microbiozindia.com/?p=4301',0,'post','',0),(4302,2,'2020-02-24 15:50:45','2020-02-24 15:50:45','','TestaPR32-imageA','','inherit','open','closed','','testapr32-imagea','','','2020-02-24 15:50:45','2020-02-24 15:50:45','',4301,'https://microbiozindia.com/wp-content/uploads/2020/02/TestaPR32-imageA.jpg',0,'attachment','image/jpeg',0),(4303,2,'2020-02-24 15:51:19','2020-02-24 15:51:19','Testa Analytical Solutions e.K reports on its development of a unique high temperature UV detector for a leading European polymer research centre.\r\n\r\nThe new high temperature UV detector is being used as part of a temperature-dependent size exclusion chromatography (TD-SEC) system to provide insights into reaction processes that were not accessible with previous methods. By measuring the size of macromolecules during polymerisation, it is now possible to obtain information about the mechanisms of attachment and cleavage of chemical bonds triggered by temperature changes and thus to better understand the thermodynamics of reactions.\r\n\r\nDr Carlo Dessy, Managing Director of Testa Analytical said \"Operate over a wide temperature range (25 to 200 °C) the potential applications for TD-SEC are considerable. Since essentially only changes in the size of polymers and molar mass distribution are observed, the TD-SEC technique can be used to study many polymer systems without preconditions (such as the presence of certain functional groups required by some spectroscopic methods). Using the TD-SEC technique allows researchers to determine complete molar mass distributions rather than average values. The integration of our new high-temperature UV detector into the TD-SEC system has enabled chemical composition to be determined in even greater depth\".\r\n\r\nHe added \"Initial work using the TD-SEC system with high temperature UV detector has focused on the development of novel self-healing materials. In this work the researchers are investigating temperature-dependent binding mechanisms that restore the chemical structure of polymer materials after they had been damaged\".\r\n\r\nBacked by decades of experience, Testa Analytical has created a range of high-performance GPC/SEC detectors, GPC/SEC Pumps, accessories and software products customizable to meet your exact needs. Our team of knowledgeable technical and engineering staff are available to discuss your OEM needs and to provide seamless integration of our technology into your existing or new product.\r\n\r\nFor further information on contract OEM development of optimised GPC/SEC detectors and systems please visit www.testa-analytical.com/oem-projects.html or contact Testa Analytical Solutions on +49-30-864-24076 / info@testa-analytical.com.\r\n\r\nTesta Analytical Solutions e.K. is a company dedicated to supplying the best possible instrumental solutions for characterization of polymers, particles, nanomaterials and proteins. Drawing upon over 30 years’ experience of technologies serving these markets, the staff at Testa Analytical are happy to share their knowledge with researchers worldwide to help provide them with a working solution for even the most demanding applications.','UV Detector for High Temperature Applications','','inherit','closed','closed','','4301-revision-v1','','','2020-02-24 15:51:19','2020-02-24 15:51:19','',4301,'https://microbiozindia.com/uncategorized/4301-revision-v1/',0,'revision','',0),(4304,2,'2020-02-24 16:16:47','2020-02-24 16:16:47','','fgg','','inherit','open','closed','','fgg','','','2020-02-24 16:16:47','2020-02-24 16:16:47','',4301,'https://microbiozindia.com/wp-content/uploads/2020/02/fgg.png',0,'attachment','image/png',0),(4305,2,'2020-02-25 18:12:51','2020-02-25 18:12:51','At this year’s Analytica exhibition, Postnova Analytics will present its unmatched line-up of high-performance field-flow fractionation instruments, detectors and ground breaking applications data.\r\n\r\nAt the Messe München Conference Centre / Stand A1.322, visitors will be able to see live demonstrations of new NovaAnalysis software, the pioneering EAF2000 Electrical Asymmetrical Field-Flow Fractionation system and meet the Postnova Analytics team.\r\n\r\n<img class=\"alignnone size-medium wp-image-4307\" src=\"https://microbiozindia.com/wp-content/uploads/2020/02/postnovapr39-imageB-300x300.png\" alt=\"\" width=\"300\" height=\"300\" />\r\n\r\nAt the event, Dr Gerhard Heinzmann will give a presentation entitled \'The Technology of Field-Flow Fractionation (FFF)\'. In this new talk - different kinds of FFF-techniques will be discussed in the context of benefits they offer in the fields of biopharmaceuticals, polymers, nanotechnology and environmental analysis. In addition, Dr Heinzmann will cover the coupling of FFF with a variety of different detectors including Multi-Angle Light Scattering (MALS), Dynamic Light Scattering (DLS), Raman Microscopy and Inductively Coupled Plasma/Mass Spectrometry (ICP/MS).\r\n\r\nThe Postnova Analytics team will also present a series of new applications data by means of poster displays on topics including \'Hyphenation of FFF and ICP/MS overcomes the limitations of ICP/MS\' and \'Electrical Asymmetrical Field-Flow Fractionation for the analysis of size distribution, aspect ratio and surface charge of cellulose nanocrystals\'.\r\n\r\nIf you are not able attend Analytica 2020 – copies of the application posters, the talk and information about the Field Flow Fractionation products on show will be available (after the event) by contacting Postnova Analytics on +49-8191-985-6880 / +44-1885-475007 / +1-801-521-2004 or info@postnova.com.\r\nFounded in 1997, Postnova Analytics is the inventor and leading international supplier of Field-Flow Fractionation (FFF) systems for markets including biopharmaceuticals, polymers, materials, nanotechnology and environmental sciences. Leveraging its unique and patented modular FFF - Light Scattering Platform, Postnova has been able to provide high performance solutions to a wide range of applications. Today the company\'s growing product portfolio also includes Flow FFF, Centrifugal FFF, Thermal FFF, Size Exclusion Chromatography (SEC), MALS and DLS. Postnova (www.postnova.com) is located and headquartered in Landsberg am Lech (Germany) and has subsidiaries in the USA, UK and Finland. These offices, in conjunction with a highly qualified and trained distribution network, provide informed local support to customers worldwide.','Comprehensive Characterisation by Field-Flow Fractionation','','publish','open','open','','comprehensive-characterisation-by-field-flow-fractionation','','','2020-02-25 18:12:51','2020-02-25 18:12:51','',0,'https://microbiozindia.com/?p=4305',0,'post','',0),(4306,2,'2020-02-25 18:11:58','2020-02-25 18:11:58','','HFFH','','inherit','open','closed','','hffh','','','2020-02-25 18:11:58','2020-02-25 18:11:58','',4305,'https://microbiozindia.com/wp-content/uploads/2020/02/HFFH.png',0,'attachment','image/png',0),(4307,2,'2020-02-25 18:12:32','2020-02-25 18:12:32','','postnovapr39-imageB','','inherit','open','closed','','postnovapr39-imageb','','','2020-02-25 18:12:32','2020-02-25 18:12:32','',4305,'https://microbiozindia.com/wp-content/uploads/2020/02/postnovapr39-imageB.png',0,'attachment','image/png',0),(4308,2,'2020-02-25 18:12:51','2020-02-25 18:12:51','At this year’s Analytica exhibition, Postnova Analytics will present its unmatched line-up of high-performance field-flow fractionation instruments, detectors and ground breaking applications data.\r\n\r\nAt the Messe München Conference Centre / Stand A1.322, visitors will be able to see live demonstrations of new NovaAnalysis software, the pioneering EAF2000 Electrical Asymmetrical Field-Flow Fractionation system and meet the Postnova Analytics team.\r\n\r\n<img class=\"alignnone size-medium wp-image-4307\" src=\"https://microbiozindia.com/wp-content/uploads/2020/02/postnovapr39-imageB-300x300.png\" alt=\"\" width=\"300\" height=\"300\" />\r\n\r\nAt the event, Dr Gerhard Heinzmann will give a presentation entitled \'The Technology of Field-Flow Fractionation (FFF)\'. In this new talk - different kinds of FFF-techniques will be discussed in the context of benefits they offer in the fields of biopharmaceuticals, polymers, nanotechnology and environmental analysis. In addition, Dr Heinzmann will cover the coupling of FFF with a variety of different detectors including Multi-Angle Light Scattering (MALS), Dynamic Light Scattering (DLS), Raman Microscopy and Inductively Coupled Plasma/Mass Spectrometry (ICP/MS).\r\n\r\nThe Postnova Analytics team will also present a series of new applications data by means of poster displays on topics including \'Hyphenation of FFF and ICP/MS overcomes the limitations of ICP/MS\' and \'Electrical Asymmetrical Field-Flow Fractionation for the analysis of size distribution, aspect ratio and surface charge of cellulose nanocrystals\'.\r\n\r\nIf you are not able attend Analytica 2020 – copies of the application posters, the talk and information about the Field Flow Fractionation products on show will be available (after the event) by contacting Postnova Analytics on +49-8191-985-6880 / +44-1885-475007 / +1-801-521-2004 or info@postnova.com.\r\nFounded in 1997, Postnova Analytics is the inventor and leading international supplier of Field-Flow Fractionation (FFF) systems for markets including biopharmaceuticals, polymers, materials, nanotechnology and environmental sciences. Leveraging its unique and patented modular FFF - Light Scattering Platform, Postnova has been able to provide high performance solutions to a wide range of applications. Today the company\'s growing product portfolio also includes Flow FFF, Centrifugal FFF, Thermal FFF, Size Exclusion Chromatography (SEC), MALS and DLS. Postnova (www.postnova.com) is located and headquartered in Landsberg am Lech (Germany) and has subsidiaries in the USA, UK and Finland. These offices, in conjunction with a highly qualified and trained distribution network, provide informed local support to customers worldwide.','Comprehensive Characterisation by Field-Flow Fractionation','','inherit','closed','closed','','4305-revision-v1','','','2020-02-25 18:12:51','2020-02-25 18:12:51','',4305,'https://microbiozindia.com/uncategorized/4305-revision-v1/',0,'revision','',0),(4309,2,'2020-02-27 12:22:48','2020-02-27 12:22:48','Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives today announced the first to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets approved by the U.S. Food and Drug Administration (USFDA).\r\n“This launch is a testament to our core strengths in areas of research and development and intellectual property,” says Marc Kikuchi, Chief Executive Officer, North America Generics. “We are excited to be a part of forming the first generic market for Vimovo® Tablets and to provide an affordable treatment alternative for patients.” The Vimovo® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets brand had U.S. sales of approximately $414 million MAT for the most recent twelve months ending in December 2019 according to IQVIA Health*. Dr. Reddy’s Naproxen and Esomeprazole Magnesium Delayed-Release Tablets are available in 375 mg/20 mg and 500 mg/20 mg tablets in bottle count sizes of 60.','Dr. Reddy’s announces the launch of therapeutic equivalent generic version of Vimovo®','','publish','open','open','','dr-reddys-announces-the-launch-therapeutic-equivalent-generic-version-of-vimovo','','','2020-02-27 14:38:23','2020-02-27 14:38:23','',0,'https://microbiozindia.com/?p=4309',0,'post','',0),(4310,2,'2020-02-27 12:22:29','2020-02-27 12:22:29','','DD','','inherit','open','closed','','dd-2','','','2020-02-27 12:22:29','2020-02-27 12:22:29','',4309,'https://microbiozindia.com/wp-content/uploads/2020/02/DD.png',0,'attachment','image/png',0),(4311,2,'2020-02-27 12:22:48','2020-02-27 12:22:48','Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives today announced the first to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets approved by the U.S. Food and Drug Administration (USFDA).\r\n“This launch is a testament to our core strengths in areas of research and development and intellectual property,” says Marc Kikuchi, Chief Executive Officer, North America Generics. “We are excited to be a part of forming the first generic market for Vimovo® Tablets and to provide an affordable treatment alternative for patients.” The Vimovo® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets brand had U.S. sales of approximately $414 million MAT for the most recent twelve months ending in December 2019 according to IQVIA Health*. Dr. Reddy’s Naproxen and Esomeprazole Magnesium Delayed-Release Tablets are available in 375 mg/20 mg and 500 mg/20 mg tablets in bottle count sizes of 60.','Dr. Reddy’s announces the launch therapeutic equivalent generic version of Vimovo®','','inherit','closed','closed','','4309-revision-v1','','','2020-02-27 12:22:48','2020-02-27 12:22:48','',4309,'https://microbiozindia.com/uncategorized/4309-revision-v1/',0,'revision','',0),(4312,2,'2020-02-27 14:25:11','2020-02-27 14:25:11','','352x286','','inherit','open','closed','','352x286','','','2020-02-27 14:25:11','2020-02-27 14:25:11','',3645,'https://microbiozindia.com/wp-content/uploads/2019/11/352x286.jpg',0,'attachment','image/jpeg',0),(4313,2,'2020-02-27 14:27:42','2020-02-27 14:27:42','','IPR 352x286','','inherit','open','closed','','ipr-352x286','','','2020-02-27 14:27:42','2020-02-27 14:27:42','',26,'https://microbiozindia.com/wp-content/uploads/2019/11/IPR-352x286-1.gif',0,'attachment','image/gif',0),(4314,2,'2020-07-22 11:22:54','2020-07-22 11:22:54','','Thermo Fisher','','inherit','closed','closed','','3649-autosave-v1','','','2020-07-22 11:22:54','2020-07-22 11:22:54','',3649,'https://microbiozindia.com/uncategorized/3649-autosave-v1/',0,'revision','',0),(4315,2,'2020-02-27 14:29:55','2020-02-27 14:29:55','','798x103','','inherit','open','closed','','798x103','','','2020-02-27 14:29:55','2020-02-27 14:29:55','',3649,'https://microbiozindia.com/wp-content/uploads/2019/11/798x103.gif',0,'attachment','image/gif',0),(4317,2,'2020-02-27 14:31:12','2020-02-27 14:31:12','','PAT QbD 352x286','','inherit','open','closed','','pat-qbd-352x286','','','2020-02-27 14:31:12','2020-02-27 14:31:12','',0,'https://microbiozindia.com/wp-content/uploads/2020/02/PAT-QbD-352x286-1.jpg',0,'attachment','image/jpeg',0),(4319,2,'2020-02-27 14:34:05','2020-02-27 14:34:05','','MT','','publish','closed','closed','','ipr-2','','','2020-05-04 16:04:53','2020-05-04 16:04:53','',0,'https://microbiozindia.com/?post_type=ads&#038;p=4319',0,'ads','',0),(4320,2,'2020-02-27 14:33:56','2020-02-27 14:33:56','','IPR 798x103','','inherit','open','closed','','ipr-798x103','','','2020-02-27 14:33:56','2020-02-27 14:33:56','',4319,'https://microbiozindia.com/wp-content/uploads/2020/02/IPR-798x103-1.jpg',0,'attachment','image/jpeg',0),(4321,2,'2020-02-27 14:38:23','2020-02-27 14:38:23','Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives today announced the first to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets approved by the U.S. Food and Drug Administration (USFDA).\r\n“This launch is a testament to our core strengths in areas of research and development and intellectual property,” says Marc Kikuchi, Chief Executive Officer, North America Generics. “We are excited to be a part of forming the first generic market for Vimovo® Tablets and to provide an affordable treatment alternative for patients.” The Vimovo® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets brand had U.S. sales of approximately $414 million MAT for the most recent twelve months ending in December 2019 according to IQVIA Health*. Dr. Reddy’s Naproxen and Esomeprazole Magnesium Delayed-Release Tablets are available in 375 mg/20 mg and 500 mg/20 mg tablets in bottle count sizes of 60.','Dr. Reddy’s announces the launch of therapeutic equivalent generic version of Vimovo®','','inherit','closed','closed','','4309-revision-v1','','','2020-02-27 14:38:23','2020-02-27 14:38:23','',4309,'https://microbiozindia.com/uncategorized/4309-revision-v1/',0,'revision','',0),(4322,2,'2020-02-25 17:54:59','2020-02-25 17:54:59','Quality is the utmost important thing in the pharmaceutical industry as people’s lives are directly dependent on the quality of medicines given to them for the treatment of diseases. The pharmaceutical quality control laboratory serves one of the most important functions in pharmaceutical production and control. A significant portion of the CGMP regulations pertain to the quality control laboratory and product testing.Similar concepts apply to bulk drugs. In pharmaceutical manufacturing, analytical procedures are involved in various stages such as the quality control of raw materials and products, effluent monitoring,pharmacokinetics, pharmacological assays, clinical trials, stability indicating assays, impurities profiling etc.','Green Analytics:Food,Water and Environmental Analysis in Pharmaceutical Drug Manufacturing','','publish','closed','closed','','green-analyticsfoodwater-and-environmental-analysis-in-pharmaceutical-drig-manufacturing','','','2020-04-02 17:53:16','2020-04-02 17:53:16','',0,'https://microbiozindia.com/?post_type=magazines&#038;p=4322',0,'magazines','',0),(4324,2,'2020-03-03 17:58:10','2020-03-03 17:58:10','','rsz_aa','','inherit','open','closed','','rsz_aa','','','2020-03-03 17:58:10','2020-03-03 17:58:10','',4322,'https://microbiozindia.com/wp-content/uploads/2020/03/rsz_aa.png',0,'attachment','image/png',0),(4325,2,'2020-03-03 17:58:11','2020-03-03 17:58:11','','WEB001 (1)','','inherit','open','closed','','web001-1-2','','','2020-03-03 17:58:11','2020-03-03 17:58:11','',4322,'https://microbiozindia.com/wp-content/uploads/2020/03/WEB001-1.png',0,'attachment','image/png',0),(4326,2,'2020-03-03 17:58:12','2020-03-03 17:58:12','','WEB001 (2)','','inherit','open','closed','','web001-2-2','','','2020-03-03 17:58:12','2020-03-03 17:58:12','',4322,'https://microbiozindia.com/wp-content/uploads/2020/03/WEB001-2.png',0,'attachment','image/png',0),(4327,2,'2020-03-03 17:58:13','2020-03-03 17:58:13','','WEB001 (3)','','inherit','open','closed','','web001-3-2','','','2020-03-03 17:58:13','2020-03-03 17:58:13','',4322,'https://microbiozindia.com/wp-content/uploads/2020/03/WEB001-3.png',0,'attachment','image/png',0),(4328,2,'2020-03-03 17:58:14','2020-03-03 17:58:14','','WEB001 (4)','','inherit','open','closed','','web001-4-2','','','2020-03-03 17:58:14','2020-03-03 17:58:14','',4322,'https://microbiozindia.com/wp-content/uploads/2020/03/WEB001-4.png',0,'attachment','image/png',0),(4329,2,'2020-03-03 18:13:35','2020-03-03 18:13:35','Quality is the utmost important thing in the pharmaceutical industry as people’s lives are directly dependent on the quality of medicines given to them for the treatment of diseases. The pharmaceutical quality control laboratory serves one of the most important functions in pharmaceutical production and control. A significant portion of the CGMP regulations pertain to the quality control laboratory and product testing.Similar concepts apply to bulk drugs. In pharmaceutical manufacturing, analytical procedures are involved in various stages such as the quality control of raw materials and products, effluent monitoring,pharmacokinetics, pharmacological assays, clinical trials, stability indicating assays, impurities profiling etc.','Green Analytics:Food,Water and Environmental Analysis in Pharmaceutical Drig Manufacturing','','inherit','closed','closed','','4322-revision-v1','','','2020-03-03 18:13:35','2020-03-03 18:13:35','',4322,'https://microbiozindia.com/uncategorized/4322-revision-v1/',0,'revision','',0),(4330,2,'2020-03-05 13:25:05','2020-03-05 13:25:05','10 years old medication used to treat irritation in joint inflammation patients could be the response to the world\'s apprehensions of the coronavirus.\r\n\r\nActemra, an enemy of irritation medicate made by Swiss drugmaker Roche, has been endorsed by the Chinese government to treat serious coronavirus manifestations. This comes when nations around the globe are urgently looking for approaches to battle the fatal disease.\r\n\r\nThe Swiss medication creator gave about $2 million worth of Actemra to China, its neighborhood activities said in a blog entry on Monday.\r\n\r\nAs per reports, 14 genuine and fundamentally sick patients treated with existing drugs at a clinic subsidiary with the University of Science and Technology of China (USTC) demonstrated positive outcomes.\r\n\r\nSince Actemra\'s endorsement 10 years back, it has become the go-to tranquilize for incendiary conditions, incorporating cytokine storms in malignant growth patients accepting cell treatment.\r\n\r\nThe Swiss organization, for which China is its No. 2 market behind the United States, is likewise making indicative rigging to recognize the coronavirus.\r\n\r\nAs of now, there is no distributed clinical preliminary information on the medication\'s security or viability against the infection.\r\n\r\nIn excess of 3,000 individuals have kicked the bucket and 93,000 have been contaminated by the novel coronavirus thought to have begun in Wuhan, China, before spreading to around 90 nations including the United States, Italy, Switzerland, France and Germany, and India.','Coronavirus medication: A joint inflammation medication could be the appropriate response everybody is searching for','','publish','open','open','','coronavirus-medication-a-joint-inflammation-medication-could-be-the-appropriate-response-everybody-is-searching-for','','','2020-03-05 13:25:05','2020-03-05 13:25:05','',0,'https://microbiozindia.com/?p=4330',0,'post','',0),(4331,2,'2020-03-05 13:24:55','2020-03-05 13:24:55','','CORONA','','inherit','open','closed','','corona','','','2020-03-05 13:24:55','2020-03-05 13:24:55','',4330,'https://microbiozindia.com/wp-content/uploads/2020/03/CORONA.png',0,'attachment','image/png',0),(4332,2,'2020-03-05 13:25:05','2020-03-05 13:25:05','10 years old medication used to treat irritation in joint inflammation patients could be the response to the world\'s apprehensions of the coronavirus.\r\n\r\nActemra, an enemy of irritation medicate made by Swiss drugmaker Roche, has been endorsed by the Chinese government to treat serious coronavirus manifestations. This comes when nations around the globe are urgently looking for approaches to battle the fatal disease.\r\n\r\nThe Swiss medication creator gave about $2 million worth of Actemra to China, its neighborhood activities said in a blog entry on Monday.\r\n\r\nAs per reports, 14 genuine and fundamentally sick patients treated with existing drugs at a clinic subsidiary with the University of Science and Technology of China (USTC) demonstrated positive outcomes.\r\n\r\nSince Actemra\'s endorsement 10 years back, it has become the go-to tranquilize for incendiary conditions, incorporating cytokine storms in malignant growth patients accepting cell treatment.\r\n\r\nThe Swiss organization, for which China is its No. 2 market behind the United States, is likewise making indicative rigging to recognize the coronavirus.\r\n\r\nAs of now, there is no distributed clinical preliminary information on the medication\'s security or viability against the infection.\r\n\r\nIn excess of 3,000 individuals have kicked the bucket and 93,000 have been contaminated by the novel coronavirus thought to have begun in Wuhan, China, before spreading to around 90 nations including the United States, Italy, Switzerland, France and Germany, and India.','Coronavirus medication: A joint inflammation medication could be the appropriate response everybody is searching for','','inherit','closed','closed','','4330-revision-v1','','','2020-03-05 13:25:05','2020-03-05 13:25:05','',4330,'https://microbiozindia.com/uncategorized/4330-revision-v1/',0,'revision','',0),(4333,2,'2020-03-05 13:38:55','2020-03-05 13:38:55','The US Congress has decided in favor of a $8.3bn crisis subsidizing bundle to battle the <a href=\"https://www.who.int/health-topics/coronavirus\">coronavirus.</a>\r\n\r\nThe move comes as the nation announced a sum of 11 passings, remembering one for California, the first outside Washington state. More cases have likewise risen in New York and Los Angeles with California pronouncing a highly sensitive situation.\r\n\r\nIn the interim Bosnia and Herzegovina, Slovenia and South Africa have denoted their first instances of coronavirus while the scriptural Church of Nativity in Bethlehem in the involved West Bank closes due to coronavirus fears.\r\n\r\nAll inclusive, in excess of 95,000 individuals have been determined to have <a href=\"https://www.cdc.gov/coronavirus/2019-ncov/about/share-facts.html\">COVID-19</a>, by far most in China where the infection began before the end of last year.','South Africa affirms first instance of coronavirus','','publish','open','open','','south-africa-affirms-first-instance-of-coronavirus','','','2020-03-05 13:42:01','2020-03-05 13:42:01','',0,'https://microbiozindia.com/?p=4333',0,'post','',0),(4334,2,'2020-03-05 13:38:45','2020-03-05 13:38:45','','unnamed','','inherit','open','closed','','unnamed','','','2020-03-05 13:38:45','2020-03-05 13:38:45','',4333,'https://microbiozindia.com/wp-content/uploads/2020/03/unnamed.jpg',0,'attachment','image/jpeg',0),(4335,2,'2020-03-05 13:38:55','2020-03-05 13:38:55','The US Congress has decided in favor of a $8.3bn crisis subsidizing bundle to battle the coronavirus.\r\n\r\nThe move comes as the nation announced a sum of 11 passings, remembering one for California, the first outside Washington state. More cases have likewise risen in New York and Los Angeles with California pronouncing a highly sensitive situation.\r\n\r\nIn the interim Bosnia and Herzegovina, Slovenia and South Africa have denoted their first instances of coronavirus while the scriptural Church of Nativity in Bethlehem in the involved West Bank closes due to coronavirus fears.\r\n\r\nAll inclusive, in excess of 95,000 individuals have been determined to have COVID-19, by far most in China where the infection began before the end of last year.','South Africa affirms first instance of coronavirus','','inherit','closed','closed','','4333-revision-v1','','','2020-03-05 13:38:55','2020-03-05 13:38:55','',4333,'https://microbiozindia.com/uncategorized/4333-revision-v1/',0,'revision','',0),(4336,2,'2020-03-05 13:41:44','2020-03-05 13:41:44','The US Congress has decided in favor of a $8.3bn crisis subsidizing bundle to battle the <a href=\"https://www.who.int/health-topics/coronavirus\">coronavirus.</a>\n\nThe move comes as the nation announced a sum of 11 passings, remembering one for California, the first outside Washington state. More cases have likewise risen in New York and Los Angeles with California pronouncing a highly sensitive situation.\n\nIn the interim Bosnia and Herzegovina, Slovenia and South Africa have denoted their first instances of coronavirus while the scriptural Church of Nativity in Bethlehem in the involved West Bank closes due to coronavirus fears.\n\nAll inclusive, in excess of 95,000 individuals have been determined to have COVID-19, by far most in China where the infection began before the end of last year.','South Africa affirms first instance of coronavirus','','inherit','closed','closed','','4333-autosave-v1','','','2020-03-05 13:41:44','2020-03-05 13:41:44','',4333,'https://microbiozindia.com/uncategorized/4333-autosave-v1/',0,'revision','',0),(4337,2,'2020-03-05 13:42:01','2020-03-05 13:42:01','The US Congress has decided in favor of a $8.3bn crisis subsidizing bundle to battle the <a href=\"https://www.who.int/health-topics/coronavirus\">coronavirus.</a>\r\n\r\nThe move comes as the nation announced a sum of 11 passings, remembering one for California, the first outside Washington state. More cases have likewise risen in New York and Los Angeles with California pronouncing a highly sensitive situation.\r\n\r\nIn the interim Bosnia and Herzegovina, Slovenia and South Africa have denoted their first instances of coronavirus while the scriptural Church of Nativity in Bethlehem in the involved West Bank closes due to coronavirus fears.\r\n\r\nAll inclusive, in excess of 95,000 individuals have been determined to have <a href=\"https://www.cdc.gov/coronavirus/2019-ncov/about/share-facts.html\">COVID-19</a>, by far most in China where the infection began before the end of last year.','South Africa affirms first instance of coronavirus','','inherit','closed','closed','','4333-revision-v1','','','2020-03-05 13:42:01','2020-03-05 13:42:01','',4333,'https://microbiozindia.com/uncategorized/4333-revision-v1/',0,'revision','',0),(4338,2,'2020-03-06 03:46:05','2020-03-06 03:46:05','Zydus Cadila has gotten endorsement from the Drug Controller General of India (DCGI) for its new medication application for Saroglitazar to treat a specific state of liver, regularly known as NASH in India, the medication major said on Thursday.\r\n\r\nThe Ahmedabad-based organization said the affirmed item is the first since forever tranquilize anyplace on the planet for treatment of Non-Cirrhotic Non-Alcoholic SteatoHepatitis (NASH) which is a dynamic ailment of the liver.\r\n\r\nThe condition begins with fat collection in the liver known as non-alcoholic greasy liver ailment and progress to cirrhosis and liver disappointment.\r\n\r\nRemarking on the endorsement, Zydus Group Chairman Pankaj Patel stated, \"We are cheerful that our endeavors to find and build up a novel medication for patients living with NASH, a neglected social insurance need all around, have been effective. Saroglitazar will give trust and new rent of life for many patients in India experiencing NASH\".\r\n\r\nThe organization had propelled Saroglitazar in India in September 2013 for treatment of diabetic dyslipidemia and hypertriglyceridemia in patients with Type-2 diabetes not constrained by statins alone.\r\n\r\nIn January this year, Saroglitazar got an endorsement for the treatment of Type-2 diabetes Mellitus. Over the most recent seven years, over a million patients have profited by this medication, Zydua Cadila said.','Zydus Cadila gets DCGI gesture for world\'s first medication to treat liver illness','','publish','open','open','','zydus-cadila-gets-dcgi-nod-for-worlds-first-drug-to-treat-liver-disease','','','2020-03-06 03:51:27','2020-03-06 03:51:27','',0,'https://microbiozindia.com/?p=4338',0,'post','',0),(4339,2,'2020-03-06 03:45:56','2020-03-06 03:45:56','','tt','','inherit','open','closed','','tt-2','','','2020-03-06 03:45:56','2020-03-06 03:45:56','',4338,'https://microbiozindia.com/wp-content/uploads/2020/03/tt.png',0,'attachment','image/png',0),(4340,2,'2020-03-06 03:46:05','2020-03-06 03:46:05','Zydus Cadila has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular condition of liver, commonly known as NASH in India, the drug major said on Thursday.\r\n\r\nThe Ahmedabad-based company said the approved product is the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoholic SteatoHepatitis (NASH) which is a progressive disease of the liver.\r\n\r\nThe condition starts with fat accumulation in the liver known as non-alcoholic fatty liver disease and progress to cirrhosis and liver failure.\r\n\r\nCommenting on the approval, Zydus Group Chairman Pankaj Patel said, \"We are happy that our efforts to discover and develop a novel drug for patients living with NASH, an unmet healthcare need globally, have been successful. Saroglitazar will provide hope and new lease of life for millions of patients in India suffering from NASH\".\r\n\r\nThe company had launched Saroglitazar in India in September 2013 for treatment of diabetic dyslipidemia and hypertriglyceridemia in patients with Type-2 diabetes not controlled by statins alone.\r\n\r\nIn January this year, Saroglitazar received an approval for the treatment of Type-2 diabetes Mellitus. In the last seven years, over a million patients have benefitted from this drug, Zydua Cadila said.\r\n\r\n&nbsp;','Zydus Cadila gets DCGI nod for world\'s first drug to treat liver disease','','inherit','closed','closed','','4338-revision-v1','','','2020-03-06 03:46:05','2020-03-06 03:46:05','',4338,'https://microbiozindia.com/uncategorized/4338-revision-v1/',0,'revision','',0),(4341,2,'2020-03-06 03:51:27','2020-03-06 03:51:27','Zydus Cadila has gotten endorsement from the Drug Controller General of India (DCGI) for its new medication application for Saroglitazar to treat a specific state of liver, regularly known as NASH in India, the medication major said on Thursday.\r\n\r\nThe Ahmedabad-based organization said the affirmed item is the first since forever tranquilize anyplace on the planet for treatment of Non-Cirrhotic Non-Alcoholic SteatoHepatitis (NASH) which is a dynamic ailment of the liver.\r\n\r\nThe condition begins with fat collection in the liver known as non-alcoholic greasy liver ailment and progress to cirrhosis and liver disappointment.\r\n\r\nRemarking on the endorsement, Zydus Group Chairman Pankaj Patel stated, \"We are cheerful that our endeavors to find and build up a novel medication for patients living with NASH, a neglected social insurance need all around, have been effective. Saroglitazar will give trust and new rent of life for many patients in India experiencing NASH\".\r\n\r\nThe organization had propelled Saroglitazar in India in September 2013 for treatment of diabetic dyslipidemia and hypertriglyceridemia in patients with Type-2 diabetes not constrained by statins alone.\r\n\r\nIn January this year, Saroglitazar got an endorsement for the treatment of Type-2 diabetes Mellitus. Over the most recent seven years, over a million patients have profited by this medication, Zydua Cadila said.','Zydus Cadila gets DCGI gesture for world\'s first medication to treat liver illness','','inherit','closed','closed','','4338-revision-v1','','','2020-03-06 03:51:27','2020-03-06 03:51:27','',4338,'https://microbiozindia.com/uncategorized/4338-revision-v1/',0,'revision','',0),(4342,2,'2020-03-06 08:12:35','2020-03-06 08:12:35','A severe prohibition on the utilization and cultivating of wild creatures is being turned out across China in the wake of the lethal coronavirus pandemic, which is accepted to have begun at an untamed life advertise in Wuhan.\r\n\r\nIn spite of the fact that it is hazy which creature moved the infection to people - bat, snake and pangolin have all been recommended - China has recognized it needs to manage its rewarding untamed life industry on the off chance that it is to forestall another episode.\r\n\r\nIn late February, it slapped a brief prohibition on all cultivating and utilization of \"earthbound natural life of significant biological, logical and social worth,\" which is relied upon to be marked into law in the not so distant future.\r\n\r\nYet, finishing the exchange will be hard. The social underlying foundations of China\'s utilization of wild creatures run profound, for nourishment as well as for customary medication, apparel, decorations and even pets.\r\n\r\nThis isn\'t the first run through Chinese authorities have attempted to contain the exchange. In 2003, civets - mongoose-type animals - were prohibited and separated in enormous numbers after it was found they likely moved the SARS infection to people. The selling of snakes was additionally quickly restricted in Guangzhou after the SARS episode.\r\n\r\nBe that as it may, today dishes utilizing the creatures are still eaten in parts of China.\r\n\r\nGeneral wellbeing specialists state the boycott is a significant initial step, however are approaching Beijing to take advantage of this urgent lucky break to close escape clauses -, for example, the utilization of wild creatures in conventional Chinese medication - and start to change social mentalities in China around devouring untamed life.','China has made eating wild creatures unlawful after the coronavirus flare-up. Be that as it may, finishing the exchange won\'t be simple','','publish','open','open','','china-has-made-eating-wild-creatures-unlawful-after-the-coronavirus-flare-up-be-that-as-it-may-finishing-the-exchange-wont-be-simple','','','2020-03-06 08:12:35','2020-03-06 08:12:35','',0,'https://microbiozindia.com/?p=4342',0,'post','',0),(4343,2,'2020-03-06 08:12:02','2020-03-06 08:12:02','','merlin_167707287_451f14a2-c84f-4911-9d89-e54ad2d342c1-superJumbo','','inherit','open','closed','','merlin_167707287_451f14a2-c84f-4911-9d89-e54ad2d342c1-superjumbo','','','2020-03-06 08:12:02','2020-03-06 08:12:02','',4342,'https://microbiozindia.com/wp-content/uploads/2020/03/merlin_167707287_451f14a2-c84f-4911-9d89-e54ad2d342c1-superJumbo.jpg',0,'attachment','image/jpeg',0),(4344,2,'2020-03-06 08:12:35','2020-03-06 08:12:35','A severe prohibition on the utilization and cultivating of wild creatures is being turned out across China in the wake of the lethal coronavirus pandemic, which is accepted to have begun at an untamed life advertise in Wuhan.\r\n\r\nIn spite of the fact that it is hazy which creature moved the infection to people - bat, snake and pangolin have all been recommended - China has recognized it needs to manage its rewarding untamed life industry on the off chance that it is to forestall another episode.\r\n\r\nIn late February, it slapped a brief prohibition on all cultivating and utilization of \"earthbound natural life of significant biological, logical and social worth,\" which is relied upon to be marked into law in the not so distant future.\r\n\r\nYet, finishing the exchange will be hard. The social underlying foundations of China\'s utilization of wild creatures run profound, for nourishment as well as for customary medication, apparel, decorations and even pets.\r\n\r\nThis isn\'t the first run through Chinese authorities have attempted to contain the exchange. In 2003, civets - mongoose-type animals - were prohibited and separated in enormous numbers after it was found they likely moved the SARS infection to people. The selling of snakes was additionally quickly restricted in Guangzhou after the SARS episode.\r\n\r\nBe that as it may, today dishes utilizing the creatures are still eaten in parts of China.\r\n\r\nGeneral wellbeing specialists state the boycott is a significant initial step, however are approaching Beijing to take advantage of this urgent lucky break to close escape clauses -, for example, the utilization of wild creatures in conventional Chinese medication - and start to change social mentalities in China around devouring untamed life.','China has made eating wild creatures unlawful after the coronavirus flare-up. Be that as it may, finishing the exchange won\'t be simple','','inherit','closed','closed','','4342-revision-v1','','','2020-03-06 08:12:35','2020-03-06 08:12:35','',4342,'https://microbiozindia.com/uncategorized/4342-revision-v1/',0,'revision','',0),(4345,2,'2020-03-08 19:03:37','2020-03-08 19:03:37','The concepts of return on investment (ROI) and payback time are second nature to practicing engineers but that doesn’t mean that the associated calculations are always straight forward. When it comes to assessing analytical equipment then the upfront costs can be relatively easy to determine, but the potential return is significantly more difficult. Powder testing equipment is a particularly interesting example for the consideration of this issue. Testers for the measurement of powder flowability vary in price – from just a few thousand to tens of thousands of dollars – but also in terms of sophistication, level of automation, data quality and relevance.\r\n\r\nIn this article we consider how powder testing delivers value focusing on the features of off-line and at-line testers that are associated with higher returns. The aim is to support sound decision-making around the selection of a tester, based on rigorous economic assessment.\r\n\r\n<strong>The economic benefits of powder testing</strong>\r\nMaximizing the ROI on a powder tester relies in the first instance on realistically establishing what benefits an appropriately specified powder tester might deliver, and the value associated with them. Powder testers are used to assess powder flowability from early R&amp;D through to QC with each stage of the manufacturing cycle offering potential for economic gain.\r\n• Product development and formulation: In R&amp;D, powder testing can accelerate a program to a more successful conclusion. The most substantial economic prize is reduced time to market, which can dwarf other returns, but there is also potential for savings on pilot scale studies which can be both time-consuming and expensive, and for broader gains in experimental productivity.\r\n• Equipment design and selection: Powder testing that identifies optimal processing equipment for a given powder maximizes the likelihood of trouble-free operation over the long term, delivering economic returns by enhancing manufacturing efficiency - fewer unplanned shutdowns, for example, faster commissioning and/or less product re-work. For companies that specialize in the design and provision of powder processing solutions the ability to efficiently specify optimal solutions directly boosts productivity.\r\n• Process operation and troubleshooting: When powder processes fail to perform consistently powder testing can elucidate the cause of an operational problem and provide a secure foundation for the development of a rational solution. Solving operational problems, particularly long-standing ones, can deliver a significant economic dividend, by reducing production costs or increasing throughput, often with minimal capital expenditure.\r\n• Quality control (QC): In QC, powder testing detects a sub-standard raw material or product before it enters the plant or is released, respectively. The reliable detection of poor-quality raw materials avoids operational issues ranging from out-of-specification production to an unplanned shutdown, while the robust detection of compromised product quality safeguards profit margins and company reputation.\r\nThe valuable differences between powder testers\r\nCommercially available powder testers (Figure 1 - 3) vary considerably in terms of their ability to deliver these outlined economic benefits primarily due to substantial differences in:\r\n<img class=\"alignnone size-medium wp-image-4346\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/Figure-1-247x300.png\" alt=\"\" width=\"247\" height=\"300\" />\r\n\r\nFigure 1: Simple manual testers, such as those that measure flow through an orifice, are low cost but often lack the repeatability, sensitivity and relevance to directly address powder processing issues.\r\n<img class=\"alignnone size-medium wp-image-4347\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/Figure-2-151x300.png\" alt=\"\" width=\"151\" height=\"300\" />\r\n\r\nFigure 2: An automated uniaxial tester measures a single variable with high repeatability and reproducibility and can be a cost-efficient choice for routine testing in, for example, QC.\r\n<img class=\"alignnone size-medium wp-image-4348\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/Figure-3-223x300.png\" alt=\"\" width=\"223\" height=\"300\" />\r\n\r\nFigure 3: A powder tester that offers multiple test methodologies, in this case dynamic, shear and bulk property measurement, provides multi-faceted powder characterization that can be particularly valuable when faced with more complex processing or performance issues.\r\n<strong>• Relevance</strong>\r\nThough many powder testers measure just a single number, some generate multiple parameters, thereby providing more comprehensive insight into powder behavior. Techniques and testers also differ with respect to the extent to which the conditions applied during testing can be varied, with some allowing control of the test environment to simulate process conditions, to a greater or less extent.\r\nThe net result of these differences is that the data generated by a tester may, or may not, be relevant to the process of interest - the tester may detect a difference between samples that shows no correlation with powder performance in the process or application of interest. This issue, which is unique to powders, can significantly erode the value of a tester, particularly for more demanding applications.\r\n<strong>• Repeatability, reproducibility and sensitivity</strong>\r\nThese three parameters define the ability of a tester to detect difference, to differentiate one sample from another. A frequently encountered problem in powder processing is that materials classified as being the same go on to perform differently, because the tester is unable to provide adequate differentiation.\r\nRepeatability is a measure of instrument precision, the variability associated with repeat measurements of the same sample by the same operator, while reproducibility additionally incorporates operator-to-operator variability and errors associated with sampling and sample preparation. Sensitivity is an inherent characteristic of a technique but can also be affected by both repeatability and reproducibility so two instruments that use the same technique may differ in terms of sensitivity because of their design. A tester that uses an inherently sensitive technique and is engineered to deliver high repeatability and high reproducibility will be the most powerful and discriminating tool for testing closely similar powders.\r\n<strong>• Automation</strong>\r\nThe simplest powder testers are manually operated, with minimal automation. Upfront equipment costs are correspondingly low, a downside being that the labor cost for each measurement can be relatively high. Automation tends to be associated with more sophisticated techniques but keeps cost per measurement to a minimum and productivity high. Initial equipment costs for an automated instrument will reflect its greater complexity but a consideration of lifetime costs, factoring in labor based on typical usage, may more fairly reflect the economic merits of automation, over the long term.\r\n\r\nEqually importantly, automation offers the advantage of ensuring that a rigorously specified method is consistently applied, boosting the repeatability and reproducibility of a technique. It can therefore be a crucial foundation for achieving the sensitivity and discriminating power required for tougher powder testing challenges.\r\n\r\nThe following examples provide a simple illustration of how the relative importance of these features varies from application to application and demonstrate in principle how to estimate a ROI to justify investing in a suitably specified tester.\r\n<strong>Powder tester investment example 1:</strong>\r\nAn equipment supplier specifies turnkey powder processing solutions based on analyses of customer powder samples. The requirement is for a powder tester that will support the efficient identification of optimal processing equipment for a given powder and minimize the need for pilot scale trials.\r\nThis application calls for a tester with broad relevance, one that is suitable for powders across the cohesivity spectrum and that generates data that can be robustly correlated with a range of different unit operations. An instrument that measures multiple powder properties is likely to be particularly advantageous here, to enable the detailed characterization of each new material, and the development of a robust specification for powders that perform well in individual items of processing equipment.\r\nIn terms of economic return, accurate and relevant powder testing has the potential to accelerate the workflow of the whole company, boosting productivity at the specification stage, reducing the need for at-site modifications, and supporting trouble-free commissioning. If the average time taken to develop and deliver each solution is reduced from t1 to t2 then it is possible to serve an increased number of customers in each year, delivering an associated annualized economic gain that can be calculated from average profit per customer.\r\nAnnualized gain = Average profit per customer * Annual number of customers per year * ((t1) / (t2))\r\nFor example, if the time taken to develop a solution is reduced by just under 7% from 150 hours on average (t1) to 140 hours (t2) and the company currently delivers 45 solutions per year, each with an average profit of $20,000 then the annualized return on the powder tester is more than $60,000, assuming a market for increased sales.\r\n<strong>Powder tester investment example 2:</strong>\r\nA powder supplier can potentially access a market that pays a premium price, higher than that obtained for the current product, but only if product quality is consistently high.\r\nThis application calls for a tester with high repeatability and reproducibility but may be met by a relatively simple technique, depending on the end-use of the powder. Testing will be routine and relatively frequent, to safeguard product quality, so automation is likely to be advantageous.\r\nCalculating the return in this example is straightforward since success will mean a premium price for every ton of product.\r\n<strong>Annualized gain = Average annual throughput * Additional profit per ton</strong>\r\nFor a plant with a throughput of 10,000 tons per annum, making an additional $60 per ton of profit equates to a gain of $600,000 per year, a significant gain which highlights the potential benefit of being able to access higher value markets.\r\n<strong>Looking ahead</strong>\r\nA powder tester selected based on a realistic evaluation of likely financial return, with the performance required for success, can offer an extremely attractive ROI. Accessing such return typically relies on choosing a tester that reliably differentiates powders that perform differently, provides data that are relevant to the process of interest, and offers an appropriate level of automation. Opting for a powder tester that robustly fulfils rather than unnecessarily exceeds requirements is critical for an optimal return.\r\nThe focus of this article is off-line and at-line testers, but in-line powder flow measurement is becoming increasingly well-established as new commercial solutions are introduced. By providing real-time process monitoring these systems offer complementary opportunities to enhance manufacturing efficiency and the potential to further boost the profitability of powder processes.','The benefits of investing in powder testing equipment','','publish','open','open','','the-benefits-of-investing-in-powder-testing-equipment','','','2020-03-08 19:03:37','2020-03-08 19:03:37','',0,'https://microbiozindia.com/?p=4345',0,'post','',0),(4346,2,'2020-03-08 18:58:46','2020-03-08 18:58:46','','Figure 1','','inherit','open','closed','','figure-1','','','2020-03-08 18:58:46','2020-03-08 18:58:46','',4345,'https://microbiozindia.com/wp-content/uploads/2020/03/Figure-1.png',0,'attachment','image/png',0),(4347,2,'2020-03-08 18:58:48','2020-03-08 18:58:48','','Figure 2','','inherit','open','closed','','figure-2','','','2020-03-08 18:58:48','2020-03-08 18:58:48','',4345,'https://microbiozindia.com/wp-content/uploads/2020/03/Figure-2.png',0,'attachment','image/png',0),(4348,2,'2020-03-08 18:58:50','2020-03-08 18:58:50','','Figure 3','','inherit','open','closed','','figure-3','','','2020-03-08 18:58:50','2020-03-08 18:58:50','',4345,'https://microbiozindia.com/wp-content/uploads/2020/03/Figure-3.png',0,'attachment','image/png',0),(4349,2,'2020-03-08 19:01:30','2020-03-08 19:01:30','','YYY','','inherit','open','closed','','yyy','','','2020-03-08 19:01:30','2020-03-08 19:01:30','',4345,'https://microbiozindia.com/wp-content/uploads/2020/03/YYY.png',0,'attachment','image/png',0),(4350,2,'2020-03-08 19:03:37','2020-03-08 19:03:37','The concepts of return on investment (ROI) and payback time are second nature to practicing engineers but that doesn’t mean that the associated calculations are always straight forward. When it comes to assessing analytical equipment then the upfront costs can be relatively easy to determine, but the potential return is significantly more difficult. Powder testing equipment is a particularly interesting example for the consideration of this issue. Testers for the measurement of powder flowability vary in price – from just a few thousand to tens of thousands of dollars – but also in terms of sophistication, level of automation, data quality and relevance.\r\n\r\nIn this article we consider how powder testing delivers value focusing on the features of off-line and at-line testers that are associated with higher returns. The aim is to support sound decision-making around the selection of a tester, based on rigorous economic assessment.\r\n\r\n<strong>The economic benefits of powder testing</strong>\r\nMaximizing the ROI on a powder tester relies in the first instance on realistically establishing what benefits an appropriately specified powder tester might deliver, and the value associated with them. Powder testers are used to assess powder flowability from early R&amp;D through to QC with each stage of the manufacturing cycle offering potential for economic gain.\r\n• Product development and formulation: In R&amp;D, powder testing can accelerate a program to a more successful conclusion. The most substantial economic prize is reduced time to market, which can dwarf other returns, but there is also potential for savings on pilot scale studies which can be both time-consuming and expensive, and for broader gains in experimental productivity.\r\n• Equipment design and selection: Powder testing that identifies optimal processing equipment for a given powder maximizes the likelihood of trouble-free operation over the long term, delivering economic returns by enhancing manufacturing efficiency - fewer unplanned shutdowns, for example, faster commissioning and/or less product re-work. For companies that specialize in the design and provision of powder processing solutions the ability to efficiently specify optimal solutions directly boosts productivity.\r\n• Process operation and troubleshooting: When powder processes fail to perform consistently powder testing can elucidate the cause of an operational problem and provide a secure foundation for the development of a rational solution. Solving operational problems, particularly long-standing ones, can deliver a significant economic dividend, by reducing production costs or increasing throughput, often with minimal capital expenditure.\r\n• Quality control (QC): In QC, powder testing detects a sub-standard raw material or product before it enters the plant or is released, respectively. The reliable detection of poor-quality raw materials avoids operational issues ranging from out-of-specification production to an unplanned shutdown, while the robust detection of compromised product quality safeguards profit margins and company reputation.\r\nThe valuable differences between powder testers\r\nCommercially available powder testers (Figure 1 - 3) vary considerably in terms of their ability to deliver these outlined economic benefits primarily due to substantial differences in:\r\n<img class=\"alignnone size-medium wp-image-4346\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/Figure-1-247x300.png\" alt=\"\" width=\"247\" height=\"300\" />\r\n\r\nFigure 1: Simple manual testers, such as those that measure flow through an orifice, are low cost but often lack the repeatability, sensitivity and relevance to directly address powder processing issues.\r\n<img class=\"alignnone size-medium wp-image-4347\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/Figure-2-151x300.png\" alt=\"\" width=\"151\" height=\"300\" />\r\n\r\nFigure 2: An automated uniaxial tester measures a single variable with high repeatability and reproducibility and can be a cost-efficient choice for routine testing in, for example, QC.\r\n<img class=\"alignnone size-medium wp-image-4348\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/Figure-3-223x300.png\" alt=\"\" width=\"223\" height=\"300\" />\r\n\r\nFigure 3: A powder tester that offers multiple test methodologies, in this case dynamic, shear and bulk property measurement, provides multi-faceted powder characterization that can be particularly valuable when faced with more complex processing or performance issues.\r\n<strong>• Relevance</strong>\r\nThough many powder testers measure just a single number, some generate multiple parameters, thereby providing more comprehensive insight into powder behavior. Techniques and testers also differ with respect to the extent to which the conditions applied during testing can be varied, with some allowing control of the test environment to simulate process conditions, to a greater or less extent.\r\nThe net result of these differences is that the data generated by a tester may, or may not, be relevant to the process of interest - the tester may detect a difference between samples that shows no correlation with powder performance in the process or application of interest. This issue, which is unique to powders, can significantly erode the value of a tester, particularly for more demanding applications.\r\n<strong>• Repeatability, reproducibility and sensitivity</strong>\r\nThese three parameters define the ability of a tester to detect difference, to differentiate one sample from another. A frequently encountered problem in powder processing is that materials classified as being the same go on to perform differently, because the tester is unable to provide adequate differentiation.\r\nRepeatability is a measure of instrument precision, the variability associated with repeat measurements of the same sample by the same operator, while reproducibility additionally incorporates operator-to-operator variability and errors associated with sampling and sample preparation. Sensitivity is an inherent characteristic of a technique but can also be affected by both repeatability and reproducibility so two instruments that use the same technique may differ in terms of sensitivity because of their design. A tester that uses an inherently sensitive technique and is engineered to deliver high repeatability and high reproducibility will be the most powerful and discriminating tool for testing closely similar powders.\r\n<strong>• Automation</strong>\r\nThe simplest powder testers are manually operated, with minimal automation. Upfront equipment costs are correspondingly low, a downside being that the labor cost for each measurement can be relatively high. Automation tends to be associated with more sophisticated techniques but keeps cost per measurement to a minimum and productivity high. Initial equipment costs for an automated instrument will reflect its greater complexity but a consideration of lifetime costs, factoring in labor based on typical usage, may more fairly reflect the economic merits of automation, over the long term.\r\n\r\nEqually importantly, automation offers the advantage of ensuring that a rigorously specified method is consistently applied, boosting the repeatability and reproducibility of a technique. It can therefore be a crucial foundation for achieving the sensitivity and discriminating power required for tougher powder testing challenges.\r\n\r\nThe following examples provide a simple illustration of how the relative importance of these features varies from application to application and demonstrate in principle how to estimate a ROI to justify investing in a suitably specified tester.\r\n<strong>Powder tester investment example 1:</strong>\r\nAn equipment supplier specifies turnkey powder processing solutions based on analyses of customer powder samples. The requirement is for a powder tester that will support the efficient identification of optimal processing equipment for a given powder and minimize the need for pilot scale trials.\r\nThis application calls for a tester with broad relevance, one that is suitable for powders across the cohesivity spectrum and that generates data that can be robustly correlated with a range of different unit operations. An instrument that measures multiple powder properties is likely to be particularly advantageous here, to enable the detailed characterization of each new material, and the development of a robust specification for powders that perform well in individual items of processing equipment.\r\nIn terms of economic return, accurate and relevant powder testing has the potential to accelerate the workflow of the whole company, boosting productivity at the specification stage, reducing the need for at-site modifications, and supporting trouble-free commissioning. If the average time taken to develop and deliver each solution is reduced from t1 to t2 then it is possible to serve an increased number of customers in each year, delivering an associated annualized economic gain that can be calculated from average profit per customer.\r\nAnnualized gain = Average profit per customer * Annual number of customers per year * ((t1) / (t2))\r\nFor example, if the time taken to develop a solution is reduced by just under 7% from 150 hours on average (t1) to 140 hours (t2) and the company currently delivers 45 solutions per year, each with an average profit of $20,000 then the annualized return on the powder tester is more than $60,000, assuming a market for increased sales.\r\n<strong>Powder tester investment example 2:</strong>\r\nA powder supplier can potentially access a market that pays a premium price, higher than that obtained for the current product, but only if product quality is consistently high.\r\nThis application calls for a tester with high repeatability and reproducibility but may be met by a relatively simple technique, depending on the end-use of the powder. Testing will be routine and relatively frequent, to safeguard product quality, so automation is likely to be advantageous.\r\nCalculating the return in this example is straightforward since success will mean a premium price for every ton of product.\r\n<strong>Annualized gain = Average annual throughput * Additional profit per ton</strong>\r\nFor a plant with a throughput of 10,000 tons per annum, making an additional $60 per ton of profit equates to a gain of $600,000 per year, a significant gain which highlights the potential benefit of being able to access higher value markets.\r\n<strong>Looking ahead</strong>\r\nA powder tester selected based on a realistic evaluation of likely financial return, with the performance required for success, can offer an extremely attractive ROI. Accessing such return typically relies on choosing a tester that reliably differentiates powders that perform differently, provides data that are relevant to the process of interest, and offers an appropriate level of automation. Opting for a powder tester that robustly fulfils rather than unnecessarily exceeds requirements is critical for an optimal return.\r\nThe focus of this article is off-line and at-line testers, but in-line powder flow measurement is becoming increasingly well-established as new commercial solutions are introduced. By providing real-time process monitoring these systems offer complementary opportunities to enhance manufacturing efficiency and the potential to further boost the profitability of powder processes.','The benefits of investing in powder testing equipment','','inherit','closed','closed','','4345-revision-v1','','','2020-03-08 19:03:37','2020-03-08 19:03:37','',4345,'https://microbiozindia.com/uncategorized/4345-revision-v1/',0,'revision','',0),(4352,2,'2020-03-09 02:25:13','2020-03-09 02:25:13','The loss of life from the coronavirus episode in Italy has hopped by at any rate 133 in the previous 24 hours, carrying its aggregate to 366.\r\nItaly forced an isolate in Lombardy and other seriously influenced zones, influencing around 16 million individuals as it increased determination to handle Europe\'s biggest episode.\r\nThe move came as the nation battles to contain the infection\'s spread, with 1,247 new cases recognized over the most recent 24 hours - a 25 percent flood. As of Sunday, Italy affirmed 7,375 <a href=\"https://en.wikipedia.org/wiki/Contamination\">contaminations.</a>\r\nIn the mean time in Saudi Arabia, specialists secured the eastern Qatif district in an offer to contain the quick spreading infection. Riyadh additionally said it was suspending all open and tuition based schools and colleges the nation over from Monday until further notification.\r\nLikewise on Sunday, Iran revealed 49 new coronavirus fatalities in the course of recent hours, bringing its loss of life to 194.','Increased coronavirus passings in Italy,Saudi schools shut','','publish','open','open','','increased-coronavirus-passings-in-italy-saudi-schools-shut','','','2020-03-09 02:33:56','2020-03-09 02:33:56','',0,'https://microbiozindia.com/?p=4352',0,'post','',0),(4353,2,'2020-03-09 02:25:04','2020-03-09 02:25:04','','AAAAA','','inherit','open','closed','','aaaaa','','','2020-03-09 02:25:04','2020-03-09 02:25:04','',4352,'https://microbiozindia.com/wp-content/uploads/2020/03/AAAAA.png',0,'attachment','image/png',0),(4354,2,'2020-03-09 02:25:13','2020-03-09 02:25:13','The loss of life from the <a href=\"https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\">coronavirus</a> episode in Italy has hopped by at any rate 133 in the previous 24 hours, carrying its aggregate to 366.\r\nItaly forced an isolate in Lombardy and other seriously influenced zones, influencing around 16 million individuals as it increased determination to handle Europe\'s biggest episode.\r\nThe move came as the nation battles to contain the infection\'s spread, with 1,247 new cases recognized over the most recent 24 hours - a 25 percent flood. As of Sunday, Italy affirmed 7,375 <a href=\"https://en.wikipedia.org/wiki/Contamination\">contaminations.</a>\r\nIn the mean time in Saudi Arabia, specialists secured the eastern Qatif district in an offer to contain the quick spreading infection. Riyadh additionally said it was suspending all open and tuition based schools and colleges the nation over from Monday until further notification.\r\nLikewise on Sunday, Iran revealed 49 new coronavirus fatalities in the course of recent hours, bringing its loss of life to 194.','366 coronavirus passings in Italy, Saudi schools shut','','inherit','closed','closed','','4352-revision-v1','','','2020-03-09 02:25:13','2020-03-09 02:25:13','',4352,'https://microbiozindia.com/uncategorized/4352-revision-v1/',0,'revision','',0),(4355,2,'2020-03-09 02:30:20','2020-03-09 02:30:20','The loss of life from the <a href=\"https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome_coronavirus_2\">coronavirus</a> episode in Italy has hopped by at any rate 133 in the previous 24 hours, carrying its aggregate to 366.\r\nItaly forced an isolate in Lombardy and other seriously influenced zones, influencing around 16 million individuals as it increased determination to handle Europe\'s biggest episode.\r\nThe move came as the nation battles to contain the infection\'s spread, with 1,247 new cases recognized over the most recent 24 hours - a 25 percent flood. As of Sunday, Italy affirmed 7,375 <a href=\"https://en.wikipedia.org/wiki/Contamination\">contaminations.</a>\r\nIn the mean time in Saudi Arabia, specialists secured the eastern Qatif district in an offer to contain the quick spreading infection. Riyadh additionally said it was suspending all open and tuition based schools and colleges the nation over from Monday until further notification.\r\nLikewise on Sunday, Iran revealed 49 new coronavirus fatalities in the course of recent hours, bringing its loss of life to 194.','Increased coronavirus passings in Italy, Saudi schools shut','','inherit','closed','closed','','4352-revision-v1','','','2020-03-09 02:30:20','2020-03-09 02:30:20','',4352,'https://microbiozindia.com/uncategorized/4352-revision-v1/',0,'revision','',0),(4356,2,'2020-03-09 02:33:56','2020-03-09 02:33:56','The loss of life from the coronavirus episode in Italy has hopped by at any rate 133 in the previous 24 hours, carrying its aggregate to 366.\r\nItaly forced an isolate in Lombardy and other seriously influenced zones, influencing around 16 million individuals as it increased determination to handle Europe\'s biggest episode.\r\nThe move came as the nation battles to contain the infection\'s spread, with 1,247 new cases recognized over the most recent 24 hours - a 25 percent flood. As of Sunday, Italy affirmed 7,375 <a href=\"https://en.wikipedia.org/wiki/Contamination\">contaminations.</a>\r\nIn the mean time in Saudi Arabia, specialists secured the eastern Qatif district in an offer to contain the quick spreading infection. Riyadh additionally said it was suspending all open and tuition based schools and colleges the nation over from Monday until further notification.\r\nLikewise on Sunday, Iran revealed 49 new coronavirus fatalities in the course of recent hours, bringing its loss of life to 194.','Increased coronavirus passings in Italy,Saudi schools shut','','inherit','closed','closed','','4352-revision-v1','','','2020-03-09 02:33:56','2020-03-09 02:33:56','',4352,'https://microbiozindia.com/uncategorized/4352-revision-v1/',0,'revision','',0),(4357,2,'2020-03-10 18:59:10','2020-03-10 18:59:10','As indicated by another exploration distributed by Polaris Market Research the worldwide infection filtration showcase is foreseen to reach USD 6 billion at a CAGR of 13.1% by 2026. The market is foreseen to observe a high development rate over the conjecture years inferable from the growing enthusiasm for common things, for instance, <a href=\"https://en.wikipedia.org/wiki/Vaccination\">vaccinations</a>, <a href=\"https://pennstate.pure.elsevier.com/en/publications/restorative-mechanisms-regulating-protein-balance-in-skeletal-mus\">restorative proteins</a>, blood and related blood things, cell and quality treatment, tissue, and undifferentiated cell things is a main issue driving industry improvement.\r\n\r\n<img class=\"alignnone  wp-image-4358\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/fff-300x182.png\" alt=\"\" width=\"478\" height=\"290\" />\r\n\r\nInfections are minute smaller scale living beings which are noticeable under compound magnifying lens. Infections are transmittable and have ability to reproduce themselves inside the living creature\'s body. Infections debase all the living things, for example, <a href=\"https://en.wikipedia.org/wiki/Microorganism\">microorganisms</a>, creatures, and plants, which incorporates microbes just as archaea. Infection Filtration is the significant system for expulsion of infection particles. This filtration is an employable infection evacuation apparatus for assembling natural items with government aides of the unobtrusive operability and unimportant damage to the yield. Infection filtration system is commonly done as a last cleaning step for any assembling strategy.\r\n\r\nMajor <a href=\"https://en.wikipedia.org/wiki/Biopharmaceutical\">biopharmaceuticals</a> and biotechnology organizations are enjoyed R&amp;D for making new regular items. Infection filtration is a basic development in biologics improvement, right now, growing R&amp;D on biologics is required to drive the market for these things. In 2016, significant players in the business put a large number of dollars in R&amp;D. The costs were essentially grasped to help progression and proficiency in R&amp;D to build up a commonsense pipeline of <a href=\"https://en.wikipedia.org/wiki/Inoculation\">inoculations</a> and medicines with worthwhile business openings.\r\n\r\nRising commonness of consistent ailments including danger, diabetes, and safe framework issue are relied upon to fuel the market for infection filtration in biologics fragment. According to the International Agency for Cancer Research, around 14.1 million new infection cases of development were investigated worldwide in 2012 and this number is foreseen to accomplish 21.7 million by 2030. Consequently, there is a creating enthusiasm for therapeutics biologics for the treatment of such consistent infirmities, that ceaselessly drive the enthusiasm for infection filtration item types for R&amp;D and different applications.\r\n\r\nBiopharmaceuticals are to a great extent picked up from human, animals, and plants and require an inspected infection filtration system to avoid contamination spoiling in the age. In this way, the need of this system in the midst of the age of biologics is required to help the market improvement.','Virus Filtration Market Size Worth 6 Billion By 2026','','publish','open','open','','virus-filtration-market-size-worth-6-billion-by-2026','','','2020-03-10 18:59:10','2020-03-10 18:59:10','',0,'https://microbiozindia.com/?p=4357',0,'post','',0),(4358,2,'2020-03-10 10:09:17','2020-03-10 10:09:17','','fff','','inherit','open','closed','','fff','','','2020-03-10 10:09:17','2020-03-10 10:09:17','',4357,'https://microbiozindia.com/wp-content/uploads/2020/03/fff.png',0,'attachment','image/png',0),(4359,2,'2020-03-10 10:12:21','2020-03-10 10:12:21','','imrs','','inherit','open','closed','','imrs','','','2020-03-10 10:12:21','2020-03-10 10:12:21','',4357,'https://microbiozindia.com/wp-content/uploads/2020/03/imrs.jpg',0,'attachment','image/jpeg',0),(4360,2,'2020-03-10 10:13:43','2020-03-10 10:13:43','According to a new research published by Polaris Market Research the <strong>global virus filtration market</strong> is anticipated to reach USD 6 billion at a CAGR of 13.1% by 2026. The market is anticipated to witness a high growth rate over the forecast years owing to the expanding interest for natural items, for example, immunizations, therapeutic proteins, blood and related blood items, cell and quality treatment, tissue, and undifferentiated cell items is a central point driving industry development.\r\n\r\nViruses are minute <strong>micro-organisms</strong> which are visible under compound microscope. Viruses are transmittable and have capability to replicate themselves inside the living organism’s body. Viruses contaminate all the life forms, such as microbes, animals, and plants, which includes bacteria as well as archaea. Virus Filtration is the important procedure for removal of virus particles. This filtration is an operative virus removal tool for manufacturing biological products with welfares of the modest operability and insignificant harm to the yield. Virus filtration procedure is generally carried out as a final purification step for any manufacture method.\r\n\r\nMajor biopharmaceuticals and biotechnology companies are indulged in R&amp;D for creating new natural products. Virus filtration is a critical advance in biologics improvement, in this manner, the expanding R&amp;D on biologics is required to drive the market for these items. In 2016, major players in the industry invested millions of dollars in R&amp;D. The expenses were principally embraced to support advancement and efficiency in R&amp;D to develop a practical pipeline of immunizations and treatments with lucrative business openings.\r\n\r\n<img class=\"alignnone  wp-image-4358\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/fff-300x182.png\" alt=\"\" width=\"440\" height=\"267\" />\r\n\r\nRising prevalence of constant illnesses including malignancy, diabetes, and immune system issue are expected to fuel the market for virus filtration in biologics segment. As per the International Agency for Cancer Research, approximately 14.1 million new disease instances of growth were analyzed worldwide in 2012 and this number is anticipated to achieve 21.7 million by 2030. Therefore, there is a developing interest for therapeutics biologics for the treatment of such constant ailments, that continuously drive the interest for virus filtration product types for R&amp;D and other applications.\r\n\r\nBiopharmaceuticals are largely gained from human, creatures, and plants and require an examined virus filtration technique to stay away from infection tainting in the generation. Subsequently, the need of this strategy amid the generation of biologics is required to support the market development.','Virus Filtration Market Size Worth 6 Billion By 2026','','inherit','closed','closed','','4357-revision-v1','','','2020-03-10 10:13:43','2020-03-10 10:13:43','',4357,'https://microbiozindia.com/uncategorized/4357-revision-v1/',0,'revision','',0),(4361,2,'2020-03-10 18:59:10','2020-03-10 18:59:10','As indicated by another exploration distributed by Polaris Market Research the worldwide infection filtration showcase is foreseen to reach USD 6 billion at a CAGR of 13.1% by 2026. The market is foreseen to observe a high development rate over the conjecture years inferable from the growing enthusiasm for common things, for instance, <a href=\"https://en.wikipedia.org/wiki/Vaccination\">vaccinations</a>, <a href=\"https://pennstate.pure.elsevier.com/en/publications/restorative-mechanisms-regulating-protein-balance-in-skeletal-mus\">restorative proteins</a>, blood and related blood things, cell and quality treatment, tissue, and undifferentiated cell things is a main issue driving industry improvement.\r\n\r\n<img class=\"alignnone  wp-image-4358\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/fff-300x182.png\" alt=\"\" width=\"478\" height=\"290\" />\r\n\r\nInfections are minute smaller scale living beings which are noticeable under compound magnifying lens. Infections are transmittable and have ability to reproduce themselves inside the living creature\'s body. Infections debase all the living things, for example, <a href=\"https://en.wikipedia.org/wiki/Microorganism\">microorganisms</a>, creatures, and plants, which incorporates microbes just as archaea. Infection Filtration is the significant system for expulsion of infection particles. This filtration is an employable infection evacuation apparatus for assembling natural items with government aides of the unobtrusive operability and unimportant damage to the yield. Infection filtration system is commonly done as a last cleaning step for any assembling strategy.\r\n\r\nMajor <a href=\"https://en.wikipedia.org/wiki/Biopharmaceutical\">biopharmaceuticals</a> and biotechnology organizations are enjoyed R&amp;D for making new regular items. Infection filtration is a basic development in biologics improvement, right now, growing R&amp;D on biologics is required to drive the market for these things. In 2016, significant players in the business put a large number of dollars in R&amp;D. The costs were essentially grasped to help progression and proficiency in R&amp;D to build up a commonsense pipeline of <a href=\"https://en.wikipedia.org/wiki/Inoculation\">inoculations</a> and medicines with worthwhile business openings.\r\n\r\nRising commonness of consistent ailments including danger, diabetes, and safe framework issue are relied upon to fuel the market for infection filtration in biologics fragment. According to the International Agency for Cancer Research, around 14.1 million new infection cases of development were investigated worldwide in 2012 and this number is foreseen to accomplish 21.7 million by 2030. Consequently, there is a creating enthusiasm for therapeutics biologics for the treatment of such consistent infirmities, that ceaselessly drive the enthusiasm for infection filtration item types for R&amp;D and different applications.\r\n\r\nBiopharmaceuticals are to a great extent picked up from human, animals, and plants and require an inspected infection filtration system to avoid contamination spoiling in the age. In this way, the need of this system in the midst of the age of biologics is required to help the market improvement.','Virus Filtration Market Size Worth 6 Billion By 2026','','inherit','closed','closed','','4357-revision-v1','','','2020-03-10 18:59:10','2020-03-10 18:59:10','',4357,'https://microbiozindia.com/uncategorized/4357-revision-v1/',0,'revision','',0),(4362,2,'2020-03-10 19:07:33','2020-03-10 19:07:33','','Banner Ad','','inherit','open','closed','','banner-ad','','','2020-03-10 19:07:33','2020-03-10 19:07:33','',3653,'https://microbiozindia.com/wp-content/uploads/2019/11/Banner-Ad.jpg',0,'attachment','image/jpeg',0),(4363,2,'2020-03-10 19:19:26','2020-03-10 19:19:26','','rsz_webbmm','','inherit','open','closed','','rsz_webbmm','','','2020-03-10 19:19:26','2020-03-10 19:19:26','',3653,'https://microbiozindia.com/wp-content/uploads/2019/11/rsz_webbmm.png',0,'attachment','image/png',0),(4364,2,'2020-03-10 19:20:58','2020-03-10 19:20:58','','WEBBmm','','inherit','open','closed','','webbmm','','','2020-03-10 19:20:58','2020-03-10 19:20:58','',3653,'https://microbiozindia.com/wp-content/uploads/2019/11/WEBBmm.png',0,'attachment','image/png',0),(4365,2,'2020-03-10 19:29:51','2020-03-10 19:29:51','','Banner Adnew','','inherit','open','closed','','banner-adnew','','','2020-03-10 19:29:51','2020-03-10 19:29:51','',3653,'https://microbiozindia.com/wp-content/uploads/2019/11/Banner-Adnew.jpg',0,'attachment','image/jpeg',0),(4366,2,'2020-03-10 19:35:36','2020-03-10 19:35:36','','MT','','inherit','closed','closed','','3651-autosave-v1','','','2020-03-10 19:35:36','2020-03-10 19:35:36','',3651,'https://microbiozindia.com/uncategorized/3651-autosave-v1/',0,'revision','',0),(4368,2,'2020-03-11 18:53:59','2020-03-11 18:53:59','Everyone has some risk of developing cancer, and in most cases the disease develops by chance. However, some people are genetically predisposed to developing certain types of cancer. In a small percentage of people with cancer, the disease is due to a different type of mutation called a hereditary mutation, or germline mutation. These mutations are usually inherited from one or both of the person’s parents, and are present in nearly every cell of the body. People who carry such hereditary mutations do not necessarily get cancer, but their risk of developing the disease at some point during their lifetime is higher than average.\r\n\r\n[caption id=\"attachment_4370\" align=\"alignright\" width=\"289\"]<img class=\"wp-image-4370 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/aass.-289x300.png\" alt=\"\" width=\"289\" height=\"300\" /> <span style=\"font-family: \'comic sans ms\', sans-serif;\">Chandni Luthra co-founder FutureMed</span>[/caption]\r\n\r\nIn recent years, scientists have discovered a number of mutations that can contribute to a person’s risk of developing certain cancers, including breast, ovarian, colorectal, and prostate cancer, as well as some other, less common cancer types. Futuremed promotes more than 10 different cancer panels i.e. Breast, Ovarian, Endocrine, Renal, Skin, Prostrate and Colorectal. These panels are either aligned towards risk assessment if the concerned person has family history of cancer otherwise known as genetic pre-disposition and synergistic treatment to be followed according to the mutation found.\r\n\r\nCancer can happen due to somatic or germ-line mutations but the underline reason is always genetic alternation. Reasons of somatic mutations are unhealthy lifestyle, tobacco use or environmental factors. Germ-line genetic testing can ascertain cancer prevalence across family, and types of cancer. For diagnosis purpose to check somatic mutations, tumor DNA sequencing is done to determine drug recommendation or treatment guidelines to be followed on the basis of mutation studied. The analysis will infer which treatment suits the patients considering the mutation analyzed.\r\n\r\nThere have been big advances in caring for people who have these known genetic mutations (changes).  Genetic Screening by FutureMed in addition to prevention strategies as well as some treatments based on these screenings can be targeted, and patients’ lives can be improved. Genetic testing also gives doctors the ability to use preventive measures to decrease a patient’s risk of cancer. For example, women who do not already have cancer but have a BRCA1 or BRCA2 mutation can with the help of the doctors discuss preventive measures and surgeries. Genetic testing for hereditary cancer should now become part of standard practice because of the benefits it offers patients. Testing positive for a genetic mutation is not a death sentence but an opportunity. You have options: increased surveillance, chemoprevention, and surgery. You can be proactive and fight cancer before it even starts.\r\n\r\nIn several forms of cancers, genetic testing is used to determine which medicine or treatment procedure will best work for the patient. Thus Genetic testing will potentially be helpful in developing effective strategies for early detection, prevention, and better management of hereditary breast and ovarian cancer which will have a positive impact on healthcare in India.\r\n\r\nChandni Luthra\r\n\r\nCo-founder/Director\r\n\r\nFutureMed Devices Pvt LTD\r\n\r\nD-124 Panchsheel Enclave, New Delhi\r\n\r\nwww.futuremed.co.in\r\n\r\n+919319910550','Cancer and Genetic Testing','','publish','open','open','','cancer-and-genetic-testing','','','2020-03-12 08:01:08','2020-03-12 08:01:08','',0,'https://microbiozindia.com/?p=4368',0,'post','',0),(4369,2,'2020-03-11 18:44:35','2020-03-11 18:44:35','','NEW','','inherit','open','closed','','new','','','2020-03-11 18:44:35','2020-03-11 18:44:35','',4368,'https://microbiozindia.com/wp-content/uploads/2020/03/NEW.png',0,'attachment','image/png',0),(4370,2,'2020-03-11 18:45:11','2020-03-11 18:45:11','','aass.','','inherit','open','closed','','aass','','','2020-03-11 18:45:11','2020-03-11 18:45:11','',4368,'https://microbiozindia.com/wp-content/uploads/2020/03/aass..png',0,'attachment','image/png',0),(4371,2,'2020-03-11 18:53:59','2020-03-11 18:53:59','[caption id=\"attachment_4370\" align=\"alignright\" width=\"289\"]<img class=\"wp-image-4370 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/aass.-289x300.png\" alt=\"Chandni Luthra  Co-founder\" width=\"289\" height=\"300\" /> <span style=\"font-family: \'book antiqua\', palatino, serif;\">Chandni Luthra co-founder FutureMed</span>[/caption]\r\n\r\nEveryone has some risk of developing cancer, and in most cases the disease develops by chance. However, some people are genetically predisposed to developing certain types of cancer. In a small percentage of people with cancer, the disease is due to a different type of mutation called a hereditary mutation, or germline mutation. These <a href=\"https://en.wikipedia.org/wiki/Mutation\">mutations</a> are usually inherited from one or both of the person’s parents, and are present in nearly every cell of the body. People who carry such <a href=\"https://en.wikipedia.org/wiki/Mutation\">hereditary</a> mutations do not necessarily get cancer, but their risk of developing the disease at some point during their lifetime is higher than average.\r\n\r\nIn recent years, scientists have discovered a number of mutations that can contribute to a person’s risk of developing certain cancers, including breast, ovarian, colorectal, and <a href=\"https://en.wikipedia.org/wiki/Prostate_cancer\">prostate cancer</a>, as well as some other, less common cancer types. Futuremed promotes more than 10 different cancer panels i.e. Breast, Ovarian, Endocrine, Renal, Skin, Prostrate and Colorectal. These panels are either aligned towards risk assessment if the concerned person has family history of cancer otherwise known as genetic pre-disposition and synergistic treatment to be followed according to the mutation found.\r\n\r\nCancer can happen due to somatic or germ-line mutations but the underline reason is always genetic alternation. Reasons of somatic mutations are unhealthy lifestyle, tobacco use or environmental factors. Germ-line genetic testing can ascertain cancer prevalence across family, and types of cancer. For diagnosis purpose to check somatic mutations, <a href=\"https://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000768570&amp;version=Patient&amp;language=English\">tumor DNA sequencing</a> is done to determine drug recommendation or treatment guidelines to be followed on the basis of mutation studied. The analysis will infer which treatment suits the patients considering the mutation analyzed.\r\n\r\nThere have been big advances in caring for people who have these known genetic mutations (changes).  Genetic Screening by FutureMed in addition to prevention strategies as well as some treatments based on these screenings can be targeted, and patients’ lives can be improved. Genetic testing also gives doctors the ability to use preventive measures to decrease a patient’s risk of cancer. For example, women who do not already have cancer but have a BRCA1 or BRCA2 mutation can with the help of the doctors discuss preventive measures and surgeries. Genetic testing for hereditary cancer should now become part of standard practice because of the benefits it offers patients. Testing positive for a genetic mutation is not a death sentence but an opportunity. You have options: increased surveillance, chemoprevention, and surgery. You can be proactive and fight cancer before it even starts.\r\n\r\nIn several forms of cancers, genetic testing is used to determine which medicine or treatment procedure will best work for the patient. Thus Genetic testing will potentially be helpful in developing effective strategies for early detection, prevention, and better management of hereditary breast and ovarian cancer which will have a positive impact on healthcare in India.\r\n\r\nChandni Luthra\r\n\r\nCo-founder/Director\r\n\r\nFutureMed Devices Pvt LTD\r\n\r\nD-124 Panchsheel Enclave, New Delhi\r\n\r\nwww.futuremed.co.in\r\n\r\n+919319910550','Cancer and Genetic Testing','','inherit','closed','closed','','4368-revision-v1','','','2020-03-11 18:53:59','2020-03-11 18:53:59','',4368,'https://microbiozindia.com/uncategorized/4368-revision-v1/',0,'revision','',0),(4372,2,'2020-03-12 08:00:11','2020-03-12 08:00:11','Everyone has some risk of developing cancer, and in most cases the disease develops by chance. However, some people are genetically predisposed to developing certain types of cancer. In a small percentage of people with cancer, the disease is due to a different type of mutation called a hereditary mutation, or germline mutation. These mutations are usually inherited from one or both of the person’s parents, and are present in nearly every cell of the body. People who carry such hereditary mutations do not necessarily get cancer, but their risk of developing the disease at some point during their lifetime is higher than average.\n\n<img class=\"size-medium wp-image-4370 alignright\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/aass.-289x300.png\" alt=\"\" width=\"289\" height=\"300\" />Chandni Luthra co-founder FutureMed\n\nIn recent years, scientists have discovered a number of mutations that can contribute to a person’s risk of developing certain cancers, including breast, ovarian, colorectal, and prostate cancer, as well as some other, less common cancer types. Futuremed promotes more than 10 different cancer panels i.e. Breast, Ovarian, Endocrine, Renal, Skin, Prostrate and Colorectal. These panels are either aligned towards risk assessment if the concerned person has family history of cancer otherwise known as genetic pre-disposition and synergistic treatment to be followed according to the mutation found.\n\nCancer can happen due to somatic or germ-line mutations but the underline reason is always genetic alternation. Reasons of somatic mutations are unhealthy lifestyle, tobacco use or environmental factors. Germ-line genetic testing can ascertain cancer prevalence across family, and types of cancer. For diagnosis purpose to check somatic mutations, tumor DNA sequencing is done to determine drug recommendation or treatment guidelines to be followed on the basis of mutation studied. The analysis will infer which treatment suits the patients considering the mutation analyzed.\n\nThere have been big advances in caring for people who have these known genetic mutations (changes).  Genetic Screening by FutureMed in addition to prevention strategies as well as some treatments based on these screenings can be targeted, and patients’ lives can be improved. Genetic testing also gives doctors the ability to use preventive measures to decrease a patient’s risk of cancer. For example, women who do not already have cancer but have a BRCA1 or BRCA2 mutation can with the help of the doctors discuss preventive measures and surgeries. Genetic testing for hereditary cancer should now become part of standard practice because of the benefits it offers patients. Testing positive for a genetic mutation is not a death sentence but an opportunity. You have options: increased surveillance, chemoprevention, and surgery. You can be proactive and fight cancer before it even starts.\n\nIn several forms of cancers, genetic testing is used to determine which medicine or treatment procedure will best work for the patient. Thus Genetic testing will potentially be helpful in developing effective strategies for early detection, prevention, and better management of hereditary breast and ovarian cancer which will have a positive impact on healthcare in India.\n\nChandni Luthra\n\nCo-founder/Director\n\nFutureMed Devices Pvt LTD\n\nD-124 Panchsheel Enclave, New Delhi\n\nwww.futuremed.co.in\n\n+919319910550','Cancer and Genetic Testing','','inherit','closed','closed','','4368-autosave-v1','','','2020-03-12 08:00:11','2020-03-12 08:00:11','',4368,'https://microbiozindia.com/uncategorized/4368-autosave-v1/',0,'revision','',0),(4373,2,'2020-03-11 19:05:05','2020-03-11 19:05:05','Everyone has some risk of developing cancer, and in most cases the disease develops by chance. However, some people are genetically predisposed to developing certain types of cancer. In a small percentage of people with cancer, the disease is due to a different type of mutation called a hereditary mutation, or germline mutation. These <a href=\"https://en.wikipedia.org/wiki/Mutation\">mutations</a> are usually inherited from one or both of the person’s parents, and are present in nearly every cell of the body. People who carry such <a href=\"https://en.wikipedia.org/wiki/Mutation\">hereditary</a> mutations do not necessarily get cancer, but their risk of developing the disease at some point during their lifetime is higher than average.\r\n\r\n[caption id=\"attachment_4370\" align=\"alignright\" width=\"289\"]<img class=\"wp-image-4370 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/aass.-289x300.png\" alt=\"\" width=\"289\" height=\"300\" /> Chandni Luthra co-founder FutureMed[/caption]\r\n\r\nIn recent years, scientists have discovered a number of mutations that can contribute to a person’s risk of developing certain cancers, including breast, ovarian, colorectal, and <a href=\"https://en.wikipedia.org/wiki/Prostate_cancer\">prostate cancer</a>, as well as some other, less common cancer types. Futuremed promotes more than 10 different cancer panels i.e. Breast, Ovarian, Endocrine, Renal, Skin, Prostrate and Colorectal. These panels are either aligned towards risk assessment if the concerned person has family history of cancer otherwise known as genetic pre-disposition and synergistic treatment to be followed according to the mutation found.\r\n\r\nCancer can happen due to somatic or germ-line mutations but the underline reason is always genetic alternation. Reasons of somatic mutations are unhealthy lifestyle, tobacco use or environmental factors. Germ-line genetic testing can ascertain cancer prevalence across family, and types of cancer. For diagnosis purpose to check somatic mutations, <a href=\"https://www.cancer.gov/Common/PopUps/popDefinition.aspx?id=CDR0000768570&amp;version=Patient&amp;language=English\">tumor DNA sequencing</a> is done to determine drug recommendation or treatment guidelines to be followed on the basis of mutation studied. The analysis will infer which treatment suits the patients considering the mutation analyzed.\r\n\r\nThere have been big advances in caring for people who have these known genetic mutations (changes).  Genetic Screening by FutureMed in addition to prevention strategies as well as some treatments based on these screenings can be targeted, and patients’ lives can be improved. Genetic testing also gives doctors the ability to use preventive measures to decrease a patient’s risk of cancer. For example, women who do not already have cancer but have a BRCA1 or BRCA2 mutation can with the help of the doctors discuss preventive measures and surgeries. Genetic testing for hereditary cancer should now become part of standard practice because of the benefits it offers patients. Testing positive for a genetic mutation is not a death sentence but an opportunity. You have options: increased surveillance, chemoprevention, and surgery. You can be proactive and fight cancer before it even starts.\r\n\r\nIn several forms of cancers, genetic testing is used to determine which medicine or treatment procedure will best work for the patient. Thus Genetic testing will potentially be helpful in developing effective strategies for early detection, prevention, and better management of hereditary breast and ovarian cancer which will have a positive impact on healthcare in India.\r\n\r\nChandni Luthra\r\n\r\nCo-founder/Director\r\n\r\nFutureMed Devices Pvt LTD\r\n\r\nD-124 Panchsheel Enclave, New Delhi\r\n\r\nwww.futuremed.co.in\r\n\r\n+919319910550','Cancer and Genetic Testing','','inherit','closed','closed','','4368-revision-v1','','','2020-03-11 19:05:05','2020-03-11 19:05:05','',4368,'https://microbiozindia.com/uncategorized/4368-revision-v1/',0,'revision','',0),(4374,2,'2020-03-12 07:50:42','2020-03-12 07:50:42','Particle size and shape analysis has always been an important evaluation criterion in many critical applications ranging from Ink, Paint research to industrial production. Particle size and shape can affect the physical and chemical properties of a substance such as its solubility, reaction, strength, etc.\r\nParticle analysis is used by researchers to understand the nature and reactions of the particulate based on its size and shape, or by manufacturers for quality control of its products.\r\n\r\n<img class=\"size-full wp-image-4376 alignright\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/NEWWWGFFF.png\" alt=\"\" width=\"178\" height=\"132\" /> Digital Image Analysis and Laser Diffraction are the most commonly used techniques for particle size analysis in the pharmaceutical industry, with the former currently emerging as a more preferred option. Due to the simultaneous effects of - the inherent drawbacks in Laser Diffraction method, technological advances in scientific and microscopic evaluation methods, and the significant cost reduction in digital computer imaging over the past decade, has enabled digital image analysis to become an affordable and prominent tool in the hands of researchers and QC managers.\r\nImage Analysis allows in distinguishing almost an unlimited number of discrete particles in the sample and then obtaining complex measurements of these particles, based on the computer programming in the provided software. This automation of the entire process makes it an easy and hands free alternative, and thus requires the user to do almost nothing except sit back and view the end results.\r\n<img class=\"size-full wp-image-4375 alignleft\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/NEWWWBBB.png\" alt=\"\" width=\"207\" height=\"143\" />The main advantage of optical microscopy is that the user can observe individual particles in the sample ranging from 0.5 microns to 5000 microns. Detailed information on these particles such as individual measurements and statistical results can be generated which can be then used to draw conclusions.\r\nThe Biovis PSA 2000 System from Expert Vision Labs is a complete image analysis solution that combines a microscope and high resolution digital camera with the powerful particle analysis with 21 CFR Part 11 Compliance software. The system can be easily configured to capture images of the sample and then perform evaluation to determine a number of morphological measurements such as length, breadth, area, aspect ratio, etc. After analysis the data and results can be reported or can be archived for future.\r\nThe software allows user to select from over 70 different types of measurements that can be performed over each of the individual particles in the sample. We can also differentiate the particles into different classes based on a measurement parameter, thus making it easy to distinguish and characterize the good and bad samples in the batch.\r\nParticle analysis is not just limited to the pharmaceutical industry but is also utilized in other industries which require the study of any type of particulate matter. Thus with the growth of industries and emergence of newer markets requiring Particle Size analysis, the use of microscopic image analysis for this purpose is expanding dramatically and rightly so.\r\n\r\nExpert Vision Labs\r\nEmail : sales@expertvisionlabs.com','Biovis PSA 2000 for Particle Size and Shape analysis','','publish','open','open','','biovis-psa-2000-for-particle-size-and-shape-analysis','','','2020-03-12 07:50:42','2020-03-12 07:50:42','',0,'https://microbiozindia.com/?p=4374',0,'post','',0),(4375,2,'2020-03-12 07:48:46','2020-03-12 07:48:46','','NEWWWBBB','','inherit','open','closed','','newwwbbb','','','2020-03-12 07:48:46','2020-03-12 07:48:46','',4374,'https://microbiozindia.com/wp-content/uploads/2020/03/NEWWWBBB.png',0,'attachment','image/png',0),(4376,2,'2020-03-12 07:48:48','2020-03-12 07:48:48','','NEWWWGFFF','','inherit','open','closed','','newwwgfff','','','2020-03-12 07:48:48','2020-03-12 07:48:48','',4374,'https://microbiozindia.com/wp-content/uploads/2020/03/NEWWWGFFF.png',0,'attachment','image/png',0),(4377,2,'2020-03-12 07:49:21','2020-03-12 07:49:21','','fff','','inherit','open','closed','','fff-2','','','2020-03-12 07:49:21','2020-03-12 07:49:21','',4374,'https://microbiozindia.com/wp-content/uploads/2020/03/fff-1.png',0,'attachment','image/png',0),(4378,2,'2020-03-12 07:50:42','2020-03-12 07:50:42','Particle size and shape analysis has always been an important evaluation criterion in many critical applications ranging from Ink, Paint research to industrial production. Particle size and shape can affect the physical and chemical properties of a substance such as its solubility, reaction, strength, etc.\r\nParticle analysis is used by researchers to understand the nature and reactions of the particulate based on its size and shape, or by manufacturers for quality control of its products.\r\n\r\n<img class=\"size-full wp-image-4376 alignright\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/NEWWWGFFF.png\" alt=\"\" width=\"178\" height=\"132\" /> Digital Image Analysis and Laser Diffraction are the most commonly used techniques for particle size analysis in the pharmaceutical industry, with the former currently emerging as a more preferred option. Due to the simultaneous effects of - the inherent drawbacks in Laser Diffraction method, technological advances in scientific and microscopic evaluation methods, and the significant cost reduction in digital computer imaging over the past decade, has enabled digital image analysis to become an affordable and prominent tool in the hands of researchers and QC managers.\r\nImage Analysis allows in distinguishing almost an unlimited number of discrete particles in the sample and then obtaining complex measurements of these particles, based on the computer programming in the provided software. This automation of the entire process makes it an easy and hands free alternative, and thus requires the user to do almost nothing except sit back and view the end results.\r\n<img class=\"size-full wp-image-4375 alignleft\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/NEWWWBBB.png\" alt=\"\" width=\"207\" height=\"143\" />The main advantage of optical microscopy is that the user can observe individual particles in the sample ranging from 0.5 microns to 5000 microns. Detailed information on these particles such as individual measurements and statistical results can be generated which can be then used to draw conclusions.\r\nThe Biovis PSA 2000 System from Expert Vision Labs is a complete image analysis solution that combines a microscope and high resolution digital camera with the powerful particle analysis with 21 CFR Part 11 Compliance software. The system can be easily configured to capture images of the sample and then perform evaluation to determine a number of morphological measurements such as length, breadth, area, aspect ratio, etc. After analysis the data and results can be reported or can be archived for future.\r\nThe software allows user to select from over 70 different types of measurements that can be performed over each of the individual particles in the sample. We can also differentiate the particles into different classes based on a measurement parameter, thus making it easy to distinguish and characterize the good and bad samples in the batch.\r\nParticle analysis is not just limited to the pharmaceutical industry but is also utilized in other industries which require the study of any type of particulate matter. Thus with the growth of industries and emergence of newer markets requiring Particle Size analysis, the use of microscopic image analysis for this purpose is expanding dramatically and rightly so.\r\n\r\nExpert Vision Labs\r\nEmail : sales@expertvisionlabs.com','Biovis PSA 2000 for Particle Size and Shape analysis','','inherit','closed','closed','','4374-revision-v1','','','2020-03-12 07:50:42','2020-03-12 07:50:42','',4374,'https://microbiozindia.com/uncategorized/4374-revision-v1/',0,'revision','',0),(4380,2,'2020-03-12 08:01:08','2020-03-12 08:01:08','Everyone has some risk of developing cancer, and in most cases the disease develops by chance. However, some people are genetically predisposed to developing certain types of cancer. In a small percentage of people with cancer, the disease is due to a different type of mutation called a hereditary mutation, or germline mutation. These mutations are usually inherited from one or both of the person’s parents, and are present in nearly every cell of the body. People who carry such hereditary mutations do not necessarily get cancer, but their risk of developing the disease at some point during their lifetime is higher than average.\r\n\r\n[caption id=\"attachment_4370\" align=\"alignright\" width=\"289\"]<img class=\"wp-image-4370 size-medium\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/aass.-289x300.png\" alt=\"\" width=\"289\" height=\"300\" /> <span style=\"font-family: \'comic sans ms\', sans-serif;\">Chandni Luthra co-founder FutureMed</span>[/caption]\r\n\r\nIn recent years, scientists have discovered a number of mutations that can contribute to a person’s risk of developing certain cancers, including breast, ovarian, colorectal, and prostate cancer, as well as some other, less common cancer types. Futuremed promotes more than 10 different cancer panels i.e. Breast, Ovarian, Endocrine, Renal, Skin, Prostrate and Colorectal. These panels are either aligned towards risk assessment if the concerned person has family history of cancer otherwise known as genetic pre-disposition and synergistic treatment to be followed according to the mutation found.\r\n\r\nCancer can happen due to somatic or germ-line mutations but the underline reason is always genetic alternation. Reasons of somatic mutations are unhealthy lifestyle, tobacco use or environmental factors. Germ-line genetic testing can ascertain cancer prevalence across family, and types of cancer. For diagnosis purpose to check somatic mutations, tumor DNA sequencing is done to determine drug recommendation or treatment guidelines to be followed on the basis of mutation studied. The analysis will infer which treatment suits the patients considering the mutation analyzed.\r\n\r\nThere have been big advances in caring for people who have these known genetic mutations (changes).  Genetic Screening by FutureMed in addition to prevention strategies as well as some treatments based on these screenings can be targeted, and patients’ lives can be improved. Genetic testing also gives doctors the ability to use preventive measures to decrease a patient’s risk of cancer. For example, women who do not already have cancer but have a BRCA1 or BRCA2 mutation can with the help of the doctors discuss preventive measures and surgeries. Genetic testing for hereditary cancer should now become part of standard practice because of the benefits it offers patients. Testing positive for a genetic mutation is not a death sentence but an opportunity. You have options: increased surveillance, chemoprevention, and surgery. You can be proactive and fight cancer before it even starts.\r\n\r\nIn several forms of cancers, genetic testing is used to determine which medicine or treatment procedure will best work for the patient. Thus Genetic testing will potentially be helpful in developing effective strategies for early detection, prevention, and better management of hereditary breast and ovarian cancer which will have a positive impact on healthcare in India.\r\n\r\nChandni Luthra\r\n\r\nCo-founder/Director\r\n\r\nFutureMed Devices Pvt LTD\r\n\r\nD-124 Panchsheel Enclave, New Delhi\r\n\r\nwww.futuremed.co.in\r\n\r\n+919319910550','Cancer and Genetic Testing','','inherit','closed','closed','','4368-revision-v1','','','2020-03-12 08:01:08','2020-03-12 08:01:08','',4368,'https://microbiozindia.com/uncategorized/4368-revision-v1/',0,'revision','',0),(4381,2,'2020-03-12 08:23:39','2020-03-12 08:23:39','Worthington Industries the leading global supplier of pressure tanks and cylinders for cryogenic applications launches RoboStor in India, an automated cryogenic storage and retrieval system for sample storage and management.\r\n\r\nThe Worthington RoboStor&#x2122; by Celltrio product offering gives computerized cryogenic capacity and recovery framework for test sample storage and management.RoboStor&#x2122; is intended for investigate and improvement, bio banking and cell refined applications.\r\n\r\n<strong>Designed with Safety in mind:</strong>\r\n• Robotic recovery limits test presentation to room temperatures\r\n\r\n• Eliminate manual lifting and venturing into the cooler\r\n\r\n<strong>Offers enhanced storage security</strong>\r\n• Three-level review trail for following client activities and information on a for each client premise\r\n\r\n• Inventory the board framework incorporates scanner tag peruser to empower test approval\r\n\r\n<strong>Provides efficient operations</strong>\r\n• Search work gives brisk recognizable proof and area of tests away\r\n\r\n• RoboStor&#x2122; prescribes upgraded capacity areas dependent on current stockpiling usage.\r\n\r\n<strong>Around-the-clock monitoring</strong>\r\n• Automatic fluid nitrogen conveyance is activated when levels each a predefined esteem\r\n\r\n• Provides a discretionary association with an office caution framework.\r\n\r\nFor more information:\r\n<span style=\"font-family: \'comic sans ms\', sans-serif;\">Biolinx India Pvt Ltd</span>\r\n<span style=\"font-family: \'comic sans ms\', sans-serif;\">biolinx@gmail.com</span>','An automated cryogenic storage and retrieval system for sample storage and management','','publish','open','open','','an-automated-cryogenic-storage-and-retrieval-system-for-sample-storage-and-management','','','2020-03-12 10:25:39','2020-03-12 10:25:39','',0,'https://microbiozindia.com/?p=4381',0,'post','',0),(4382,2,'2020-03-12 08:23:27','2020-03-12 08:23:27','','ROBOSTAR','','inherit','open','closed','','robostar','','','2020-03-12 08:23:27','2020-03-12 08:23:27','',4381,'https://microbiozindia.com/wp-content/uploads/2020/03/ROBOSTAR.png',0,'attachment','image/png',0),(4383,2,'2020-03-12 08:23:39','2020-03-12 08:23:39','Worthington Industries the main worldwide provider of weight tanks and chambers for cryogenic applications launches RoboStor in India, a computerized cryogenic capacity and recovery framework for sample storage and management.\r\n\r\nThe Worthington RoboStor&#x2122; by Celltrio product offering gives computerized cryogenic capacity and recovery framework for test sample storage and management.\r\nRoboStor&#x2122; is intended for investigate and improvement, bio banking and cell refined applications.\r\n\r\n<strong>Designed with Safety in mind:</strong>\r\n• Robotic recovery limits test presentation to room temperatures\r\n\r\n• Eliminate manual lifting and venturing into the cooler\r\n\r\n<strong>Offers enhanced storage security</strong>\r\n• Three-level review trail for following client activities and information on a for each client premise\r\n\r\n• Inventory the board framework incorporates scanner tag peruser to empower test approval\r\n\r\n<strong>Provides efficient operations</strong>\r\n• Search work gives brisk recognizable proof and area of tests away\r\n\r\n• RoboStor&#x2122; prescribes upgraded capacity areas dependent on current stockpiling usage.\r\n\r\n<strong>Around-the-clock monitoring</strong>\r\n• Automatic fluid nitrogen conveyance is activated when levels each a predefined esteem\r\n\r\n• Provides a discretionary association with an office caution framework.\r\n\r\nFor more information:\r\n<span style=\"font-family: \'comic sans ms\', sans-serif;\">Biolinx India Pvt Ltd</span>\r\n<span style=\"font-family: \'comic sans ms\', sans-serif;\">biolinx@gmail.com</span>','An automated cryogenic storage and retrieval system for sample storage and management','','inherit','closed','closed','','4381-revision-v1','','','2020-03-12 08:23:39','2020-03-12 08:23:39','',4381,'https://microbiozindia.com/uncategorized/4381-revision-v1/',0,'revision','',0),(4384,2,'2020-03-12 09:57:26','2020-03-12 09:57:26','Workflow description- Pharmaceutical research and development laboratories typically have just a very small amount of each active ingredient they are investigating, often no more than 50–100 mg. As there are many different analyses to be carried out, each substance must be used sparingly.\r\n\r\nFor quantitative organic e<a href=\"https://en.wikipedia.org/wiki/Elemental_analysis\">lemental analysis</a>, accurate weighing of samples is a prerequisite since results are calculated on a weight percent basis.\r\n\r\n<img class=\"alignnone wp-image-4386\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/MT..-300x82.png\" alt=\"\" width=\"593\" height=\"162\" />\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">Workflow challenges and potential improvements</span></strong>\r\n\r\nTypical sample weights for elemental analysis are 3 mg with tolerances lower than ±1%. For this reason a micro- balance with a reliable performance and a low minimum weight is needed to perform the weighing of the sample into the tin or aluminum crucible.\r\n\r\nUsually there are performed 2–3 repetitions per analysis and often 20 or more samples a day plus references are analyzed. However weighing such small quantities requires high concentration and experience. There is always the danger to easily mix up the samples as well as to make mistakes in writing 6-decimal place numbers of the weighing result. Transfer the results to a PC or print it out for documentation could avoid manual transcription errors.\r\n\r\nUsually space in research laboratories is limited – instruments with a footprint as small as possible are desirable.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">Solution</span></strong>\r\n\r\nTo make the most of your valuable resources, <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalances</a> and ultra-microbalances deliver a unique level of accuracy with exceptionally low minimum weights (Fig. 22). By setting up Tolerance Profiles you can ensure weighing tasks meet defined quality requirements and regulations. In addition, as the same profile is used each time a specific task is carried out, you can be sure of consistent settings to guarantee traceable results. The GWP Approved function continuously monitors the balance status and ensures you always weigh within the safe weighing range. An on-screen icon is your reassurance of accurate, reproducible results.\r\n\r\nThe two-terminal concept simplifies operation: The main terminal can be placed wherever is most convenient and the SmartView terminal sits above the weighing chamber – right where you need it for all the basic functions you want as you carry out your weighing tasks. The compact footprint of the <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> saves valuable space in your laboratory.\r\n\r\nThe draft shield provides 270° access to the weighing pan to make dosing of small samples easier and more comfortable.\r\nThe results notepad of the <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> simplifies documentation. As you carry out your tasks, all parameters are automatically recorded on the built-in results notepad, an integral part of the main terminal. You no longer need to record results by hand or spend time typing-in data. Simply transfer task parameters and results to a PC or software application via USB. Transcription errors are completely eliminated and the integrity of your data is preserved.\r\n\r\n<img class=\"alignnone wp-image-4387\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/MT2..-300x115.png\" alt=\"\" width=\"577\" height=\"221\" />\r\n\r\nFig. 22: The high-resolution <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> incorporates a range of innovative new technologies to deliver the highest accuracy in theirclass and to help make your micro-weighing tasks simpler, safer and more secure.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">About METTLER TOLEDO</span></strong>\r\n<a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> is a leading global supplier of precision instruments and services. The Company is the world’s largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. <a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> also holds top-three market positions in several related analytical instruments and is a leading provider of automated chemistry systems used in drug and chemical compound discovery and development. In addition, the Company is the world’s largest manufacturer and marketer of metal detection and other end-of-line inspection systems used in production and packaging and holds a leading position in certain process analytics applications. Additional information about <a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> can be found at www.mt.com.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">For more information-</span></strong>\r\nVisit: <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">www.mt.com/xpr-microbalances</a>\r\nEmail- sales.mtin@mt.com\r\nContact-1800 22 8884 / 1800 10 28460 (Toll Free)','Quantitative Elemental Analysis in Research Labs','','publish','open','open','','quantitative-elemental-analysis-in-research-labs','','','2020-03-12 09:59:56','2020-03-12 09:59:56','',0,'https://microbiozindia.com/?p=4384',0,'post','',0),(4385,2,'2020-03-12 09:52:45','2020-03-12 09:52:45','','METTLER','','inherit','open','closed','','mettler','','','2020-03-12 09:52:45','2020-03-12 09:52:45','',4384,'https://microbiozindia.com/wp-content/uploads/2020/03/METTLER.png',0,'attachment','image/png',0),(4386,2,'2020-03-12 09:52:47','2020-03-12 09:52:47','','MT..','','inherit','open','closed','','mt','','','2020-03-12 09:52:47','2020-03-12 09:52:47','',4384,'https://microbiozindia.com/wp-content/uploads/2020/03/MT...png',0,'attachment','image/png',0),(4387,2,'2020-03-12 09:52:49','2020-03-12 09:52:49','','MT2..','','inherit','open','closed','','mt2','','','2020-03-12 09:52:49','2020-03-12 09:52:49','',4384,'https://microbiozindia.com/wp-content/uploads/2020/03/MT2...png',0,'attachment','image/png',0),(4388,2,'2020-03-12 09:57:26','2020-03-12 09:57:26','<span style=\"font-family: tahoma, arial, helvetica, sans-serif;\">Workflow description:</span> Pharmaceutical research and development laboratories typically have just a very small amount of each active ingredient they are investigating, often no more than 50–100 mg. As there are many different analyses to be carried out, each substance must be used sparingly.\r\n\r\nFor quantitative organic e<a href=\"https://en.wikipedia.org/wiki/Elemental_analysis\">lemental analysis</a>, accurate weighing of samples is a prerequisite since results are calculated on a weight percent basis.\r\n\r\n<img class=\"alignnone  wp-image-4386\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/MT..-300x82.png\" alt=\"\" width=\"593\" height=\"162\" />\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">Workflow challenges and potential improvements</span></strong>\r\n\r\nTypical sample weights for elemental analysis are 3 mg with tolerances lower than ±1%. For this reason a micro- balance with a reliable performance and a low minimum weight is needed to perform the weighing of the sample into the tin or aluminum crucible.\r\n\r\nUsually there are performed 2–3 repetitions per analysis and often 20 or more samples a day plus references are analyzed. However weighing such small quantities requires high concentration and experience. There is always the danger to easily mix up the samples as well as to make mistakes in writing 6-decimal place numbers of the weighing result. Transfer the results to a PC or print it out for documentation could avoid manual transcription errors.\r\n\r\nUsually space in research laboratories is limited – instruments with a footprint as small as possible are desirable.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">Solution</span></strong>\r\n\r\nTo make the most of your valuable resources, <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalances</a> and ultra-microbalances deliver a unique level of accuracy with exceptionally low minimum weights (Fig. 22). By setting up Tolerance Profiles you can ensure weighing tasks meet defined quality requirements and regulations. In addition, as the same profile is used each time a specific task is carried out, you can be sure of consistent settings to guarantee traceable results. The GWP Approved function continuously monitors the balance status and ensures you always weigh within the safe weighing range. An on-screen icon is your reassurance of accurate, reproducible results.\r\n\r\nThe two-terminal concept simplifies operation: The main terminal can be placed wherever is most convenient and the SmartView terminal sits above the weighing chamber – right where you need it for all the basic functions you want as you carry out your weighing tasks. The compact footprint of the <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> saves valuable space in your laboratory.\r\n\r\nThe draft shield provides 270° access to the weighing pan to make dosing of small samples easier and more comfortable.\r\nThe results notepad of the <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> simplifies documentation. As you carry out your tasks, all parameters are automatically recorded on the built-in results notepad, an integral part of the main terminal. You no longer need to record results by hand or spend time typing-in data. Simply transfer task parameters and results to a PC or software application via USB. Transcription errors are completely eliminated and the integrity of your data is preserved.\r\n\r\n<img class=\"alignnone  wp-image-4387\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/MT2..-300x115.png\" alt=\"\" width=\"577\" height=\"221\" />\r\n\r\nFig. 22: The high-resolution <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> incorporates a range of innovative new technologies to deliver the highest accuracy in theirclass and to help make your micro-weighing tasks simpler, safer and more secure.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">About METTLER TOLEDO</span></strong>\r\n<a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> is a leading global supplier of precision instruments and services. The Company is the world’s largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. <a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> also holds top-three market positions in several related analytical instruments and is a leading provider of automated chemistry systems used in drug and chemical compound discovery and development. In addition, the Company is the world’s largest manufacturer and marketer of metal detection and other end-of-line inspection systems used in production and packaging and holds a leading position in certain process analytics applications. Additional information about <a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> can be found at www.mt.com.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">For more information-</span></strong>\r\nVisit: <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">www.mt.com/xpr-microbalances</a>\r\nEmail- sales.mtin@mt.com\r\nContact-1800 22 8884 / 1800 10 28460 (Toll Free)','Quantitative Elemental Analysis in Research Labs','','inherit','closed','closed','','4384-revision-v1','','','2020-03-12 09:57:26','2020-03-12 09:57:26','',4384,'https://microbiozindia.com/uncategorized/4384-revision-v1/',0,'revision','',0),(4389,2,'2020-03-12 09:58:14','2020-03-12 09:58:14','<span style=\"font-family: tahoma, arial, helvetica, sans-serif;\">Workflow description</span>\r\n\r\nPharmaceutical research and development laboratories typically have just a very small amount of each active ingredient they are investigating, often no more than 50–100 mg. As there are many different analyses to be carried out, each substance must be used sparingly.\r\n\r\nFor quantitative organic e<a href=\"https://en.wikipedia.org/wiki/Elemental_analysis\">lemental analysis</a>, accurate weighing of samples is a prerequisite since results are calculated on a weight percent basis.\r\n\r\n<img class=\"alignnone wp-image-4386\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/MT..-300x82.png\" alt=\"\" width=\"593\" height=\"162\" />\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">Workflow challenges and potential improvements</span></strong>\r\n\r\nTypical sample weights for elemental analysis are 3 mg with tolerances lower than ±1%. For this reason a micro- balance with a reliable performance and a low minimum weight is needed to perform the weighing of the sample into the tin or aluminum crucible.\r\n\r\nUsually there are performed 2–3 repetitions per analysis and often 20 or more samples a day plus references are analyzed. However weighing such small quantities requires high concentration and experience. There is always the danger to easily mix up the samples as well as to make mistakes in writing 6-decimal place numbers of the weighing result. Transfer the results to a PC or print it out for documentation could avoid manual transcription errors.\r\n\r\nUsually space in research laboratories is limited – instruments with a footprint as small as possible are desirable.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">Solution</span></strong>\r\n\r\nTo make the most of your valuable resources, <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalances</a> and ultra-microbalances deliver a unique level of accuracy with exceptionally low minimum weights (Fig. 22). By setting up Tolerance Profiles you can ensure weighing tasks meet defined quality requirements and regulations. In addition, as the same profile is used each time a specific task is carried out, you can be sure of consistent settings to guarantee traceable results. The GWP Approved function continuously monitors the balance status and ensures you always weigh within the safe weighing range. An on-screen icon is your reassurance of accurate, reproducible results.\r\n\r\nThe two-terminal concept simplifies operation: The main terminal can be placed wherever is most convenient and the SmartView terminal sits above the weighing chamber – right where you need it for all the basic functions you want as you carry out your weighing tasks. The compact footprint of the <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> saves valuable space in your laboratory.\r\n\r\nThe draft shield provides 270° access to the weighing pan to make dosing of small samples easier and more comfortable.\r\nThe results notepad of the <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> simplifies documentation. As you carry out your tasks, all parameters are automatically recorded on the built-in results notepad, an integral part of the main terminal. You no longer need to record results by hand or spend time typing-in data. Simply transfer task parameters and results to a PC or software application via USB. Transcription errors are completely eliminated and the integrity of your data is preserved.\r\n\r\n<img class=\"alignnone wp-image-4387\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/MT2..-300x115.png\" alt=\"\" width=\"577\" height=\"221\" />\r\n\r\nFig. 22: The high-resolution <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> incorporates a range of innovative new technologies to deliver the highest accuracy in theirclass and to help make your micro-weighing tasks simpler, safer and more secure.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">About METTLER TOLEDO</span></strong>\r\n<a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> is a leading global supplier of precision instruments and services. The Company is the world’s largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. <a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> also holds top-three market positions in several related analytical instruments and is a leading provider of automated chemistry systems used in drug and chemical compound discovery and development. In addition, the Company is the world’s largest manufacturer and marketer of metal detection and other end-of-line inspection systems used in production and packaging and holds a leading position in certain process analytics applications. Additional information about <a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> can be found at www.mt.com.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">For more information-</span></strong>\r\nVisit: <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">www.mt.com/xpr-microbalances</a>\r\nEmail- sales.mtin@mt.com\r\nContact-1800 22 8884 / 1800 10 28460 (Toll Free)','Quantitative Elemental Analysis in Research Labs','','inherit','closed','closed','','4384-revision-v1','','','2020-03-12 09:58:14','2020-03-12 09:58:14','',4384,'https://microbiozindia.com/uncategorized/4384-revision-v1/',0,'revision','',0),(4390,2,'2020-03-12 09:59:02','2020-03-12 09:59:02','Pharmaceutical research and development laboratories typically have just a very small amount of each active ingredient they are investigating, often no more than 50–100 mg. As there are many different analyses to be carried out, each substance must be used sparingly.\r\n\r\nFor quantitative organic e<a href=\"https://en.wikipedia.org/wiki/Elemental_analysis\">lemental analysis</a>, accurate weighing of samples is a prerequisite since results are calculated on a weight percent basis.\r\n\r\n<img class=\"alignnone wp-image-4386\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/MT..-300x82.png\" alt=\"\" width=\"593\" height=\"162\" />\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">Workflow challenges and potential improvements</span></strong>\r\n\r\nTypical sample weights for elemental analysis are 3 mg with tolerances lower than ±1%. For this reason a micro- balance with a reliable performance and a low minimum weight is needed to perform the weighing of the sample into the tin or aluminum crucible.\r\n\r\nUsually there are performed 2–3 repetitions per analysis and often 20 or more samples a day plus references are analyzed. However weighing such small quantities requires high concentration and experience. There is always the danger to easily mix up the samples as well as to make mistakes in writing 6-decimal place numbers of the weighing result. Transfer the results to a PC or print it out for documentation could avoid manual transcription errors.\r\n\r\nUsually space in research laboratories is limited – instruments with a footprint as small as possible are desirable.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">Solution</span></strong>\r\n\r\nTo make the most of your valuable resources, <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalances</a> and ultra-microbalances deliver a unique level of accuracy with exceptionally low minimum weights (Fig. 22). By setting up Tolerance Profiles you can ensure weighing tasks meet defined quality requirements and regulations. In addition, as the same profile is used each time a specific task is carried out, you can be sure of consistent settings to guarantee traceable results. The GWP Approved function continuously monitors the balance status and ensures you always weigh within the safe weighing range. An on-screen icon is your reassurance of accurate, reproducible results.\r\n\r\nThe two-terminal concept simplifies operation: The main terminal can be placed wherever is most convenient and the SmartView terminal sits above the weighing chamber – right where you need it for all the basic functions you want as you carry out your weighing tasks. The compact footprint of the <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> saves valuable space in your laboratory.\r\n\r\nThe draft shield provides 270° access to the weighing pan to make dosing of small samples easier and more comfortable.\r\nThe results notepad of the <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> simplifies documentation. As you carry out your tasks, all parameters are automatically recorded on the built-in results notepad, an integral part of the main terminal. You no longer need to record results by hand or spend time typing-in data. Simply transfer task parameters and results to a PC or software application via USB. Transcription errors are completely eliminated and the integrity of your data is preserved.\r\n\r\n<img class=\"alignnone wp-image-4387\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/MT2..-300x115.png\" alt=\"\" width=\"577\" height=\"221\" />\r\n\r\nFig. 22: The high-resolution <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> incorporates a range of innovative new technologies to deliver the highest accuracy in theirclass and to help make your micro-weighing tasks simpler, safer and more secure.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">About METTLER TOLEDO</span></strong>\r\n<a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> is a leading global supplier of precision instruments and services. The Company is the world’s largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. <a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> also holds top-three market positions in several related analytical instruments and is a leading provider of automated chemistry systems used in drug and chemical compound discovery and development. In addition, the Company is the world’s largest manufacturer and marketer of metal detection and other end-of-line inspection systems used in production and packaging and holds a leading position in certain process analytics applications. Additional information about <a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> can be found at www.mt.com.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">For more information-</span></strong>\r\nVisit: <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">www.mt.com/xpr-microbalances</a>\r\nEmail- sales.mtin@mt.com\r\nContact-1800 22 8884 / 1800 10 28460 (Toll Free)','Quantitative Elemental Analysis in Research Labs','','inherit','closed','closed','','4384-revision-v1','','','2020-03-12 09:59:02','2020-03-12 09:59:02','',4384,'https://microbiozindia.com/uncategorized/4384-revision-v1/',0,'revision','',0),(4391,2,'2020-03-12 09:59:56','2020-03-12 09:59:56','Workflow description- Pharmaceutical research and development laboratories typically have just a very small amount of each active ingredient they are investigating, often no more than 50–100 mg. As there are many different analyses to be carried out, each substance must be used sparingly.\r\n\r\nFor quantitative organic e<a href=\"https://en.wikipedia.org/wiki/Elemental_analysis\">lemental analysis</a>, accurate weighing of samples is a prerequisite since results are calculated on a weight percent basis.\r\n\r\n<img class=\"alignnone wp-image-4386\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/MT..-300x82.png\" alt=\"\" width=\"593\" height=\"162\" />\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">Workflow challenges and potential improvements</span></strong>\r\n\r\nTypical sample weights for elemental analysis are 3 mg with tolerances lower than ±1%. For this reason a micro- balance with a reliable performance and a low minimum weight is needed to perform the weighing of the sample into the tin or aluminum crucible.\r\n\r\nUsually there are performed 2–3 repetitions per analysis and often 20 or more samples a day plus references are analyzed. However weighing such small quantities requires high concentration and experience. There is always the danger to easily mix up the samples as well as to make mistakes in writing 6-decimal place numbers of the weighing result. Transfer the results to a PC or print it out for documentation could avoid manual transcription errors.\r\n\r\nUsually space in research laboratories is limited – instruments with a footprint as small as possible are desirable.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">Solution</span></strong>\r\n\r\nTo make the most of your valuable resources, <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalances</a> and ultra-microbalances deliver a unique level of accuracy with exceptionally low minimum weights (Fig. 22). By setting up Tolerance Profiles you can ensure weighing tasks meet defined quality requirements and regulations. In addition, as the same profile is used each time a specific task is carried out, you can be sure of consistent settings to guarantee traceable results. The GWP Approved function continuously monitors the balance status and ensures you always weigh within the safe weighing range. An on-screen icon is your reassurance of accurate, reproducible results.\r\n\r\nThe two-terminal concept simplifies operation: The main terminal can be placed wherever is most convenient and the SmartView terminal sits above the weighing chamber – right where you need it for all the basic functions you want as you carry out your weighing tasks. The compact footprint of the <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> saves valuable space in your laboratory.\r\n\r\nThe draft shield provides 270° access to the weighing pan to make dosing of small samples easier and more comfortable.\r\nThe results notepad of the <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> simplifies documentation. As you carry out your tasks, all parameters are automatically recorded on the built-in results notepad, an integral part of the main terminal. You no longer need to record results by hand or spend time typing-in data. Simply transfer task parameters and results to a PC or software application via USB. Transcription errors are completely eliminated and the integrity of your data is preserved.\r\n\r\n<img class=\"alignnone wp-image-4387\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/MT2..-300x115.png\" alt=\"\" width=\"577\" height=\"221\" />\r\n\r\nFig. 22: The high-resolution <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">XPR microbalance</a> incorporates a range of innovative new technologies to deliver the highest accuracy in theirclass and to help make your micro-weighing tasks simpler, safer and more secure.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">About METTLER TOLEDO</span></strong>\r\n<a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> is a leading global supplier of precision instruments and services. The Company is the world’s largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. <a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> also holds top-three market positions in several related analytical instruments and is a leading provider of automated chemistry systems used in drug and chemical compound discovery and development. In addition, the Company is the world’s largest manufacturer and marketer of metal detection and other end-of-line inspection systems used in production and packaging and holds a leading position in certain process analytics applications. Additional information about <a href=\"https://en.wikipedia.org/wiki/Mettler_Toledo\">METTLER TOLEDO</a> can be found at www.mt.com.\r\n\r\n<strong><span style=\"font-family: helvetica, arial, sans-serif;\">For more information-</span></strong>\r\nVisit: <a href=\"https://www.mt.com/in/en/home/products/Laboratory_Weighing_Solutions/Micro_Ultra_Balances/XPR_MicroBalance.html?cmp=als_xpr-microbalances\">www.mt.com/xpr-microbalances</a>\r\nEmail- sales.mtin@mt.com\r\nContact-1800 22 8884 / 1800 10 28460 (Toll Free)','Quantitative Elemental Analysis in Research Labs','','inherit','closed','closed','','4384-revision-v1','','','2020-03-12 09:59:56','2020-03-12 09:59:56','',4384,'https://microbiozindia.com/uncategorized/4384-revision-v1/',0,'revision','',0),(4392,2,'2020-03-12 10:25:27','2020-03-12 10:25:27','Worthington Industries the leading global supplier of pressure tanks and cylinders for cryogenic applications launches RoboStor in India, an automated cryogenic storage and retrieval system for sample storage and management.\n\nThe Worthington RoboStor&#x2122; by Celltrio product offering gives computerized cryogenic capacity and recovery framework for test sample storage and management.RoboStor&#x2122; is intended for investigate and improvement, bio banking and cell refined applications.\n\n<strong>Designed with Safety in mind:</strong>\n• Robotic recovery limits test presentation to room temperatures\n\n• Eliminate manual lifting and venturing into the cooler\n\n<strong>Offers enhanced storage security</strong>\n• Three-level review trail for following client activities and information on a for each client premise\n\n• Inventory the board framework incorporates scanner tag peruser to empower test approval\n\n<strong>Provides efficient operations</strong>\n• Search work gives brisk recognizable proof and area of tests away\n\n• RoboStor&#x2122; prescribes upgraded capacity areas dependent on current stockpiling usage.\n\n<strong>Around-the-clock monitoring</strong>\n• Automatic fluid nitrogen conveyance is activated when levels each a predefined esteem\n\n• Provides a discretionary association with an office caution framework.\n\nFor more information:\n<span style=\"font-family: \'comic sans ms\', sans-serif;\">Biolinx India Pvt Ltd</span>\n<span style=\"font-family: \'comic sans ms\', sans-serif;\">biolinx@gmail.com</span>','An automated cryogenic storage and retrieval system for sample storage and management','','inherit','closed','closed','','4381-autosave-v1','','','2020-03-12 10:25:27','2020-03-12 10:25:27','',4381,'https://microbiozindia.com/uncategorized/4381-autosave-v1/',0,'revision','',0),(4393,2,'2020-03-12 10:25:39','2020-03-12 10:25:39','Worthington Industries the leading global supplier of pressure tanks and cylinders for cryogenic applications launches RoboStor in India, an automated cryogenic storage and retrieval system for sample storage and management.\r\n\r\nThe Worthington RoboStor&#x2122; by Celltrio product offering gives computerized cryogenic capacity and recovery framework for test sample storage and management.RoboStor&#x2122; is intended for investigate and improvement, bio banking and cell refined applications.\r\n\r\n<strong>Designed with Safety in mind:</strong>\r\n• Robotic recovery limits test presentation to room temperatures\r\n\r\n• Eliminate manual lifting and venturing into the cooler\r\n\r\n<strong>Offers enhanced storage security</strong>\r\n• Three-level review trail for following client activities and information on a for each client premise\r\n\r\n• Inventory the board framework incorporates scanner tag peruser to empower test approval\r\n\r\n<strong>Provides efficient operations</strong>\r\n• Search work gives brisk recognizable proof and area of tests away\r\n\r\n• RoboStor&#x2122; prescribes upgraded capacity areas dependent on current stockpiling usage.\r\n\r\n<strong>Around-the-clock monitoring</strong>\r\n• Automatic fluid nitrogen conveyance is activated when levels each a predefined esteem\r\n\r\n• Provides a discretionary association with an office caution framework.\r\n\r\nFor more information:\r\n<span style=\"font-family: \'comic sans ms\', sans-serif;\">Biolinx India Pvt Ltd</span>\r\n<span style=\"font-family: \'comic sans ms\', sans-serif;\">biolinx@gmail.com</span>','An automated cryogenic storage and retrieval system for sample storage and management','','inherit','closed','closed','','4381-revision-v1','','','2020-03-12 10:25:39','2020-03-12 10:25:39','',4381,'https://microbiozindia.com/uncategorized/4381-revision-v1/',0,'revision','',0),(4394,2,'2020-03-12 11:15:54','2020-03-12 11:15:54','India forced stringent travel checks to the nation as the <a href=\"https://en.wikipedia.org/wiki/World_Health_Organization\">World Health Organization (WHO)</a> proclaimed the <a href=\"https://en.wikipedia.org/wiki/Coronavirus_disease_2019\">Covid-19</a> episode a pandemic with in excess of 118,000 affirmed cases and 4,291 passings in 114 nations. India\'s check of tainted individuals is 62 with no affirmed passings so distant from the ailment.\r\nThe <a href=\"https://en.wikipedia.org/wiki/World_Health_Organization\">WHO</a> had ordered the <a href=\"https://en.wikipedia.org/wiki/Coronavirus\">coronavirus</a> episode as a worldwide general wellbeing crisis on January 30 and had been hesitant to consider it a pandemic over worries that it would make superfluous frenzy.\r\nThe administration late on Wednesday suspended \"every current visa, with the exception of strategic, official, UN/worldwide associations, business, venture visas\" until April 15. The visafree travel office for Overseas Citizen of India (OCI) holders has been suspended until a similar date. The controls go live at 1200 GMT on March 13 at the port of takeoff.\r\n\r\n<strong>Visas Valid for Those Already in India</strong>\r\nAny remote national who needs to venture out to India earnestly should contact the closest Indian crucial. This incorporates holders of clinical visas. Aside from this and in continuation with prior warnings, the wellbeing service said a 14-day isolate was obligatory for all voyagers, including Indian nationals, showing up from or having visited China, Italy, Iran, South Korea, France, Spain and Germany after February 15.\r\nApproaching explorers, including Indian nationals, are encouraged to stay away from insignificant travel and are educated that they can be isolated for at least 14 days on appearance. Indian nationals have additionally been encouraged to maintain a strategic distance from all unimportant abroad travel, the wellbeing service said. On their arrival, they can be exposed to isolate for at least 14 days. Universal traffic through land fringes will be limited to assigned check posts with strong screening offices.','India closes entryways for outcasts, under deliberate isolate:Coronavirus a pandemic','','publish','open','open','','india-closes-entryways-for-outcasts-under-deliberate-isolatecoronavirus-a-pandemic','','','2020-03-12 11:15:54','2020-03-12 11:15:54','',0,'https://microbiozindia.com/?p=4394',0,'post','',0),(4395,2,'2020-03-12 11:13:29','2020-03-12 11:13:29','','c66d0f80259842c39afecb7d280e9e4e_18','','inherit','open','closed','','c66d0f80259842c39afecb7d280e9e4e_18','','','2020-03-12 11:13:29','2020-03-12 11:13:29','',4394,'https://microbiozindia.com/wp-content/uploads/2020/03/c66d0f80259842c39afecb7d280e9e4e_18.jpg',0,'attachment','image/jpeg',0),(4396,2,'2020-03-12 11:15:54','2020-03-12 11:15:54','India forced stringent travel checks to the nation as the <a href=\"https://en.wikipedia.org/wiki/World_Health_Organization\">World Health Organization (WHO)</a> proclaimed the <a href=\"https://en.wikipedia.org/wiki/Coronavirus_disease_2019\">Covid-19</a> episode a pandemic with in excess of 118,000 affirmed cases and 4,291 passings in 114 nations. India\'s check of tainted individuals is 62 with no affirmed passings so distant from the ailment.\r\nThe <a href=\"https://en.wikipedia.org/wiki/World_Health_Organization\">WHO</a> had ordered the <a href=\"https://en.wikipedia.org/wiki/Coronavirus\">coronavirus</a> episode as a worldwide general wellbeing crisis on January 30 and had been hesitant to consider it a pandemic over worries that it would make superfluous frenzy.\r\nThe administration late on Wednesday suspended \"every current visa, with the exception of strategic, official, UN/worldwide associations, business, venture visas\" until April 15. The visafree travel office for Overseas Citizen of India (OCI) holders has been suspended until a similar date. The controls go live at 1200 GMT on March 13 at the port of takeoff.\r\n\r\n<strong>Visas Valid for Those Already in India</strong>\r\nAny remote national who needs to venture out to India earnestly should contact the closest Indian crucial. This incorporates holders of clinical visas. Aside from this and in continuation with prior warnings, the wellbeing service said a 14-day isolate was obligatory for all voyagers, including Indian nationals, showing up from or having visited China, Italy, Iran, South Korea, France, Spain and Germany after February 15.\r\nApproaching explorers, including Indian nationals, are encouraged to stay away from insignificant travel and are educated that they can be isolated for at least 14 days on appearance. Indian nationals have additionally been encouraged to maintain a strategic distance from all unimportant abroad travel, the wellbeing service said. On their arrival, they can be exposed to isolate for at least 14 days. Universal traffic through land fringes will be limited to assigned check posts with strong screening offices.','India closes entryways for outcasts, under deliberate isolate:Coronavirus a pandemic','','inherit','closed','closed','','4394-revision-v1','','','2020-03-12 11:15:54','2020-03-12 11:15:54','',4394,'https://microbiozindia.com/uncategorized/4394-revision-v1/',0,'revision','',0),(4397,2,'2020-03-12 17:34:16','2020-03-12 17:34:16','Postnova Analytics reports that its CF2000 Centrifugal Field Flow Fractionation system is delivering exciting new data to scientists developing drug delivery systems.\r\n\r\nSoheyl Tadjiki, Managing Director of Postnova Analytics Inc. commented \"One of the grand challenges of characterization of any drug delivery system is the determination of cargo mass per delivery vesicle. Size characterization techniques are inherently inadequate to provide such information. By comparison we have found that our CF2000 <a href=\"https://www.norlab.com/infocenter/190\">Centrifugal Field-Flow Fractionation (CF3)</a> system, a mass-based, high resolution separation instrument, is capable of measuring the cargo mass per vesicle to a limit of quantification of 12 attogram (12 x 10-18 g)\".\r\n\r\nIn <a href=\"https://www.norlab.com/infocenter/190\">Centrifugal Field-Flow Fractionation (CF3)</a> the separation force is established by a centrifugal field, which is generated by spinning the complete circular channel at a high rate. The bigger and denser particles are forced more in the direction of the outer wall than the smaller particles. As a consequence, bigger particles are eluted later from the CF3 channel as they are located in slower streamlines in the channel than the smaller particles which are located in faster stream lines. <img class=\"size-medium wp-image-4399 alignright\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/postnovapr38-imageB-300x168.jpg\" alt=\"\" width=\"300\" height=\"168\" />\r\n\r\nBased on the CF3 principle, the Postnova CF2000 employs a centrifugal field as the driving force for separations. Particles affected by this field are separated by dynamic diffusion on the basis of both particle size and density. This unique feature of the CF2000 allows the separation of different particulate materials having the same particle size. Separations on the CF2000 can be further optimized by using different eluents and temperature programs. As a consequence, the CF2000 system is proving an ideal tool for the separation and characterization of complex particulate samples in areas including agriculture, cosmetics, nanomaterials and pharmaceutical drug delivery systems.\r\n\r\nIn contrast to traditional particle sizing techniques which work in the batch mode, the CF3 technique physically separates each particle fraction prior to sizing. This avoids numerous disadvantages of these batch techniques such as, low size resolution, discrimination and under estimation of smaller compared to larger particles. Using Postnova CF3 technology no special sample preparation is necessary as they can be injected directly without filtration, allowing the characterization of even complex particulate materials without alteration and damage.\r\n\r\n<span style=\"font-family: \'comic sans ms\', sans-serif;\">For further information on the Postnova CF2000 system please visi</span>t https://www.postnova.com/product/systems/cf2000-centri-fff.html. To learn more about how the CF3 technique can help characterize your drug delivery systems contact Postnova Analytics on +49-8191-985-6880 / +44-1885-475007 / +1-801-521-2004 or info@postnova.com.\r\n\r\n<span style=\"font-family: tahoma, arial, helvetica, sans-serif; font-size: 10pt;\">Founded in 1997, Postnova Analytics is the inventor and leading international supplier of Field-Flow Fractionation (FFF) systems for markets including biopharmaceuticals, polymers, materials, nanotechnology and environmental sciences. Leveraging its unique and patented modular FFF - Light Scattering Platform, Postnova has been able to provide high performance solutions to a wide range of applications. Today the company\'s growing product portfolio also includes Flow FFF, Centrifugal FFF, Thermal FFF, Size Exclusion Chromatography (SEC), MALS and DLS. Postnova (www.postnova.com) is located and headquartered in Landsberg am Lech (Germany) and has subsidiaries in the USA, UK and Finland. These offices, in conjunction with a highly qualified and trained distribution network, provide informed local support to customers worldwide.</span>','Centrifugal Field Flow Fractionation Improves Characterization of Drug Delivery Systems','','publish','open','open','','centrifugal-field-flow-fractionation-improves-characterization-of-drug-delivery-systems','','','2020-03-12 17:34:16','2020-03-12 17:34:16','',0,'https://microbiozindia.com/?p=4397',0,'post','',0),(4398,2,'2020-03-12 17:33:24','2020-03-12 17:33:24','','AAA','','inherit','open','closed','','aaa-9','','','2020-03-12 17:33:24','2020-03-12 17:33:24','',4397,'https://microbiozindia.com/wp-content/uploads/2020/03/AAA.png',0,'attachment','image/png',0),(4399,2,'2020-03-12 17:33:26','2020-03-12 17:33:26','','postnovapr38-imageB','','inherit','open','closed','','postnovapr38-imageb','','','2020-03-12 17:33:26','2020-03-12 17:33:26','',4397,'https://microbiozindia.com/wp-content/uploads/2020/03/postnovapr38-imageB.jpg',0,'attachment','image/jpeg',0),(4400,2,'2020-03-12 17:34:16','2020-03-12 17:34:16','Postnova Analytics reports that its CF2000 Centrifugal Field Flow Fractionation system is delivering exciting new data to scientists developing drug delivery systems.\r\n\r\nSoheyl Tadjiki, Managing Director of Postnova Analytics Inc. commented \"One of the grand challenges of characterization of any drug delivery system is the determination of cargo mass per delivery vesicle. Size characterization techniques are inherently inadequate to provide such information. By comparison we have found that our CF2000 <a href=\"https://www.norlab.com/infocenter/190\">Centrifugal Field-Flow Fractionation (CF3)</a> system, a mass-based, high resolution separation instrument, is capable of measuring the cargo mass per vesicle to a limit of quantification of 12 attogram (12 x 10-18 g)\".\r\n\r\nIn <a href=\"https://www.norlab.com/infocenter/190\">Centrifugal Field-Flow Fractionation (CF3)</a> the separation force is established by a centrifugal field, which is generated by spinning the complete circular channel at a high rate. The bigger and denser particles are forced more in the direction of the outer wall than the smaller particles. As a consequence, bigger particles are eluted later from the CF3 channel as they are located in slower streamlines in the channel than the smaller particles which are located in faster stream lines. <img class=\"size-medium wp-image-4399 alignright\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/postnovapr38-imageB-300x168.jpg\" alt=\"\" width=\"300\" height=\"168\" />\r\n\r\nBased on the CF3 principle, the Postnova CF2000 employs a centrifugal field as the driving force for separations. Particles affected by this field are separated by dynamic diffusion on the basis of both particle size and density. This unique feature of the CF2000 allows the separation of different particulate materials having the same particle size. Separations on the CF2000 can be further optimized by using different eluents and temperature programs. As a consequence, the CF2000 system is proving an ideal tool for the separation and characterization of complex particulate samples in areas including agriculture, cosmetics, nanomaterials and pharmaceutical drug delivery systems.\r\n\r\nIn contrast to traditional particle sizing techniques which work in the batch mode, the CF3 technique physically separates each particle fraction prior to sizing. This avoids numerous disadvantages of these batch techniques such as, low size resolution, discrimination and under estimation of smaller compared to larger particles. Using Postnova CF3 technology no special sample preparation is necessary as they can be injected directly without filtration, allowing the characterization of even complex particulate materials without alteration and damage.\r\n\r\n<span style=\"font-family: \'comic sans ms\', sans-serif;\">For further information on the Postnova CF2000 system please visi</span>t https://www.postnova.com/product/systems/cf2000-centri-fff.html. To learn more about how the CF3 technique can help characterize your drug delivery systems contact Postnova Analytics on +49-8191-985-6880 / +44-1885-475007 / +1-801-521-2004 or info@postnova.com.\r\n\r\n<span style=\"font-family: tahoma, arial, helvetica, sans-serif; font-size: 10pt;\">Founded in 1997, Postnova Analytics is the inventor and leading international supplier of Field-Flow Fractionation (FFF) systems for markets including biopharmaceuticals, polymers, materials, nanotechnology and environmental sciences. Leveraging its unique and patented modular FFF - Light Scattering Platform, Postnova has been able to provide high performance solutions to a wide range of applications. Today the company\'s growing product portfolio also includes Flow FFF, Centrifugal FFF, Thermal FFF, Size Exclusion Chromatography (SEC), MALS and DLS. Postnova (www.postnova.com) is located and headquartered in Landsberg am Lech (Germany) and has subsidiaries in the USA, UK and Finland. These offices, in conjunction with a highly qualified and trained distribution network, provide informed local support to customers worldwide.</span>','Centrifugal Field Flow Fractionation Improves Characterization of Drug Delivery Systems','','inherit','closed','closed','','4397-revision-v1','','','2020-03-12 17:34:16','2020-03-12 17:34:16','',4397,'https://microbiozindia.com/uncategorized/4397-revision-v1/',0,'revision','',0),(4401,2,'2020-03-13 04:36:27','2020-03-13 04:36:27','As the novel coronavirus started spreading far and wide this year, one basic abstain from doubters of the crisis measures being set up to stop the flare-up was that it was much the same as influenza - risky to delicate gatherings however normal and not something to get into lockdown over.\r\n\r\nWe currently realize that appraisal isn\'t right. At its most minimal evaluated casualty rate dependent on ebb and flow information, <a href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">Covid-19</a>, the infection brought about by the coronavirus, is thought to execute some 1-2% of known patients, contrasted with around 0.1% for winter flu. The coronavirus likewise gives off an impression of being about as irresistible as this season\'s cold virus, and possibly more along these lines, particularly as there are no particular treatment, fix or <a href=\"https://www.who.int/ith/ITH-Chapter6.pdf\">occasional immunization.</a>\r\n\r\nThere is one territory in which specialists trust the infection will at present act like flu, be that as it may, by decreasing in spring.\r\n\"This is a respiratory virus and they always give us trouble during cold weather, for obvious reasons,\" Nelson Michael, a leading US military medical researcher, said of the novel coronavirus last week. \"We\'re all inside, the windows are closed, etcetera, so we typically call that the influenza or the flu season.\"\r\nFlu flourishes in cold and dry conditions, which is the reason winter is influenza season for a great part of the northern side of the equator. Social contrasts in winter can likewise have an impact. Michael anticipated the coronavirus may carry on like this season\'s cold virus and give us \"less difficulty as the climate heats up,\" in any case, he forewarned, it could return when the climate gets cold once more.\r\n\r\nThe expectation is that, alongside radical activity by governments and people in general to diminish the quantity of new cases, decreased spread during hotter climate would give wellbeing frameworks space to adapt to the underlying flood of coronavirus patients, and purchase time for a potential antibody to be created.\r\n\r\n\"This is the reason it\'s extremely critical to comprehend that a ton of what we\'re doing now is preparing ourselves for what we\'re calling the second influx of this,\" Michael cautioned.\r\n\r\nBe that as it may, imagine a scenario in which the infection doesn\'t act like flu. Might we be able to manage contamination rates that stay high consistently? In excess of 100 cases have been affirmed in Singapore, where it\'s hot and damp essentially all year. Australia, Brazil and Argentina, all right now in the center of summer, have likewise detailed many cases.','Will hotter climate help battle the coronavirus?','','publish','open','open','','will-hotter-climate-help-battle-the-coronavirus','','','2020-03-13 04:36:27','2020-03-13 04:36:27','',0,'https://microbiozindia.com/?p=4401',0,'post','',0),(4402,2,'2020-03-13 04:36:15','2020-03-13 04:36:15','','AAAA','','inherit','open','closed','','aaaa-2','','','2020-03-13 04:36:15','2020-03-13 04:36:15','',4401,'https://microbiozindia.com/wp-content/uploads/2020/03/AAAA.png',0,'attachment','image/png',0),(4403,2,'2020-03-13 04:36:27','2020-03-13 04:36:27','As the novel coronavirus started spreading far and wide this year, one basic abstain from doubters of the crisis measures being set up to stop the flare-up was that it was much the same as influenza - risky to delicate gatherings however normal and not something to get into lockdown over.\r\n\r\nWe currently realize that appraisal isn\'t right. At its most minimal evaluated casualty rate dependent on ebb and flow information, <a href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it\">Covid-19</a>, the infection brought about by the coronavirus, is thought to execute some 1-2% of known patients, contrasted with around 0.1% for winter flu. The coronavirus likewise gives off an impression of being about as irresistible as this season\'s cold virus, and possibly more along these lines, particularly as there are no particular treatment, fix or <a href=\"https://www.who.int/ith/ITH-Chapter6.pdf\">occasional immunization.</a>\r\n\r\nThere is one territory in which specialists trust the infection will at present act like flu, be that as it may, by decreasing in spring.\r\n\"This is a respiratory virus and they always give us trouble during cold weather, for obvious reasons,\" Nelson Michael, a leading US military medical researcher, said of the novel coronavirus last week. \"We\'re all inside, the windows are closed, etcetera, so we typically call that the influenza or the flu season.\"\r\nFlu flourishes in cold and dry conditions, which is the reason winter is influenza season for a great part of the northern side of the equator. Social contrasts in winter can likewise have an impact. Michael anticipated the coronavirus may carry on like this season\'s cold virus and give us \"less difficulty as the climate heats up,\" in any case, he forewarned, it could return when the climate gets cold once more.\r\n\r\nThe expectation is that, alongside radical activity by governments and people in general to diminish the quantity of new cases, decreased spread during hotter climate would give wellbeing frameworks space to adapt to the underlying flood of coronavirus patients, and purchase time for a potential antibody to be created.\r\n\r\n\"This is the reason it\'s extremely critical to comprehend that a ton of what we\'re doing now is preparing ourselves for what we\'re calling the second influx of this,\" Michael cautioned.\r\n\r\nBe that as it may, imagine a scenario in which the infection doesn\'t act like flu. Might we be able to manage contamination rates that stay high consistently? In excess of 100 cases have been affirmed in Singapore, where it\'s hot and damp essentially all year. Australia, Brazil and Argentina, all right now in the center of summer, have likewise detailed many cases.','Will hotter climate help battle the coronavirus?','','inherit','closed','closed','','4401-revision-v1','','','2020-03-13 04:36:27','2020-03-13 04:36:27','',4401,'https://microbiozindia.com/uncategorized/4401-revision-v1/',0,'revision','',0),(4404,2,'2020-03-13 12:08:53','2020-03-13 12:08:53','Terrassa (Barcelona) 2020, March 13th.A new generation of environmentally friendly laboratory freeze dryers that operate with natural gases has been developed by Telstar. LyoQuest Arctic is an innovative bench-top laboratory freeze dryer that integrates pre-freezing, primary drying and secondary drying processes avoiding the use of conventional HFC or HFO cooling gases.\r\n\r\nThe new freeze-dryer, which operates with natural gases composed by R-170 (Ethane) &amp; R-290 (Propane), guarantees the long-term compliance with increasingly restrictive International regulations (like F-gas). In fact, since 2015 high GWP (Global Warming Potential) gases are not allowed except for very low temperatures applications below -50ºC. Due to this ban for non-critical applications the availability and use of the usual HFC gases will be compromised in the short term.\r\n\r\nThe global warming potential (GWP) of a gas is a value that measures global warming and, specifically, it measures the warming impact from the emission of one unit of a certain gas when compared to one unit of carbon dioxide. Carbon dioxide is the reference gas and is thus assigned a value of 1. Natural gases integrated in LyoQuest Arctic provide Zero ODP (Ozone Depletion Potencial) besides very a low GWP (under 6) in contrast with higher than 3000 GWP of current HFC’s. Even the new HFOs gases under development to replace them have a GWP higher than 1500.\r\n\r\nThe new environmentally friendly freeze-dryer LyoQuest Arctic combines flexibility with performance into a single unit so that users can carry out complete cycles using different containers (vials, trays, ampoules, and flasks) with the same piece of equipment. In addition to being versatile, LyoQuest Arctic also enables users to create recipes that include time, temperature and vacuum control via its integrated PLC control system. The innovative design of this freeze dryer results in an extremely compact unit with large condensation capacity of up to 8 liters. The freeze-dryer’s ice condenser includes an automatic defrosting function for quick and easy de-icing. Furthermore, its design enables many product formats to be pre-frozen in the unit, without the need for an additional freezer.','Telstar develops a new laboratory freeze dryer operating with natural gases','','publish','open','open','','telstar-develops-a-new-laboratory-freeze-dryer-operating-with-natural-gases','','','2020-03-13 12:08:53','2020-03-13 12:08:53','',0,'https://microbiozindia.com/?p=4404',0,'post','',0),(4405,2,'2020-03-13 12:08:31','2020-03-13 12:08:31','','rr','','inherit','open','closed','','rr','','','2020-03-13 12:08:31','2020-03-13 12:08:31','',4404,'https://microbiozindia.com/wp-content/uploads/2020/03/rr.png',0,'attachment','image/png',0),(4406,2,'2020-03-13 12:08:53','2020-03-13 12:08:53','Terrassa (Barcelona) 2020, March 13th.A new generation of environmentally friendly laboratory freeze dryers that operate with natural gases has been developed by Telstar. LyoQuest Arctic is an innovative bench-top laboratory freeze dryer that integrates pre-freezing, primary drying and secondary drying processes avoiding the use of conventional HFC or HFO cooling gases.\r\n\r\nThe new freeze-dryer, which operates with natural gases composed by R-170 (Ethane) &amp; R-290 (Propane), guarantees the long-term compliance with increasingly restrictive International regulations (like F-gas). In fact, since 2015 high GWP (Global Warming Potential) gases are not allowed except for very low temperatures applications below -50ºC. Due to this ban for non-critical applications the availability and use of the usual HFC gases will be compromised in the short term.\r\n\r\nThe global warming potential (GWP) of a gas is a value that measures global warming and, specifically, it measures the warming impact from the emission of one unit of a certain gas when compared to one unit of carbon dioxide. Carbon dioxide is the reference gas and is thus assigned a value of 1. Natural gases integrated in LyoQuest Arctic provide Zero ODP (Ozone Depletion Potencial) besides very a low GWP (under 6) in contrast with higher than 3000 GWP of current HFC’s. Even the new HFOs gases under development to replace them have a GWP higher than 1500.\r\n\r\nThe new environmentally friendly freeze-dryer LyoQuest Arctic combines flexibility with performance into a single unit so that users can carry out complete cycles using different containers (vials, trays, ampoules, and flasks) with the same piece of equipment. In addition to being versatile, LyoQuest Arctic also enables users to create recipes that include time, temperature and vacuum control via its integrated PLC control system. The innovative design of this freeze dryer results in an extremely compact unit with large condensation capacity of up to 8 liters. The freeze-dryer’s ice condenser includes an automatic defrosting function for quick and easy de-icing. Furthermore, its design enables many product formats to be pre-frozen in the unit, without the need for an additional freezer.','Telstar develops a new laboratory freeze dryer operating with natural gases','','inherit','closed','closed','','4404-revision-v1','','','2020-03-13 12:08:53','2020-03-13 12:08:53','',4404,'https://microbiozindia.com/uncategorized/4404-revision-v1/',0,'revision','',0),(4407,2,'2020-03-13 15:15:36','2020-03-13 15:15:36','Complete case mean coronavirus has arrived at 81 in India. Maharashtra is in a lockdown mode.\r\nThe administration on Friday proclaimed covers, including N95, and hand sanitizers as \'fundamental commodities\'.The choice comes in the wake of the <a href=\"https://en.wikipedia.org/wiki/Coronavirus\">coronavirus</a> alarm prompting deficiencies and dark showcasing of these items.These things will stay under basic products fragment till June-end.\r\nThe administration has told a request to announce covers (2 handle and 3 utilize careful veils, N95 covers) and hand santizers as basic items up to June 30, 2020.The choice has engaged the Center too states to manage creation, quality, disseminations of covers and hand sanitiziers,\r\nIt will likewise smoothen deal and accessibility of these things, and for complete activities against examiners.\r\nThe <a href=\"https://www.cdc.gov/\">CDC</a> had suggested that human services laborers interfacing with coronavirus patients or suspected cases wear N95 respirators, alongside outfits, gloves and eye defenders. The N95 channels must be custom-fitted and cost more than careful covers.\r\nThe <a href=\"https://www.cdc.gov/\">CDC</a> direction has been in conversation for quite a long time, and in excess of twelve associations had recently said they were against any adjustments in proposals in light of the fact that rising sicknesses like covid-19 represent a word related peril for laborers on the bleeding edges, particularly medicinal services laborers.','Covers and sanitizers announced \'fundamental items\' briefly','','publish','open','open','','covers-and-sanitizers-announced-fundamental-items-briefly','','','2020-03-13 15:15:36','2020-03-13 15:15:36','',0,'https://microbiozindia.com/?p=4407',0,'post','',0),(4408,2,'2020-03-13 15:13:57','2020-03-13 15:13:57','','n95_respirator','','inherit','open','closed','','n95_respirator','','','2020-03-13 15:13:57','2020-03-13 15:13:57','',4407,'https://microbiozindia.com/wp-content/uploads/2020/03/n95_respirator.jpg',0,'attachment','image/jpeg',0),(4409,2,'2020-03-13 15:15:36','2020-03-13 15:15:36','Complete case mean coronavirus has arrived at 81 in India. Maharashtra is in a lockdown mode.\r\nThe administration on Friday proclaimed covers, including N95, and hand sanitizers as \'fundamental commodities\'.The choice comes in the wake of the <a href=\"https://en.wikipedia.org/wiki/Coronavirus\">coronavirus</a> alarm prompting deficiencies and dark showcasing of these items.These things will stay under basic products fragment till June-end.\r\nThe administration has told a request to announce covers (2 handle and 3 utilize careful veils, N95 covers) and hand santizers as basic items up to June 30, 2020.The choice has engaged the Center too states to manage creation, quality, disseminations of covers and hand sanitiziers,\r\nIt will likewise smoothen deal and accessibility of these things, and for complete activities against examiners.\r\nThe <a href=\"https://www.cdc.gov/\">CDC</a> had suggested that human services laborers interfacing with coronavirus patients or suspected cases wear N95 respirators, alongside outfits, gloves and eye defenders. The N95 channels must be custom-fitted and cost more than careful covers.\r\nThe <a href=\"https://www.cdc.gov/\">CDC</a> direction has been in conversation for quite a long time, and in excess of twelve associations had recently said they were against any adjustments in proposals in light of the fact that rising sicknesses like covid-19 represent a word related peril for laborers on the bleeding edges, particularly medicinal services laborers.','Covers and sanitizers announced \'fundamental items\' briefly','','inherit','closed','closed','','4407-revision-v1','','','2020-03-13 15:15:36','2020-03-13 15:15:36','',4407,'https://microbiozindia.com/uncategorized/4407-revision-v1/',0,'revision','',0),(4410,2,'2020-03-14 10:32:24','2020-03-14 10:32:24','Pfizer and Merck KGaA\'s Bavencio tossed another Javelin however missed their objective in head and neck malignant growth.\r\nAdding Bavencio to <strong><a href=\"https://en.wikipedia.org/wiki/Chemoradiotherapy\">chemoradiotherapy</a></strong> didn\'t furnish a lot of additional advantage to patients with beforehand untreated privately progressed squamous cell carcinoma of the head and neck, the pair uncovered Friday.\r\nThe autonomous information checking advisory group found at a break investigation that the combo wasn\'t probably going to essentially stretch out the opportunity to tumor movement or demise versus standard-of-care <strong><a href=\"https://en.wikipedia.org/wiki/Chemoradiotherapy\">chemoradiotherapy</a></strong> alone. At the specialists\' suggestion, the two organizations have chosen to end their stage 3 preliminary, called Javelin Head and Neck 100.\r\nPfizer and Merck KGaA aren\'t abandoning the PD-L1 prescription\'s potential in head and neck malignant growth. The union is trying Bavencio in various immuno-oncology mixes in the Javelin Medley preliminary. Investigational drugs the organizations are blending with it incorporate Pfizer\'s enemy of 4-1BB immune response utomilumab and OX40 inhibitor PF-04518600, and on them, <strong><a href=\"https://www.businesswire.com/news/home/20191001005189/en/Checkmate-Pharmaceuticals-Announces-Dosing-Patient-Phase-1b2\">Checkmate Pharmaceuticals\'</a></strong> TLR9 agonist CMP-001, explicitly for head and neck patients.\r\n\r\nAt present inside the PD-1/L1 class, Merck and Co\'s. Keytruda is the just one with a FDA gesture in bleeding edge head and neck disease. Bristol Myers Squibb\'s Opdivo is permitted in patients with illness movement on or after platinum-based chemotherapy.\r\n\r\nIn the mean time, AstraZeneca\'s relied upon to report discoveries this year from the stage 3 Kestrel study that joins its PD-L1 Imfinzi with CTLA4 inhibitor tremelimumab in first-line head and neck disease. AZ is depending on the investigation after the double <strong><a href=\"https://en.wikipedia.org/wiki/Immunotherapy\">immunotherapy</a></strong> routine slumped in patients who had just bombed on chemo.\r\n\r\nWith respect to Roche\'s Tecentriq, the Swiss drugmaker is running the stage 3 IMvoke010 study to test its latent capacity. The Roche is attempting to pitch Tecentriq as an adjuvant treatment utilized just after conclusive nearby treatment in patients with high-take an enormous risk malignant growth to forestall sickness repeat or movement.\r\n\r\nIn the interim, it\'s been somewhat of a rollercoaster for Bavencio in different signs of late, with the medication as of late posting one win and one misfortune in the facility. In January, Pfizer and Merck KGaA said Bavencio helped bladder malignant growth patients whose infection had not advanced after enlistment chemo live altogether longer contrasted and best strong consideration. It denoted the principal win for an immuno-oncology specialist in that first-line upkeep setting.\r\n\r\nIn any case, the upkeep system didn\'t happen for Bavencio in stomach malignant growth. After one round of chemo, the prescription neglected to top proceeding chemo or best steady consideration at broadening patients\' lives. The medication bombed no matter how you look at it, as even patients whose tumors tried positive for biomarker PD-L1—who will in general show improvement over others on PD-1/L1 drugs—didn\'t profit by the treatment.','Pfizer, Merck KGaA\'s Bavencio pierced by Javelin in head and neck malignancy','','publish','open','open','','pfizer-merck-kgaas-bavencio-pierced-by-javelin-in-head-and-neck-malignancy','','','2020-03-14 10:32:24','2020-03-14 10:32:24','',0,'https://microbiozindia.com/?p=4410',0,'post','',0),(4411,2,'2020-03-14 10:29:45','2020-03-14 10:29:45','','AWW','','inherit','open','closed','','aww','','','2020-03-14 10:29:45','2020-03-14 10:29:45','',4410,'https://microbiozindia.com/wp-content/uploads/2020/03/AWW.png',0,'attachment','image/png',0),(4412,2,'2020-03-14 10:32:24','2020-03-14 10:32:24','Pfizer and Merck KGaA\'s Bavencio tossed another Javelin however missed their objective in head and neck malignant growth.\r\nAdding Bavencio to <strong><a href=\"https://en.wikipedia.org/wiki/Chemoradiotherapy\">chemoradiotherapy</a></strong> didn\'t furnish a lot of additional advantage to patients with beforehand untreated privately progressed squamous cell carcinoma of the head and neck, the pair uncovered Friday.\r\nThe autonomous information checking advisory group found at a break investigation that the combo wasn\'t probably going to essentially stretch out the opportunity to tumor movement or demise versus standard-of-care <strong><a href=\"https://en.wikipedia.org/wiki/Chemoradiotherapy\">chemoradiotherapy</a></strong> alone. At the specialists\' suggestion, the two organizations have chosen to end their stage 3 preliminary, called Javelin Head and Neck 100.\r\nPfizer and Merck KGaA aren\'t abandoning the PD-L1 prescription\'s potential in head and neck malignant growth. The union is trying Bavencio in various immuno-oncology mixes in the Javelin Medley preliminary. Investigational drugs the organizations are blending with it incorporate Pfizer\'s enemy of 4-1BB immune response utomilumab and OX40 inhibitor PF-04518600, and on them, <strong><a href=\"https://www.businesswire.com/news/home/20191001005189/en/Checkmate-Pharmaceuticals-Announces-Dosing-Patient-Phase-1b2\">Checkmate Pharmaceuticals\'</a></strong> TLR9 agonist CMP-001, explicitly for head and neck patients.\r\n\r\nAt present inside the PD-1/L1 class, Merck and Co\'s. Keytruda is the just one with a FDA gesture in bleeding edge head and neck disease. Bristol Myers Squibb\'s Opdivo is permitted in patients with illness movement on or after platinum-based chemotherapy.\r\n\r\nIn the mean time, AstraZeneca\'s relied upon to report discoveries this year from the stage 3 Kestrel study that joins its PD-L1 Imfinzi with CTLA4 inhibitor tremelimumab in first-line head and neck disease. AZ is depending on the investigation after the double <strong><a href=\"https://en.wikipedia.org/wiki/Immunotherapy\">immunotherapy</a></strong> routine slumped in patients who had just bombed on chemo.\r\n\r\nWith respect to Roche\'s Tecentriq, the Swiss drugmaker is running the stage 3 IMvoke010 study to test its latent capacity. The Roche is attempting to pitch Tecentriq as an adjuvant treatment utilized just after conclusive nearby treatment in patients with high-take an enormous risk malignant growth to forestall sickness repeat or movement.\r\n\r\nIn the interim, it\'s been somewhat of a rollercoaster for Bavencio in different signs of late, with the medication as of late posting one win and one misfortune in the facility. In January, Pfizer and Merck KGaA said Bavencio helped bladder malignant growth patients whose infection had not advanced after enlistment chemo live altogether longer contrasted and best strong consideration. It denoted the principal win for an immuno-oncology specialist in that first-line upkeep setting.\r\n\r\nIn any case, the upkeep system didn\'t happen for Bavencio in stomach malignant growth. After one round of chemo, the prescription neglected to top proceeding chemo or best steady consideration at broadening patients\' lives. The medication bombed no matter how you look at it, as even patients whose tumors tried positive for biomarker PD-L1—who will in general show improvement over others on PD-1/L1 drugs—didn\'t profit by the treatment.','Pfizer, Merck KGaA\'s Bavencio pierced by Javelin in head and neck malignancy','','inherit','closed','closed','','4410-revision-v1','','','2020-03-14 10:32:24','2020-03-14 10:32:24','',4410,'https://microbiozindia.com/uncategorized/4410-revision-v1/',0,'revision','',0),(4413,2,'2020-03-14 11:30:08','2020-03-14 11:30:08','Sisco Research Laboratories Pvt Ltd was recently presented SME of the Year 2020 - Manufacturing Sector (Chemicals) Award at the function organized by the Small &amp; Medium Enterprise (SME) Chamber of India at Sahara Star Hotel, Mumbai.\r\n\r\n<img class=\"alignnone wp-image-4414\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/AAA-1-300x188.png\" alt=\"\" width=\"424\" height=\"266\" />\r\n\r\nThe award was presented to Mr. S.K. Agarwal (Chairman &amp; MD), Mr. Ramesh Agarwal (Director), Mr. Akash Agarwal (Director) &amp; Mr. Vikas Agarwal (Director) at the hands of Shri R.M. Mishra - Special Secretary and Development Commissioner, Ministry of MSME, Government of India.\r\n\r\nThis award is a testament of their growing presence &amp; dominance as a part of the Indian Scientific &amp; Laboratory Chemical Industry.\r\nMr. S. K. Agarwal expressed his heartfelt gratitude to all of his business partners who have helped SRL to achieve this recognition. He further dedicated this award to all the scientists, researchers &amp; students for patronizing SRL Biochemicals &amp; Regents since more than 4 decades.\r\n\r\nFor more information:\r\nmarketing@srlchem.com','SISCO Research Laboratories Pvt Ltd is awarded with SME of the year 2020','','publish','open','open','','sisco-research-laboratories-pvt-ltd-is-awarded-with-sme-of-the-year-2020','','','2020-03-14 11:30:47','2020-03-14 11:30:47','',0,'https://microbiozindia.com/?p=4413',0,'post','',0),(4414,2,'2020-03-14 11:29:24','2020-03-14 11:29:24','','AAA','','inherit','open','closed','','aaa-10','','','2020-03-14 11:29:24','2020-03-14 11:29:24','',4413,'https://microbiozindia.com/wp-content/uploads/2020/03/AAA-1.png',0,'attachment','image/png',0),(4415,2,'2020-03-14 11:29:26','2020-03-14 11:29:26','','SRL.','','inherit','open','closed','','srl','','','2020-03-14 11:29:26','2020-03-14 11:29:26','',4413,'https://microbiozindia.com/wp-content/uploads/2020/03/SRL..png',0,'attachment','image/png',0),(4416,2,'2020-03-14 11:30:08','2020-03-14 11:30:08','Sisco Research Laboratories Pvt Ltd was recently presented SME of the Year 2020 - Manufacturing Sector (Chemicals) Award at the function organized by the Small &amp; Medium Enterprise (SME) Chamber of India at Sahara Star Hotel, Mumbai.\r\n\r\n<img class=\"alignnone  wp-image-4414\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/AAA-1-300x188.png\" alt=\"\" width=\"424\" height=\"266\" />\r\n\r\nThe award was presented to Mr. S.K. Agarwal (Chairman &amp; MD), Mr. Ramesh Agarwal (Director), Mr. Akash Agarwal (Director) &amp; Mr. Vikas Agarwal (Director) at the hands of Shri R.M. Mishra - Special Secretary and Development Commissioner, Ministry of MSME, Government of India.\r\n\r\nThis award is a testament of their growing presence &amp; dominance as a part of the Indian Scientific &amp; Laboratory Chemical Industry.\r\nMr. S. K. Agarwal expressed his heartfelt gratitude to all of his business partners who have helped SRL to achieve this recognition. He further dedicated this award to all the scientists, researchers &amp; students for patronizing SRL Biochemicals &amp; Regents since more than 4 decades.\r\n\r\nFor more information:\r\nmarketing@srlchem.com','SISCO Research Laboratories Pvt Ltd is awarded with SME of the year 2020','','inherit','closed','closed','','4413-revision-v1','','','2020-03-14 11:30:08','2020-03-14 11:30:08','',4413,'https://microbiozindia.com/uncategorized/4413-revision-v1/',0,'revision','',0),(4417,2,'2020-03-15 09:40:55','2020-03-15 09:40:55','As per ICMR specialists, the consideration of the counter <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.webmd.com/hiv-aids/aids-hiv-medication\">HIV drugs</a></span> for treating Covid-19 depended on prior proof about their adequacy against <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Middle_East_respiratory_syndrome-related_coronavirus\">SARS and MERS</a></span> coronaviruses that prompted episodes in various pieces of the world in 2002-03 and 2012, individually, just as the docking examines led by National Institute of Virology, Pune.\r\n\r\n<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12662125\"><span style=\"color: #ff6600;\">Anti-HIV medications, Lopinavir and Ritonavir</span></a>, can be utilized to treat Covid-19 patients in extreme cases.\r\n\r\nIndia\'s top wellbeing research body, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Council_of_Medical_Research\">Indian Council of Medical Research (ICMR)</a></span>, has recommended this in the treatment convention for Covid-19 distributed by it in IJMR, a clinical diary.\r\n\r\nLopinavir and Ritonavir, the convention recommends, can be utilized in grown-ups more than 18 years old who are affirmed positive for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Coronavirus_disease_2019\">Covid-19</a></span> and have intricacies, for example, extreme respiratory pain, low circulatory strain and new-beginning organ brokenness. It has fixed parameters to choose how extreme the respiratory pain ought to be for the fixed portion mix to be utilized on a patient.\r\n\r\nComparable parameters have been fixed for other potential confusions also, whereupon the medication can be utilized to spare the patients.\r\n\r\nAs per ICMR specialists, the consideration of the counter HIV drugs for treating Covid-19 depended on prior proof about their viability against SARS and MERS coronaviruses that prompted flare-ups in various pieces of the world in 2002-03 and 2012, separately, just as the docking examines led by National Institute of Virology, Pune.\r\n“Use of IFN-B1b (a drug used for treating multiple sclerosis) and Ribavarin (an antiviral medication used to treat certain respiratory infections, hepatitis C and some viral haemorrhagic fevers) was not considered due to their reported toxicity whereas Oseltamivir (used to treat swine flu) was not considered due to its unproven efficacy against CoVs (coronaviruses),” states the treatment protocol published in Indian Journal of Medical Research (IJMR). The fixed dose drug combination (Lopinavir/Ritonavir 200 mg/50 mg) is to be given two tablets every 12 hours for 14 days or for seven days after becoming symptomatic, whichever is earlier, as per the protocol.\r\n\r\nThe anti-HIV drugs have been tried on some <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Coronavirus_disease_2019\">Covid-19</a></span> patients in India already, including the Italian national admitted at Sawai Man Singh hospital in Jaipur, with promising results, said sources.\r\nRecently, in a draft report made public by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/World_Health_Organization\">World Health Organisation</a></span>, the experts claimed Lopinavir and Ritonavir — either alone or in combination with IFNbeta was the suitable second option for rapid implementation in clinical trials among the repurposed drugs under consideration for Covid-19.\r\n\r\nWHO experts claimed that Remdesivir, a drug developed for use against Ebola, is most promising for treating Covid-19.\r\n\r\n“This is because the in-vitro (tests performed in test tube) and in-vivo (tests performed in living organism) data for the drug are available for coronaviruses.”\r\n\r\n“Further, studies in mice using Remdesivir showed superior efficacy over Kaletra+IFNbeta,” they stated in the draft report. Remdesivir slows the infection of healthy cells by blocking viral replication.','Coronavirus: HIV medications can be utilized in extreme cases, says ICMR','','publish','open','open','','coronavirus-hiv-medications-can-be-utilized-in-extreme-cases-says-icmr','','','2020-03-15 09:40:55','2020-03-15 09:40:55','',0,'https://microbiozindia.com/?p=4417',0,'post','',0),(4418,2,'2020-03-15 09:40:39','2020-03-15 09:40:39','','GettyImages-950596850-scaled','','inherit','open','closed','','gettyimages-950596850-scaled','','','2020-03-15 09:40:39','2020-03-15 09:40:39','',4417,'https://microbiozindia.com/wp-content/uploads/2020/03/GettyImages-950596850-scaled-1.jpg',0,'attachment','image/jpeg',0),(4419,2,'2020-03-15 09:40:55','2020-03-15 09:40:55','As per ICMR specialists, the consideration of the counter <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.webmd.com/hiv-aids/aids-hiv-medication\">HIV drugs</a></span> for treating Covid-19 depended on prior proof about their adequacy against <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Middle_East_respiratory_syndrome-related_coronavirus\">SARS and MERS</a></span> coronaviruses that prompted episodes in various pieces of the world in 2002-03 and 2012, individually, just as the docking examines led by National Institute of Virology, Pune.\r\n\r\n<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12662125\"><span style=\"color: #ff6600;\">Anti-HIV medications, Lopinavir and Ritonavir</span></a>, can be utilized to treat Covid-19 patients in extreme cases.\r\n\r\nIndia\'s top wellbeing research body, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Council_of_Medical_Research\">Indian Council of Medical Research (ICMR)</a></span>, has recommended this in the treatment convention for Covid-19 distributed by it in IJMR, a clinical diary.\r\n\r\nLopinavir and Ritonavir, the convention recommends, can be utilized in grown-ups more than 18 years old who are affirmed positive for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Coronavirus_disease_2019\">Covid-19</a></span> and have intricacies, for example, extreme respiratory pain, low circulatory strain and new-beginning organ brokenness. It has fixed parameters to choose how extreme the respiratory pain ought to be for the fixed portion mix to be utilized on a patient.\r\n\r\nComparable parameters have been fixed for other potential confusions also, whereupon the medication can be utilized to spare the patients.\r\n\r\nAs per ICMR specialists, the consideration of the counter HIV drugs for treating Covid-19 depended on prior proof about their viability against SARS and MERS coronaviruses that prompted flare-ups in various pieces of the world in 2002-03 and 2012, separately, just as the docking examines led by National Institute of Virology, Pune.\r\n“Use of IFN-B1b (a drug used for treating multiple sclerosis) and Ribavarin (an antiviral medication used to treat certain respiratory infections, hepatitis C and some viral haemorrhagic fevers) was not considered due to their reported toxicity whereas Oseltamivir (used to treat swine flu) was not considered due to its unproven efficacy against CoVs (coronaviruses),” states the treatment protocol published in Indian Journal of Medical Research (IJMR). The fixed dose drug combination (Lopinavir/Ritonavir 200 mg/50 mg) is to be given two tablets every 12 hours for 14 days or for seven days after becoming symptomatic, whichever is earlier, as per the protocol.\r\n\r\nThe anti-HIV drugs have been tried on some <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Coronavirus_disease_2019\">Covid-19</a></span> patients in India already, including the Italian national admitted at Sawai Man Singh hospital in Jaipur, with promising results, said sources.\r\nRecently, in a draft report made public by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/World_Health_Organization\">World Health Organisation</a></span>, the experts claimed Lopinavir and Ritonavir — either alone or in combination with IFNbeta was the suitable second option for rapid implementation in clinical trials among the repurposed drugs under consideration for Covid-19.\r\n\r\nWHO experts claimed that Remdesivir, a drug developed for use against Ebola, is most promising for treating Covid-19.\r\n\r\n“This is because the in-vitro (tests performed in test tube) and in-vivo (tests performed in living organism) data for the drug are available for coronaviruses.”\r\n\r\n“Further, studies in mice using Remdesivir showed superior efficacy over Kaletra+IFNbeta,” they stated in the draft report. Remdesivir slows the infection of healthy cells by blocking viral replication.','Coronavirus: HIV medications can be utilized in extreme cases, says ICMR','','inherit','closed','closed','','4417-revision-v1','','','2020-03-15 09:40:55','2020-03-15 09:40:55','',4417,'https://microbiozindia.com/uncategorized/4417-revision-v1/',0,'revision','',0),(4420,2,'2020-03-16 10:21:49','2020-03-16 10:21:49','Alembic Pharmaceuticals share value falls more than 4 percent in early exchange on March 16 after the organization got 4 perceptions from the USFDA.\r\n\r\nUS Food and Drug Administration (USFDA) has directed an investigation at the organization’s general oral strong plan office situated at Panelav from March 9 to 13, 2020.\r\n\r\nThis was a booked investigation and toward the finish of the assessment, the USFDA gave a Form 483 with four procedural perceptions.\r\n\r\nNone of the perceptions are identified with information uprightness or dull in nature, organization said in discharge.\r\n\r\nThe organization will give complete restorative activity report to address every perception.\r\n\r\nThe organization is focused on keeping up best gauges that fulfill USFDA guidelines, it included.\r\n\r\nAt 09:27 hrs Alembic Pharmaceuticals was citing at Rs 550, down Rs 25, or 4.35 percent on the BSE.','Alembic Pharma share value sheds 4% as USFDA issues 4 perceptions','','publish','open','open','','alembic-pharma-share-value-sheds-4-as-usfda-issues-4-perceptions','','','2020-03-19 19:36:15','2020-03-19 19:36:15','',0,'https://microbiozindia.com/?p=4420',0,'post','',0),(4421,2,'2020-03-16 10:19:23','2020-03-16 10:19:23','','hjh','','inherit','open','closed','','hjh','','','2020-03-16 10:19:23','2020-03-16 10:19:23','',4420,'https://microbiozindia.com/wp-content/uploads/2020/03/hjh.png',0,'attachment','image/png',0),(4422,2,'2020-03-16 10:21:49','2020-03-16 10:21:49','Alembic Pharmaceuticals share value falls more than 4 percent in early exchange on March 16 after the organization got 4 perceptions from the <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Food_and_Drug_Administration\">USFDA.</a></span></strong>\r\n\r\n<strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Food_and_Drug_Administration\">US Food and Drug Administration (USFDA)</a> </span></strong>has directed an investigation at the organization\'s general oral strong plan office situated at Panelav from March 9 to 13, 2020.\r\n\r\nThis was a booked investigation and toward the finish of the assessment, the <span style=\"color: #ff6600;\"><strong><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Food_and_Drug_Administration\">USFDA</a></strong></span> gave a Form 483 with four procedural perceptions.\r\n\r\nNone of the perceptions are identified with information uprightness or dull in nature, organization said in discharge.\r\n\r\nThe organization will give complete restorative activity report to address every perception.\r\n\r\nThe organization is focused on keeping up best gauges that fulfill <span style=\"color: #ff6600;\"><strong><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Food_and_Drug_Administration\">USFDA</a></strong></span> guidelines, it included.\r\n\r\nAt 09:27 hrs <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Alembic_Pharmaceuticals_Ltd\">Alembic Pharmaceuticals</a></span></strong> was citing at Rs 550, down Rs 25, or 4.35 percent on the BSE.','Alembic Pharma share value sheds 4% as USFDA issues 4 perceptions','','inherit','closed','closed','','4420-revision-v1','','','2020-03-16 10:21:49','2020-03-16 10:21:49','',4420,'https://microbiozindia.com/uncategorized/4420-revision-v1/',0,'revision','',0),(4423,2,'2020-03-16 11:20:10','2020-03-16 11:20:10','AMSBIO announce the availability of recombinant proteins and antibodies for detection of <strong><span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.who.int/health-topics/coronavirus\">Coronavirus</a> </span></strong>(COVID-19) and related RNA viruses.\r\n\r\nHistorically strains of Coronavirus able to infect humans (HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoVHKU1) were not highly pathogenic and only caused mild respiratory illness. By comparison more recent strains - SARS-CoV, MERS-CoV and COVID-19 that emerged in Wuhan, China at the end of 2019 are highly pathogenic resulting in large scale pandemics.\r\n\r\n<a href=\"https://www.who.int/health-topics/coronavirus\"><strong><span style=\"color: #ff9900;\">Coronaviruses</span></strong></a> are a group of enveloped positive-stranded RNA viruses, which contains four structural proteins including spike glycoprotein, envelope protein, membrane protein, and nucleocapsid protein. Spike glycoprotein is the most important surface protein of <a href=\"https://www.who.int/health-topics/coronavirus\"><strong><span style=\"color: #ff9900;\">coronavirus</span></strong></a>, which can mediate the entrance to human respiratory epithelial cells by interacting with cell surface receptor angiotensin-converting enzyme 2 (ACE2). The spike glycoprotein includes two regions, S1 and S2, where S1 is for host cell receptor binding and S2 is for membrane fusion. Spike glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics.\r\n\r\nTo facilitate research into developing antiviral drugs, vaccines and diagnostics - AMSBIO is able to supply high quality 2019-nCoV full length S protein, S1 protein and human ACE2 protein based on the HEK293 human cell expression platform. The binding activity of these products has been verified by Surface Plasmon Resonance (SPR) and Biolayer Interferometry (BLI) technologies. Also available are antibodies, including antibody pairs against coronavirus for ELISA, PCR detection kit for SARS-CoV-2 and ACE2 expression vectors, shRNA vectors and <a href=\"https://geneticliteracyproject.org/2020/03/10/fighting-the-coronavirus-outbreak-with-genetic-sequencing-crispr-and-synthetic-biology/\"><strong><span style=\"color: #ff9900;\">CRISPR</span></strong> kits.</a>\r\n\r\nFor further information on recombinant proteins, antibodies and kits for detection of Coronavirus – COVID-19 (2019-nCoV) please visit www.amsbio.com/coronavirus.aspx or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / info@amsbio.com.\r\n\r\nFounded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics.\r\n\r\nFor drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.','AMSBIO Launch Coronavirus – COVID-19 Research Products','','publish','open','open','','amsbio-launch-coronavirus-covid-19-research-products','','','2020-03-16 11:20:10','2020-03-16 11:20:10','',0,'https://microbiozindia.com/?p=4423',0,'post','',0),(4424,2,'2020-03-16 11:17:35','2020-03-16 11:17:35','','AA','','inherit','open','closed','','aa-4','','','2020-03-16 11:17:35','2020-03-16 11:17:35','',4423,'https://microbiozindia.com/wp-content/uploads/2020/03/AA.png',0,'attachment','image/png',0),(4425,2,'2020-03-16 11:20:10','2020-03-16 11:20:10','AMSBIO announce the availability of recombinant proteins and antibodies for detection of <strong><span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.who.int/health-topics/coronavirus\">Coronavirus</a> </span></strong>(COVID-19) and related RNA viruses.\r\n\r\nHistorically strains of Coronavirus able to infect humans (HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoVHKU1) were not highly pathogenic and only caused mild respiratory illness. By comparison more recent strains - SARS-CoV, MERS-CoV and COVID-19 that emerged in Wuhan, China at the end of 2019 are highly pathogenic resulting in large scale pandemics.\r\n\r\n<a href=\"https://www.who.int/health-topics/coronavirus\"><strong><span style=\"color: #ff9900;\">Coronaviruses</span></strong></a> are a group of enveloped positive-stranded RNA viruses, which contains four structural proteins including spike glycoprotein, envelope protein, membrane protein, and nucleocapsid protein. Spike glycoprotein is the most important surface protein of <a href=\"https://www.who.int/health-topics/coronavirus\"><strong><span style=\"color: #ff9900;\">coronavirus</span></strong></a>, which can mediate the entrance to human respiratory epithelial cells by interacting with cell surface receptor angiotensin-converting enzyme 2 (ACE2). The spike glycoprotein includes two regions, S1 and S2, where S1 is for host cell receptor binding and S2 is for membrane fusion. Spike glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics.\r\n\r\nTo facilitate research into developing antiviral drugs, vaccines and diagnostics - AMSBIO is able to supply high quality 2019-nCoV full length S protein, S1 protein and human ACE2 protein based on the HEK293 human cell expression platform. The binding activity of these products has been verified by Surface Plasmon Resonance (SPR) and Biolayer Interferometry (BLI) technologies. Also available are antibodies, including antibody pairs against coronavirus for ELISA, PCR detection kit for SARS-CoV-2 and ACE2 expression vectors, shRNA vectors and <a href=\"https://geneticliteracyproject.org/2020/03/10/fighting-the-coronavirus-outbreak-with-genetic-sequencing-crispr-and-synthetic-biology/\"><strong><span style=\"color: #ff9900;\">CRISPR</span></strong> kits.</a>\r\n\r\nFor further information on recombinant proteins, antibodies and kits for detection of Coronavirus – COVID-19 (2019-nCoV) please visit www.amsbio.com/coronavirus.aspx or contact AMSBIO on +44-1235-828200 / +1-617-945-5033 / info@amsbio.com.\r\n\r\nFounded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics.\r\n\r\nFor drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.','AMSBIO Launch Coronavirus – COVID-19 Research Products','','inherit','closed','closed','','4423-revision-v1','','','2020-03-16 11:20:10','2020-03-16 11:20:10','',4423,'https://microbiozindia.com/uncategorized/4423-revision-v1/',0,'revision','',0),(4426,2,'2020-03-16 17:19:20','2020-03-16 17:19:20','Microsoft has propelled another intelligent Bing guide to give data on the spread of COVID-19, the infection brought about by the novel coronavirus. The guide shows the measure of cases on a for every nation premise, separated by the quantity of at present dynamic cases, recuperated cases, and deadly cases. In the US, in the interim, you can see data state-by-state. Choosing singular nations or states will give connects to pertinent reports and recordings.\r\n\r\nSadly, the tales being advanced aren\'t generally the most auspicious or helpful to comprehend the present condition of the developing pandemic.\r\nMicrosoft says the instrument is pulling information from an assortment of sources including the World Health Organization (WHO), the US Centers for Disease Control and Prevention (CDC), the European Center for Disease Prevention and Control (ECDC), and Wikipedia. The device itself doesn\'t state how as often as possible its numbers are being refreshed, however at the hour of production we found the information to have been refreshed in the most recent hour.\r\n\r\n[caption id=\"attachment_4427\" align=\"alignright\" width=\"151\"]<img class=\"wp-image-4427\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/AASST-300x147.png\" alt=\"\" width=\"151\" height=\"74\" /> <span style=\"color: #ff9900;\"><strong><a style=\"color: #ff9900;\" href=\"https://www.bing.com/covid\">Click here to enlarge</a></strong></span>[/caption]\r\n\r\nDespite the fact that the case numbers the device is pulling are reliable with those distributed by the WHO, Microsoft\'s COVID-19 tracker has all the earmarks of being experiencing difficulty surfacing significant reports. At the point when we attempted to check reports that <strong><span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.reuters.com/article/health-coronavirus-kingfisher-idUSL8N2B926M\">were important to the episode in the UK, for instance,</a></span></strong> one of the reports it surfaced was about a progression of home improvement stores shutting in France and Spain. Significantly more abnormally, the lead video was an old news section from January 24th with the title<strong><span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.youtube.com/watch?v=9_kBdO4h5ro\"> \"No affirmed instances of coronavirus yet in the United Kingdom,\"</a></span></strong> in spite of the tracker posting 1,391 cases in the nation.','Microsoft Bing dispatches intelligent COVID-19 guide to give pandemic news','','publish','open','open','','microsoft-bing-dispatches-intelligent-covid-19-guide-to-give-pandemic-news','','','2020-03-16 17:37:22','2020-03-16 17:37:22','',0,'https://microbiozindia.com/?p=4426',0,'post','',0),(4427,2,'2020-03-16 17:13:26','2020-03-16 17:13:26','','AASST','','inherit','open','closed','','aasst','','','2020-03-16 17:13:26','2020-03-16 17:13:26','',4426,'https://microbiozindia.com/wp-content/uploads/2020/03/AASST.png',0,'attachment','image/png',0),(4428,2,'2020-03-16 17:13:28','2020-03-16 17:13:28','','Microsoft-Logo-2012','','inherit','open','closed','','microsoft-logo-2012','','','2020-03-16 17:13:28','2020-03-16 17:13:28','',4426,'https://microbiozindia.com/wp-content/uploads/2020/03/Microsoft-Logo-2012.jpg',0,'attachment','image/jpeg',0),(4429,2,'2020-03-16 17:19:20','2020-03-16 17:19:20','Microsoft has propelled another intelligent <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bing.com/covid\">Bing guide</a></span></strong> to give data on the spread of COVID-19, the infection brought about by the novel coronavirus. The guide shows the measure of cases on a for every nation premise, separated by the quantity of at present dynamic cases, recuperated cases, and deadly cases. In the US, in the interim, you can see data state-by-state. Choosing singular nations or states will give connects to pertinent reports and recordings. Sadly, the tales being advanced aren\'t generally the most auspicious or helpful to comprehend the present condition of the developing pandemic.\r\n\r\nMicrosoft says the instrument is pulling information from an assortment of sources including the World Health Organization (WHO), the <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cdc.gov/\">US Centers for Disease Control and Prevention (CDC)</a></span></strong>, the European Center for Disease Prevention and Control (ECDC), and Wikipedia. The device itself doesn\'t state how as often as possible its numbers are being refreshed, however at the hour of production we found the information to have been refreshed in the most recent hour.\r\n\r\n<img class=\"alignnone  wp-image-4427\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/AASST-300x147.png\" alt=\"\" width=\"588\" height=\"288\" />\r\n\r\nDespite the fact that the case numbers the device is pulling are reliable with those distributed by the WHO, Microsoft\'s COVID-19 tracker has all the earmarks of being experiencing difficulty surfacing significant reports. At the point when we attempted to check reports that were important to the episode in the UK, for instance, one of the reports it surfaced was about a progression of home improvement <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.reuters.com/article/health-coronavirus-kingfisher-idUSL8N2B926M\">stores shutting in France and Spain.</a></span></strong> Significantly more abnormally, the lead video was an old news section from January 24th with the title <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.youtube.com/watch?v=9_kBdO4h5ro\">\"No affirmed instances of coronavirus yet in the United Kingdom,</a></span></strong>\" in spite of the tracker posting 1,391 cases in the nation.','Microsoft Bing dispatches intelligent COVID-19 guide to give pandemic news','','inherit','closed','closed','','4426-revision-v1','','','2020-03-16 17:19:20','2020-03-16 17:19:20','',4426,'https://microbiozindia.com/uncategorized/4426-revision-v1/',0,'revision','',0),(4430,2,'2020-03-16 17:22:09','2020-03-16 17:22:09','Microsoft has propelled another intelligent <strong><span style=\"color: #ff6600;\">Bing guide</span></strong> to give data on the spread of COVID-19, the infection brought about by the novel coronavirus. The guide shows the measure of cases on a for every nation premise, separated by the quantity of at present dynamic cases, recuperated cases, and deadly cases. In the US, in the interim, you can see data state-by-state. Choosing singular nations or states will give connects to pertinent reports and recordings. Sadly, the tales being advanced aren\'t generally the most auspicious or helpful to comprehend the present condition of the developing pandemic.\r\n\r\nMicrosoft says the instrument is pulling information from an assortment of sources including the World Health Organization (WHO), the <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cdc.gov/\">US Centers for Disease Control and Prevention (CDC)</a></span></strong>, the European Center for Disease Prevention and Control (ECDC), and Wikipedia. The device itself doesn\'t state how as often as possible its numbers are being refreshed, however at the hour of production we found the information to have been refreshed in the most recent hour.\r\n\r\n<img class=\"alignnone wp-image-4427\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/AASST-300x147.png\" alt=\"\" width=\"588\" height=\"288\" />\r\n\r\nDespite the fact that the case numbers the device is pulling are reliable with those distributed by the WHO, Microsoft\'s COVID-19 tracker has all the earmarks of being experiencing difficulty surfacing significant reports. At the point when we attempted to check reports that were important to the episode in the UK, for instance, one of the reports it surfaced was about a progression of home improvement <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.reuters.com/article/health-coronavirus-kingfisher-idUSL8N2B926M\">stores shutting in France and Spain.</a></span></strong> Significantly more abnormally, the lead video was an old news section from January 24th with the title <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.youtube.com/watch?v=9_kBdO4h5ro\">\"No affirmed instances of coronavirus yet in the United Kingdom,</a></span></strong>\" in spite of the tracker posting 1,391 cases in the nation.','Microsoft Bing dispatches intelligent COVID-19 guide to give pandemic news','','inherit','closed','closed','','4426-revision-v1','','','2020-03-16 17:22:09','2020-03-16 17:22:09','',4426,'https://microbiozindia.com/uncategorized/4426-revision-v1/',0,'revision','',0),(4431,2,'2020-03-16 17:35:28','2020-03-16 17:35:28','Microsoft has propelled another intelligent Bing guide to give data on the spread of COVID-19, the infection brought about by the novel coronavirus. The guide shows the measure of cases on a for every nation premise, separated by the quantity of at present dynamic cases, recuperated cases, and deadly cases. In the US, in the interim, you can see data state-by-state. Choosing singular nations or states will give connects to pertinent reports and recordings. Sadly, the tales being advanced aren\'t generally the most auspicious or helpful to comprehend the present condition of the developing pandemic.\nMicrosoft says the instrument is pulling information from an assortment of sources including the World Health Organization (WHO), the US Centers for Disease Control and Prevention (CDC), the European Center for Disease Prevention and Control (ECDC), and Wikipedia. The device itself doesn\'t state how as often as possible its numbers are being refreshed, however at the hour of production we found the information to have been refreshed in the most recent hour.\n\n[caption id=\"attachment_4427\" align=\"alignright\" width=\"151\"]<img class=\"wp-image-4427\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/AASST-300x147.png\" alt=\"\" width=\"151\" height=\"74\" /> <span style=\"color: #ff9900;\"><strong><a style=\"color: #ff9900;\" href=\"https://www.bing.com/covid\">Click here to enlarge</a></strong></span>[/caption]\n\nDespite the fact that the case numbers the device is pulling are reliable with those distributed by the WHO, Microsoft\'s COVID-19 tracker has all the earmarks of being experiencing difficulty surfacing significant reports. At the point when we attempted to check reports that were important to the episode in the UK, for instance, one of the reports it surfaced was about a progression of home improvement stores shutting in France and Spain. Significantly more abnormally, the lead video was an old news section from January 24th with the title \"No affirmed instances of coronavirus yet in the United Kingdom,\" in spite of the tracker posting 1,391 cases in the nation.','Microsoft Bing dispatches intelligent COVID-19 guide to give pandemic news','','inherit','closed','closed','','4426-autosave-v1','','','2020-03-16 17:35:28','2020-03-16 17:35:28','',4426,'https://microbiozindia.com/uncategorized/4426-autosave-v1/',0,'revision','',0),(4432,2,'2020-03-16 17:25:37','2020-03-16 17:25:37','','ADDD','','inherit','open','closed','','addd','','','2020-03-16 17:25:37','2020-03-16 17:25:37','',4426,'https://microbiozindia.com/wp-content/uploads/2020/03/ADDD.png',0,'attachment','image/png',0),(4433,2,'2020-03-16 17:25:44','2020-03-16 17:25:44','Microsoft has propelled another intelligent <a href=\"https://www.bing.com/covid\"><strong><span style=\"color: #ff6600;\">Bing guide</span></strong></a> to give data on the spread of COVID-19, the infection brought about by the novel coronavirus. The guide shows the measure of cases on a for every nation premise, separated by the quantity of at present dynamic cases, recuperated cases, and deadly cases. In the US, in the interim, you can see data state-by-state. Choosing singular nations or states will give connects to pertinent reports and recordings. Sadly, the tales being advanced aren\'t generally the most auspicious or helpful to comprehend the present condition of the developing pandemic.\r\n\r\nMicrosoft says the instrument is pulling information from an assortment of sources including the World Health Organization (WHO), the <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cdc.gov/\">US Centers for Disease Control and Prevention (CDC)</a></span></strong>, the European Center for Disease Prevention and Control (ECDC), and Wikipedia. The device itself doesn\'t state how as often as possible its numbers are being refreshed, however at the hour of production we found the information to have been refreshed in the most recent hour.\r\n\r\n<img class=\"alignnone wp-image-4427\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/AASST-300x147.png\" alt=\"\" width=\"588\" height=\"288\" />\r\n\r\nDespite the fact that the case numbers the device is pulling are reliable with those distributed by the WHO, Microsoft\'s COVID-19 tracker has all the earmarks of being experiencing difficulty surfacing significant reports. At the point when we attempted to check reports that were important to the episode in the UK, for instance, one of the reports it surfaced was about a progression of home improvement <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.reuters.com/article/health-coronavirus-kingfisher-idUSL8N2B926M\">stores shutting in France and Spain.</a></span></strong> Significantly more abnormally, the lead video was an old news section from January 24th with the title <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.youtube.com/watch?v=9_kBdO4h5ro\">\"No affirmed instances of coronavirus yet in the United Kingdom,</a></span></strong>\" in spite of the tracker posting 1,391 cases in the nation.','Microsoft Bing dispatches intelligent COVID-19 guide to give pandemic news','','inherit','closed','closed','','4426-revision-v1','','','2020-03-16 17:25:44','2020-03-16 17:25:44','',4426,'https://microbiozindia.com/uncategorized/4426-revision-v1/',0,'revision','',0),(4434,2,'2020-03-16 17:30:04','2020-03-16 17:30:04','Microsoft has propelled another intelligent Bing guide to give data on the spread of COVID-19, the infection brought about by the novel coronavirus. The guide shows the measure of cases on a for every nation premise, separated by the quantity of at present dynamic cases, recuperated cases, and deadly cases. In the US, in the interim, you can see data state-by-state. Choosing singular nations or states will give connects to pertinent reports and recordings. Sadly, the tales being advanced aren\'t generally the most auspicious or helpful to comprehend the present condition of the developing pandemic.\r\nMicrosoft says the instrument is pulling information from an assortment of sources including the World Health Organization (WHO), the US Centers for Disease Control and Prevention (CDC), the European Center for Disease Prevention and Control (ECDC), and Wikipedia. The device itself doesn\'t state how as often as possible its numbers are being refreshed, however at the hour of production we found the information to have been refreshed in the most recent hour.\r\n\r\nDespite the fact that the case numbers the device is pulling are reliable with those distributed by the WHO, Microsoft\'s COVID-19 tracker has all the earmarks of being experiencing difficulty surfacing significant reports. At the point when we attempted to check reports that were important to the episode in the UK, for instance, one of the reports it surfaced was about a progression of home improvement stores shutting in France and Spain. Significantly more abnormally, the lead video was an old news section from January 24th with the title \"No affirmed instances of coronavirus yet in the United Kingdom,\" in spite of the tracker posting 1,391 cases in the nation.','Microsoft Bing dispatches intelligent COVID-19 guide to give pandemic news','','inherit','closed','closed','','4426-revision-v1','','','2020-03-16 17:30:04','2020-03-16 17:30:04','',4426,'https://microbiozindia.com/uncategorized/4426-revision-v1/',0,'revision','',0),(4435,2,'2020-03-16 17:31:29','2020-03-16 17:31:29','Microsoft has propelled another intelligent <span style=\"color: #ff6600;\"><strong><a style=\"color: #ff6600;\" href=\"https://www.bing.com/covid\">Bing guide</a></strong></span> to give data on the spread of COVID-19, the infection brought about by the novel coronavirus. The guide shows the measure of cases on a for every nation premise, separated by the quantity of at present dynamic cases, recuperated cases, and deadly cases. In the US, in the interim, you can see data state-by-state. Choosing singular nations or states will give connects to pertinent reports and recordings. Sadly, the tales being advanced aren\'t generally the most auspicious or helpful to comprehend the present condition of the developing pandemic.\r\nMicrosoft says the instrument is pulling information from an assortment of sources including the World Health Organization (WHO), the US Centers for Disease Control and Prevention (CDC), the European Center for Disease Prevention and Control (ECDC), and Wikipedia. The device itself doesn\'t state how as often as possible its numbers are being refreshed, however at the hour of production we found the information to have been refreshed in the most recent hour.\r\n\r\n<img class=\"alignnone  wp-image-4427\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/AASST-300x147.png\" alt=\"\" width=\"610\" height=\"299\" />\r\n\r\nDespite the fact that the case numbers the device is pulling are reliable with those distributed by the WHO, Microsoft\'s COVID-19 tracker has all the earmarks of being experiencing difficulty surfacing significant reports. At the point when we attempted to check reports that were important to the episode in the UK, for instance, one of the reports it surfaced was about a progression of home improvement stores shutting in France and Spain. Significantly more abnormally, the lead video was an old news section from January 24th with the title \"No affirmed instances of coronavirus yet in the United Kingdom,\" in spite of the tracker posting 1,391 cases in the nation.','Microsoft Bing dispatches intelligent COVID-19 guide to give pandemic news','','inherit','closed','closed','','4426-revision-v1','','','2020-03-16 17:31:29','2020-03-16 17:31:29','',4426,'https://microbiozindia.com/uncategorized/4426-revision-v1/',0,'revision','',0),(4436,2,'2020-03-16 17:31:57','2020-03-16 17:31:57','Microsoft has propelled another intelligent <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bing.com/covid\">Bing guide</a></span> to give data on the spread of COVID-19, the infection brought about by the novel coronavirus. The guide shows the measure of cases on a for every nation premise, separated by the quantity of at present dynamic cases, recuperated cases, and deadly cases. In the US, in the interim, you can see data state-by-state. Choosing singular nations or states will give connects to pertinent reports and recordings. Sadly, the tales being advanced aren\'t generally the most auspicious or helpful to comprehend the present condition of the developing pandemic.\r\nMicrosoft says the instrument is pulling information from an assortment of sources including the World Health Organization (WHO), the US Centers for Disease Control and Prevention (CDC), the European Center for Disease Prevention and Control (ECDC), and Wikipedia. The device itself doesn\'t state how as often as possible its numbers are being refreshed, however at the hour of production we found the information to have been refreshed in the most recent hour.\r\n\r\n<img class=\"alignnone wp-image-4427\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/AASST-300x147.png\" alt=\"\" width=\"610\" height=\"299\" />\r\n\r\nDespite the fact that the case numbers the device is pulling are reliable with those distributed by the WHO, Microsoft\'s COVID-19 tracker has all the earmarks of being experiencing difficulty surfacing significant reports. At the point when we attempted to check reports that were important to the episode in the UK, for instance, one of the reports it surfaced was about a progression of home improvement stores shutting in France and Spain. Significantly more abnormally, the lead video was an old news section from January 24th with the title \"No affirmed instances of coronavirus yet in the United Kingdom,\" in spite of the tracker posting 1,391 cases in the nation.','Microsoft Bing dispatches intelligent COVID-19 guide to give pandemic news','','inherit','closed','closed','','4426-revision-v1','','','2020-03-16 17:31:57','2020-03-16 17:31:57','',4426,'https://microbiozindia.com/uncategorized/4426-revision-v1/',0,'revision','',0),(4437,2,'2020-03-16 17:32:24','2020-03-16 17:32:24','Microsoft has propelled another intelligent <span style=\"color: #ff6600;\">Bing guide</span> to give data on the spread of COVID-19, the infection brought about by the novel coronavirus. The guide shows the measure of cases on a for every nation premise, separated by the quantity of at present dynamic cases, recuperated cases, and deadly cases. In the US, in the interim, you can see data state-by-state. Choosing singular nations or states will give connects to pertinent reports and recordings. Sadly, the tales being advanced aren\'t generally the most auspicious or helpful to comprehend the present condition of the developing pandemic.\r\nMicrosoft says the instrument is pulling information from an assortment of sources including the World Health Organization (WHO), the US Centers for Disease Control and Prevention (CDC), the European Center for Disease Prevention and Control (ECDC), and Wikipedia. The device itself doesn\'t state how as often as possible its numbers are being refreshed, however at the hour of production we found the information to have been refreshed in the most recent hour.\r\n\r\n<img class=\"alignnone wp-image-4427\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/AASST-300x147.png\" alt=\"\" width=\"610\" height=\"299\" />\r\n\r\nDespite the fact that the case numbers the device is pulling are reliable with those distributed by the WHO, Microsoft\'s COVID-19 tracker has all the earmarks of being experiencing difficulty surfacing significant reports. At the point when we attempted to check reports that were important to the episode in the UK, for instance, one of the reports it surfaced was about a progression of home improvement stores shutting in France and Spain. Significantly more abnormally, the lead video was an old news section from January 24th with the title \"No affirmed instances of coronavirus yet in the United Kingdom,\" in spite of the tracker posting 1,391 cases in the nation.','Microsoft Bing dispatches intelligent COVID-19 guide to give pandemic news','','inherit','closed','closed','','4426-revision-v1','','','2020-03-16 17:32:24','2020-03-16 17:32:24','',4426,'https://microbiozindia.com/uncategorized/4426-revision-v1/',0,'revision','',0),(4438,2,'2020-03-16 17:37:22','2020-03-16 17:37:22','Microsoft has propelled another intelligent Bing guide to give data on the spread of COVID-19, the infection brought about by the novel coronavirus. The guide shows the measure of cases on a for every nation premise, separated by the quantity of at present dynamic cases, recuperated cases, and deadly cases. In the US, in the interim, you can see data state-by-state. Choosing singular nations or states will give connects to pertinent reports and recordings.\r\n\r\nSadly, the tales being advanced aren\'t generally the most auspicious or helpful to comprehend the present condition of the developing pandemic.\r\nMicrosoft says the instrument is pulling information from an assortment of sources including the World Health Organization (WHO), the US Centers for Disease Control and Prevention (CDC), the European Center for Disease Prevention and Control (ECDC), and Wikipedia. The device itself doesn\'t state how as often as possible its numbers are being refreshed, however at the hour of production we found the information to have been refreshed in the most recent hour.\r\n\r\n[caption id=\"attachment_4427\" align=\"alignright\" width=\"151\"]<img class=\"wp-image-4427\" src=\"https://microbiozindia.com/wp-content/uploads/2020/03/AASST-300x147.png\" alt=\"\" width=\"151\" height=\"74\" /> <span style=\"color: #ff9900;\"><strong><a style=\"color: #ff9900;\" href=\"https://www.bing.com/covid\">Click here to enlarge</a></strong></span>[/caption]\r\n\r\nDespite the fact that the case numbers the device is pulling are reliable with those distributed by the WHO, Microsoft\'s COVID-19 tracker has all the earmarks of being experiencing difficulty surfacing significant reports. At the point when we attempted to check reports that <strong><span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.reuters.com/article/health-coronavirus-kingfisher-idUSL8N2B926M\">were important to the episode in the UK, for instance,</a></span></strong> one of the reports it surfaced was about a progression of home improvement stores shutting in France and Spain. Significantly more abnormally, the lead video was an old news section from January 24th with the title<strong><span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.youtube.com/watch?v=9_kBdO4h5ro\"> \"No affirmed instances of coronavirus yet in the United Kingdom,\"</a></span></strong> in spite of the tracker posting 1,391 cases in the nation.','Microsoft Bing dispatches intelligent COVID-19 guide to give pandemic news','','inherit','closed','closed','','4426-revision-v1','','','2020-03-16 17:37:22','2020-03-16 17:37:22','',4426,'https://microbiozindia.com/uncategorized/4426-revision-v1/',0,'revision','',0),(4439,2,'2020-03-17 04:50:41','2020-03-17 04:50:41','A 35-year-elderly person experiencing influenza fled from three private wellbeing offices in Jalandhar, Hoshiarpur and Ludhiana areas after she would not complete her tests for the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.nation.co.ke/news/explainers/-Do-I-have-influenza-or-coronavirus/5337446-5493014-53ppmpz/index.html\">coronavirus</a></span>, sending the wellbeing specialists and police into a tantrum.\r\n\r\nThe lady being referred to, who was potentially experiencing coronavirus and hails from Jalandhar city, flew back to the Philippines where she lives, hours after she stayed untraceable, the police said.\r\n\r\nShe showed up in Jalandhar on March 6 and remained at her habitation for two or three days, it was found out. She continued visiting her family members during this time. The last area of her versatile was followed to Ludhiana\'s Sherpur Chowk on Sunday evening, following which the telephone was turned off.\r\n\r\nA wellbeing office official said she initially visited a private facility in Jalandhar\'s Model Town region on Sunday morning as she had dry hack and fever. The specialists there requested that her go to the nearby respectful emergency clinic to get herself tried for the coronavirus, he included.\r\n\r\nShe rather went to a facility in Hoshiarpur locale\'s Garhshankar toward the evening. The specialists there too encouraged to even think about getting herself inspected for the illness yet she gave them a slip.\r\n\r\nAt night, she arrived at a private emergency clinic at Gurdev Nagar in Ludhiana.\r\n\r\n\"Since the lady demonstrated indications of the infection, we requested that her stay in contact with the wellbeing specialists or visit the common medical clinic for coronavirus test. Be that as it may, she left our medical clinic in a quiet notwithstanding our having guided her till 12 PM. Since we are not approved to bind an individual, we promptly sounded a caution and educated the wellbeing office specialists about this,\" said Dr GS Grewal who runs the clinical office.Ludhiana police commissioner Rakesh Agrawal said, “We received information about the woman with symptoms of flu. We put her mobile phone under surveillance.”\r\nPrincipal secretary (health and family welfare) Anurag Aggarwal said, “An exercise was conducted under the supervision of the Jalandhar and Patiala deputy commissioners. We kept tracking the woman through the people she contacted until she switched off her phone. We received information Ttoday morning that she had taken a return flight.”\r\n“As per our knowledge, she has reached Singapore. She went to Delhi in a private vehicle. Since no test was conducted on her, we cannot term her a confirmed or suspected coronavirus case. She only had symptoms. Since she came from a coronavirus-affected country we asked her to get her tests done.”','Suspected lady corona patient escapes 3 centers, flies back to Philippines','','publish','open','open','','suspected-lady-corona-patient-escapes-3-centers-flies-back-to-philippines','','','2020-03-17 05:08:00','2020-03-17 05:08:00','',0,'https://microbiozindia.com/?p=4439',0,'post','',0),(4440,2,'2020-03-17 04:47:40','2020-03-17 04:47:40','','Coronavirus-cure-is-a-vaccine-being-made-COVID19-drugs-trials-latest-coronavirus-news-1252020','','inherit','open','closed','','coronavirus-cure-is-a-vaccine-being-made-covid19-drugs-trials-latest-coronavirus-news-1252020','','','2020-03-17 04:47:40','2020-03-17 04:47:40','',4439,'https://microbiozindia.com/wp-content/uploads/2020/03/Coronavirus-cure-is-a-vaccine-being-made-COVID19-drugs-trials-latest-coronavirus-news-1252020.jpg',0,'attachment','image/jpeg',0),(4441,2,'2020-03-17 04:50:41','2020-03-17 04:50:41','A 35-year-elderly person experiencing <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mayoclinic.org/diseases-conditions/flu/symptoms-causes/syc-20351719\">influenza</a></span> fled from three private wellbeing offices in Jalandhar, Hoshiarpur and Ludhiana areas after she would not complete her tests for the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gov.uk/government/topical-events/coronavirus-covid-19-uk-government-response\">coronavirus</a></span>, sending the wellbeing specialists and police into a tantrum.\r\n\r\nThe lady being referred to, who was potentially experiencing coronavirus and hails from Jalandhar city, flew back to the Philippines where she lives, hours after she stayed untraceable, the police said.\r\n\r\nShe showed up in Jalandhar on March 6 and remained at her habitation for two or three days, it was found out. She continued visiting her family members during this time. The last area of her versatile was followed to Ludhiana\'s Sherpur Chowk on Sunday evening, following which the telephone was turned off.\r\n\r\nA wellbeing office official said she initially visited a private facility in Jalandhar\'s Model Town region on Sunday morning as she had dry hack and fever. The specialists there requested that her go to the nearby respectful emergency clinic to get herself tried for the coronavirus, he included.\r\n\r\nShe rather went to a facility in Hoshiarpur locale\'s Garhshankar toward the evening. The specialists there too encouraged to even think about getting herself inspected for the illness yet she gave them a slip.\r\n\r\nAt night, she arrived at a private emergency clinic at Gurdev Nagar in Ludhiana.\r\n\r\n\"Since the lady demonstrated indications of the infection, we requested that her stay in contact with the wellbeing specialists or visit the common medical clinic for coronavirus test. Be that as it may, she left our medical clinic in a quiet notwithstanding our having guided her till 12 PM. Since we are not approved to bind an individual, we promptly sounded a caution and educated the wellbeing office specialists about this,\" said Dr GS Grewal who runs the clinical office.Ludhiana police commissioner Rakesh Agrawal said, “We received information about the woman with symptoms of flu. We put her mobile phone under surveillance.”\r\nPrincipal secretary (health and family welfare) Anurag Aggarwal said, “An exercise was conducted under the supervision of the Jalandhar and Patiala deputy commissioners. We kept tracking the woman through the people she contacted until she switched off her phone. We received information Ttoday morning that she had taken a return flight.”\r\n“As per our knowledge, she has reached Singapore. She went to Delhi in a private vehicle. Since no test was conducted on her, we cannot term her a confirmed or suspected coronavirus case. She only had symptoms. Since she came from a coronavirus-affected country we asked her to get her tests done.”','Suspected lady corona patient escapes 3 centers, flies back to Philippines','','inherit','closed','closed','','4439-revision-v1','','','2020-03-17 04:50:41','2020-03-17 04:50:41','',4439,'https://microbiozindia.com/uncategorized/4439-revision-v1/',0,'revision','',0),(4443,2,'2020-03-17 04:52:20','2020-03-17 04:52:20','A 35-year-elderly person experiencing <span style=\"color: #ff6600;\">influenza</span> fled from three private wellbeing offices in Jalandhar, Hoshiarpur and Ludhiana areas after she would not complete her tests for the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gov.uk/government/topical-events/coronavirus-covid-19-uk-government-response\">coronavirus</a></span>, sending the wellbeing specialists and police into a tantrum.\r\n\r\nThe lady being referred to, who was potentially experiencing coronavirus and hails from Jalandhar city, flew back to the Philippines where she lives, hours after she stayed untraceable, the police said.\r\n\r\nShe showed up in Jalandhar on March 6 and remained at her habitation for two or three days, it was found out. She continued visiting her family members during this time. The last area of her versatile was followed to Ludhiana\'s Sherpur Chowk on Sunday evening, following which the telephone was turned off.\r\n\r\nA wellbeing office official said she initially visited a private facility in Jalandhar\'s Model Town region on Sunday morning as she had dry hack and fever. The specialists there requested that her go to the nearby respectful emergency clinic to get herself tried for the coronavirus, he included.\r\n\r\nShe rather went to a facility in Hoshiarpur locale\'s Garhshankar toward the evening. The specialists there too encouraged to even think about getting herself inspected for the illness yet she gave them a slip.\r\n\r\nAt night, she arrived at a private emergency clinic at Gurdev Nagar in Ludhiana.\r\n\r\n\"Since the lady demonstrated indications of the infection, we requested that her stay in contact with the wellbeing specialists or visit the common medical clinic for coronavirus test. Be that as it may, she left our medical clinic in a quiet notwithstanding our having guided her till 12 PM. Since we are not approved to bind an individual, we promptly sounded a caution and educated the wellbeing office specialists about this,\" said Dr GS Grewal who runs the clinical office.Ludhiana police commissioner Rakesh Agrawal said, “We received information about the woman with symptoms of flu. We put her mobile phone under surveillance.”\r\nPrincipal secretary (health and family welfare) Anurag Aggarwal said, “An exercise was conducted under the supervision of the Jalandhar and Patiala deputy commissioners. We kept tracking the woman through the people she contacted until she switched off her phone. We received information Ttoday morning that she had taken a return flight.”\r\n“As per our knowledge, she has reached Singapore. She went to Delhi in a private vehicle. Since no test was conducted on her, we cannot term her a confirmed or suspected coronavirus case. She only had symptoms. Since she came from a coronavirus-affected country we asked her to get her tests done.”','Suspected lady corona patient escapes 3 centers, flies back to Philippines','','inherit','closed','closed','','4439-revision-v1','','','2020-03-17 04:52:20','2020-03-17 04:52:20','',4439,'https://microbiozindia.com/uncategorized/4439-revision-v1/',0,'revision','',0),(4444,2,'2020-03-17 04:58:25','2020-03-17 04:58:25','A 35-year-elderly person experiencing <a href=\"https://www.nation.co.ke/news/explainers/-Do-I-have-influenza-or-coronavirus/5337446-5493014-53ppmpz/index.html\"><span style=\"color: #ff6600;\">influenza</span></a> fled from three private wellbeing offices in Jalandhar, Hoshiarpur and Ludhiana areas after she would not complete her tests for the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gov.uk/government/topical-events/coronavirus-covid-19-uk-government-response\">coronavirus</a></span>, sending the wellbeing specialists and police into a tantrum.\n\nThe lady being referred to, who was potentially experiencing coronavirus and hails from Jalandhar city, flew back to the Philippines where she lives, hours after she stayed untraceable, the police said.\n\nShe showed up in Jalandhar on March 6 and remained at her habitation for two or three days, it was found out. She continued visiting her family members during this time. The last area of her versatile was followed to Ludhiana\'s Sherpur Chowk on Sunday evening, following which the telephone was turned off.\n\nA wellbeing office official said she initially visited a private facility in Jalandhar\'s Model Town region on Sunday morning as she had dry hack and fever. The specialists there requested that her go to the nearby respectful emergency clinic to get herself tried for the coronavirus, he included.\n\nShe rather went to a facility in Hoshiarpur locale\'s Garhshankar toward the evening. The specialists there too encouraged to even think about getting herself inspected for the illness yet she gave them a slip.\n\nAt night, she arrived at a private emergency clinic at Gurdev Nagar in Ludhiana.\n\n\"Since the lady demonstrated indications of the infection, we requested that her stay in contact with the wellbeing specialists or visit the common medical clinic for coronavirus test. Be that as it may, she left our medical clinic in a quiet notwithstanding our having guided her till 12 PM. Since we are not approved to bind an individual, we promptly sounded a caution and educated the wellbeing office specialists about this,\" said Dr GS Grewal who runs the clinical office.Ludhiana police commissioner Rakesh Agrawal said, “We received information about the woman with symptoms of flu. We put her mobile phone under surveillance.”\nPrincipal secretary (health and family welfare) Anurag Aggarwal said, “An exercise was conducted under the supervision of the Jalandhar and Patiala deputy commissioners. We kept tracking the woman through the people she contacted until she switched off her phone. We received information Ttoday morning that she had taken a return flight.”\n“As per our knowledge, she has reached Singapore. She went to Delhi in a private vehicle. Since no test was conducted on her, we cannot term her a confirmed or suspected coronavirus case. She only had symptoms. Since she came from a coronavirus-affected country we asked her to get her tests done.”','Suspected lady corona patient escapes 3 centers, flies back to Philippines','','inherit','closed','closed','','4439-autosave-v1','','','2020-03-17 04:58:25','2020-03-17 04:58:25','',4439,'https://microbiozindia.com/uncategorized/4439-autosave-v1/',0,'revision','',0),(4445,2,'2020-03-17 04:58:27','2020-03-17 04:58:27','','AA','','inherit','open','closed','','aa-5','','','2020-03-17 04:58:27','2020-03-17 04:58:27','',4439,'https://microbiozindia.com/wp-content/uploads/2020/03/AA-1.png',0,'attachment','image/png',0),(4446,2,'2020-03-17 04:58:38','2020-03-17 04:58:38','A 35-year-elderly person experiencing <a href=\"https://www.nation.co.ke/news/explainers/-Do-I-have-influenza-or-coronavirus/5337446-5493014-53ppmpz/index.html\"><span style=\"color: #ff6600;\">influenza</span></a> fled from three private wellbeing offices in Jalandhar, Hoshiarpur and Ludhiana areas after she would not complete her tests for the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gov.uk/government/topical-events/coronavirus-covid-19-uk-government-response\">coronavirus</a></span>, sending the wellbeing specialists and police into a tantrum.\r\n\r\nThe lady being referred to, who was potentially experiencing coronavirus and hails from Jalandhar city, flew back to the Philippines where she lives, hours after she stayed untraceable, the police said.\r\n\r\nShe showed up in Jalandhar on March 6 and remained at her habitation for two or three days, it was found out. She continued visiting her family members during this time. The last area of her versatile was followed to Ludhiana\'s Sherpur Chowk on Sunday evening, following which the telephone was turned off.\r\n\r\nA wellbeing office official said she initially visited a private facility in Jalandhar\'s Model Town region on Sunday morning as she had dry hack and fever. The specialists there requested that her go to the nearby respectful emergency clinic to get herself tried for the coronavirus, he included.\r\n\r\nShe rather went to a facility in Hoshiarpur locale\'s Garhshankar toward the evening. The specialists there too encouraged to even think about getting herself inspected for the illness yet she gave them a slip.\r\n\r\nAt night, she arrived at a private emergency clinic at Gurdev Nagar in Ludhiana.\r\n\r\n\"Since the lady demonstrated indications of the infection, we requested that her stay in contact with the wellbeing specialists or visit the common medical clinic for coronavirus test. Be that as it may, she left our medical clinic in a quiet notwithstanding our having guided her till 12 PM. Since we are not approved to bind an individual, we promptly sounded a caution and educated the wellbeing office specialists about this,\" said Dr GS Grewal who runs the clinical office.Ludhiana police commissioner Rakesh Agrawal said, “We received information about the woman with symptoms of flu. We put her mobile phone under surveillance.”\r\nPrincipal secretary (health and family welfare) Anurag Aggarwal said, “An exercise was conducted under the supervision of the Jalandhar and Patiala deputy commissioners. We kept tracking the woman through the people she contacted until she switched off her phone. We received information Ttoday morning that she had taken a return flight.”\r\n“As per our knowledge, she has reached Singapore. She went to Delhi in a private vehicle. Since no test was conducted on her, we cannot term her a confirmed or suspected coronavirus case. She only had symptoms. Since she came from a coronavirus-affected country we asked her to get her tests done.”','Suspected lady corona patient escapes 3 centers, flies back to Philippines','','inherit','closed','closed','','4439-revision-v1','','','2020-03-17 04:58:38','2020-03-17 04:58:38','',4439,'https://microbiozindia.com/uncategorized/4439-revision-v1/',0,'revision','',0),(4447,2,'2020-03-17 04:59:13','2020-03-17 04:59:13','A 35-year-elderly person experiencing <span style=\"color: #ff6600;\">influenza</span> fled from three private wellbeing offices in Jalandhar, Hoshiarpur and Ludhiana areas after she would not complete her tests for the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.gov.uk/government/topical-events/coronavirus-covid-19-uk-government-response\">coronavirus</a></span>, sending the wellbeing specialists and police into a tantrum.\r\n\r\nThe lady being referred to, who was potentially experiencing coronavirus and hails from Jalandhar city, flew back to the Philippines where she lives, hours after she stayed untraceable, the police said.\r\n\r\nShe showed up in Jalandhar on March 6 and remained at her habitation for two or three days, it was found out. She continued visiting her family members during this time. The last area of her versatile was followed to Ludhiana\'s Sherpur Chowk on Sunday evening, following which the telephone was turned off.\r\n\r\nA wellbeing office official said she initially visited a private facility in Jalandhar\'s Model Town region on Sunday morning as she had dry hack and fever. The specialists there requested that her go to the nearby respectful emergency clinic to get herself tried for the coronavirus, he included.\r\n\r\nShe rather went to a facility in Hoshiarpur locale\'s Garhshankar toward the evening. The specialists there too encouraged to even think about getting herself inspected for the illness yet she gave them a slip.\r\n\r\nAt night, she arrived at a private emergency clinic at Gurdev Nagar in Ludhiana.\r\n\r\n\"Since the lady demonstrated indications of the infection, we requested that her stay in contact with the wellbeing specialists or visit the common medical clinic for coronavirus test. Be that as it may, she left our medical clinic in a quiet notwithstanding our having guided her till 12 PM. Since we are not approved to bind an individual, we promptly sounded a caution and educated the wellbeing office specialists about this,\" said Dr GS Grewal who runs the clinical office.Ludhiana police commissioner Rakesh Agrawal said, “We received information about the woman with symptoms of flu. We put her mobile phone under surveillance.”\r\nPrincipal secretary (health and family welfare) Anurag Aggarwal said, “An exercise was conducted under the supervision of the Jalandhar and Patiala deputy commissioners. We kept tracking the woman through the people she contacted until she switched off her phone. We received information Ttoday morning that she had taken a return flight.”\r\n“As per our knowledge, she has reached Singapore. She went to Delhi in a private vehicle. Since no test was conducted on her, we cannot term her a confirmed or suspected coronavirus case. She only had symptoms. Since she came from a coronavirus-affected country we asked her to get her tests done.”','Suspected lady corona patient escapes 3 centers, flies back to Philippines','','inherit','closed','closed','','4439-revision-v1','','','2020-03-17 04:59:13','2020-03-17 04:59:13','',4439,'https://microbiozindia.com/uncategorized/4439-revision-v1/',0,'revision','',0),(4448,2,'2020-03-17 05:06:58','2020-03-17 05:06:58','A 35-year-elderly person experiencing influenza fled from three private wellbeing offices in Jalandhar, Hoshiarpur and Ludhiana areas after she would not complete her tests for the coronavirus, sending the wellbeing specialists and police into a tantrum.\r\n\r\nThe lady being referred to, who was potentially experiencing coronavirus and hails from Jalandhar city, flew back to the Philippines where she lives, hours after she stayed untraceable, the police said.\r\n\r\nShe showed up in Jalandhar on March 6 and remained at her habitation for two or three days, it was found out. She continued visiting her family members during this time. The last area of her versatile was followed to Ludhiana\'s Sherpur Chowk on Sunday evening, following which the telephone was turned off.\r\n\r\nA wellbeing office official said she initially visited a private facility in Jalandhar\'s Model Town region on Sunday morning as she had dry hack and fever. The specialists there requested that her go to the nearby respectful emergency clinic to get herself tried for the coronavirus, he included.\r\n\r\nShe rather went to a facility in Hoshiarpur locale\'s Garhshankar toward the evening. The specialists there too encouraged to even think about getting herself inspected for the illness yet she gave them a slip.\r\n\r\nAt night, she arrived at a private emergency clinic at Gurdev Nagar in Ludhiana.\r\n\r\n\"Since the lady demonstrated indications of the infection, we requested that her stay in contact with the wellbeing specialists or visit the common medical clinic for coronavirus test. Be that as it may, she left our medical clinic in a quiet notwithstanding our having guided her till 12 PM. Since we are not approved to bind an individual, we promptly sounded a caution and educated the wellbeing office specialists about this,\" said Dr GS Grewal who runs the clinical office.Ludhiana police commissioner Rakesh Agrawal said, “We received information about the woman with symptoms of flu. We put her mobile phone under surveillance.”\r\nPrincipal secretary (health and family welfare) Anurag Aggarwal said, “An exercise was conducted under the supervision of the Jalandhar and Patiala deputy commissioners. We kept tracking the woman through the people she contacted until she switched off her phone. We received information Ttoday morning that she had taken a return flight.”\r\n“As per our knowledge, she has reached Singapore. She went to Delhi in a private vehicle. Since no test was conducted on her, we cannot term her a confirmed or suspected coronavirus case. She only had symptoms. Since she came from a coronavirus-affected country we asked her to get her tests done.”','Suspected lady corona patient escapes 3 centers, flies back to Philippines','','inherit','closed','closed','','4439-revision-v1','','','2020-03-17 05:06:58','2020-03-17 05:06:58','',4439,'https://microbiozindia.com/uncategorized/4439-revision-v1/',0,'revision','',0),(4449,2,'2020-03-17 05:08:00','2020-03-17 05:08:00','A 35-year-elderly person experiencing influenza fled from three private wellbeing offices in Jalandhar, Hoshiarpur and Ludhiana areas after she would not complete her tests for the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.nation.co.ke/news/explainers/-Do-I-have-influenza-or-coronavirus/5337446-5493014-53ppmpz/index.html\">coronavirus</a></span>, sending the wellbeing specialists and police into a tantrum.\r\n\r\nThe lady being referred to, who was potentially experiencing coronavirus and hails from Jalandhar city, flew back to the Philippines where she lives, hours after she stayed untraceable, the police said.\r\n\r\nShe showed up in Jalandhar on March 6 and remained at her habitation for two or three days, it was found out. She continued visiting her family members during this time. The last area of her versatile was followed to Ludhiana\'s Sherpur Chowk on Sunday evening, following which the telephone was turned off.\r\n\r\nA wellbeing office official said she initially visited a private facility in Jalandhar\'s Model Town region on Sunday morning as she had dry hack and fever. The specialists there requested that her go to the nearby respectful emergency clinic to get herself tried for the coronavirus, he included.\r\n\r\nShe rather went to a facility in Hoshiarpur locale\'s Garhshankar toward the evening. The specialists there too encouraged to even think about getting herself inspected for the illness yet she gave them a slip.\r\n\r\nAt night, she arrived at a private emergency clinic at Gurdev Nagar in Ludhiana.\r\n\r\n\"Since the lady demonstrated indications of the infection, we requested that her stay in contact with the wellbeing specialists or visit the common medical clinic for coronavirus test. Be that as it may, she left our medical clinic in a quiet notwithstanding our having guided her till 12 PM. Since we are not approved to bind an individual, we promptly sounded a caution and educated the wellbeing office specialists about this,\" said Dr GS Grewal who runs the clinical office.Ludhiana police commissioner Rakesh Agrawal said, “We received information about the woman with symptoms of flu. We put her mobile phone under surveillance.”\r\nPrincipal secretary (health and family welfare) Anurag Aggarwal said, “An exercise was conducted under the supervision of the Jalandhar and Patiala deputy commissioners. We kept tracking the woman through the people she contacted until she switched off her phone. We received information Ttoday morning that she had taken a return flight.”\r\n“As per our knowledge, she has reached Singapore. She went to Delhi in a private vehicle. Since no test was conducted on her, we cannot term her a confirmed or suspected coronavirus case. She only had symptoms. Since she came from a coronavirus-affected country we asked her to get her tests done.”','Suspected lady corona patient escapes 3 centers, flies back to Philippines','','inherit','closed','closed','','4439-revision-v1','','','2020-03-17 05:08:00','2020-03-17 05:08:00','',4439,'https://microbiozindia.com/uncategorized/4439-revision-v1/',0,'revision','',0),(4450,2,'2020-03-17 12:33:58','2020-03-17 12:33:58','Maharashtra Chief Minister Uddhav Thackeray will take a vital choice on suspending Mumbai\'s life saver, the neighborhood train administrations, for a couple of days, as one of the proportions of \'social separating\' to forestall the spread of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-supply-chain-update\">COVID-19</a></span>, Health Minister Rajesh Tope said here on Tuesday.\r\n\r\nThe issue will be talked about at the state bureau meeting on Tuesday evening as the administration is firm that the coronavirus must not be permitted to spread from \'Stage II to Phase III\' at any expense.\r\n\r\nOther than the rural trains, the choice could likewise incorporate the Mumbai Metro Rail, Monorail and other open methods of transport which can possibly practically deaden the nation\'s business capital.\r\n\r\n\"There are alternatives - like disinfecting all train mentors, restricting the quantity of workers to the seats accessible in each intruder to abstain from swarming - being viewed as other than totally halting the neighborhood train administrations,\" Tope said.\r\n\r\nSpread over the Central Railway and its Harbor Line, in addition to Western Railway, the rural trains are the help of Mumbai which ship over 8.50 million suburbanites day by day serving Mumbai, Thane, Palghar and Raigad locale.\r\n\r\nMaharashtra at present has 38 <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-supply-chain-update\">COVID-19</a></span> positive cases including a 64-year-old coronavirus persistent, who died at Mumbai\'s Kasturba Hospital, today.\r\n\r\nAll forthcoming neighborhood bodies and city races in the state have been deferred by a quarter of a year, the shutdown of scholastic foundations in urban focuses has been reached out to cover every single instructive organization even in rustic zones.\r\n\r\nMaharashtra CM Uddhav Thackeray declared a unique ₹45 crore reserve to handle the pandemic to be disseminated among the Divisional Commissioners at Konkan and Pune, while ₹5 crore each will be dispensed to Nagpur, Amravati, Aurangabad and Nashik.\r\n\r\nThe cash would be used to give different offices at the isolate focuses including nourishment, TVs, indoor games like carroms, and so on. The locale specialists have been approved to make crisis acquisition of ventilators or required clinical hardware.\r\n\r\nThackeray claimed that the individuals who have been exhorted home isolate should deliberately avoid venturing out in the open to forestall any hazard to other people.','Mumbai to settle on closing off its help \'local trains\' after first Corona demise','','publish','open','open','','mumbai-to-settle-on-closing-off-its-help-local-trains-after-first-corona-demise','','','2020-03-17 12:33:58','2020-03-17 12:33:58','',0,'https://microbiozindia.com/?p=4450',0,'post','',0),(4451,2,'2020-03-17 12:33:46','2020-03-17 12:33:46','','ghgh','','inherit','open','closed','','ghgh','','','2020-03-17 12:33:46','2020-03-17 12:33:46','',4450,'https://microbiozindia.com/wp-content/uploads/2020/03/ghgh.png',0,'attachment','image/png',0),(4452,2,'2020-03-17 12:33:58','2020-03-17 12:33:58','Maharashtra Chief Minister Uddhav Thackeray will take a vital choice on suspending Mumbai\'s life saver, the neighborhood train administrations, for a couple of days, as one of the proportions of \'social separating\' to forestall the spread of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-supply-chain-update\">COVID-19</a></span>, Health Minister Rajesh Tope said here on Tuesday.\r\n\r\nThe issue will be talked about at the state bureau meeting on Tuesday evening as the administration is firm that the coronavirus must not be permitted to spread from \'Stage II to Phase III\' at any expense.\r\n\r\nOther than the rural trains, the choice could likewise incorporate the Mumbai Metro Rail, Monorail and other open methods of transport which can possibly practically deaden the nation\'s business capital.\r\n\r\n\"There are alternatives - like disinfecting all train mentors, restricting the quantity of workers to the seats accessible in each intruder to abstain from swarming - being viewed as other than totally halting the neighborhood train administrations,\" Tope said.\r\n\r\nSpread over the Central Railway and its Harbor Line, in addition to Western Railway, the rural trains are the help of Mumbai which ship over 8.50 million suburbanites day by day serving Mumbai, Thane, Palghar and Raigad locale.\r\n\r\nMaharashtra at present has 38 <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-supply-chain-update\">COVID-19</a></span> positive cases including a 64-year-old coronavirus persistent, who died at Mumbai\'s Kasturba Hospital, today.\r\n\r\nAll forthcoming neighborhood bodies and city races in the state have been deferred by a quarter of a year, the shutdown of scholastic foundations in urban focuses has been reached out to cover every single instructive organization even in rustic zones.\r\n\r\nMaharashtra CM Uddhav Thackeray declared a unique ₹45 crore reserve to handle the pandemic to be disseminated among the Divisional Commissioners at Konkan and Pune, while ₹5 crore each will be dispensed to Nagpur, Amravati, Aurangabad and Nashik.\r\n\r\nThe cash would be used to give different offices at the isolate focuses including nourishment, TVs, indoor games like carroms, and so on. The locale specialists have been approved to make crisis acquisition of ventilators or required clinical hardware.\r\n\r\nThackeray claimed that the individuals who have been exhorted home isolate should deliberately avoid venturing out in the open to forestall any hazard to other people.','Mumbai to settle on closing off its help \'local trains\' after first Corona demise','','inherit','closed','closed','','4450-revision-v1','','','2020-03-17 12:33:58','2020-03-17 12:33:58','',4450,'https://microbiozindia.com/uncategorized/4450-revision-v1/',0,'revision','',0),(4454,2,'2020-03-18 05:27:42','2020-03-18 05:27:42','','COVID_1583083636953_1584178552996','','inherit','open','closed','','covid_1583083636953_1584178552996','','','2020-03-18 05:27:42','2020-03-18 05:27:42','',0,'https://microbiozindia.com/wp-content/uploads/2020/03/COVID_1583083636953_1584178552996.jpg',0,'attachment','image/jpeg',0),(4457,2,'2020-03-18 10:08:21','2020-03-18 10:08:21','Can some juice arranged from lemon, ginger and amla forestall the COVID-19 spread? Science says no, however a 65-year-old Briton, who runs a cafeteria at Varkala sea shore in Kerala, suspected something and attempted to hawk his pseudoscience, that at long last landed him in police care.\r\n\r\nThe individual has been running the cafeteria close the helipad for long. In any case, he went under the radar of Varkala police after he put a little board outside his shop promoting his \"anti corona juice\". The juice that he professed to have hostile to Corona properties were sold at Rs 150 for glass.\r\n\r\nAfter the issue became obvious on Tuesday, Varkala police stepped in and arrested the man. He evidently told the police that he had intended to feature the general restorative properties of the home grown juice and it had no demonstrated protection from the feared infection.\r\n\r\nThe police carefully cautioned him not to rehash the slip-up and let him go. The police had additionally requested that he expel the promotion board. Varkala police are keeping up vigil after an outsider, who remained in a hotel, had turned positive for COVID-19.','Kerala police capture 65-year-elderly person for selling \'anti corona juice\'','','publish','open','open','','kerala-police-capture-65-year-elderly-person-for-selling-anti-corona-juice','','','2020-03-18 10:08:21','2020-03-18 10:08:21','',0,'https://microbiozindia.com/?p=4457',0,'post','',0),(4458,2,'2020-03-18 10:07:55','2020-03-18 10:07:55','','Anti_Coronavirus_Juice','','inherit','open','closed','','anti_coronavirus_juice','','','2020-03-18 10:07:55','2020-03-18 10:07:55','',4457,'https://microbiozindia.com/wp-content/uploads/2020/03/Anti_Coronavirus_Juice.jpg',0,'attachment','image/jpeg',0),(4459,2,'2020-03-18 10:08:21','2020-03-18 10:08:21','Can some juice arranged from lemon, ginger and amla forestall the COVID-19 spread? Science says no, however a 65-year-old Briton, who runs a cafeteria at Varkala sea shore in Kerala, suspected something and attempted to hawk his pseudoscience, that at long last landed him in police care.\r\n\r\nThe individual has been running the cafeteria close the helipad for long. In any case, he went under the radar of Varkala police after he put a little board outside his shop promoting his \"anti corona juice\". The juice that he professed to have hostile to Corona properties were sold at Rs 150 for glass.\r\n\r\nAfter the issue became obvious on Tuesday, Varkala police stepped in and arrested the man. He evidently told the police that he had intended to feature the general restorative properties of the home grown juice and it had no demonstrated protection from the feared infection.\r\n\r\nThe police carefully cautioned him not to rehash the slip-up and let him go. The police had additionally requested that he expel the promotion board. Varkala police are keeping up vigil after an outsider, who remained in a hotel, had turned positive for COVID-19.','Kerala police capture 65-year-elderly person for selling \'anti corona juice\'','','inherit','closed','closed','','4457-revision-v1','','','2020-03-18 10:08:21','2020-03-18 10:08:21','',4457,'https://microbiozindia.com/uncategorized/4457-revision-v1/',0,'revision','',0),(4460,2,'2020-03-18 14:01:04','2020-03-18 14:01:04','Swiss firm Roche Diagnostics India got the permit for leading coronavirus tests after endorsement from medicate controller DCGI, making it the principal private firm to get such consent after the administration chose to permit authorize private labs to test for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://news.un.org/en/story/2020/03/1059261\">COVID-19.</a></span>\r\n\r\nAs per a senior authority, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://cdsco.gov.in/opencms/opencms/en/About-us/who/\">Drug Controller General of India (DCGI)</a></span> is presently evaluating offering permit to another private analytic firm, biomerieux, which has additionally looked for endorsement to direct tests for coronavirus.\r\n\r\nThe authority said two Indian analytic organizations - <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.trivitron.com/\">Trivitron Healthcare</a></span> and Mylab Discovery Solution- - have likewise looked for endorsement from the DCGI for the coronavirus testing packs created by them.\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Ministry_of_Health_and_Family_Welfare\">Union Health Ministry</a></span> had on Tuesday given rules for private segment research centers aiming to start COVID-19 testing while at the same time engaging them to lead the tests liberated from cost.','Roche Diagnostics India first private firm to get COVID-19 test endorsement','','publish','open','open','','roche-diagnostics-india-first-private-firm-to-get-covid-19-test-approval','','','2020-03-18 14:42:01','2020-03-18 14:42:01','',0,'https://microbiozindia.com/?p=4460',0,'post','',0),(4461,2,'2020-03-18 13:54:57','2020-03-18 13:54:57','','molecular-diagnostic-740','','inherit','open','closed','','molecular-diagnostic-740','','','2020-03-18 13:54:57','2020-03-18 13:54:57','',4460,'https://microbiozindia.com/wp-content/uploads/2020/03/molecular-diagnostic-740.jpg',0,'attachment','image/jpeg',0),(4462,2,'2020-03-18 14:01:04','2020-03-18 14:01:04','Swiss firm Roche Diagnostics India received the license for conducting coronavirus tests after approval from drug regulator DCGI, making it the first private firm to get such permission after the government decided to allow accredited private labs to test for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://news.un.org/en/story/2020/03/1059261\">COVID-19.</a></span>\r\n\r\nAccording to a senior official, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://cdsco.gov.in/opencms/opencms/en/About-us/who/\">Drug Controller General of India (DCGI)</a></span> is now assessing giving license to another private diagnostic firm, biomerieux, which has also sought approval to conduct tests for coronavirus.\r\n\r\nThe official said two Indian diagnostic companies-- <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bloomberg.com/profile/company/6595108Z:IN\">Trivitron Healthcare</a></span> and Mylab Discovery Solution-- have also sought approval from the DCGI for the coronavirus testing kits developed by them.\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Ministry_of_Health_and_Family_Welfare\">Union health ministry</a></span> had on Tuesday issued guidelines for private sector laboratories intending to initiate COVID-19 testing while appealing them to conduct the tests free of cost.','Roche Diagnostics India first private firm to get COVID-19 test approval','','inherit','closed','closed','','4460-revision-v1','','','2020-03-18 14:01:04','2020-03-18 14:01:04','',4460,'https://microbiozindia.com/uncategorized/4460-revision-v1/',0,'revision','',0),(4463,2,'2020-03-18 14:40:56','2020-03-18 14:40:56','Swiss firm Roche Diagnostics India got the permit for leading coronavirus tests after endorsement from medicate controller DCGI, making it the principal private firm to get such consent after the administration chose to permit authorize private labs to test for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://news.un.org/en/story/2020/03/1059261\">COVID-19.</a></span>\n\nAs per a senior authority, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://cdsco.gov.in/opencms/opencms/en/About-us/who/\">Drug Controller General of India (DCGI)</a></span> is presently evaluating offering permit to another private analytic firm, biomerieux, which has additionally looked for endorsement to direct tests for coronavirus.\n\nThe authority said two Indian analytic organizations - Trivitron Healthcare and Mylab Discovery Solution- - have likewise looked for endorsement from the DCGI for the coronavirus testing packs created by them.\n\nThe Union wellbeing service had on Tuesday given rules for private segment research centers aiming to start COVID-19 testing while at the same time engaging them to lead the tests liberated from cost.','Roche Diagnostics India first private firm to get COVID-19 test endorsement','','inherit','closed','closed','','4460-autosave-v1','','','2020-03-18 14:40:56','2020-03-18 14:40:56','',4460,'https://microbiozindia.com/uncategorized/4460-autosave-v1/',0,'revision','',0),(4464,2,'2020-03-18 14:42:01','2020-03-18 14:42:01','Swiss firm Roche Diagnostics India got the permit for leading coronavirus tests after endorsement from medicate controller DCGI, making it the principal private firm to get such consent after the administration chose to permit authorize private labs to test for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://news.un.org/en/story/2020/03/1059261\">COVID-19.</a></span>\r\n\r\nAs per a senior authority, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://cdsco.gov.in/opencms/opencms/en/About-us/who/\">Drug Controller General of India (DCGI)</a></span> is presently evaluating offering permit to another private analytic firm, biomerieux, which has additionally looked for endorsement to direct tests for coronavirus.\r\n\r\nThe authority said two Indian analytic organizations - <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.trivitron.com/\">Trivitron Healthcare</a></span> and Mylab Discovery Solution- - have likewise looked for endorsement from the DCGI for the coronavirus testing packs created by them.\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Ministry_of_Health_and_Family_Welfare\">Union Health Ministry</a></span> had on Tuesday given rules for private segment research centers aiming to start COVID-19 testing while at the same time engaging them to lead the tests liberated from cost.','Roche Diagnostics India first private firm to get COVID-19 test endorsement','','inherit','closed','closed','','4460-revision-v1','','','2020-03-18 14:42:01','2020-03-18 14:42:01','',4460,'https://microbiozindia.com/uncategorized/4460-revision-v1/',0,'revision','',0),(4465,2,'2020-03-18 15:07:41','2020-03-18 15:07:41','Incorporating a novel dual hydrophobically treated matrix filter, Microlute&#x2122; Protein Precipitation Plate from Porvair Sciences set a new standard for labs looking to remove interfering proteins from serum, plasma or even whole blood samples prior to analysis by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Liquid_chromatography%E2%80%93mass_spectrometry\">Liquid Chromatography / Mass Spectrometry (LC/MS).</a></span>\r\n\r\nBiological samples commonly contain proteins that interfere with downstream applications such as LC/MS analysis. Microlute&#x2122; Protein Precipitation Plates (PPP) use the CRASH method, in which protein is denatured with acetonitrile and the flocculant filtered out, allowing 96 samples to be processed in parallel.\r\n\r\nBased on the industry standard MicroLute&#x2122; format, but without the chromatographic sorbent, protein ‘crashes’ out of solution and precipitates directly in each well when acetonitrile is added, thus solving all common problems associated with the <a href=\"https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Supelco/Posters/1/t408163h.pdf\">CRASH technique of protein clean-up</a>. The novel dual frit, hydrophobically treated matrix used by the Microlute&#x2122; PPP means that there is no ‘wetting out’ and leakage of sample before the application of vacuum.\r\n\r\nDue to its ease of use, high performance and reliability the Microlute&#x2122; PPP is commonly used as the protein precipitation plate of choice in many major pharmaceutical companies worldwide.\r\n\r\nTo review the operational protocol for the Microlute&#x2122; PPP please visit www.microplates.com/resources/microlute-ppp-protocol/. To watch a video demonstration of the Microlute&#x2122; PPP please visit <a href=\"http://www.microplates.com/protein-precipitation-plates/\">www.microplates.com/protein-precipitation-plates/</a>\r\n\r\nFor further information on the Microlute&#x2122; PPP please contact Porvair Sciences on +44-1978-666222 or int.sales@porvairsciences.com.\r\n\r\nEstablished in 1992, Porvair Sciences is one of the largest global manufacturers of ultra-clean microplates and top-quality microplate equipment for life science, synthetic chemistry and many other applications. Throughout North America - Porvair Sciences products are available and locally supported from sister company - JG Finneran Associates Inc. which also designs, manufactures and distributes a complimentary range of specialist laboratory consumables including vials, filters, microplates and closures. Porvair Sciences is a wholly owned subsidiary of Porvair plc.','Fast & Effective Removal of Interfering Proteins','','publish','open','open','','fast-effective-removal-of-interfering-proteins','','','2020-03-18 15:07:41','2020-03-18 15:07:41','',0,'https://microbiozindia.com/?p=4465',0,'post','',0),(4466,2,'2020-03-18 15:04:52','2020-03-18 15:04:52','','AAA','','inherit','open','closed','','aaa-11','','','2020-03-18 15:04:52','2020-03-18 15:04:52','',4465,'https://microbiozindia.com/wp-content/uploads/2020/03/AAA-2.png',0,'attachment','image/png',0),(4467,2,'2020-03-18 15:07:41','2020-03-18 15:07:41','Incorporating a novel dual hydrophobically treated matrix filter, Microlute&#x2122; Protein Precipitation Plate from Porvair Sciences set a new standard for labs looking to remove interfering proteins from serum, plasma or even whole blood samples prior to analysis by <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Liquid_chromatography%E2%80%93mass_spectrometry\">Liquid Chromatography / Mass Spectrometry (LC/MS).</a></span>\r\n\r\nBiological samples commonly contain proteins that interfere with downstream applications such as LC/MS analysis. Microlute&#x2122; Protein Precipitation Plates (PPP) use the CRASH method, in which protein is denatured with acetonitrile and the flocculant filtered out, allowing 96 samples to be processed in parallel.\r\n\r\nBased on the industry standard MicroLute&#x2122; format, but without the chromatographic sorbent, protein ‘crashes’ out of solution and precipitates directly in each well when acetonitrile is added, thus solving all common problems associated with the <a href=\"https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Supelco/Posters/1/t408163h.pdf\">CRASH technique of protein clean-up</a>. The novel dual frit, hydrophobically treated matrix used by the Microlute&#x2122; PPP means that there is no ‘wetting out’ and leakage of sample before the application of vacuum.\r\n\r\nDue to its ease of use, high performance and reliability the Microlute&#x2122; PPP is commonly used as the protein precipitation plate of choice in many major pharmaceutical companies worldwide.\r\n\r\nTo review the operational protocol for the Microlute&#x2122; PPP please visit www.microplates.com/resources/microlute-ppp-protocol/. To watch a video demonstration of the Microlute&#x2122; PPP please visit <a href=\"http://www.microplates.com/protein-precipitation-plates/\">www.microplates.com/protein-precipitation-plates/</a>\r\n\r\nFor further information on the Microlute&#x2122; PPP please contact Porvair Sciences on +44-1978-666222 or int.sales@porvairsciences.com.\r\n\r\nEstablished in 1992, Porvair Sciences is one of the largest global manufacturers of ultra-clean microplates and top-quality microplate equipment for life science, synthetic chemistry and many other applications. Throughout North America - Porvair Sciences products are available and locally supported from sister company - JG Finneran Associates Inc. which also designs, manufactures and distributes a complimentary range of specialist laboratory consumables including vials, filters, microplates and closures. Porvair Sciences is a wholly owned subsidiary of Porvair plc.','Fast & Effective Removal of Interfering Proteins','','inherit','closed','closed','','4465-revision-v1','','','2020-03-18 15:07:41','2020-03-18 15:07:41','',4465,'https://microbiozindia.com/uncategorized/4465-revision-v1/',0,'revision','',0),(4468,2,'2020-03-19 07:36:59','2020-03-19 07:36:59','Pharma mammoth Pfizer declared on Tuesday that it\'s dealing with a potential <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://time.com/tag/covid-19/\">COVID-19</a></span> antibody with BioNTech, a German organization taking a shot at new sorts of immunotherapy medicines. The joint exertion, affirmed Tuesday by means of a marked letter of aim, will see the two accomplices cooperate on an envoy <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-019-1804-8\">RNA-based antibody</a></span> that will try to keep individuals from getting the new coronavirus.\r\n\r\nIt merits an update that any antibody is going to take, at least, between a year and year and a half to create and affirm for general human use, so don\'t imagine this is going to bring about any sort of momentary arrangement. Be that as it may, the joint effort brings together one of the biggest and most settled players in the domain of pharmaceutical biotech with a more youthful organization working at the bleeding edge of mRNA-based invulnerable treatments.\r\n\r\nThese treatments don\'t utilize tests of the infection itself, as run of the mill antibodies do (in either dead or debilitated structure, to kick off the body\'s common resistances). Rather, they depend on RNA to launch the creation of proteins comparative enough to the infection that they trigger the body\'s improvement of antibodies successful against the genuine objective.\r\n\r\nThis joint effort should bring about a clinical test that could commence as ahead of schedule as April. The two gatherings aren\'t beginning without any preparation as far as their work on mRNA-based antibodies: they started cooperating on R&amp;D to make medicines for this season\'s cold virus beginning in 2018.\r\n\r\nWhile take a shot at the collective exertion starts quickly, across groups situated in both the U.S. what\'s more, Germany, the two accomplices despite everything need to pound out subtleties, including money related terms and commercialization of whatever outcomes. The way that they\'re willing to start working before the ink is dry on those subtleties should give you some thought of the direness felt behind the undertaking.\r\n\r\nThis isn\'t the main mRNA-based potential COVID-19 immunization being developed: Earlier this week, Moderna declared that they\'d just started human clinical preliminaries of their own coronavirus immunotherapy, after optimizing its advancement in organization with the National Institutes of Health.','Pfizer and BioNTech declare joint advancement of a potential COVID-19 antibody','','publish','open','open','','pfizer-and-biontech-declare-joint-advancement-of-a-potential-covid-19-antibody','','','2020-03-19 07:36:59','2020-03-19 07:36:59','',0,'https://microbiozindia.com/?p=4468',0,'post','',0),(4469,2,'2020-03-19 07:34:22','2020-03-19 07:34:22','','140639_Pfizer-shutterstock_602782373','','inherit','open','closed','','140639_pfizer-shutterstock_602782373','','','2020-03-19 07:34:22','2020-03-19 07:34:22','',4468,'https://microbiozindia.com/wp-content/uploads/2020/03/140639_Pfizer-shutterstock_602782373.jpg',0,'attachment','image/jpeg',0),(4470,2,'2020-03-19 07:36:59','2020-03-19 07:36:59','Pharma mammoth Pfizer declared on Tuesday that it\'s dealing with a potential <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://time.com/tag/covid-19/\">COVID-19</a></span> antibody with BioNTech, a German organization taking a shot at new sorts of immunotherapy medicines. The joint exertion, affirmed Tuesday by means of a marked letter of aim, will see the two accomplices cooperate on an envoy <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-019-1804-8\">RNA-based antibody</a></span> that will try to keep individuals from getting the new coronavirus.\r\n\r\nIt merits an update that any antibody is going to take, at least, between a year and year and a half to create and affirm for general human use, so don\'t imagine this is going to bring about any sort of momentary arrangement. Be that as it may, the joint effort brings together one of the biggest and most settled players in the domain of pharmaceutical biotech with a more youthful organization working at the bleeding edge of mRNA-based invulnerable treatments.\r\n\r\nThese treatments don\'t utilize tests of the infection itself, as run of the mill antibodies do (in either dead or debilitated structure, to kick off the body\'s common resistances). Rather, they depend on RNA to launch the creation of proteins comparative enough to the infection that they trigger the body\'s improvement of antibodies successful against the genuine objective.\r\n\r\nThis joint effort should bring about a clinical test that could commence as ahead of schedule as April. The two gatherings aren\'t beginning without any preparation as far as their work on mRNA-based antibodies: they started cooperating on R&amp;D to make medicines for this season\'s cold virus beginning in 2018.\r\n\r\nWhile take a shot at the collective exertion starts quickly, across groups situated in both the U.S. what\'s more, Germany, the two accomplices despite everything need to pound out subtleties, including money related terms and commercialization of whatever outcomes. The way that they\'re willing to start working before the ink is dry on those subtleties should give you some thought of the direness felt behind the undertaking.\r\n\r\nThis isn\'t the main mRNA-based potential COVID-19 immunization being developed: Earlier this week, Moderna declared that they\'d just started human clinical preliminaries of their own coronavirus immunotherapy, after optimizing its advancement in organization with the National Institutes of Health.','Pfizer and BioNTech declare joint advancement of a potential COVID-19 antibody','','inherit','closed','closed','','4468-revision-v1','','','2020-03-19 07:36:59','2020-03-19 07:36:59','',4468,'https://microbiozindia.com/uncategorized/4468-revision-v1/',0,'revision','',0),(4471,2,'2020-03-19 09:14:58','2020-03-19 09:14:58','The 2020 version of its Particle Solutions Software Suite is now available free of charge from Testa Analytical Solutions e.K for users of their NanoBrook series of particle characterization instruments.\r\n\r\nCarlo Dessy, Managing Director of Testa Analytical commented \"In line with our total commitment to excellent customer support this latest version of our comprehensive particle characterization software, Particle Solutions, is available for free download now. Simply visit our website, click on the \'Download Software\' tab, and fill out the form. If you need a license for Particle Solutions, click on the \'Request a Software License\' tab and fill out the form\". Mr Dessy added \"For those of you who are new user or just a little rusty, we have produced an informative training video to help you brush up on your Particle Solutions software skills\".\r\n\r\nThe 2020 version of Particle Solutions software suite from Testa Analytical integrates characterization of the DLS, SLS, Phase Analysis Light Scattering (PALS), Micro-Rheology, and Size Exclusion Chromatography particle measurement technologies in one easy-to-use integrated package. Designed for both occasional and advanced user - the Particle Solutions software suite includes laboratory information management system support, surface zeta potential measurement capability, multimodal size distribution refinement, health mode post-measurement analysis, and statistical process control.\r\n\r\nTo download the latest version of the Particle Solutions Software Suite please visit <a href=\"https://testa-analytical.com/particle-solution-software.html\">https://testa-analytical.com/particle-solution-software.html</a> or contact Testa Analytical Solutions now on +49-30-864-24076 / info@testa-analytical.com.','Particle Characterization Software','','publish','open','open','','particle-characterization-software','','','2020-03-19 09:14:58','2020-03-19 09:14:58','',0,'https://microbiozindia.com/?p=4471',0,'post','',0),(4472,2,'2020-03-19 09:13:46','2020-03-19 09:13:46','','AADSAD','','inherit','open','closed','','aadsad','','','2020-03-19 09:13:46','2020-03-19 09:13:46','',4471,'https://microbiozindia.com/wp-content/uploads/2020/03/AADSAD.png',0,'attachment','image/png',0),(4473,2,'2020-03-19 09:14:58','2020-03-19 09:14:58','The 2020 version of its Particle Solutions Software Suite is now available free of charge from Testa Analytical Solutions e.K for users of their NanoBrook series of particle characterization instruments.\r\n\r\nCarlo Dessy, Managing Director of Testa Analytical commented \"In line with our total commitment to excellent customer support this latest version of our comprehensive particle characterization software, Particle Solutions, is available for free download now. Simply visit our website, click on the \'Download Software\' tab, and fill out the form. If you need a license for Particle Solutions, click on the \'Request a Software License\' tab and fill out the form\". Mr Dessy added \"For those of you who are new user or just a little rusty, we have produced an informative training video to help you brush up on your Particle Solutions software skills\".\r\n\r\nThe 2020 version of Particle Solutions software suite from Testa Analytical integrates characterization of the DLS, SLS, Phase Analysis Light Scattering (PALS), Micro-Rheology, and Size Exclusion Chromatography particle measurement technologies in one easy-to-use integrated package. Designed for both occasional and advanced user - the Particle Solutions software suite includes laboratory information management system support, surface zeta potential measurement capability, multimodal size distribution refinement, health mode post-measurement analysis, and statistical process control.\r\n\r\nTo download the latest version of the Particle Solutions Software Suite please visit <a href=\"https://testa-analytical.com/particle-solution-software.html\">https://testa-analytical.com/particle-solution-software.html</a> or contact Testa Analytical Solutions now on +49-30-864-24076 / info@testa-analytical.com.','Particle Characterization Software','','inherit','closed','closed','','4471-revision-v1','','','2020-03-19 09:14:58','2020-03-19 09:14:58','',4471,'https://microbiozindia.com/uncategorized/4471-revision-v1/',0,'revision','',0),(4474,2,'2020-03-19 11:13:16','2020-03-19 11:13:16','Bangalore, March 19, 2020: In the wake of the on-going coronavirus (COVID-19) outbreak, Aster CMI Hospital and Aster RV Hospital as a part of Aster Volunteers initiative have launched a 24/7 <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a> </span>Support Centre for people. The tele-triage (assessment of the condition and appropriate guidance for treatment) service will be free for everyone who are seeking medical help if they suspect they have symptoms related to the novel coronavirus disease. India has reported many cases and appropriate precautionary measures need to be adopted to curb its spread by identifying and reporting the symptoms early on.\r\n\r\nPeople can register on the website or Facebook page of the hospital and book an appointment with healthcare experts. The appointment would be conducted by internal medicine and emergency experts through a video call following medical protocols approved by local authorities and WHO for triaging COVID-19 patients. This facility is available at all Aster’s 13 hospitals in India.\r\n\r\nSpeaking about the initiative, <strong>Dr. Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare said</strong>, “In these trying time, we would like to put every possible measure in place to help people identify symptoms related to coronavirus and get appropriate help on time. The online service promotes social distancing while it also gives patients easy access to expert advice when they need it the most. A teleconsulting tool like Aster COVID Support Centre has the potential to enable earlier detection of cases and channelize patients to seek appropriate treatment on time.”\r\n\r\n<strong>Dr Harish Pillai, Chief Executive Officer, Aster DM Healthcare India</strong> said, “Through this online support centre, we aim to reach out to patients who might be experiencing symptoms related to the coronavirus infection and are seeking professional help. Our experienced doctors will be available to answer all questions to the best of their knowledge under the guidelines defined by the government and the World Health Organisation.”\r\n\r\n<strong>‘Aster COVID-19 Support Centre’ </strong>has been operational from 18 March, 2020. People can log into the below websites to seek appointments:\r\n\r\nAster CMI Hospital, Bengaluru: <a href=\"https://www.asterbangalore.com/aster-cmi-hebbal\">https://www.asterbangalore.com/aster-cmi-hebbal</a>\r\n\r\nAster RV Hospital, Bengaluru:<a href=\"https://www.asterbangalore.com/aster-rv-jp-nagar/\">https://www.asterbangalore.com/aster-rv-jp-nagar/</a>','Aster Hospitals Bangalore launches 24/7, online COVID-19 portal to advice people seeking medical help','','publish','open','open','','aster-hospitals-bangalore-launches-24-7-online-covid-19-portal-to-advice-people-seeking-medical-help','','','2020-03-19 11:13:16','2020-03-19 11:13:16','',0,'https://microbiozindia.com/?p=4474',0,'post','',0),(4475,2,'2020-03-19 11:12:35','2020-03-19 11:12:35','','AAW2','','inherit','open','closed','','aaw2','','','2020-03-19 11:12:35','2020-03-19 11:12:35','',4474,'https://microbiozindia.com/wp-content/uploads/2020/03/AAW2.png',0,'attachment','image/png',0),(4476,2,'2020-03-19 11:13:16','2020-03-19 11:13:16','Bangalore, March 19, 2020: In the wake of the on-going coronavirus (COVID-19) outbreak, Aster CMI Hospital and Aster RV Hospital as a part of Aster Volunteers initiative have launched a 24/7 <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a> </span>Support Centre for people. The tele-triage (assessment of the condition and appropriate guidance for treatment) service will be free for everyone who are seeking medical help if they suspect they have symptoms related to the novel coronavirus disease. India has reported many cases and appropriate precautionary measures need to be adopted to curb its spread by identifying and reporting the symptoms early on.\r\n\r\nPeople can register on the website or Facebook page of the hospital and book an appointment with healthcare experts. The appointment would be conducted by internal medicine and emergency experts through a video call following medical protocols approved by local authorities and WHO for triaging COVID-19 patients. This facility is available at all Aster’s 13 hospitals in India.\r\n\r\nSpeaking about the initiative, <strong>Dr. Azad Moopen, Founder Chairman and Managing Director, Aster DM Healthcare said</strong>, “In these trying time, we would like to put every possible measure in place to help people identify symptoms related to coronavirus and get appropriate help on time. The online service promotes social distancing while it also gives patients easy access to expert advice when they need it the most. A teleconsulting tool like Aster COVID Support Centre has the potential to enable earlier detection of cases and channelize patients to seek appropriate treatment on time.”\r\n\r\n<strong>Dr Harish Pillai, Chief Executive Officer, Aster DM Healthcare India</strong> said, “Through this online support centre, we aim to reach out to patients who might be experiencing symptoms related to the coronavirus infection and are seeking professional help. Our experienced doctors will be available to answer all questions to the best of their knowledge under the guidelines defined by the government and the World Health Organisation.”\r\n\r\n<strong>‘Aster COVID-19 Support Centre’ </strong>has been operational from 18 March, 2020. People can log into the below websites to seek appointments:\r\n\r\nAster CMI Hospital, Bengaluru: <a href=\"https://www.asterbangalore.com/aster-cmi-hebbal\">https://www.asterbangalore.com/aster-cmi-hebbal</a>\r\n\r\nAster RV Hospital, Bengaluru:<a href=\"https://www.asterbangalore.com/aster-rv-jp-nagar/\">https://www.asterbangalore.com/aster-rv-jp-nagar/</a>','Aster Hospitals Bangalore launches 24/7, online COVID-19 portal to advice people seeking medical help','','inherit','closed','closed','','4474-revision-v1','','','2020-03-19 11:13:16','2020-03-19 11:13:16','',4474,'https://microbiozindia.com/uncategorized/4474-revision-v1/',0,'revision','',0),(4477,2,'2020-03-19 19:35:14','2020-03-19 19:35:14','Alembic Pharmaceuticals share value falls more than 4 percent in early exchange on March 16 after the organization got 4 perceptions from the <strong><span style=\"color: #ff6600;\">USFDA.</span></strong>\r\n\r\n<strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Food_and_Drug_Administration\">US Food and Drug Administration (USFDA)</a> </span></strong>has directed an investigation at the organization\'s general oral strong plan office situated at Panelav from March 9 to 13, 2020.\r\n\r\nThis was a booked investigation and toward the finish of the assessment, the <span style=\"color: #ff6600;\"><strong><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Food_and_Drug_Administration\">USFDA</a></strong></span> gave a Form 483 with four procedural perceptions.\r\n\r\nNone of the perceptions are identified with information uprightness or dull in nature, organization said in discharge.\r\n\r\nThe organization will give complete restorative activity report to address every perception.\r\n\r\nThe organization is focused on keeping up best gauges that fulfill <span style=\"color: #ff6600;\"><strong><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Food_and_Drug_Administration\">USFDA</a></strong></span> guidelines, it included.\r\n\r\nAt 09:27 hrs <strong><span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Alembic_Pharmaceuticals_Ltd\">Alembic Pharmaceuticals</a></span></strong> was citing at Rs 550, down Rs 25, or 4.35 percent on the BSE.','Alembic Pharma share value sheds 4% as USFDA issues 4 perceptions','','inherit','closed','closed','','4420-revision-v1','','','2020-03-19 19:35:14','2020-03-19 19:35:14','',4420,'https://microbiozindia.com/uncategorized/4420-revision-v1/',0,'revision','',0),(4478,2,'2020-03-19 19:36:15','2020-03-19 19:36:15','Alembic Pharmaceuticals share value falls more than 4 percent in early exchange on March 16 after the organization got 4 perceptions from the USFDA.\r\n\r\nUS Food and Drug Administration (USFDA) has directed an investigation at the organization’s general oral strong plan office situated at Panelav from March 9 to 13, 2020.\r\n\r\nThis was a booked investigation and toward the finish of the assessment, the USFDA gave a Form 483 with four procedural perceptions.\r\n\r\nNone of the perceptions are identified with information uprightness or dull in nature, organization said in discharge.\r\n\r\nThe organization will give complete restorative activity report to address every perception.\r\n\r\nThe organization is focused on keeping up best gauges that fulfill USFDA guidelines, it included.\r\n\r\nAt 09:27 hrs Alembic Pharmaceuticals was citing at Rs 550, down Rs 25, or 4.35 percent on the BSE.','Alembic Pharma share value sheds 4% as USFDA issues 4 perceptions','','inherit','closed','closed','','4420-revision-v1','','','2020-03-19 19:36:15','2020-03-19 19:36:15','',4420,'https://microbiozindia.com/uncategorized/4420-revision-v1/',0,'revision','',0),(4479,2,'2020-03-20 13:23:35','2020-03-20 13:23:35','Pharma shares were exchanging the green in Friday\'s meeting with their sectoral list exchanging higher.\r\n\r\nPortions of Cadila Healthcare (up 15.09 percent), Dr Reddys Laboratories (up 7.41 percent), Cipla (up 5.8 percent), Biocon (up 5.63 percent), Glenmark Pharmaceuticals (up 4.98 percent), Divis Laboratories (up 4.87 percent), Aurobindo Pharma (up 4.34 percent), Sun Pharmaceutical Industries (up 4.01 percent), Lupin (up 3.38 percent) and Piramal Enterprises (up 2.79 percent) were among the top gainers.\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.moneycontrol.com/news/business/markets/d-street-buzz-nifty-pharma-in-green-led-by-lupin-volumes-of-vodafone-idea-itc-yes-bank-surge-5050831.html\">Nifty Pharma</a></span> file was exchanging 5.39 percent up at 7014.4 around 12:23 pm.\r\n\r\nBenchmark NSE Nifty50 file was up 384.90 focuses at 8648.35 , while the BSE Sensex was up 1296.2 focuses at 29584.43 .Portions of Vodafone Idea, ONGC, YES Bank, IDFC First Bank Ltd., Ashok Leyland, ITC, ICICI Bank, Tata Motors and SBI were among the most exchanged offers on the NSE.','Pharma shares advance; Cadila Healthcare floods 15%','','publish','open','open','','pharma-shares-advance-cadila-healthcare-floods-15','','','2020-03-20 14:05:34','2020-03-20 14:05:34','',0,'https://microbiozindia.com/?p=4479',0,'post','',0),(4480,2,'2020-03-20 13:21:53','2020-03-20 13:21:53','','cadila (1)','','inherit','open','closed','','cadila-1','','','2020-03-20 13:21:53','2020-03-20 13:21:53','',4479,'https://microbiozindia.com/wp-content/uploads/2020/03/cadila-1.jpg',0,'attachment','image/jpeg',0),(4481,2,'2020-03-20 13:23:35','2020-03-20 13:23:35','Pharma shares were exchanging the green in Friday\'s meeting with their sectoral list exchanging higher.\r\n\r\nPortions of Cadila Healthcare (up 15.09 percent), Dr Reddys Laboratories (up 7.41 percent), Cipla (up 5.8 percent), Biocon (up 5.63 percent), Glenmark Pharmaceuticals (up 4.98 percent), Divis Laboratories (up 4.87 percent), Aurobindo Pharma (up 4.34 percent), Sun Pharmaceutical Industries (up 4.01 percent), Lupin (up 3.38 percent) and Piramal Enterprises (up 2.79 percent) were among the top gainers.\r\n\r\nThe <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.moneycontrol.com/news/business/markets/d-street-buzz-nifty-pharma-in-green-led-by-lupin-volumes-of-vodafone-idea-itc-yes-bank-surge-5050831.html\">Nifty Pharma</a></span> file was exchanging 5.39 percent up at 7014.4 around 12:23 pm.\r\n\r\nBenchmark NSE Nifty50 file was up 384.90 focuses at 8648.35 , while the BSE Sensex was up 1296.2 focuses at 29584.43 .Portions of Vodafone Idea, ONGC, YES Bank, IDFC First Bank Ltd., Ashok Leyland, ITC, ICICI Bank, Tata Motors and SBI were among the most exchanged offers on the NSE.','Pharma shares advance; Cadila Healthcare floods 15%','','inherit','closed','closed','','4479-revision-v1','','','2020-03-20 13:23:35','2020-03-20 13:23:35','',4479,'https://microbiozindia.com/uncategorized/4479-revision-v1/',0,'revision','',0),(4482,2,'2020-03-20 13:33:37','2020-03-20 13:33:37','The US Food and Drug Administration (USFDA) has given an admonition letter to sedate major Cipla for damaging current great assembling practice standards at its Goa-based plant. In a letter to organization\'s Managing Director and Global CEO Umang Vohra, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">USFDA</a></span> said overseers during September 16-27, 2019, had discovered noteworthy deviations from standard assembling rehearses at Cipla\'s Goa (Verna) based plant.\r\n\"This warning letter summarises significant violations of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/pharmaceutical-quality-resources/facts-about-current-good-manufacturing-practices-cgmps\">current good manufacturing practice (CGMP)</a> </span>regulations for finished pharmaceuticals...because your methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/pharmaceutical-quality-resources/facts-about-current-good-manufacturing-practices-cgmps\">CGMP</a></span>, your drug products are adulterated,\" the USFDA said.\r\nThe significant violations included company\'s failure \"to clean, maintain, and, as appropriate for the nature of the drug, sanitise and/or sterilise equipment and utensils at appropriate intervals to prevent malfunctions or contamination that would alter the safety, identity, strength, quality, or purity of the drug,\" it added.\r\nThe USFDA said the company\'s cleaning procedure for non-dedicated equipment, including equipment is inadequate.\r\n\"Our investigators observed multiple containing residues of what appeared to be different products inside the exhaust ducts. Analytical testing conducted by your firm on the residues collected from this manufacturing equipment confirmed the presence of multiple active ingredients,\" it added.\r\nBesides, the company failed to thoroughly investigate any discrepancy or failure of a batch or any of its components to meet any of its specifications, whether or not the batch has already been distributed, USFDA noted.\r\n\"Your firm failed to follow appropriate written procedures that are designed to prevent microbiological contamination of drug products purporting to be sterile, and that include validation of all aseptic and sterilization processes,\" it added.\r\nThe violations cited in this letter are not intended to be an all-inclusive list of violations that exist at the company\'s facility, USFDA said.\r\n\"You are responsible for investigating and determining the causes of these violations and for preventing their recurrence or the occurrence of other violations,\" he added.\r\nUntil the sum total of what rectifications have been finished and FDA has affirmed amendments of the infringement and the association\'s consistence with CGMP, FDA may retain endorsement of any new applications or enhancements, the USFDA said. What\'s more, the organization\'s inability to address these infringement may bring about FDA proceeding to reject confirmation of articles produced at the plant into the US, it included. The FDA gave the letter on February 25, and had given the organization 15 days to react.','USFDA issues cautioning letter to Cipla for Goa plant','','publish','open','open','','usfda-issues-cautioning-letter-to-cipla-for-goa-plant','','','2020-03-20 13:33:37','2020-03-20 13:33:37','',0,'https://microbiozindia.com/?p=4482',0,'post','',0),(4483,2,'2020-03-20 13:30:55','2020-03-20 13:30:55','','AACIPLA','','inherit','open','closed','','aacipla','','','2020-03-20 13:30:55','2020-03-20 13:30:55','',4482,'https://microbiozindia.com/wp-content/uploads/2020/03/AACIPLA.jpg',0,'attachment','image/jpeg',0),(4484,2,'2020-03-20 13:33:37','2020-03-20 13:33:37','The US Food and Drug Administration (USFDA) has given an admonition letter to sedate major Cipla for damaging current great assembling practice standards at its Goa-based plant. In a letter to organization\'s Managing Director and Global CEO Umang Vohra, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/home\">USFDA</a></span> said overseers during September 16-27, 2019, had discovered noteworthy deviations from standard assembling rehearses at Cipla\'s Goa (Verna) based plant.\r\n\"This warning letter summarises significant violations of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/pharmaceutical-quality-resources/facts-about-current-good-manufacturing-practices-cgmps\">current good manufacturing practice (CGMP)</a> </span>regulations for finished pharmaceuticals...because your methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/drugs/pharmaceutical-quality-resources/facts-about-current-good-manufacturing-practices-cgmps\">CGMP</a></span>, your drug products are adulterated,\" the USFDA said.\r\nThe significant violations included company\'s failure \"to clean, maintain, and, as appropriate for the nature of the drug, sanitise and/or sterilise equipment and utensils at appropriate intervals to prevent malfunctions or contamination that would alter the safety, identity, strength, quality, or purity of the drug,\" it added.\r\nThe USFDA said the company\'s cleaning procedure for non-dedicated equipment, including equipment is inadequate.\r\n\"Our investigators observed multiple containing residues of what appeared to be different products inside the exhaust ducts. Analytical testing conducted by your firm on the residues collected from this manufacturing equipment confirmed the presence of multiple active ingredients,\" it added.\r\nBesides, the company failed to thoroughly investigate any discrepancy or failure of a batch or any of its components to meet any of its specifications, whether or not the batch has already been distributed, USFDA noted.\r\n\"Your firm failed to follow appropriate written procedures that are designed to prevent microbiological contamination of drug products purporting to be sterile, and that include validation of all aseptic and sterilization processes,\" it added.\r\nThe violations cited in this letter are not intended to be an all-inclusive list of violations that exist at the company\'s facility, USFDA said.\r\n\"You are responsible for investigating and determining the causes of these violations and for preventing their recurrence or the occurrence of other violations,\" he added.\r\nUntil the sum total of what rectifications have been finished and FDA has affirmed amendments of the infringement and the association\'s consistence with CGMP, FDA may retain endorsement of any new applications or enhancements, the USFDA said. What\'s more, the organization\'s inability to address these infringement may bring about FDA proceeding to reject confirmation of articles produced at the plant into the US, it included. The FDA gave the letter on February 25, and had given the organization 15 days to react.','USFDA issues cautioning letter to Cipla for Goa plant','','inherit','closed','closed','','4482-revision-v1','','','2020-03-20 13:33:37','2020-03-20 13:33:37','',4482,'https://microbiozindia.com/uncategorized/4482-revision-v1/',0,'revision','',0),(4486,2,'2020-03-20 13:45:37','2020-03-20 13:45:37','Biocon NSE 8.54 % on Friday said it has gotten the establishment inspection report (EIR) from US wellbeing controller for the post-endorsement and goodt manufacturing practice (GMP) investigation of its little particles producing office in Bengaluru.\r\n\r\n\"The EIR has been shut with an voluntary activity showed (VAI) grouping for the perceptions, the organization representative said in a recording to BSE.\r\n\r\n\"Biocon has gotten the EIR from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.usa.gov/federal-agencies/food-and-drug-administration\">US Food and Drug Administration</a></span> (FDA) for the post-endorsement and GMP investigation of its little atoms dynamic pharmaceutical fixing (API) fabricating office at twentieth KM, Biocon Campus, Bengaluru, directed between Feb 20 and Feb 26, 2020,\" according to the documenting.\r\n\r\nAt the finish of the assessment a month ago, the office had given a Form 483, with two perceptions, which were procedural in nature and are being tended to by the organization, the documenting said.\r\n\r\n\"We stay focused on worldwide norms of value and consistence,\" organization representative included.','Biocon gets EIR from USFDA for assembling office in Bengaluru','','publish','open','open','','biocon-gets-eir-from-usfda-for-assembling-office-in-bengaluru','','','2020-03-20 13:45:37','2020-03-20 13:45:37','',0,'https://microbiozindia.com/?p=4486',0,'post','',0),(4487,2,'2020-03-20 13:42:34','2020-03-20 13:42:34','','Biocon-770x433','','inherit','open','closed','','biocon-770x433','','','2020-03-20 13:42:34','2020-03-20 13:42:34','',4486,'https://microbiozindia.com/wp-content/uploads/2020/03/Biocon-770x433-1.jpg',0,'attachment','image/jpeg',0),(4488,2,'2020-03-20 13:45:37','2020-03-20 13:45:37','Biocon NSE 8.54 % on Friday said it has gotten the establishment inspection report (EIR) from US wellbeing controller for the post-endorsement and goodt manufacturing practice (GMP) investigation of its little particles producing office in Bengaluru.\r\n\r\n\"The EIR has been shut with an voluntary activity showed (VAI) grouping for the perceptions, the organization representative said in a recording to BSE.\r\n\r\n\"Biocon has gotten the EIR from the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.usa.gov/federal-agencies/food-and-drug-administration\">US Food and Drug Administration</a></span> (FDA) for the post-endorsement and GMP investigation of its little atoms dynamic pharmaceutical fixing (API) fabricating office at twentieth KM, Biocon Campus, Bengaluru, directed between Feb 20 and Feb 26, 2020,\" according to the documenting.\r\n\r\nAt the finish of the assessment a month ago, the office had given a Form 483, with two perceptions, which were procedural in nature and are being tended to by the organization, the documenting said.\r\n\r\n\"We stay focused on worldwide norms of value and consistence,\" organization representative included.','Biocon gets EIR from USFDA for assembling office in Bengaluru','','inherit','closed','closed','','4486-revision-v1','','','2020-03-20 13:45:37','2020-03-20 13:45:37','',4486,'https://microbiozindia.com/uncategorized/4486-revision-v1/',0,'revision','',0),(4489,2,'2020-03-20 14:05:27','2020-03-20 14:05:27','','Zydus-Cadila','','inherit','open','closed','','zydus-cadila','','','2020-03-20 14:05:27','2020-03-20 14:05:27','',4479,'https://microbiozindia.com/wp-content/uploads/2020/03/Zydus-Cadila.jpg',0,'attachment','image/jpeg',0),(4490,2,'2020-03-20 14:22:02','2020-03-20 14:22:02','The epic coronavirus, or COVID-19, pandemic has sickened in excess of 2,10,300 individuals in any event 145 nations and more than 9,000 individuals have passed on, the greater part of them outside China, where the pestilence initially started in the city of Wuhan.\r\n\r\nThere are in any event 223 dynamic detailed instances of the novel coronavirus in India at this moment. The Union Health Ministry has said that 15 individuals have recouped up until this point, however four have kicked the bucket. Executive Narendra Modi, during his location to the country today, claimed residents to show \'resolve and tolerance\' to hold over the emergency. He has called for \'Janata check in time\' on March 22 to contain the spread of coronavirus.','Kerala reports 12 new instances of COVID-19','','publish','open','open','','kerala-reports-12-new-instances-of-covid-19','','','2020-03-20 14:23:09','2020-03-20 14:23:09','',0,'https://microbiozindia.com/?p=4490',0,'post','',0),(4491,2,'2020-03-20 14:19:30','2020-03-20 14:19:30','','26VIRUS-EXPLAINER-update1-articleLarge','','inherit','open','closed','','26virus-explainer-update1-articlelarge','','','2020-03-20 14:19:30','2020-03-20 14:19:30','',4490,'https://microbiozindia.com/wp-content/uploads/2020/03/26VIRUS-EXPLAINER-update1-articleLarge.jpg',0,'attachment','image/jpeg',0),(4492,2,'2020-03-20 14:22:02','2020-03-20 14:22:02','The epic coronavirus, or <span style=\"color: #ff6600;\">COVID-19</span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020\">pandemic</a></span> has sickened in excess of 2,10,300 individuals in any event 145 nations and more than 9,000 individuals have passed on, the greater part of them outside China, where the pestilence initially started in the city of Wuhan.\r\n\r\nThere are in any event 223 dynamic detailed instances of the novel coronavirus in India at this moment. The <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Ministry_of_Health_and_Family_Welfare\">Union Health Ministry</a></span> has said that 15 individuals have recouped up until this point, however four have kicked the bucket. Executive Narendra Modi, during his location to the country today, claimed residents to show \'resolve and tolerance\' to hold over the emergency. He has called for \'Janata check in time\' on March 22 to contain the spread of coronavirus.','Kerala reports 12 new instances of COVID-19','','inherit','closed','closed','','4490-revision-v1','','','2020-03-20 14:22:02','2020-03-20 14:22:02','',4490,'https://microbiozindia.com/uncategorized/4490-revision-v1/',0,'revision','',0),(4493,2,'2020-03-20 14:22:39','2020-03-20 14:22:39','The epic coronavirus, or <span style=\"color: #ff6600;\">COVID-19</span>, <span style=\"color: #ff6600;\">pandemic</span> has sickened in excess of 2,10,300 individuals in any event 145 nations and more than 9,000 individuals have passed on, the greater part of them outside China, where the pestilence initially started in the city of Wuhan.\r\n\r\nThere are in any event 223 dynamic detailed instances of the novel coronavirus in India at this moment. The <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Ministry_of_Health_and_Family_Welfare\">Union Health Ministry</a></span> has said that 15 individuals have recouped up until this point, however four have kicked the bucket. Executive Narendra Modi, during his location to the country today, claimed residents to show \'resolve and tolerance\' to hold over the emergency. He has called for \'Janata check in time\' on March 22 to contain the spread of coronavirus.','Kerala reports 12 new instances of COVID-19','','inherit','closed','closed','','4490-revision-v1','','','2020-03-20 14:22:39','2020-03-20 14:22:39','',4490,'https://microbiozindia.com/uncategorized/4490-revision-v1/',0,'revision','',0),(4494,2,'2020-03-20 14:23:09','2020-03-20 14:23:09','The epic coronavirus, or COVID-19, pandemic has sickened in excess of 2,10,300 individuals in any event 145 nations and more than 9,000 individuals have passed on, the greater part of them outside China, where the pestilence initially started in the city of Wuhan.\r\n\r\nThere are in any event 223 dynamic detailed instances of the novel coronavirus in India at this moment. The Union Health Ministry has said that 15 individuals have recouped up until this point, however four have kicked the bucket. Executive Narendra Modi, during his location to the country today, claimed residents to show \'resolve and tolerance\' to hold over the emergency. He has called for \'Janata check in time\' on March 22 to contain the spread of coronavirus.','Kerala reports 12 new instances of COVID-19','','inherit','closed','closed','','4490-revision-v1','','','2020-03-20 14:23:09','2020-03-20 14:23:09','',4490,'https://microbiozindia.com/uncategorized/4490-revision-v1/',0,'revision','',0),(4495,2,'2020-03-20 20:16:26','2020-03-20 20:16:26','WHO is propelled an informing administration with accomplices <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://twitter.com/WhatsApp?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\">WhatsApp</a></span> and <a href=\"https://en.wikipedia.org/wiki/Facebook\"><span style=\"color: #ff9900;\">Facebook</span></a> to protect individuals from coronavirus.\r\n\r\nThis simple to-utilize informing administration can possibly contact 2 billion individuals and empowers <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">WHO</a></span> to get data straightforwardly under the control of the individuals that need it.\r\n\r\nFrom government pioneers to wellbeing laborers and loved ones, this informing administration will give the most recent news and data on coronavirus remembering subtleties for manifestations and how individuals can secure themselves as well as other people. It likewise gives the most recent circumstance reports and numbers continuously to help government chiefs ensure the soundness of their populaces.\r\n\r\nThe administration can be gotten to through a connection that starts a discussion on WhatsApp. Clients can just sort \"hey\" to initiate the discussion, provoking a menu of alternatives that can help answer their inquiries regarding <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.cdc.gov/coronavirus/2019-ncov/about/index.html\">COVID-19.</a></span>\r\n\r\nThe WHO Health Alert was created as a team with <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.praekelt.org/\">Praekelt.Org</a></span>, utilizing <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.turn.io/\">Turn</a></span> AI innovation.','WHO Health Alert brings COVID-19 realities to billions by means of WhatsApp','','publish','open','open','','who-health-alert-brings-covid-19-realities-to-billions-by-means-of-whatsapp','','','2020-03-20 20:16:26','2020-03-20 20:16:26','',0,'https://microbiozindia.com/?p=4495',0,'post','',0),(4496,2,'2020-03-20 20:09:37','2020-03-20 20:09:37','','RRTT','','inherit','open','closed','','rrtt','','','2020-03-20 20:09:37','2020-03-20 20:09:37','',4495,'https://microbiozindia.com/wp-content/uploads/2020/03/RRTT.png',0,'attachment','image/png',0),(4497,2,'2020-03-20 20:16:26','2020-03-20 20:16:26','WHO is propelled an informing administration with accomplices <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://twitter.com/WhatsApp?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\">WhatsApp</a></span> and <a href=\"https://en.wikipedia.org/wiki/Facebook\"><span style=\"color: #ff9900;\">Facebook</span></a> to protect individuals from coronavirus.\r\n\r\nThis simple to-utilize informing administration can possibly contact 2 billion individuals and empowers <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">WHO</a></span> to get data straightforwardly under the control of the individuals that need it.\r\n\r\nFrom government pioneers to wellbeing laborers and loved ones, this informing administration will give the most recent news and data on coronavirus remembering subtleties for manifestations and how individuals can secure themselves as well as other people. It likewise gives the most recent circumstance reports and numbers continuously to help government chiefs ensure the soundness of their populaces.\r\n\r\nThe administration can be gotten to through a connection that starts a discussion on WhatsApp. Clients can just sort \"hey\" to initiate the discussion, provoking a menu of alternatives that can help answer their inquiries regarding <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.cdc.gov/coronavirus/2019-ncov/about/index.html\">COVID-19.</a></span>\r\n\r\nThe WHO Health Alert was created as a team with <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.praekelt.org/\">Praekelt.Org</a></span>, utilizing <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https://www.turn.io/\">Turn</a></span> AI innovation.','WHO Health Alert brings COVID-19 realities to billions by means of WhatsApp','','inherit','closed','closed','','4495-revision-v1','','','2020-03-20 20:16:26','2020-03-20 20:16:26','',4495,'https://microbiozindia.com/uncategorized/4495-revision-v1/',0,'revision','',0),(4498,2,'2020-03-21 17:09:35','2020-03-21 17:09:35','Prime Minister Shri Nadrendra Modi collaborated with the pioneers of Pharma industry by means of video conferencing. Executive said that pharma makers and merchants have a vital task to carry out in battling the test of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a></span>. He said that not exclusively does the business need to guarantee upkeep of supply lines of fundamental drugs, clinical units and types of gear, and yet should attempt to think of new and imaginative arrangements.\r\nHe said that the legislature is focused on helping the business in keeping up supply of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.verywellhealth.com/api-active-pharmaceutical-ingredient-2663020\">Active Pharmaceutical Ingredients (API)</a></span>, underlining the significance of assembling of such APIs inside the nation. He said that so as to guarantee creation of basic medications and clinical hardware inside the nation, the administration has affirmed plans worth Rs 10,000 crore and Rs 4,000 crore separately.\r\n<a href=\"https://www.verywellhealth.com/api-active-pharmaceutical-ingredient-2663020\"><span style=\"text-decoration: underline; color: #1b8f89;\">Executive mentioned the business chiefs to take a shot at assembling of RNA Diagnostic Kits for COVID-19 on war balance. </span></a>\r\nHe asked the medication retailers and drug specialists to be on consistent vigil to guarantee that dark promoting and storing of meds is evaded and supply of fundamentals kept up. He proposed that any place practical, supply of drugs in mass might be stayed away from.\r\nExecutive said that right now need, it is basic for the business to work ceaselessly and furthermore guarantee that there is no lack of workforce in the pharma division. He proposed investigation of home-conveyance model to take into account upkeep of social removing at drug stores, and furthermore advancement of utilization of computerized installment instruments to forestall the spread of the infection.\r\nThe Pharmaceutical Associations said thanks to the Prime Minister for his administration right now emergency.\r\n\r\nThe Associations said that they are focused on keeping up supply of basic medications and gear, and are additionally dealing with creating antibodies. They said that administration\'s approach declarations for the Pharma segment will give the division a colossal lift.\r\nHead administrator valued the devotion and duty of the business and the enthusiasm with which they are working. He said that because of the trust of individuals in them, they additionally have a significant task to carry out in dispersal of logical data to the individuals.','Pharma producers and distributors have a crucial role to play in combating the challenge of COVID-19: Prime Minister Nadrendra Modi','','publish','open','open','','pharma-producers-and-distributors-have-a-crucial-role-to-play-in-combating-the-challenge-of-covid-19-prime-minister-nadrendra-modi','','','2020-03-21 17:09:35','2020-03-21 17:09:35','',0,'https://microbiozindia.com/?p=4498',0,'post','',0),(4499,2,'2020-03-21 17:03:23','2020-03-21 17:03:23','','aa','','inherit','open','closed','','aa-6','','','2020-03-21 17:03:23','2020-03-21 17:03:23','',4498,'https://microbiozindia.com/wp-content/uploads/2020/03/aa-2.png',0,'attachment','image/png',0),(4500,2,'2020-03-21 17:09:35','2020-03-21 17:09:35','Prime Minister Shri Nadrendra Modi collaborated with the pioneers of Pharma industry by means of video conferencing. Executive said that pharma makers and merchants have a vital task to carry out in battling the test of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a></span>. He said that not exclusively does the business need to guarantee upkeep of supply lines of fundamental drugs, clinical units and types of gear, and yet should attempt to think of new and imaginative arrangements.\r\nHe said that the legislature is focused on helping the business in keeping up supply of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.verywellhealth.com/api-active-pharmaceutical-ingredient-2663020\">Active Pharmaceutical Ingredients (API)</a></span>, underlining the significance of assembling of such APIs inside the nation. He said that so as to guarantee creation of basic medications and clinical hardware inside the nation, the administration has affirmed plans worth Rs 10,000 crore and Rs 4,000 crore separately.\r\n<a href=\"https://www.verywellhealth.com/api-active-pharmaceutical-ingredient-2663020\"><span style=\"text-decoration: underline; color: #1b8f89;\">Executive mentioned the business chiefs to take a shot at assembling of RNA Diagnostic Kits for COVID-19 on war balance. </span></a>\r\nHe asked the medication retailers and drug specialists to be on consistent vigil to guarantee that dark promoting and storing of meds is evaded and supply of fundamentals kept up. He proposed that any place practical, supply of drugs in mass might be stayed away from.\r\nExecutive said that right now need, it is basic for the business to work ceaselessly and furthermore guarantee that there is no lack of workforce in the pharma division. He proposed investigation of home-conveyance model to take into account upkeep of social removing at drug stores, and furthermore advancement of utilization of computerized installment instruments to forestall the spread of the infection.\r\nThe Pharmaceutical Associations said thanks to the Prime Minister for his administration right now emergency.\r\n\r\nThe Associations said that they are focused on keeping up supply of basic medications and gear, and are additionally dealing with creating antibodies. They said that administration\'s approach declarations for the Pharma segment will give the division a colossal lift.\r\nHead administrator valued the devotion and duty of the business and the enthusiasm with which they are working. He said that because of the trust of individuals in them, they additionally have a significant task to carry out in dispersal of logical data to the individuals.','Pharma producers and distributors have a crucial role to play in combating the challenge of COVID-19: Prime Minister Nadrendra Modi','','inherit','closed','closed','','4498-revision-v1','','','2020-03-21 17:09:35','2020-03-21 17:09:35','',4498,'https://microbiozindia.com/uncategorized/4498-revision-v1/',0,'revision','',0),(4501,2,'2020-03-22 05:10:38','2020-03-22 05:10:38','The U.S. Food  and Drug Administration (FDA) has given crisis endorsement to a test that could analyze COVID-19 out of 45 minutes, <span style=\"color: #ff6600;\">CNN detailed.</span>\r\n\r\nThe tests were created by California-based organization Cepheid and will be sent to U.S. offices by March 30, as per a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-first-emergency-use-authorization-point-care-diagnostic\">FDA declaration</a></span>. Notwithstanding, at the present time, the tests are likely just going to be utilized in a clinic setting, where a patient is now in a crisis room or emergency clinic triage wing and should be analyzed quickly, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.statnews.com/2020/03/21/coronavirus-test-returns-results-in-45-minutes/\">STAT detailed.</a></span>\r\n\r\n\"We don\'t accept this innovation ought to be utilized, at any rate at first, in a specialist\'s office,\" David Persing, boss clinical official of Cepheid, told STAT. \"This isn\'t a test for the stressed well.\"\r\n\r\nHalfway, that is on the grounds that Cepheid\'s creation limit is restricted; it can deliver a large number of tests over the coming weeks, Persing told STAT. Paradoxically, different organizations with endorsed tests will have the option to deliver a great many tests for each week by April, as indicated by STAT.\r\n\r\nThe U.S. has been tormented by a serious deficiency of tests, which permitted the new coronavirus SARS-CoV-2 to spread undetected for quite a long time. Test units at first sent by the Centers for Disease Control and Prevention were defective, and for quite a long time the legislature restricted neighborhood labs from building up their own packs.\r\n\r\nTesting has increase fundamentally in the previous two weeks, and thus, the quantity of affirmed cases in the nation has soar. As of Saturday (March 21), the U.S. had logged in excess of 24,000 cases, the greater part in the province of New York.','Quick coronavirus test affirmed by the FDA','','publish','open','open','','quick-coronavirus-test-affirmed-by-the-fda','','','2020-03-22 05:10:38','2020-03-22 05:10:38','',0,'https://microbiozindia.com/?p=4501',0,'post','',0),(4502,2,'2020-03-22 05:10:29','2020-03-22 05:10:29','','shutterstock_662348971','','inherit','open','closed','','shutterstock_662348971','','','2020-03-22 05:10:29','2020-03-22 05:10:29','',4501,'https://microbiozindia.com/wp-content/uploads/2020/03/shutterstock_662348971.jpg',0,'attachment','image/jpeg',0),(4503,2,'2020-03-22 05:10:38','2020-03-22 05:10:38','The U.S. Food  and Drug Administration (FDA) has given crisis endorsement to a test that could analyze COVID-19 out of 45 minutes, <span style=\"color: #ff6600;\">CNN detailed.</span>\r\n\r\nThe tests were created by California-based organization Cepheid and will be sent to U.S. offices by March 30, as per a <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-first-emergency-use-authorization-point-care-diagnostic\">FDA declaration</a></span>. Notwithstanding, at the present time, the tests are likely just going to be utilized in a clinic setting, where a patient is now in a crisis room or emergency clinic triage wing and should be analyzed quickly, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.statnews.com/2020/03/21/coronavirus-test-returns-results-in-45-minutes/\">STAT detailed.</a></span>\r\n\r\n\"We don\'t accept this innovation ought to be utilized, at any rate at first, in a specialist\'s office,\" David Persing, boss clinical official of Cepheid, told STAT. \"This isn\'t a test for the stressed well.\"\r\n\r\nHalfway, that is on the grounds that Cepheid\'s creation limit is restricted; it can deliver a large number of tests over the coming weeks, Persing told STAT. Paradoxically, different organizations with endorsed tests will have the option to deliver a great many tests for each week by April, as indicated by STAT.\r\n\r\nThe U.S. has been tormented by a serious deficiency of tests, which permitted the new coronavirus SARS-CoV-2 to spread undetected for quite a long time. Test units at first sent by the Centers for Disease Control and Prevention were defective, and for quite a long time the legislature restricted neighborhood labs from building up their own packs.\r\n\r\nTesting has increase fundamentally in the previous two weeks, and thus, the quantity of affirmed cases in the nation has soar. As of Saturday (March 21), the U.S. had logged in excess of 24,000 cases, the greater part in the province of New York.','Quick coronavirus test affirmed by the FDA','','inherit','closed','closed','','4501-revision-v1','','','2020-03-22 05:10:38','2020-03-22 05:10:38','',4501,'https://microbiozindia.com/uncategorized/4501-revision-v1/',0,'revision','',0),(4505,2,'2020-03-23 07:00:09','2020-03-23 07:00:09','IPCA labs, one of the biggest provider of hostile to malarial medication <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://medlineplus.gov/druginfo/meds/a682318.html\">Chloroquine</a></span> and the Rheumatoid Artharitis tranquilize Hydroxychloroquine has got its import alert suspended as the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/coronavirus-disease-2019-covid-19\">USFDA</a></span> by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/coronavirus-disease-2019-covid-19\">USFDA</a></span> made a special case to the organization due to the conceivable ascent sought after of these medications emerging out of the<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30134-X/fulltext\"> Covid-19 pandemic.</a> </span>\r\n\r\n\"We wish to inform you that due to the shortage implications and/or medical necessity of certain drugs and finished products, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/coronavirus-disease-2019-covid-19\">United States Food and Drug Administration (FDA)</a> </span>vide its e-mails dated 20th March, 2020 has made exception to the import alert for the Company\'s following A<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/medicines/areas/quality_safety/quality_assurance/DefinitionAPI-QAS11-426Rev1-08082011.pdf\">ctive Pharmaceutical Ingredients (APls)</a> </span>and finished products (Formulations)\", IPCA said to stock exchanges.\r\n\r\nIPCA\'s shares on Friday\'s trade had closed 9% up at Rs 1371.\r\n\r\nAs indicated by the Center for Disease Control USA, an examination in China announced that chloroquine treatment of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30134-X/fulltext\">COVID-19</a></span> patients had clinical and virologic advantage versus a correlation gathering, and chloroquine was included as a prescribed antiviral for treatment of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30134-X/fulltext\">COVID-19</a></span> in China. In view of these restricted preliminary numbers, these medications are getting prescribed for treatment for patients who are hospitalized for Covid-19. The high poisonous quality of the medication has likewise been a stressing factor.\r\n\r\nIPCA has a piece of the pie of about 70% of these medications, as it is perhaps the biggest provider of the dynamic pharmaceutical element of these prescriptions to a few enormous global medication organizations. Since the Covid-19 episode the organization has provided almost 5 lakh tablets over the world.\r\n\r\n\"We have been ramping our production and looking at ways to expand our supply chain as we are getting enquiries from several countries to supply this drug\", said A K Jain, Joint MD IPCA labs to ET. Jain however added that the company\'s first priority will be to supply to India and its domestic facility has enough raw materials to manufacture the drug for the Indian market. The company said it has intermediary stock till July. \"Any hospital the government will ask to supply we will do it\", Jain said.','Mumbai based IPCA gets a jolt as USFDA suspends import boycott for key Covid-19 medication','','publish','open','open','','mumbai-based-ipca-gets-a-jolt-as-usfda-suspends-import-boycott-for-key-covid-19-medication','','','2020-03-23 07:00:09','2020-03-23 07:00:09','',0,'https://microbiozindia.com/?p=4505',0,'post','',0),(4506,2,'2020-03-23 06:55:36','2020-03-23 06:55:36','','c66d0f80259842c39afecb7d280e9e4e_18','','inherit','open','closed','','c66d0f80259842c39afecb7d280e9e4e_18-2','','','2020-03-23 06:55:36','2020-03-23 06:55:36','',4505,'https://microbiozindia.com/wp-content/uploads/2020/03/c66d0f80259842c39afecb7d280e9e4e_18-1.jpg',0,'attachment','image/jpeg',0),(4507,2,'2020-03-23 06:55:57','2020-03-23 06:55:57','','is_200320_pills_vial_800x450','','inherit','open','closed','','is_200320_pills_vial_800x450','','','2020-03-23 06:55:57','2020-03-23 06:55:57','',4505,'https://microbiozindia.com/wp-content/uploads/2020/03/is_200320_pills_vial_800x450.jpg',0,'attachment','image/jpeg',0),(4508,2,'2020-03-23 07:00:09','2020-03-23 07:00:09','IPCA labs, one of the biggest provider of hostile to malarial medication <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://medlineplus.gov/druginfo/meds/a682318.html\">Chloroquine</a></span> and the Rheumatoid Artharitis tranquilize Hydroxychloroquine has got its import alert suspended as the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/coronavirus-disease-2019-covid-19\">USFDA</a></span> by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/coronavirus-disease-2019-covid-19\">USFDA</a></span> made a special case to the organization due to the conceivable ascent sought after of these medications emerging out of the<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30134-X/fulltext\"> Covid-19 pandemic.</a> </span>\r\n\r\n\"We wish to inform you that due to the shortage implications and/or medical necessity of certain drugs and finished products, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/coronavirus-disease-2019-covid-19\">United States Food and Drug Administration (FDA)</a> </span>vide its e-mails dated 20th March, 2020 has made exception to the import alert for the Company\'s following A<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/medicines/areas/quality_safety/quality_assurance/DefinitionAPI-QAS11-426Rev1-08082011.pdf\">ctive Pharmaceutical Ingredients (APls)</a> </span>and finished products (Formulations)\", IPCA said to stock exchanges.\r\n\r\nIPCA\'s shares on Friday\'s trade had closed 9% up at Rs 1371.\r\n\r\nAs indicated by the Center for Disease Control USA, an examination in China announced that chloroquine treatment of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30134-X/fulltext\">COVID-19</a></span> patients had clinical and virologic advantage versus a correlation gathering, and chloroquine was included as a prescribed antiviral for treatment of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30134-X/fulltext\">COVID-19</a></span> in China. In view of these restricted preliminary numbers, these medications are getting prescribed for treatment for patients who are hospitalized for Covid-19. The high poisonous quality of the medication has likewise been a stressing factor.\r\n\r\nIPCA has a piece of the pie of about 70% of these medications, as it is perhaps the biggest provider of the dynamic pharmaceutical element of these prescriptions to a few enormous global medication organizations. Since the Covid-19 episode the organization has provided almost 5 lakh tablets over the world.\r\n\r\n\"We have been ramping our production and looking at ways to expand our supply chain as we are getting enquiries from several countries to supply this drug\", said A K Jain, Joint MD IPCA labs to ET. Jain however added that the company\'s first priority will be to supply to India and its domestic facility has enough raw materials to manufacture the drug for the Indian market. The company said it has intermediary stock till July. \"Any hospital the government will ask to supply we will do it\", Jain said.','Mumbai based IPCA gets a jolt as USFDA suspends import boycott for key Covid-19 medication','','inherit','closed','closed','','4505-revision-v1','','','2020-03-23 07:00:09','2020-03-23 07:00:09','',4505,'https://microbiozindia.com/uncategorized/4505-revision-v1/',0,'revision','',0),(4509,2,'2020-03-23 11:07:39','2020-03-23 11:07:39','Novartis will give enough dosages of jungle fever tranquilize <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.webmd.com/drugs/2/drug-5482/hydroxychloroquine-oral/details\">hydroxychloroquine</a></span> to treat a few million patients in the battle against the coronavirus, in the event that it wins endorsement, the Swiss organization said on Friday.\r\n\r\nThere are no immunizations or medicines endorsed for the illness, yet there is at present a 1,500-man preliminary, drove by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://minnesota.cbslocal.com/2020/03/22/u-of-m-cardiac-anesthesia-fellow-creates-simple-cheaper-ventilator/\">University of Minnesota</a></span>, to see whether <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.webmd.com/drugs/2/drug-5482/hydroxychloroquine-oral/details\">hydroxychloroquine</a></span> can forestall or lessen the seriousness of COVID-19. Two different preliminaries are contemplating pulse medicate losartan as a potential treatment.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bloomberg.com/profile/company/NOVN:SW\">Novartis</a> </span>makes the jungle fever medicate, which is additionally used to treat lupus and rheumatoid joint inflammation, at its Sandoz unit in the United States. It intends to give 130 million portions of the medication and is in converses with U.S. Nourishment and Drug Administration controllers over growing its utilization for coronavirus.\r\n\r\n\"Novartis is supporting continuous clinical preliminary endeavors, and will assess requirements for extra clinical preliminaries,\" it said in an announcement.\r\n\r\nIn Washington, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.biography.com/us-president/donald-trump\">U.S. President Donald Trump</a></span> said during a news meeting on Friday he is idealistic about the jungle fever treatment\'s utilization against <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://swarajyamag.com/insta/covid-19-india-recommends-hydroxychloroquine-as-prophylaxis-for-healthcare-providers-patient-family-members\">COVID-19.</a></span>\r\n\r\nAnthony Fauci, chief of the U.S. National Institute of Allergy and Infectious Diseases, didn\'t disagree with Trump\'s confidence, yet said the medication\'s guarantee is put together so far with respect to episodic proof in France and that more information is required.\r\n\r\n\"I\'m stating that it may - it may - be successful. I\'m not saying that it isn\'t,\" Fauci said.\r\n\r\nFauci additionally said that while poisonous responses to the medications are uncommon dependent on many years of patient utilize and can be reversible much of the time, that isn\'t known for COVID-19.\r\n\r\n\"What we don\'t know is the point at which you put it with regards to another malady whether it\'s protected. In a general sense, I think it most likely will be protected, however I like to demonstrate things first,\" Fauci said.\r\n\r\nNovartis has 50 million dosages in stock, and would like to create another 80 million before the finish of May for gift. The gifts might be adequate to treat a few million patients, contingent upon the dosing routine, Novartis said.\r\n\r\nThe American Society of Health-System Pharmacists (ASHP), added hydroxychloroquine to its rundown of medications hard to come by this week. Four out of eight makers of the medication are hard to come by, it said.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bloomberg.com/profile/company/BAYN:GR\">Bayer AG</a></span> has given 3,000,000 tablets of the jungle fever tranquilize Resochin, which is like hydroxychloroquine, to the U.S. government for potential use against coronavirus.\r\n\r\n<a href=\"https://www.forbes.com/companies/mylan/#5b82fa391126\"><span style=\"color: #ff6600;\">Mylan</span></a> NV is increase creation and hopes to start providing it all the more comprehensively in mid-April. It said with the crude materials available it can make 50 million tablets to possibly treat more than 1.5 million patients.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://tevapharm.com/\">Teva Pharmaceuticals Industries Ltd</a></span> said it would give in excess of 6,000,000 portions of hydroxychloroquine sulfate tablets.','Novartis to give malaria drug in battle against coronavirus','','publish','open','open','','novartis-to-give-malaria-drug-in-battle-against-coronavirus','','','2020-03-23 11:07:39','2020-03-23 11:07:39','',0,'https://microbiozindia.com/?p=4509',0,'post','',0),(4510,2,'2020-03-23 11:02:23','2020-03-23 11:02:23','','AAA','','inherit','open','closed','','aaa-12','','','2020-03-23 11:02:23','2020-03-23 11:02:23','',4509,'https://microbiozindia.com/wp-content/uploads/2020/03/AAA-3.png',0,'attachment','image/png',0),(4511,2,'2020-03-23 11:07:39','2020-03-23 11:07:39','Novartis will give enough dosages of jungle fever tranquilize <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.webmd.com/drugs/2/drug-5482/hydroxychloroquine-oral/details\">hydroxychloroquine</a></span> to treat a few million patients in the battle against the coronavirus, in the event that it wins endorsement, the Swiss organization said on Friday.\r\n\r\nThere are no immunizations or medicines endorsed for the illness, yet there is at present a 1,500-man preliminary, drove by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://minnesota.cbslocal.com/2020/03/22/u-of-m-cardiac-anesthesia-fellow-creates-simple-cheaper-ventilator/\">University of Minnesota</a></span>, to see whether <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.webmd.com/drugs/2/drug-5482/hydroxychloroquine-oral/details\">hydroxychloroquine</a></span> can forestall or lessen the seriousness of COVID-19. Two different preliminaries are contemplating pulse medicate losartan as a potential treatment.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bloomberg.com/profile/company/NOVN:SW\">Novartis</a> </span>makes the jungle fever medicate, which is additionally used to treat lupus and rheumatoid joint inflammation, at its Sandoz unit in the United States. It intends to give 130 million portions of the medication and is in converses with U.S. Nourishment and Drug Administration controllers over growing its utilization for coronavirus.\r\n\r\n\"Novartis is supporting continuous clinical preliminary endeavors, and will assess requirements for extra clinical preliminaries,\" it said in an announcement.\r\n\r\nIn Washington, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.biography.com/us-president/donald-trump\">U.S. President Donald Trump</a></span> said during a news meeting on Friday he is idealistic about the jungle fever treatment\'s utilization against <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://swarajyamag.com/insta/covid-19-india-recommends-hydroxychloroquine-as-prophylaxis-for-healthcare-providers-patient-family-members\">COVID-19.</a></span>\r\n\r\nAnthony Fauci, chief of the U.S. National Institute of Allergy and Infectious Diseases, didn\'t disagree with Trump\'s confidence, yet said the medication\'s guarantee is put together so far with respect to episodic proof in France and that more information is required.\r\n\r\n\"I\'m stating that it may - it may - be successful. I\'m not saying that it isn\'t,\" Fauci said.\r\n\r\nFauci additionally said that while poisonous responses to the medications are uncommon dependent on many years of patient utilize and can be reversible much of the time, that isn\'t known for COVID-19.\r\n\r\n\"What we don\'t know is the point at which you put it with regards to another malady whether it\'s protected. In a general sense, I think it most likely will be protected, however I like to demonstrate things first,\" Fauci said.\r\n\r\nNovartis has 50 million dosages in stock, and would like to create another 80 million before the finish of May for gift. The gifts might be adequate to treat a few million patients, contingent upon the dosing routine, Novartis said.\r\n\r\nThe American Society of Health-System Pharmacists (ASHP), added hydroxychloroquine to its rundown of medications hard to come by this week. Four out of eight makers of the medication are hard to come by, it said.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.bloomberg.com/profile/company/BAYN:GR\">Bayer AG</a></span> has given 3,000,000 tablets of the jungle fever tranquilize Resochin, which is like hydroxychloroquine, to the U.S. government for potential use against coronavirus.\r\n\r\n<a href=\"https://www.forbes.com/companies/mylan/#5b82fa391126\"><span style=\"color: #ff6600;\">Mylan</span></a> NV is increase creation and hopes to start providing it all the more comprehensively in mid-April. It said with the crude materials available it can make 50 million tablets to possibly treat more than 1.5 million patients.\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://tevapharm.com/\">Teva Pharmaceuticals Industries Ltd</a></span> said it would give in excess of 6,000,000 portions of hydroxychloroquine sulfate tablets.','Novartis to give malaria drug in battle against coronavirus','','inherit','closed','closed','','4509-revision-v1','','','2020-03-23 11:07:39','2020-03-23 11:07:39','',4509,'https://microbiozindia.com/uncategorized/4509-revision-v1/',0,'revision','',0),(4512,2,'2020-03-23 15:12:05','2020-03-23 15:12:05','A quarter of a year into the novel coronavirus pandemic, it\'s as yet hazy which medications could battle the viral infection and which won\'t — notwithstanding open figures like President Donald Trump lauding the problematic guarantee of certain meds. With general wellbeing on the line, mainstream researchers is scanning for answers quicker than any time in recent memory.\r\n\r\nAt the point when the novel coronavirus tore through China in January and February, specialists and specialists immediately propelled many clinical preliminaries to test existing meds against <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cbsnews.com/live-updates/coronavirus-disease-covid-19-latest-news-deaths-2020-03-23/\">COVID-19,</a> </span>the sickness brought about by the novel coronavirus. In any case, the examination done as such far in China hasn\'t created enough information for indisputable answers.\r\n\r\n\"We compliment the specialists around the globe who have met up to fundamentally assess test therapeutics,\" said Tedros Adhanom, executive general of the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.youtube.com/channel/UC07-dOwgza1IguKA86jqxNA\">World Health Organization (WHO)</a></span>, in a press preparation. \"Various little preliminaries with various strategies may not give us the reasonable, solid proof we need about which medicines help to spare lives.\"\r\n\r\nIn their battle for \"clear, solid proof,\" the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.youtube.com/channel/UC07-dOwgza1IguKA86jqxNA\">WHO</a></span> is propelling a multicountry clinical preliminary to test four medication regimens as <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cbsnews.com/live-updates/coronavirus-disease-covid-19-latest-news-deaths-2020-03-23/\">COIVD-19</a></span> treatments: an exploratory antiviral medication called remdesivir, the antimalarial sedate chloroquine (or the related hydroxychloroquine), a mix of two HIV drugs, and those equivalent two HIV tranquilizes alongside the mitigating interferon beta.\r\n\r\nThe preliminary will be adaptable and could include or drop extra treatment approaches or areas after some time. In that manner, it seems, by all accounts, to be like the versatile preliminary that the National Institute of Allergy and Infectious Diseases began in the US in February, which at first set out to test remdesivir yet could extend to different medications. The US isn\'t as of now engaged with the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.youtube.com/channel/UC07-dOwgza1IguKA86jqxNA\">WHO</a></span> preliminary.\r\n\r\nSeveral other clinical preliminaries are in progress, and different gatherings additionally keep on testing the prescriptions that the WHO chose — here\'s a breakdown of a portion of the medications that analysts are focusing in on.\r\n\r\nCHLOROQUINE AND HYDROXYCHLOROQUINE\r\n\r\nStudies found that hydroxychloroquine and the related chloroquine can prevent the novel coronavirus from tainting in cells in the lab, and narrative proof recommends that it might assist patients with <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19.</a></span> Since the medication has been around for a considerable length of time as an antimalarial treatment, researchers have involvement in it.\r\n\r\n\"It\'s a known medication,\" says Caleb Skipper, an irresistible infection postdoctoral individual at the University of Minnesota who\'s taking a shot at a littler preliminary of the medication. \"Little blips of lab information in the course of the most recent quite a long while show this medication has action against infections.\"\r\n\r\nCaptain\'s preliminary is hoping to check whether hydroxychloroquine can forestall individuals who are presented to the infection from creating serious illness. They\'re planning to enroll medicinal services laborers, who are at a high danger of presentation to the infection, to take an interest in the preliminary.','Researchers are hustling to locate the best medications to treat COVID-19','','publish','open','open','','researchers-are-hustling-to-locate-the-best-medications-to-treat-covid-19','','','2020-03-23 15:12:05','2020-03-23 15:12:05','',0,'https://microbiozindia.com/?p=4512',0,'post','',0),(4513,2,'2020-03-23 15:08:18','2020-03-23 15:08:18','','jiynqhmepAMTcHD7y58r8Z','','inherit','open','closed','','jiynqhmepamtchd7y58r8z','','','2020-03-23 15:08:18','2020-03-23 15:08:18','',4512,'https://microbiozindia.com/wp-content/uploads/2020/03/jiynqhmepAMTcHD7y58r8Z.jpg',0,'attachment','image/jpeg',0),(4514,2,'2020-03-23 15:12:05','2020-03-23 15:12:05','A quarter of a year into the novel coronavirus pandemic, it\'s as yet hazy which medications could battle the viral infection and which won\'t — notwithstanding open figures like President Donald Trump lauding the problematic guarantee of certain meds. With general wellbeing on the line, mainstream researchers is scanning for answers quicker than any time in recent memory.\r\n\r\nAt the point when the novel coronavirus tore through China in January and February, specialists and specialists immediately propelled many clinical preliminaries to test existing meds against <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cbsnews.com/live-updates/coronavirus-disease-covid-19-latest-news-deaths-2020-03-23/\">COVID-19,</a> </span>the sickness brought about by the novel coronavirus. In any case, the examination done as such far in China hasn\'t created enough information for indisputable answers.\r\n\r\n\"We compliment the specialists around the globe who have met up to fundamentally assess test therapeutics,\" said Tedros Adhanom, executive general of the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.youtube.com/channel/UC07-dOwgza1IguKA86jqxNA\">World Health Organization (WHO)</a></span>, in a press preparation. \"Various little preliminaries with various strategies may not give us the reasonable, solid proof we need about which medicines help to spare lives.\"\r\n\r\nIn their battle for \"clear, solid proof,\" the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.youtube.com/channel/UC07-dOwgza1IguKA86jqxNA\">WHO</a></span> is propelling a multicountry clinical preliminary to test four medication regimens as <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cbsnews.com/live-updates/coronavirus-disease-covid-19-latest-news-deaths-2020-03-23/\">COIVD-19</a></span> treatments: an exploratory antiviral medication called remdesivir, the antimalarial sedate chloroquine (or the related hydroxychloroquine), a mix of two HIV drugs, and those equivalent two HIV tranquilizes alongside the mitigating interferon beta.\r\n\r\nThe preliminary will be adaptable and could include or drop extra treatment approaches or areas after some time. In that manner, it seems, by all accounts, to be like the versatile preliminary that the National Institute of Allergy and Infectious Diseases began in the US in February, which at first set out to test remdesivir yet could extend to different medications. The US isn\'t as of now engaged with the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.youtube.com/channel/UC07-dOwgza1IguKA86jqxNA\">WHO</a></span> preliminary.\r\n\r\nSeveral other clinical preliminaries are in progress, and different gatherings additionally keep on testing the prescriptions that the WHO chose — here\'s a breakdown of a portion of the medications that analysts are focusing in on.\r\n\r\nCHLOROQUINE AND HYDROXYCHLOROQUINE\r\n\r\nStudies found that hydroxychloroquine and the related chloroquine can prevent the novel coronavirus from tainting in cells in the lab, and narrative proof recommends that it might assist patients with <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019\">COVID-19.</a></span> Since the medication has been around for a considerable length of time as an antimalarial treatment, researchers have involvement in it.\r\n\r\n\"It\'s a known medication,\" says Caleb Skipper, an irresistible infection postdoctoral individual at the University of Minnesota who\'s taking a shot at a littler preliminary of the medication. \"Little blips of lab information in the course of the most recent quite a long while show this medication has action against infections.\"\r\n\r\nCaptain\'s preliminary is hoping to check whether hydroxychloroquine can forestall individuals who are presented to the infection from creating serious illness. They\'re planning to enroll medicinal services laborers, who are at a high danger of presentation to the infection, to take an interest in the preliminary.','Researchers are hustling to locate the best medications to treat COVID-19','','inherit','closed','closed','','4512-revision-v1','','','2020-03-23 15:12:05','2020-03-23 15:12:05','',4512,'https://microbiozindia.com/uncategorized/4512-revision-v1/',0,'revision','',0),(4515,2,'2020-03-23 17:44:56','2020-03-23 17:44:56','Pune-based sub-atomic diagnostics organization Mylab Discovery Solutions Pvt Ltd, which spends significant time in sub-atomic analytic units has grown originally made-in-India test pack for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a> </span>of every a record time of about a month and a half. The unit - Mylab PathoDetect <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a></span> Qualitative PCR pack - is the first to get business endorsement from the Indian FDA/Central Drugs Standard Control Organization (CDSCO). Furthermore, Mylab is the main Indian organization to have accomplished 100 percent affectability and particularity in the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Council_of_Medical_Research\">ICMR</a></span> assessment.\r\n\r\n\"With accentuation on \'Make in India\' and backing from neighborhood and focal government, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a></span> pack has been made according to WHO/CDC rules. It was created and assessed in a record time,\" Hasmukh Rawal, Managing Director, Mylab Discovery Solutions said. He further included that the help and the prompt activity from administrative bodies (CDSCO/FDA), assessment focal point of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Council_of_Medical_Research\">ICMR</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/National_Institute_of_Virology\">NIV</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.birac.nic.in/\">Biotechnology Industry Research Assistance Council (BIRAC)</a></span> and the focal and state governments during this national crisis is estimable.\r\n\r\nMylab has quite a long while of involvement with assembling RTPCR units. It fabricates a scope of units at the office affirmed by Indian FDA/CDSCO and is agreeable with MDR 2017 guideline for assembling clinical gadgets of Class C and D, the most stringent and controlled items by the legislature. Mylab at present makes ID-NAT screening packs for blood donation centers/medical clinics, Quantitative HIV, HBV and HCV units. Mylab has likewise gotten freedom from Drugs Controller General of India (DCGI) to produce the COVID-19 Qualitative pack, in a similar office. The Mylab <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a></span> pack had been assessed at the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Council_of_Medical_Research\">Indian Council of Medical Research (ICMR).</a></span>\r\n\r\n\"We have been making a decent attempt to make front line innovation accessible to our nation at a sensible and moderate cost. Since this test depends on the touchy PCR innovation, even beginning period disease can be recognized, with most elevated precision as has been seen during tests at ICMR. The <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Council_of_Medical_Research\">ICMR</a></span> tried, CDSCO affirmed unit makes location quicker as well,\" said Shailendra Kawade, Executive Director at Mylab.\r\n\r\nAs of now, India positions most reduced as far as testing done per million populace. The number is as low as 6.8. Nations like South Korea and Singapore have had the option to contain the developing number of Coronavirus cases by improving the quantity of testing.\r\n\r\nSo far the Indian government has been sourcing a huge number of testing packs from Germany to encourage testing to analyze Coronavirus patients PAN-India. In any case, the reliance on outside units has been problematic and supply is getting obstructed due to grounded aircrafts. This can change with the endorsement for made in India packs.\r\n\r\nMylab guaranteed that it can fabricate up to 1 lakh tests in seven days that can be additionally scaled up if necessary. Further, the organization guarantees that its test units can test around 100 patients with one pack. A normal lab with mechanized PCR can test in excess of 1000 patients per day.\r\n\r\nWith neighborhood sourcing of test packs, it will be a leap forward for India as the testing unit by Mylab would cost about one-fourth of the present acquisition cost. In addition, Mylab PathoDetect <a href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\"><span style=\"color: #ff6600;\">COVID-19</span></a> Qualitative PCR pack screens and distinguishes the contamination inside 2.5 hours, contrasted with seven or more hours taken by current conventions. This implies research centers will have the option to do double the quantity of responses simultaneously on one machine.\r\n\r\nThe Mylab fabricating office, affirmed by FDA/CDSCO is consistent with MDR 2017 guideline for Manufacturing Medical Device of Class A, B, C and D and ISO 13485: 2016 affirmation.','First Made-in-India COVID-19 test pack by Mylab gets business endorsement','','publish','open','open','','first-made-in-india-covid-19-test-pack-by-mylab-gets-business-endorsement','','','2020-03-24 12:57:10','2020-03-24 12:57:10','',0,'https://microbiozindia.com/?p=4515',0,'post','',0),(4516,2,'2020-03-23 17:33:36','2020-03-23 17:33:36','','ggg','','inherit','open','closed','','ggg-4','','','2020-03-23 17:33:36','2020-03-23 17:33:36','',4515,'https://microbiozindia.com/wp-content/uploads/2020/03/ggg.png',0,'attachment','image/png',0),(4517,2,'2020-03-23 17:44:56','2020-03-23 17:44:56','Pune-based sub-atomic diagnostics organization <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://mylabdiscoverysolutions.com/\">Mylab Discovery Solutions Pvt Ltd,</a></span> which spends significant time in sub-atomic analytic units has grown originally made-in-India test pack for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a> </span>of every a record time of about a month and a half. The unit - Mylab PathoDetect <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a></span> Qualitative PCR pack - is the first to get business endorsement from the Indian FDA/Central Drugs Standard Control Organization (CDSCO). Furthermore, Mylab is the main Indian organization to have accomplished 100 percent affectability and particularity in the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Council_of_Medical_Research\">ICMR</a></span> assessment.\r\n\r\n\"With accentuation on \'Make in India\' and backing from neighborhood and focal government, the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a></span> pack has been made according to WHO/CDC rules. It was created and assessed in a record time,\" Hasmukh Rawal, Managing Director, Mylab Discovery Solutions said. He further included that the help and the prompt activity from administrative bodies (CDSCO/FDA), assessment focal point of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Council_of_Medical_Research\">ICMR</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/National_Institute_of_Virology\">NIV</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.birac.nic.in/\">Biotechnology Industry Research Assistance Council (BIRAC)</a></span> and the focal and state governments during this national crisis is estimable.\r\n\r\nMylab has quite a long while of involvement with assembling RTPCR units. It fabricates a scope of units at the office affirmed by Indian FDA/CDSCO and is agreeable with MDR 2017 guideline for assembling clinical gadgets of Class C and D, the most stringent and controlled items by the legislature. Mylab at present makes ID-NAT screening packs for blood donation centers/medical clinics, Quantitative HIV, HBV and HCV units. Mylab has likewise gotten freedom from Drugs Controller General of India (DCGI) to produce the COVID-19 Qualitative pack, in a similar office. The Mylab <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\">COVID-19</a></span> pack had been assessed at the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Council_of_Medical_Research\">Indian Council of Medical Research (ICMR).</a></span>\r\n\r\n\"We have been making a decent attempt to make front line innovation accessible to our nation at a sensible and moderate cost. Since this test depends on the touchy PCR innovation, even beginning period disease can be recognized, with most elevated precision as has been seen during tests at ICMR. The <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://en.wikipedia.org/wiki/Indian_Council_of_Medical_Research\">ICMR</a></span> tried, CDSCO affirmed unit makes location quicker as well,\" said Shailendra Kawade, Executive Director at Mylab.\r\n\r\nAs of now, India positions most reduced as far as testing done per million populace. The number is as low as 6.8. Nations like South Korea and Singapore have had the option to contain the developing number of Coronavirus cases by improving the quantity of testing.\r\n\r\nSo far the Indian government has been sourcing a huge number of testing packs from Germany to encourage testing to analyze Coronavirus patients PAN-India. In any case, the reliance on outside units has been problematic and supply is getting obstructed due to grounded aircrafts. This can change with the endorsement for made in India packs.\r\n\r\nMylab guaranteed that it can fabricate up to 1 lakh tests in seven days that can be additionally scaled up if necessary. Further, the organization guarantees that its test units can test around 100 patients with one pack. A normal lab with mechanized PCR can test in excess of 1000 patients per day.\r\n\r\nWith neighborhood sourcing of test packs, it will be a leap forward for India as the testing unit by Mylab would cost about one-fourth of the present acquisition cost. In addition, Mylab PathoDetect <a href=\"https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen\"><span style=\"color: #ff6600;\">COVID-19</span></a> Qualitative PCR pack screens and distinguishes the contamination inside 2.5 hours, contrasted with seven or more hours taken by current conventions. This implies research centers will have the option to do double the quantity of responses simultaneously on one machine.\r\n\r\nThe Mylab fabricating office, affirmed by FDA/CDSCO is consistent with MDR 2017 guideline for Manufacturing Medical Device of Class A, B, C and D and ISO 13485: 2016 affirmation.','First Made-in-India COVID-19 test pack by Mylab gets business endorsement','','inherit','closed','closed','','4515-revision-v1','','','2020-03-23 17:44:56','2020-03-23 17:44:56','',4515,'https://microbiozindia.com/uncategorized/4515-revision-v1/',0,'revision','',0),(4518,2,'2020-03-24 11:58:51','2020-03-24 11:58:51','Indeed, even as the coronavirus flare-up overwhelms the world, various different illnesses are additionally popping up.\r\n\r\nInstances of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.nhs.uk/conditions/swine-flu/\">swine flu</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.healthline.com/health/avian-influenza\">bird flu</a></span> have just been accounted for in India and different nations. Presently, a man from China has tried positive for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mayoclinic.org/diseases-conditions/hantavirus-pulmonary-syndrome/symptoms-causes/syc-20351838\">hantavirus.</a></span>\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.globaltimes.cn/index.html\">China\'s Global Times</a></span> tweeted that the man from Yunnan Province kicked the bucket while on his way back to Shandong Province for take a shot at a transport on Monday. The 32 others on the transport were likewise tried for the infection.\r\n\r\nAs indicated by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/vaccine_safety/initiative/communication/network/nip/en/\">Centers for Disease Control and Prevention (CDC),</a> <a style=\"color: #ff6600;\" href=\"https://www.mayoclinic.org/diseases-conditions/hantavirus-pulmonary-syndrome/symptoms-causes/syc-20351838\">hantaviruses</a></span> are a group of infections which are spread for the most part by rodents and can cause shifted illnesses in individuals.\r\n\r\nIt can cause hantavirus pneumonic disorder (HPS) and haemorrhagic fever with renal disorder (HFRS).\r\n\r\nThe infection isn\'t airborne and can possibly spread to individuals on the off chance that they interact with pee, excrement, and salivation of rodents and less every now and again by a nibble\r\n\r\n<strong>Symptoms of hantavirus</strong>\r\n\r\nEarly symptoms of HPS incorporate weakness, fever, and muscle throbs, alongside migraines, tipsiness, chills and stomach issues. Whenever left untreated, it can prompt hacking and brevity of breath and can be lethal, with a death pace of 38 percent, as indicated by CDC.\r\n\r\nWhile the underlying indications of HFRS too continue as before, it can cause low circulatory strain, intense stun, vascular spillage, and intense kidney disappointment.\r\n\r\nHPS can\'t be given from individual to individual, while HFRS transmission between individuals is incredibly uncommon.\r\n\r\nAccording to the CDC, rat populace control is the essential methodology for forestalling hantavirus diseases.','Man Killed by Hantavirus in China:All you have to think about the infection,and how it spreads','','publish','open','open','','man-killed-by-hantavirus-in-china-all-you-have-to-think-about-the-infection-and-how-it-spreads','','','2020-03-24 12:55:05','2020-03-24 12:55:05','',0,'https://microbiozindia.com/?p=4518',0,'post','',0),(4519,2,'2020-03-24 11:54:54','2020-03-24 11:54:54','','mouse','','inherit','open','closed','','mouse','','','2020-03-24 11:54:54','2020-03-24 11:54:54','',4518,'https://microbiozindia.com/wp-content/uploads/2020/03/mouse.jpg',0,'attachment','image/jpeg',0),(4520,2,'2020-03-24 11:58:51','2020-03-24 11:58:51','Indeed, even as the coronavirus flare-up overwhelms the world, various different illnesses are additionally popping up. Instances of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://wgntv.com/news/coronavirus/what-the-swine-flu-pandemic-can-teach-us-bout-covid-19/\">swine flu</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.healthline.com/health/avian-influenza\">bird flu</a></span> have just been accounted for in India and different nations. Presently, a man from China has tried positive for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cdc.gov/hantavirus/index.html\">hantavirus.</a></span>\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.globaltimes.cn/index.html\">China\'s Global Times</a></span> tweeted that the man from Yunnan Province kicked the bucket while on his way back to Shandong Province for take a shot at a transport on Monday. The 32 others on the transport were likewise tried for the infection.\r\n\r\nAs indicated by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/vaccine_safety/initiative/communication/network/nip/en/\">Centers for Disease Control and Prevention (CDC)</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cdc.gov/hantavirus/index.html\">hantaviruses</a> </span>are a group of infections which are spread for the most part by rodents and can cause shifted illnesses in individuals.\r\n\r\nIt can cause hantavirus pneumonic disorder (HPS) and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mayoclinic.org/diseases-conditions/viral-hemorrhagic-fevers/symptoms-causes/syc-20351260\">haemorrhagic fever</a></span> with renal disorder (HFRS).\r\n\r\nThe infection isn\'t airborne and can possibly spread to individuals on the off chance that they interact with pee, excrement, and salivation of rodents and less every now and again by a nibble\r\n\r\n<strong>Symptoms of hantavirus</strong>\r\n\r\nEarly manifestations of HPS incorporate weakness, fever, and muscle throbs, alongside migraines, tipsiness, chills and stomach issues. Whenever left untreated, it can prompt hacking and brevity of breath and can be lethal, with a death pace of 38 percent, as indicated by CDC.\r\n\r\nWhile the underlying indications of HFRS too continue as before, it can cause low circulatory strain, intense stun, vascular spillage, and intense kidney disappointment.\r\n\r\nHPS can\'t be given from individual to individual, while HFRS transmission between individuals is incredibly uncommon.\r\n\r\nAccording to the CDC, rat populace control is the essential methodology for forestalling hantavirus diseases.','Man Killed by Hantavirus in China :All you have to think about the infection, and how it spreads','','inherit','closed','closed','','4518-revision-v1','','','2020-03-24 11:58:51','2020-03-24 11:58:51','',4518,'https://microbiozindia.com/uncategorized/4518-revision-v1/',0,'revision','',0),(4521,2,'2020-03-24 11:59:35','2020-03-24 11:59:35','Indeed, even as the coronavirus flare-up overwhelms the world, various different illnesses are additionally popping up. Instances of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://wgntv.com/news/coronavirus/what-the-swine-flu-pandemic-can-teach-us-bout-covid-19/\">swine flu</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.healthline.com/health/avian-influenza\">bird flu</a></span> have just been accounted for in India and different nations. Presently, a man from China has tried positive for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cdc.gov/hantavirus/index.html\">hantavirus.</a></span>\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.globaltimes.cn/index.html\">China\'s Global Times</a></span> tweeted that the man from Yunnan Province kicked the bucket while on his way back to Shandong Province for take a shot at a transport on Monday. The 32 others on the transport were likewise tried for the infection.\r\n\r\nAs indicated by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/vaccine_safety/initiative/communication/network/nip/en/\">Centers for Disease Control and Prevention (CDC)</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cdc.gov/hantavirus/index.html\">hantaviruses</a> </span>are a group of infections which are spread for the most part by rodents and can cause shifted illnesses in individuals.\r\n\r\nIt can cause hantavirus pneumonic disorder (HPS) and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mayoclinic.org/diseases-conditions/viral-hemorrhagic-fevers/symptoms-causes/syc-20351260\">haemorrhagic fever</a></span> with renal disorder (HFRS).\r\n\r\nThe infection isn\'t airborne and can possibly spread to individuals on the off chance that they interact with pee, excrement, and salivation of rodents and less every now and again by a nibble\r\n\r\n<strong>Symptoms of hantavirus</strong>\r\n\r\nEarly manifestations of HPS incorporate weakness, fever, and muscle throbs, alongside migraines, tipsiness, chills and stomach issues. Whenever left untreated, it can prompt hacking and brevity of breath and can be lethal, with a death pace of 38 percent, as indicated by CDC.\r\n\r\nWhile the underlying indications of HFRS too continue as before, it can cause low circulatory strain, intense stun, vascular spillage, and intense kidney disappointment.\r\n\r\nHPS can\'t be given from individual to individual, while HFRS transmission between individuals is incredibly uncommon.\r\n\r\nAccording to the CDC, rat populace control is the essential methodology for forestalling hantavirus diseases.','Man Killed by Hantavirus in China:All you have to think about the infection, and how it spreads','','inherit','closed','closed','','4518-revision-v1','','','2020-03-24 11:59:35','2020-03-24 11:59:35','',4518,'https://microbiozindia.com/uncategorized/4518-revision-v1/',0,'revision','',0),(4522,2,'2020-03-24 12:02:46','2020-03-24 12:02:46','','AAA','','inherit','open','closed','','aaa-13','','','2020-03-24 12:02:46','2020-03-24 12:02:46','',4518,'https://microbiozindia.com/wp-content/uploads/2020/03/AAA-4.png',0,'attachment','image/png',0),(4523,2,'2020-03-24 12:03:31','2020-03-24 12:03:31','Indeed, even as the coronavirus flare-up overwhelms the world, various different illnesses are additionally popping up.\r\n\r\nInstances of <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://wgntv.com/news/coronavirus/what-the-swine-flu-pandemic-can-teach-us-bout-covid-19/\">swine flu</a></span> and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.healthline.com/health/avian-influenza\">bird flu</a></span> have just been accounted for in India and different nations. Presently, a man from China has tried positive for <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cdc.gov/hantavirus/index.html\">hantavirus.</a></span>\r\n\r\n<span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.globaltimes.cn/index.html\">China\'s Global Times</a></span> tweeted that the man from Yunnan Province kicked the bucket while on his way back to Shandong Province for take a shot at a transport on Monday. The 32 others on the transport were likewise tried for the infection.\r\n\r\nAs indicated by the <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.who.int/vaccine_safety/initiative/communication/network/nip/en/\">Centers for Disease Control and Prevention (CDC)</a></span>, <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.cdc.gov/hantavirus/index.html\">hantaviruses</a> </span>are a group of infections which are spread for the most part by rodents and can cause shifted illnesses in individuals.\r\n\r\nIt can cause hantavirus pneumonic disorder (HPS) and <span style=\"color: #ff6600;\"><a style=\"color: #ff6600;\" href=\"https://www.mayoclinic.org/diseases-conditions/viral-hemorrhagic-fevers/symptoms-causes/syc-20351260\">haemorrhagic fever</a></span> with renal disorder (HFRS).\r\n\r\nThe infection isn\'t airborne and can possibly spread to individuals on the off chance that they interact with pee, excrement, and salivation of rodents and less every now and again by a nibble\r\n\r\n<strong>Symptoms of hantavirus</strong>\r\n\r\nEarly manifestations of HPS incorporate weakness, fever, and muscle throbs, alongside migraines, tipsiness, chills and stomach issues. Whenever left untreated, it can prompt hacking and brevity of breath and can be lethal, with a death pace of 38 percent, as indicated by CDC.\r\n\r\nWhile the underlying indications of HFRS too continue as before, it can cause low circulatory strain, intense stun, vascular spillage, and intense kidney disappointment.\r\n\r\nHPS can\'t be given from individual to individual, while HFRS transmission between individuals is incredibly uncommon.\r\n\r\nAccording to the CDC, rat populace control is the essential methodology for forestalling hantavirus diseases.','Man Killed by Hantavirus in China:All you have to think about the infection, and how it spreads','','inherit','closed','closed','','4518-revision-v1','','','2020-03-24 12:03:31','2020-03-24 12:03:31','',4518,'https://microbiozindia.com/uncategorized/4518-revision-v1/',0,'revision','',0),